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 Abstract 
Background 
Case fatality in African children with severe acute malnutrition (SAM) remains high 
despite implementation of WHO management guidelines.  Many deaths occur suddenly 
and unexpectedly leading to speculation about sudden cardiac death. Fluid therapy 
remains controversial since SAM children are thought to be at high risk of cardiac failure. 
The evidence base for these recommendations is limited. We conducted a systematic 
review of the literature on cardiac function in severe malnutrition, and a comprehensive 
prospective observational study of Cardiac Physiology in Malnutrition (The CAPMAL 
Study).  
Methods 
Eighty-eight hospitalised Kenyan children with SAM were prospectively recruited and a 
detailed cardiovascular profiling including clinical, biochemical, echocardiographic and 
electrocardiographic assessment at admission, during nutritional rehabilitation, and at 
28-day follow-up was undertaken.  The findings were compared with a group of non-
malnourished hospital controls (n=22), frequency matched by age, gender and 
presenting clinical syndrome.  
Results 
Little evidence was found of clinically significant cardiac failure among children with 
SAM, including those who received intravenous fluids. Echocardiography indicated that 
cardiac dysfunction was common but typically associated with underlying comorbidities 
such as sepsis and HIV. We also found increased SVRI, which was negatively correlated 
with the severity of malnutrition. We did not find strong evidence that children with 
SAM were more likely to have cardiac dysfunction or arrhythmias than matched 
controls, or that the cardiovascular profile of marasmus differed from kwashiorkor.  
Conclusions 
Clinical cardiac failure and sudden death from arrhythmias were not common among 
children in our study. The appropriate physiological response observed to IV fluids 
suggests they may be better tolerated than current guidelines suggest. Further studies 
are urgently needed to define optimal IV fluid regimens for children with SAM and shock 
and to investigate the role of increased systemic vascular resistance on gut perfusion 
and myocardial wall stress. 
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1 Introduction  
1.1 Malnutrition: a major cause of childhood illness, disability and death globally  Undernutrition is a major public health problem worldwide and its reduction (halving the proportion of population affected by 2015), was made one of the United Nations Millennium Development Goals (MDG) in 2000.1 It is estimated that 100 million children in the developing world are underweight. In 2010 this translated to a prevalence in developing countries of 17.9% of those under 5 years old.  It is projected to continuously fall in most regions apart from Africa, where the HIV epidemic, as well as social and political instability, are responsible for the projected increase in prevalence. 2-4 
Figure 1.1 The world’s territories shown in proportion to the percentage of “underweight” children 
(www.worldmapper.org) 
 Long-term effects of early childhood malnutrition include impaired cognitive development and fine motor skills, behavioural problems, and poorer socioeconomic outcomes in adulthood,5-7 leading to a vicious cycle of poverty and inequality from one generation to the next. Malnutrition has also been implicated in more than half of the 7.6 million deaths 8 of children under the age of five - “a proportion unmatched by any infectious disease since the Black Death” (Jean-Louis Sarbib, 2006).9 Worldwide, it is estimated that 2.1 million children die annually as a direct consequence of malnutrition, which translates to 21% of deaths in children under the age of five years. 10 11 
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 1.2 Aetiology, pathophysiology and classification of severe malnutrition  Chronic undernutrition leads to stunted growth with or without wasting, while acute malnutrition causes wasting with or without oedema. All forms may overlap and be accompanied by micronutrient deficiencies. This thesis will focus on the cardiovascular consequences of severe malnutrition as defined by the World Health Organisation,12 which may present as marasmus (non-oedematous malnutrition) or kwashiorkor (oedematous malnutrition). 
1.2.1 Pathophysiology of malnutrition Although the causes for the nutritional insult may vary and go as far back as maternal undernutrition with subsequent intrauterine growth restriction, the effect of reduced energy supply is a slow down or halt in growth of the child (stunting) in order to preserve protein and energy for maintaining vital body functions. However, if the energy deficit exceeds the body’s demands, e.g. during an acute episode of illness or prolonged starvation, the energy balance cannot be maintained and wasting occurs. Why some malnourished children develop oedema (kwashiorkor), particularly in Africa, remains poorly understood. In the past it was thought that kwashiorkor resulted from an insufficient protein diet13 leading to low serum albumin levels, and was triggered by an infection. Over the last five decades however this view has been challenged and there are now two main hypotheses:14 15 16 a dysadaptation in protein metabolism;13 14 and/or anti-oxidant deficiency leading to damage of cellular membranes by stress-induced production of free-radicals during infection or toxin exposure.17-20 Antioxidant supplementation has been shown to promote faster rehabilitation in children with kwashiorkor and in other settings of critical illness.21 22 However, it remains unclear why, on a background of low antioxidant levels in children with kwashiorkor, a randomised controlled trial in Malawi by Ciliberto et al did not show any effect of an antioxidant cocktail on the prevention of kwashiorkor.23 One of the possible explanations therefore is the relatively small dose of antioxidants given in this trial.    
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 1.2.2 Clinical presentation In marasmus, visible severe emaciation, in absence of oedema, is due to an almost total loss of subcutaneous fat and gross muscle wasting. Kwashiorkor presents with acute onset of oedema, which may be peripheral (bipedal oedema) or generalized (anasarka) and accompanied by serous effusions. The abdomen is frequently distended due to low gastrointestinal motility and bacterial or parasitic overgrowth and hepatomegaly may be present. Hair and skin changes are common, including hypo- or hyper-pigmentation, and flaky patches that sometimes leave raw, exudative, burn-like areas. Children with kwashiorkor often appear listless, apathetic and irritable with loss of appetite and low mood. 
1.2.3 Definition and classification of malnutrition The severity and type of malnutrition is usually defined by anthropometric and/or clinical indices. Several classifications have been developed and used in the past, making comparisons between studies difficult.  Most commonly used are the Gomez (1956), Wellcome (1970), Waterlow (1976) and WHO classifications.12 24-26 All definitions use anthropometric indices that are compared to a reference population.  Data is either expressed as a percentage of the normal value, or as a multiple of the standard deviation from the reference mean, known as the z- score. The weight for height z-score (WHZs) is the weight relative to expected weight for a child of the same height and is used to define severe wasting (marasmus). WHO definitions also incorporate mean upper arm circumference (MUAC), a simple measure that has been shown to predict mortality better than any other anthropometric measure.27-33   The WHO defines severe acute malnutrition as severe wasting (WHZ score ≤ -3 or MUAC < 11.5 cm), and/or symmetrical oedema involving at least the feet (oedematous malnutrition, kwashiorkor). 33 Prior to 2006, reference population data from the US National Centre for Health Statistics (NCHS) were used. Following completion of the Multicentre Growth Reference Study (MGRS), which collected growth data on 8500 children from different ethnic backgrounds across 6 countries over 6 years,34 MGRS population data was adopted as the reference standard. At the same time the MUAC cut-off was changed from 11.0 cm to 11.5 cm since this better identified children as severely wasted.33 35 The new definitions predict mortality risk more accurately than previous cut-offs based on NCHS reference data.36 37 
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1.3 Management of severe malnutrition: strategies and challenges  The WHO has developed management guidelines for both outpatient and inpatient care of children with SM. These guidelines were developed by an expert committee largely nutritionists, with most of the recommendation based on professional opinion and data from observational studies.  The inpatient guidelines use a `10 steps` approach (Figure 1.2), and, despite their very different clinical presentations, recommend an identical approach for both marasmus and kwashiorkor.    
Figure 1.2 Ten steps for routine management of children with severe malnutrition recommended by 
the WHO and developed by Ashworth et al (1996)38  
 The greater part of the guideline focuses on treatment and prevention of acute medical conditions including hypoglycaemia, hypothermia, dehydration and infection during the initial stabilization phase; in parallel with nutritional and general rehabilitation. Other much shorter sections deal with “Emergency treatment of shock and severe anaemia”, “Treatment of associated conditions”, “Failure to respond to treatment” and “Discharge before recovery is complete”.  Although there has been a global decline in the overall prevalence of severe malnutrition associated with improved levels of primary health care and community awareness, there has been no concomitant improvement in survival even after careful implementation of the in-patient management guidelines, especially on the African contintent.39 Some experts contend that, with strict protocol adherence, mortality 
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 among children with severe malnutrition should be less than 5% and higher mortalities are due to faulty case management.40 41 Nevertheless, many centres have reported mortality rates that are still nowhere near the 5% target postulated by the WHO.42-45  The HIV epidemic has further exacerbated this situation in sub-Saharan Africa,46 where case fatality rates among children admitted to hospital with severe malnutrition frequently range from 20% to 50%.47 44 45 Poor feasibility, for example in providing 2-hourly feeds, may play a role in many settings where staffing is not adequate or children are motherless.48 A study in Malawi however demonstrated that even with intensive nursing care, and a nurse to child ratio of 1:3, overall survival could not be improved.49 In Kilifi, implementation of the WHO guidelines reduced the case fatality rate from over 30% to around 19%, where it has remained static, despite higher clinical staff to patient ratios and better resources than most district African hospitals.50 51 Furthermore, co- morbidities such as HIV, tuberculosis (TB), sepsis, severe diarrhoea and the re-feeding syndrome are all recognized complications of malnutrition which may contribute to the high early and late mortality.52 Whether the high mortality rates observed in African hospitals are therefore due to the nature of the severity of the illness or to faulty case management remains controversial. 42 48 Whatever the cause, reducing the mortality among this vulnerable group of children further, is likely to require a better understanding of the underlying causes and mechanisms of death in these children and might require different guidelines for the treatment of marasmus and kwashiorkor.  
 19 
  
1.4 The potential role of the heart as a cause of death in severe malnutrition Over many decades groups have tried to establish the proximate causes of death in children with malnutrition.50 51 53 Dehydration and electrolyte disturbances as well as hypoglycaemia and hypothermia, infections and excessive re-feeding were among the recognized causes, and their treatment formed the basis for the management guidelines discussed above.52 54 However it has also long been suspected that many deaths may have a cardiac cause, especially during early re-alimentation when large fluid and electrolyte shifts may occur.55 56 As children die suddenly and unexpectedly it has been postulated that myocardial dysfunction in the form of either cardiac arrhythmia or heart failure may be a leading cause, 57-60 particularly as many present with features of impaired perfusion.50 In Kilifi approximately 20% of children admitted with severe acute malnutrition (SAM) presented in shock (defined by using classical cardiovascular triage parameters such as capillary refill time, temperature gradient and pulse volume) or developed shock within the first 48 hours of admission.50 61 Bradycardia present at the time of triage was likewise found to be a high risk factor for death.50   The concern, that the heart is almost failing in children with malnutrition and mortalities are higher following intravenous fluid treatment,53 has great implications for the management guidelines, which consistently discourage the use of intravenous fluids in these children except in advanced stages of shock.46 62 However evidence supporting this is sparse and derived from mainly observational studies in children with kwashiorkor which do not link clinical status, physiological investigation and response to treatment in representative cohorts of children with severe malnutrition. Importantly, the potential role of common comorbidities such as sepsis, diarrhoea and hypovolaemia, electrolyte perturbations and HIV – all of which may independently affect cardiac function - has generally been neglected. This makes it difficult to attribute any cardiac impairment necessarily to malnutrition per se, and requires an understanding of how other causes of critical illness affect cardiac function.  
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1.5 Cardiac function in critical illness and malnutrition Cardiac function is a broad term that describes the heart’s capability to adequately perfuse and oxygenate tissue. It depends on the electrophysiological and haemodynamic properties of the heart. The latter can be quantified by cardiac output (CO), which is affected by a number of variables as shown in Figure 1.3 many of which are down-regulated in severe malnutrition.   
Figure 1.3 Overview of various factors influencing oxygen delivery and oxygen consumption 
developed by Tibby et al 2003  
 
   Critical illness can impair cardiac function through multiple mechanisms whose detailed explanation would exceed the scope of this thesis. Therefore, the following will focus on the impact of sepsis, hypovolaemia and electrolyte imbalances on cardiac function, as these are commonly found in children with malnutrition.50 51 55 63-66 
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1.5.1 Myocardial dysfunction in sepsis and critical illness Infections are common in children with malnutrition.67-71 In Kilifi, there is a high prevalence of bacteraemia among malnourished children at admission, with a high associated mortality.50 One third to one half of deaths in severe malnutrition occur within 48 hours of admission, with bacteraemia being present in 23%- 37% of these cases.50 61 The pathogenesis of myocardial dysfunction in sepsis is multi-factorial and involves micro- and macrocirculatory changes affecting the pre- and afterload; immunological responses; metabolic changes; oxidative stress; and impaired intracellular calcium currents.72-74 Myocardial depressant factors such as IL-6, TNF-a and IL1-b have been shown to impair cardiac function in septic patients by reducing the intrinsic contractility of cardiomyocytes, 74-76 thereby reducing cardiac output. Cellular mechanisms underlying the cytokine-mediated cardiomyopathy in sepsis are not totally understood but nitric oxide production, impaired intracellular calcium homeostasis, oxidation reduction imbalance and altered respiratory chain activities may all play a role. 75  Furthermore, circulating thyroid hormone levels are reduced in critical illness. Characteristically there are low serum levels of free and total triiodothyronine (T3) and high levels of reverse T3 (rT3), in the presence of normal or low thyroxine (T4) and thyroid-stimulating hormone (TSH) – referred to as “euthyroid sick syndrome” or non-thyroidal illness syndrome (NTIS). This is associated with adverse outcomes in patients requiring intensive care treatment.77 The lack of negative feedback regulation (reduced thyroid hormones in the absence of TSH or TRH increase) may, it is suggested, be an adaptive response to the body during the catabolic state in severe illness and this might be an element of the acute phase response.78 Thyroid hormones have a direct effect on cardiomyocytes. T3 affects the expression of specific genes that participate in cardiac contraction. Therefore, a lack of T3 results in reduced myocardial contractility and prolongation of the diastolic relaxation phase. Furthermore, T3 causes relaxation of the vascular smooth muscle and therefore directly regulates vascular resistance and hence afterload. 77 79 80 Both effects reduce cardiac output if levels of T3 are low.  
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1.5.2 Cardiac function and hypovolaemia The amount of blood ejected with each heart beat (stroke volume) gives information about the global ventricular performance. The resulting cardiac output depends on various factors (Figure 1.3) including preload, which, in the isolated muscle strip model relates to the end-diastolic fibre length. A surrogate marker for fibre length is the end- diastolic volume. The Frank Starling Law describes, that the stroke volume of the heart increases in response to an increased end-diastolic volume (filling). The stretching of the muscle fibres enhances contractility of the myocardium and cardiac output increases (see Figure 1.4).  However, once the stretch of the myofibrils has exceeded their optimal length, any further increase in end diastolic volume results in a decrease in stroke volume, indicated by the downward slope of the Frank Starling curve. This is usually associated with a decrease in contractility, suggesting the ventricle is failing.81 Cardiac output can be impaired by hypovolaemia, which occurs in sepsis as well as in dehydrating diarrhoea. Severe dehydrating diarrhoea and hypovolaemia are common in Kilifi,50 51 Hypovolaemia leads to a reduction of the preload, which impacts on the heart’s ability to contract via the Frank-Starling mechanism.   
Figure 1.4 Frank Starling Curve1  
 
1 The diagram shows that the stroke volume increases in response to an increased filling of the heart (preload) 
until a maximum is reached which is defined as an optimal stretch in myocardial fibre sarcomeres. Any further 
increase leads to a decrease in contractility and therefore a decrease of the stroke volume, which usually causes 
signs of clinical heart failure. 
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1.5.3 Effects of electrolyte abnormalities on the heart  Electrolyte abnormalities are also a common feature among children admitted with severe malnutrition.65 82-84 Main alterations reported are excess total body sodium and a diminished total body potassium concentration.  Through a complicated hormonal mechanism, chronic starvation leads eventually to a reduced energy metabolism with subsequent reduction of cardiac output, which is driven by the decrease in oxygen demand.85 This is further impaired by the intravascular depletion following fluid shifts into the extracellular compartment caused by hypoalbuminaemia. The reduced cardiac output impairs glomerular filtration rate and results in a reduction of filtered sodium and water. The intravascular depletion in parallel stimulates aldosterone secretion, which in turn increases renal tubular sodium reabsorption. Both increased sodium absorption and reduced sodium filtration, as well as disproportionate losses in body structures,66 contribute to the excess of total body sodium and expansion of the extracellular space. Extracellular sodium concentration therefore appears to be low due to the increased extracellular space (dilution effect), and as a consequence of an impaired Na K ATPase activity, which is altered following decreased energy metabolism.  Potassium is mainly stored in muscle, hence total body depletion correlates directly with lean body mass. Furthermore, magnesium, calcium and phosphate levels are subnormal in malnutrition.65 84 These alterations are made worse by electrolyte losses through diarrhoea; or during early re-alimentation, when the development of the re-feeding syndrome can pose further challenges for clinicians managing the child with malnutrition in a low resource setting, starting with the inability to measure certain electrolytes to managing the acute clinical deteriorations.52  The re-feeding syndrome is a potentially fatal complication that can present as a constellation of cardiovascular, pulmonary, hepatic, renal, neuromuscular, metabolic and haematologic abnormalities during the nutritional rehabilitation following a period of prolonged catabolism. 86 87 It almost always develops during the early stages of re-alimentation, when a shift from fat to carbohydrate metabolism occurs. The glucose load stimulates secretion of insulin, which in turn leads to an increased cellular uptake of 
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 glucose, phosphate, potassium, magnesium, water and protein synthesis. Any or all of these electrolyte disturbances may affect the electrophysiological properties of the heart causing cardiac dysfunction or fatal arrhythmias 87 89 – which could explain the sudden unexplained death of some children with severe malnutrition. 59 90 However, there are no data on the incidence of re-feeding syndrome in African children with malnutrition (most published descriptions relate to acutely malnourished children in intensive care settings91). Nevertheless there is a recognition in guidelines for management of severe malnutrition that electrolyte and mineral deficits need to be corrected before high energy feeds are introduced. 88    
1.6 HIV, Malnutrition and the Heart Worldwide it is estimated that 3.4 million children under the age of 15 years are infected with HIV. More than 90% of these children live in Sub-Saharan Africa. Children with HIV infection are frequently malnourished and mortality amongst this group remains high.52 61 Possible causes of malnutrition in children with HIV infection include increased metabolic demands, insufficient energy intake, and/or impaired gastrointestinal absorption.92 Importantly, because they present with severe wasting similar to other causes of marasmus, their general management follows WHO malnutrition guidelines (with the addition of HIV-specific interventions where testing and treatment is available), and HIV infected children may account for a large proportion of cases of severe malnutrition in some settings. 93 94 Cardiac complications attributed to HIV infection range from subtle conduction abnormalities and haemodynamic abnormalities to serious cardiomyopathies and sudden death. Pericardial and vascular involvement, especially in long-standing HIV infection have also been described.95-97 The underlying pathophysiology of the cardiac changes in HIV is uncertain and likely to be multifactorial, including direct effects of HIV on the myocyte function, complications following secondary infection, and side effects of treatment with antiretroviral agents. 98 99 It is therefore important to understand the contribution of HIV to any cardiac dysfunction among children with severe malnutrition.  
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1.7 Aims of the CAPMAL Study and overview of the work presented in this thesis The aims of this thesis, and of the Cardiac Physiology in Malnutrition (CAPMAL) study is to conduct a prospective study describing an integrated clinical, electrophysiologic, echocardiographic and biochemical assessment of cardiac function in children with severe malnutrition. The overarching aim is to advance our understanding of the nature, burden and clinical relevance of cardiac dysfunction in African children hospitalised with malnutrition. The CAPMAL study has the following specific aims:  (1) To describe cardiac structure and function in children with severe acute malnutrition at admission, during treatment and at one month follow up.  (2) To compare cardiac function in children with kwashiorkor and marasmus. (3) To explore risk factors for cardiac dysfunction in severe acute malnutrition. (4) To describe haemodynamic responses to fluid therapy in severe malnutrition. (5) To compare cardiovascular findings in children with severe acute malnutrition with non-malnourished critically ill children admitted to the same hospital 
1.8 Hypotheses The motivation for conduct of the CAMPAL study is a widely held but poorly evidenced view that cardiac function is severely impaired in children with severe malnutrition (see section 1.4), and as a result, use of intravenous fluid therapy is discouraged. Moreover, the degree of impaired myocardial function is considered to be worse in children presenting with the oedematous phenotype (Kwashiorkor) than in those with marasmus. The null hypotheses that CAPMAL will test therefore are, respectively:   1) That there is no difference in cardiac function between critically ill children with and without severe malnutrition.  2) That there is no difference in cardiac function between children with marasmus and those with kwashiorkor.    
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 1.9 Overview of the work presented in this thesis 
There are two components to the thesis. In chapter 2, Current evidence for the effect of 
malnutrition on cardiac structure and function, I present a detailed systematic review of the existing literature on cardiac function in malnourished children published since 1946. In the remainder of the thesis I present and discuss the CAPMAL study in the context of this literature.  The CAPMAL study site and clinical and laboratory methods are described in Chapter 3, 
Patients and Methods. Additional methods are presented in the relevant chapters. In Chapter 4, Clinical Description and laboratory investigations, I present a clinical description of malnourished children recruited to the study, including results of laboratory investigations. This is followed by Echocardiographic findings in severe 
malnutrition (Chapter 5) and Electrocardiographic findings in severe malnutrition (Chapter 6). In chapter 7 I compare these findings with those in non-malnourished controls to ask the question How does cardiac function in malnutrition differ from 
controls? I then examine the effect of Intravenous fluids in children with severe 
malnutrition in Chapter 8. Finally, I summarize and try to synthesize the main results of each of these chapters in Chapter 9, Conclusions of the CAPMAL Study.  
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 2 Current evidence for the effect of malnutrition on the heart 
2.1 Introduction A wealth of circumstantial evidence supports the hypothesis that cardiac dysfunction may have an important role in causing death among children with severe malnutrition. Indeed current WHO guidelines on the management of children with severe malnutrition, in particular in respect of fluid resuscitation, are based on the belief that cardiac dysfunction is common in this group of children.58 59 100-102 However clinical data to support this are limited, the results of many studies are conflicting, published studies vary in both methodology and quality, and much of the existing data pre-dates both the HIV epidemic and the availability of non-invasive tools for cardiovascular assessment such as echocardiography. A systematic literature review was undertaken to provide an up to date critical appraisal of current knowledge of cardiac structure and function in children with severe malnutrition. 
2.2 Systematic Review Methods Ovid® was used to search Medline R, EMBASE and EMBASE Classic for studies on invasive and non-invasive assessment of the cardiovascular system in children with severe malnutrition. The databases were assessed on the 26th of March 2012 using a predefined compound search strategy detailed in the protocol provided in the appendix (Appendix 11.6, page 289). The search was limited to articles in English. Titles and abstracts of articles identified by the search strategy were screened and full texts of those that met the inclusion criteria for our review were read in detail. Reference lists of selected articles were used to identify additional secondary articles that were not identified by the Internet search. Although widely varying definitions of severe malnutrition were reported, and there was variation in the definition of severe malnutrition during the last five decades spanned by the literature, individual authors’ definitions of severe malnutrition were accepted for the purposes of this review.  Case reports and studies that focused on specific micronutrient deficiencies or underlying chronic illnesses causing malnutrition were excluded. 
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 Data were extracted using a standardized data extraction form that included variables of interest from electrocardiographic, imaging (echocardiography, dye dilution and radiography) and autopsy studies.   
2.3 Results  
2.3.1 Studies identified and included in the systematic review The search strategy revealed 344 articles. After removal of duplicates and screening titles and abstracts of articles, 55 articles were read in full, out of which 17 were found eligible for the review. A further 11 eligible studies were identified through the reference lists of the selected articles. A summary of the articles identified for this systematic review is presented in Table 2.1. 
Figure 2.1 Flow chart of systematic search using Embase Classic, Embase and Ovid MEDLINE 
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 In total, in the 28 studies included, 1245 cases with severe malnutrition and 393 controls were studied. As Figure 2 A demonstrates, studies mainly originate from Africa and Asia and focus on children with oedematous malnutrition. Kwashiorkor accounted for 940 (76%), marasmus for 305 (24%) of cases. Most malnourished patients (758, 61%) came from Africa, where 695 (92%) children had kwashiorkor and only 63 (8%) had marasmus. The second largest cohort came from Asia with 134 patients suffering oedematous and 107 patients from non-oedematous malnutrition; followed by Latin America (LA) and the Caribbean with 63 oedematous and 52 non-oedematous malnutrition cases. Only in the studies from Europe did cases of marasmus outnumber kwashiorkor (82 vs. 31). Fifty percent of the studies on cardiac function in children with malnutrition were done between the 1960s and 1980s (Figure 2 B) and therefore before the era of routine echocardiography for cardiac assessment and HIV testing.  
 
Figure 2.2 Number of oedematous and non-oedematous malnutrition cases included in previous 
published studies of cardiovascular function by  A) continent and B) decade   
 The available evidence from these studies was considered, on the effect of malnutrition on cardiac mass and size, the conducting system and on function.  
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 Table 2.1  Summary of studies that used different assessment tools to evaluate cardiac function in children with malnutrition meeting the criteria for the 
systematic review  
 Malnourished Control 
Group 
Assessment Tools 
Author Year Setting & Classification Patients Total  K M MK ECG ECHO CXR PM Dye  Kerpel Fronius 1949 Hungary WAZ  No recent infection 34 0 34 0 0 0 0 0 0 1 Kerpel Fronius 1960 Hungary NS GE  44 20 24 0 11 0 0 0 0 1 Smythe 1962 South Africa NS Ill enough to be admitted 98 98 0 0 0 1 0 1 1 0 Cronje 1963 South Africa NS NS 166 166 0 0 40 1 0 0 0 0 Alleyne 1966 Jamaica NS No GE 13 some  some most 0 0 0 0 0 1 Wharton 1967 Uganda NS NS 67 67 0 0 0 0 0 0 0 0 Horsfall 1968 South Africa B.&A Severely ill, +/-GE 48 44 4 0 0 1 0 0 0 0 Khalil 1969 Egypt NS Anaemia excluded 30 30 0 0 15 1 0 0 0 0 Wharton 1969 Uganda NS NS 51 51 0 0 0 1 0 1 1 0 Piza 1971 Costa Rica INCAP NS 82 40 42 0 11 0 0 0 1 0 Sims 1972 Uganda NS NS 7 7 0 0 0 0 0 0 1 0 Prasdo 1976 Indonesia McLaren Severely ill 80 26 48 6 0 1 0 0 0 0 Prasdo 1976 Indonesia McLaren NS 70 22 44 4 0 0 0 1 0 0 Viart 1977 Zaire NS GE 43 0 5 38 24 0 0 0 0 1 Viart 1978 Zaire NS GE 18 0 0 18 18 0 0 0 0 1 Mukherjee 1982 India NS GE 10 6 0 4 0 0 0 0 1 0 Fagoli 1985 France NS NS 5 0 5 0 5 1 0 0 0 0 Shoukry 1986 Egypt WAZ NS 17 17 0 0 17 0 1 0 0 0 Bergmann 1988 South Africa NS No GE or sepsis 21 21 0 0 0 1 1 1 0 0 Singh 1989 India IAP NS 46 most some  some 20 1 1 1 0 0 Kothari 1992 India IAP No recent infection 25 0 15 10 26 1 1 0 0 0 Olowonyo 1993 Nigeria Wellcome NS 90 90 0 0 90 1 0 1 0 0 Phornphatkul 1994 Thailand Waterlow No GE or sepsis 11 5 1 5 0 1 1 1 0 0 Olowonyo 1995 Nigeria Wellcome NS 44 44 0 0 44 1 1 1 0 0 Fuenmayer 1998 Venezuela M.C. NS 20 6 10 NS 20 1 0 0 0 0 Ocal 2001 Turkey Wellcome No GE or sepsis 30 4 19 7 17 0 1 0 0 0 El-Sayed 2006 Egypt Wellcome NS 30 14 16 0 10 1 1 0 0 0 Faddan 2010 Egypt Waterlow Anaemia excluded 45 4 38 3 25 0 1 0 0 0 TOTAL     1245 782 306 95 393 15 9 8 5 5 NS= Not specified; GE=gastroenteritis/diarrhoea, B&A= Brock & Autret; MC= Mendez Castellano, K= Kwashiorkor, M= Marasmus, MK= marasmic kwashiorkor, PM= Post mortem
 
 2.3.2 Effect of malnutrition on the mass and dimensions of the heart The size of the heart can be assessed using a variety of tools, but most precisely on post mortem specimens. Modern technology, such as echocardiography, electrocardiography and radiography also allows assessment of the heart in vivo. The available evidence for the effect of malnutrition on the cardiac size and mass using each of the above methods is summarized below. 
Post mortem studies Only five autopsy studies examined malnutrition-induced changes on the paediatric heart.59 60 102-104. These included 102 children with oedematous malnutrition, 42 with non-oedematous malnutrition and 66 controls. Most cases of oedematous malnutrition (kwashiorkor and marasmic kwashiorkor) came from the African continent (n=76). The second largest cohort of specimens, 40 children with oedematous and 42 with non-oedematous malnutrition as well as 11 controls were reported from Costa Rica. The remaining subjects came from India (oedematous malnutrition, n=10). Varying methodologies and selective presentation of different indices in the various studies makes comparability difficult.  Macroscopically, the hearts were atrophic and flabby looking.59 102 Three studies including 111 malnourished children described cardiac size59 60 102. Piza et al. reported cardiac atrophy in 23% of children with kwashiorkor based on the heart/body weight ratio; and cardiomegaly in 43% of children with marasmus.60 However Wharton et al. demonstrated that a decrease in the heart/body weight ratio is not a specific feature of malnutrition.102 Smythe noted that the right or left ventricle was often dilated when assessed macroscopically.59 None of the studies reported exact cardiac mass.  Characteristic histological findings included loss of striation, patchy necrosis, interstitial oedema, widespread subendocardial lesions (not further defined) and vacuolation. 59 102 To assess whether these changes were specific for oedematous malnutrition, Wharton at 
al. conducted a retrospective analysis on 100 unselected hearts, blinded for cause of death and nutritional status. He found that the myocardium of children with kwashiorkor showed significantly more fibre vacuolation and less interstitial oedema. There was no difference compared to non-malnourished controls in the proportion with necrosis or in heart/body weight ratios. 102   
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 In vivo assessment  Echocardiography and the cardio-thoracic ratio (CTR) determined by an AP chest radiograph have been used to describe left ventricular mass and size non-invasively. Using this, four studies found a reduced absolute left ventricular mass in children with malnutrition compared to controls. 100 101 105 106 However, when indexed to body surface area or weight, two of these studies demonstrated an increased left ventricular mass index in children with malnutrition compared to controls.100 105 Another study from Egypt reported a lower cardiac mass index in children with both marasmus and kwashiorkor compared to controls.107 However different definitions of malnutrition in these studies makes comparison difficult.   
Table 2.2 Overview of mean cardiac mass indices of studies1 included in the systematic review of 
cardiac function in severe malnutrition  
Author Year 
LV Mass (g) LV Mass Index (g/m2) 
K M All C p value K M All C p value Shoukry 1986 8.11 - - 10.7 <0.05 - - - - - Kothari 1992 - - 25.8 32.4 <0.05 - - 4.42 2.42 <0.001 Ocal 2001 10.7 14.0 14.5 19.8 <0.05 45.3 50.8 52.0 53.9 >0.05 El-Sayed 2006 - - - - - 48.2 46.3 - 60.1 <0.05 Faddan 2010 - - 19.0 29.9 <0.005 - - 67.8 64.5 >0.05 
1numbers of patients in each group are shown in Table 2.1; 2Kothari indexed to total body weight. 
K = kwashiorkor; M = marasmus; All = all malnutrition (kwashiorkor and marasmus); C = non-malnourished controls  Nine studies examined the cardiothoracic ratio (CTR) in 402 children with kwashiorkor and 64 with marasmus. Three of these studies compared findings to a control group (180 controls in total) and found smaller CTR in malnutrition.108-110 However, when indexed to body weight, Wharton found normal or even increased CTR in children with malnutrition.102 
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Table 2.3  Overview of mean cardiothoracic ratios among malnourished cases and non-malnourished 
controls1 of studies included in the systematic review of cardiac function in severe malnutrition  
Author Year M K All C p value Comments 
Smythe 1962 - - <0.5 - - - 
Wharton 1969 - - 0.48 - - - 
Prasdo 1976 - - - - - ≤0.5 in 83% 
Bergmann 1988 - - - - - <0.49 in 67% 
Singh 1989 0.47 - - 0.49 - - 
Kothari 1992 - - - - - <0.4 in 40% 
Olowonyo 1993 - - 0.49 0.55 - - 
Phornphatkul 1994 - - - - - <0.5 in 81% 
Olowonyo 1995 - - 0.49 0.55 <0.001 - 
1 numbers of patients in each group are shown in Table 2.1 
K = kwashiorkor; M = marasmus; All = all malnutrition (kwashiorkor and marasmus); C = non-malnourished controls.  Electrocardiographic studies are also consistent with reduced cardiac mass in children with severe malnutrition. Nine studies including a total of 574 children report low QRS voltages in their cohorts,59 105 107-109 111-114 although some do not define the cut-off chosen.102 115 One study which compared kwashiorkor with non-malnourished controls demonstrated highly significant reductions in the QRS amplitude across all ECG leads in children with kwashiorkor.108  Another study provides evidence of an association between low QRS amplitudes and death in severe malnutrition. Smythe found that 50% (n=49) of his cohort had QRS amplitudes of less than 1mV, and of those a high proportion (47%) died.59 Although he did not use any statistical tests, when applying the χ2 test to his data there is a significant association between low QRS amplitudes and death, which was more common in children with a QRS amplitude <1mV (47% vs. 20%, p=0.02). Overall, 70% of patients who died (23 out of 33) showed low QRS amplitudes.  
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2.3.3 Effect of malnutrition on the conducting system of the heart  Overall 15 studies that reported on electrocardiographic (ECG) findings were published between 1962 and 2006 including a total of 671 malnourished children and 285 controls.59 102 107-119 Nine of those studies were conducted in Africa including 558 children with kwashiorkor, 20 children with marasmus and 214 controls. The available evidence for the effect of malnutrition on key electrocardiographic features is summarized below. Evidence from one small autopsy study looking at the conducting tissue of the heart in 7 children with kwashiorkor and 5 controls is also reviewed.104 
 
PR interval The PR interval reflects the atrioventricular conduction time, which, when prolonged or shortened, can precipitate arrhythmias. Normal reference values for European children were recently updated. 120-122 A long PR interval may indicate first-degree heart block and can be associated for example hyperkalaemia, ischaemia, myocarditis or just increased vagal stimulation. A short PR interval may be due to hypocalcaemia orhypokalaemia.123 
 Seven studies including a total of 427 children with kwashiorkor and 68 with marasmus reported PR intervals (Table 2.4); only three of these studies included controls (n= 155) (Table 2.4). Normal ranges of the PR interval were reported in 6 of the 7 studies. One study from Egypt reported mean PR intervals that were prolonged in both kwashiorkor (0.24s) and marasmus (0.32s), but even more prolonged in non-malnourished controls  (0.66s), making interpretation of their findings difficult. 
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Table 2.4 Overview of mean PR intervals (ms) in malnourished cases and controls1 from studies 
included in the systematic review of cardiac function in severe malnutrition  
Author Year Mean PR interval (SD) p value Comments 
  M K All C - - 
Cronje  1963 - 0.96 - 0.12 0.01 - 
Horsfall   1968 - - 0.123 - - - 
Wharton  1969 - 0.110 - - - - 
Khalil  1969 - 0.98 (0.2) - 0.12 (14) 0.02  in Lead II 
Prasdo  1976 -  - - - ↑ in 5%   
Olowonyo  1993 - 126 (0.24) - 0.12 (20) >0.05 - 
El-Sayed  2006 0.32 (0.2) 240 (0.24) - 0.66 (290) <0.052 - 
1 numbers of patients in each group are shown in Table 2.1 
K = kwashiorkor; M = marasmus; All = all malnutrition (kwashiorkor and marasmus); C = non-malnourished controls   
QT Interval The QT interval reflects the time required for the ventricular depolarization and repolarization. Both, QT prolongation and shortening have been associated with sudden deaths.123 As the QT interval varies with heart rate, it needs to be adjusted for the heart rate. 124 This is usually done using the Bazett formula and is then called corrected QT interval: QTc= QT measured/√ RR interval Eleven studies (Table 2.5) of 534 children with kwashiorkor and 94 children with marasmus measured QT intervals, six of which included controls (n=211; Table 2.5). 105 107 108 110 116 119 Nine studies used the QTc interval, but numeric values of the mean QTc intervals were only presented in six studies; three of these studies107 110 119 reported a prolonged mean QTc interval above the normal range published by Davignon (mQTc >0.44 sec).125 One of the studies demonstrated a significant difference in mean QTc intervals between marasmic Egyptian children and controls (0.46 vs. 0.41 sec, P<0.01).107 The same author compared different types of severe malnutrition and reported slightly longer QTc intervals in children with marasmus compared with kwashiorkor. The other two studies, by Singh et al and Fagoli et al, did not include formal comparisons with a control group so are difficult to interpret.110 119 
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 Although a fourth study by Olowonyo et al. demonstrated a statistically significant difference in the mean QTc interval between malnourished children and controls (0.42 versus 0.41, respectively) both values lie within the normal reference range.108 The remaining studies also report mean QTc intervals that fall within the normal limits published by Davignon. 59 102 105 111 114 116  Interestingly Fuenmeyer et al. reported an increased QT interval dispersion (difference between maximal and minimal measured QT interval) in the precordial leads of malnourished children compared to controls, which might be reflect increased arrhythmogenic potential.  One study, by Smythe et al, found that 13/33 (39%) of severely malnourished children who died had mean QTc intervals greater than 0.49 seconds.59 However, although this study tries to describe the ECG changes in view of electrolyte changes, it fails to specify any underlying comorbidities in this group.  
Table 2.5  Overview of mean QTc intervals among malnourished cases and non-malnourished 
controls1 reported in studies included in the systematic review of cardiac function in severe 
malnutrition 
  Mean QTc Interval (sec)  
Author Year K M C p value Comments 
Smythe 1962 - - - - some prolonged QTc 
Cronje 1963 - - - - some prolonged QTc 
Wharton 1968 0.39 - - - 46% values > mean 
Prasdo 1976 - - - - 7.5% had ↑ QTc interval 
Fagoli 1985 - 0.482 0.432 - - 
Bergmann 1988 normal - - - - 
Singh 1989 0.46 - 0.37 - - 
Kothari 1992 - normal normal - - 
Olowonyo 1993 0.42 - 0.41 <0.05 - 
Fuenmayer 1998 - 0.41 0.40 0.268 - 
El-Sayed 2006 0.44 0.46 0.41 - - 
 1 numbers of patients in each group are shown in Table 2.1  2 not adjusted for heart rate 
K = kwashiorkor; M = marasmus; C = non-malnourished controls 
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T-wave morphology The T-wave reflects the repolarization of the ventricular action potential and abnormalities can be caused by abnormal voltage gradients and by changes in the sequence of repolarization by various reasons including hyperkalaemia, volume overload (tall peaked T waves), hypokalaemia, ischaemia, myocarditis or hypothyroidism.123 Children over the age of one month usually have inverted T waves in lead V1-V3 that will progress to become upright in the order V3, V2, V1. Negative T-waves in leads V5 and V6 are always pathological in children.125 126 Six studies including 373 children with kwashiorkor, 72 with marasmus and 75 controls reported T-wave morphology (Table 2.6). T-wave inversion and flattening are commonly reported. 59 112-116 However only three studies compared findings with a control group, two of which did not report T wave changes. 112 115 116 Cronje et al. found bizarre T-wave changes (details not specified) in both kwashiorkor and controls, but did not consider them to be of any significance. 112 
 
 
Table 2.6 Overview of reported T-wave abnormalities in malnourished children and controls1 in 
studies included in the systematic review of cardiac function in severe malnutrition  
Author Year Overall malnutrition Kwashiorkor Controls 
Smythe 1962 Flat or inverted  - - 
Cronje 1963 - Bizarre Bizarre 
Horsefall 1968 - Flat or inverted - 
Khalil 1969 - Inverted in V5 in 26.6% No 
inversion 
Prasdo  1976 71% flat, 15% inverted - - 
Fuenmayer 1998 Flat or inverted in 90% - Normal 
in 90% 
1 numbers of patients in each group are shown in Table 2.1 
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Heart rate and rhythm Eleven studies in this review including 389 children with kwashiorkor, 97 with marasmus and 230 controls, reported the heart rate and/or rhythm (Table 2.7). No studies reported bradycardia among children with malnutrition, although two studies from Zaire reported a lower mean heart rate in malnutrition than in controls. 127 128 Smythe reported in his study one case of bradycardia with AV dissociation and nodal escape rhythm and one case of atrial fibrillation.59 Tachycardia was more common, however, with four studies reporting either an “increased” heart rate or a mean heart rate >140/min.59 114-116 Heart rate tended range up to 40-50% over the mean control values across all ages, and to increase with increasing severity of malnutrition.110  
Table 2.7  Overview of mean heart rates (bpm) in malnourished children and controls1 reported in 
the studies included in the systematic review of cardiac function in severe malnutrition  
    
Author Year Malnutrition Controls p value 
Smythe 1962 Tachycardia - - 
Khalil 1969 Increased (125-210) - - 
Prasdo 1976 142 - - 
Viart 1977 107 1152 <0.01 
Viart  1978 105 119 - 
Mukherjee 1982 120-160 - - 
Singh 1989 Increased - - 
Kothari 1992 126 117 >0.05 
Olowonyo 1993 121 96 <0.001 
Fuenmayer 1998 Normal Normal - 
Ocal 2001 139 140 >0.05 
1 numbers of patients in each group are shown in Table 2.1; 2 convalescent children. 
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 Histological evidence of effects on the conducting tissue  One study was identified that examined the myocardium of 7 Ugandan children with kwashiorkor and 5 controls.104 The cohort included five children with diarrhoea and vomiting, one child with heart failure and one child with a skin rash. Pathological findings included lower respiratory tract infection, malaria and malabsorption. The post-mortem diagnosis of the child with the clinical diagnosis of heart failure was found to be viral pneumonia and malaria. Histological examination of the myocardium showed wasting and disintegration of conducting fibres in 5 cases. The AV node (4 cases), bundle (4 cases) and branches (2 cases) were affected. No pre-mortem ECG data were available with which to correlate the findings, but the authors hypothesized that myolysis might produce failure of atrioventricular conduction and cause sudden death.104   
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2.3.4 Effect of malnutrition on the systolic and diastolic function of the heart  
Systolic function Systolic function describes the myocardial ability to contract. Whereas fractional shortening (FS) and ejection fraction (EF) are measures of circumferential (transverse) fibre shortening, mitral annular plane systolic excursion (MAPSE) and tricuspid annular plane systolic excursion (TAPSE) as well as the early systolic mitral annular velocity (S’) deliver information about the longitudinal shortening of the oblique fibres and are thought to be less load dependent. 129-131 The myocardial performance index (Tei Index), another potentially load independent parameter is used to assess global (systolic and diastolic) heart function, 132 but again has never been assessed in malnourished children before.  So far, studies have only assessed fractional shortening or ejection fraction in children with malnutrition. In general, a FS of less than 28% and an EF of less than 40% are generally considered considered abnormal.  
Table 2.8 Overview of measures of systolic function in malnourished cases and controls1 reported in 
studies included in the systematic review of cardiac function in severe malnutrition  
Author Year 
Mean Ejection Fraction (%) Mean Fractional Shortening (%) 
K M MK All  C K M MK All  C 
Shoukry 1986 71.0 - - - 74 32.0 - - - 36.0 
Bergmann 1988 - - - - - 38.0 - - -  - 
Singh 1989 - 54.3 - - 69.8 - - - - 33.4 
Kothari 1992 - - - 62.4 67.0 - - - - - 
Phornphatkul 1994 - - - - - - - 14.0  - - 
Olowonyo 1995 - - - - - 28.2 - - - 31.4 
Ocal 2001 68.0 65.0 68.0 66.0 69.0 38.0 34.5 37.5 35.7 37.1 
El-Sayed 2006 68.5 69.1 - - 70.5 34.4 34.4 -  - 32.0 
Faddan 2010 - - - 40.0 55.5 45.0 42 - 46.0 57.0 
1 numbers of patients in each group are shown in Table 2.1 
K = kwashiorkor; M = marasmus; MK = marasmic kwashiorkor; All = all malnutrition (kwashiorkor and marasmus); C = 
non-malnourished controls.  
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  Nine studies used echocardiography to assess the systolic function of the heart in a total including 180 children with kwashiorkor, 89 with marasmus, and 142 controls (Table 2.8). Only two studies demonstrated abnormal systolic function in malnutrition. 110 118 Singh et al. used the Indian Academy of Pediatrics (IAP) classification from 1972 for malnutrition, which grades malnutrition into 4 groups according to the percentage of expected weight for age and only group 4 (expected weight for age <=50%) had abnormal fractional shortenings (mean FS 27.0% compared to the control group (mean FS 33.4%).110 Two other studies compared systolic function in kwashiorkor and marasmus but failed to demonstrate any difference.106 107 Of the two studies which compared malnourished children with non-malnourished controls, El-Sayed reported slightly higher mean fractional shortening in malnutrition whereas Ocal reported a slightly lower fractional shortening in the malnourished group. 106 107 Neither difference met criteria for statistical significance.   
Diastolic function Measures of the diastolic function of the heart deliver information on the hearts ability to relax and fill and can be divided into four components: Isovolumic relaxation, which describes the time from the semilunar valve closure to the onset of the flow across the AV valve, is follow by rapid filling, during which the pressure in the ventricles decreases leading to a pressure difference between the atria and ventricles which initiates ventricular filling and is reflected by the E (early filling) velocity wave. As pressures within the atria and ventricles equalize, diastasis occurs in mid-diastole, which minimizes the flow across the atrioventricular valves (AV). Finally, the atrial contraction in late diastole generates a second wave of flow across the AV valve (A wave). Diastolic function measures change with age, loading conditions, heart rate, rhythm, intrathoracic pressure changes during respiration. 133 134 It is also influenced by the systolic function of the heart. Diastolic function is assessed by looking at mitral and pulmonary venous inflow Doppler patterns. Classically, Doppler interrogation of the mitral valve inflow pattern Doppler index, the E/A wave ratio, has been used to assess diastolic function. Generally, an E/A ratio of less than 1.0 reflects abnormal relaxation (mildest form of diastolic impairment) whereas an E/A ratio of more than 1.5 reflects a restrictive physiology in which there is abnormal ventricular compliance. More recently, Doppler 
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 tissue imaging, which is less sensitive to loading conditions, gives information about the longitudinal mitral annular motion and the ability of the heart to recoil and expand (early diastolic annular motion).81 135 Only five studies, comprising 42 children with kwashiorkor and 88 children with marasmus, examined diastolic function (Table 2.9). All five studies included a control group (n=98) but none demonstrate a difference in E/A ratios between malnourished children and controls.100 106 107  
Table 2.9 Overview of E/A ratios as a measure of diastolic function in malnourished cases and 
controls1 reported in studies included in the systematic review of cardiac function in severe 
malnutrition   
Author Year M K All C p value Comments 
Singh 1989 - - - - - Normal flow dopplers 
Kothari 1992 - - - - - Reported as normal 
Ocal 2001 - - 1.16 1.19 >0.05 - 
El-Sayed 2006 1.66 1.8 - 1.5 >0.05 - 
Faddan 2010 - - 72.6 75.1 >0.05 Unusual way to present it 
1 numbers of patients in each group are shown in Table 2.1 
K = kwashiorkor; M = marasmus; All = all malnutrition (kwashiorkor and marasmus); C = non-malnourished controls 
 43 
  
2.3.5 Effect of malnutrition on the cardiac output Ten studies examined cardiac output in malnourished children (Table 2.10). Four studies between 1949 and 1978, comprising a total of 56 children with kwashiorkor and 39 with marasmus, reported low cardiac output in malnourished children using the dye dilution method. 127 128 136 137 The two studies from Zaire showed that cardiac output was lower than in controls, even when indexed to body surface area (BSA).127 128  The remaining six studies assessed cardiac output by echocardiography and included a total of 108 kwashiorkor and 51 marasmus cases. Five studies included a control group (n=90).105-107 One study demonstrated a reduced cardiac output in grade IV malnourished children compared to controls (0.82 l/min vs. 1.4l/min, P<0.001). 110 Indexed to BSA however, three studies reported cardiac indices (CI) to be above105 106 or the same 107 as those of controls.   
Table 2.10 Summary of cardiac output and cardiac index measures in malnourished cases and 
controls1 reported in studies included in the systematic review of cardiac function in severe 
malnutrition 
Author Year 
Mean Cardiac Output (L/min) Mean Cardiac Index (L/min/m2) 
K M All C   p value K M All C   p value 
Kerpel-Fronius 1949 Reduced with increasing severity of malnutrition 
Alleyne 1966 - - 1.99 - - - - 5.26 - - 
Viart 1977 - - 0.95 1.9 - - - 1.9 3.27 - 
Viart  1978 - - 1.0 1.85 - - - 2.09 3.25 - 
Shoukry 1986 1.46 - - 2.48 >0.05 - - - - <0.001 
Singh 1989 - 0.82 - 1.4 - - - - - - 
Kothari 1992 - - 2.03 2.75 <0.002 - - 5.95 4.97 <0.05 
Phornphatkul 1994 Individual case descriptions, no means presented 
Ocal 2001 - 1.5 1.6 2.1 <0.05 6.0 5.7 5.9 5.7 >0.05 
El-Sayed 2006 - - - - - 3.05 3.06 - 3.5 >0.05 
1 Numbers of patients in each group shown in Table 2.1 2 only grade IV severely malnourished 
K = kwashiorkor; M = marasmus; All = all malnutrition (kwashiorkor and marasmus); C = non-malnourished controls. 
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2.4 Discussion  Our systematic review identified 28 studies of cardiac mass and function in childhood malnutrition, derived from all 4 continents over a period of 60 years. Although some common themes do emerge, a number of factors nevertheless make it difficult to interpret many of the results reported.  Firstly, different authors use different classifications for the definition of severe malnutrition (Table 2.1), making it difficult to compare between studies. In addition, there is little information about the study population. Importantly, the prevalence of comorbidities such as sepsis, HIV, diarrhoea, dehydration and electrolyte abnormalities is rarely reported. Since these conditions are common among children with severe malnutrition in many settings, and may each be associated with cardiac dysfunction, this makes it difficult to conclude whether specific findings are due to these conditions or malnutrition per se.  Related to this, very few studies compared findings in severe malnutrition with a control group of children without malnutrition, and none were designed to take account of important confounders such as the comorbidities discussed above, for example by having an appropriately matched control group or adjusting for confounders in the analysis. Only two studies attempted a comparison between the heart function of children with kwashiorkor and those with marasmus but were not powered enough to detect any significant differences. 106 107  Other factors making comparison between studies difficult include the failure to present or summarize numerical data (for example by simply stating that a particular parameter was “normal”) and to define clear cut-offs for normality. Whilst there were some clear trends suggesting significant differences between malnourished patients and controls where numerical data are presented, what is often not emphasized is that findings were still within normal limits in the majority of cases. Failure to present the clinical significance of many abnormal findings (e.g. in terms of complications or poor outcome) makes interpretation especially difficult.  Despite all these limitations a few conclusions may be made from the available literature. There is general agreement that the heart mass in malnourished children is reduced compared to non-malnourished controls. 100 101 105 106 111 Although documented evidence 
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 from autopsy studies is limited, in vivo assessments using cardiothoracic ratios, echocardiography and ECGs support this conclusion. Cardio-thoracic ratios (CTR) in children with malnutrition seem to correlate with left cardiac mass. However, it is important to remember that the CTR is highly dependent on the filling status of the ventricles, so a lower CTR might be purely due to the overall reduction in intravascular filling in malnourished children rather than explained by a reduction in cardiac mass.59 138 Echocardiography allows better evaluation of heart dimensions and function. The first echocardiographic study in children with severe malnutrition was published in 1986.101 This and subsequent studies have demonstrated that cardiac structure is modified in children with malnutrition compared to controls, with reduction in left ventricular mass. A major challenge in interpreting these studies relates to the fact that by definition all the malnourished children had reduced body size – they were stunted, wasted, or both. In clinical practice differences in size due to age are taken into account by indexing echocardiographic measurements to body ‘size’ in some way. Once cardiac size was indexed to body surface area or total body weight the cardiac mass seemed to be reduced in proportion to the overall weight and size of the child in most studies. 105-107 136 However, the debate on how best to index it and whether or not the reduction is proportionate to the overall reduction in body size is still ongoing.139 140 I return to the subject of indexing in Chapter 5.  There may be even reported a slightly increased left ventricular mass index in children with malnutrition compared to controls.100 105 Comorbidities, such as HIV or anaemia, which can independently cause left ventricular hypertrophy, might have prevented the myocardium from wasting in proportion to the overall muscle wasting in these cases.95-97 141 However, since analyses were not presented for these specific subgroups, this remains speculation. Ideally, studies should document and control for these important confounders. A significant electrocardiographic feature in children with severe malnutrition is the generally low QRS amplitude observed. Classically, low voltages are found in myocarditis, pericardial effusions, hypothyroidism, subcutaneous oedema, healthy neonates and obesity.142-144 More recently, hypoalbuminaemia has also been shown to correlate with low QRS voltages. 145 146 Since ventricular hypertrophy is associated with large complexes it is also possible that small complexes might be due to reduced cardiac 
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 mass. However, there appears to be no scientific basis for the criteria defining low QRS voltages (<0.5mV in limb leads and <1mV in pre-cordial leads) and furthermore, they fail to take age and sex into account.147 Looking at Davignon´s centile charts for QRS voltages, which account for age but not gender, and taking the 2nd percentile as the lower limit of normal, QRS voltages greatly depend on age and they are generally below the fixed threshold of 1mV (Davignon only published amplitudes for precordial leads).125. However, more recent studies by Rijnbeek et al. and Semizel have also taken gender into account and generally found higher amplitudes.120-122 The authors believe this is due to the difference in the sampling frequency of the recording ECG system, as Davignon used a sampling rate of 333Hz, 125 which is lower than the sampling rate used by Semizel and Rijnbeek. Only one study demonstrated significantly reduced QRS amplitudes in all leads compared to controls.108 Nonetheless they were still higher than the arbitrary cut-offs used for low QRS voltages like 0.5mV for limb and 1mV for pre-cordial leads.148 Only the mean amplitude of the QRS complex in lead aVL was below 0.5mV (0.45mV). In view of these findings, the general statement of “low QRS amplitudes” in children with malnutrition should be interpreted cautiously and more effort should be made in defining low amplitudes according to current available reference values. Furthermore, low amplitudes should not just be regarded as a reflection of diminished cardiac mass, but other underlying pathology such as hypoalbuminaemia, depressed thyroid function or interstitial oedema (e.g. kwashiorkor) must be taken into account in the analysis.  The detailed morphology of the electrocardiogram provides information on the integrity of the conducting system and can help identifying a myocardium at risk of developing arrhythmias. Although there is very little information from autopsy studies, the single small study that is available suggests the conducting system of the heart may be affected by malnutrition,104 and there is a suggestion that the myocardium may be affected more generally.104  We critically reviewed the literature on frequently cited electrocardiographic changes like PR-interval shortening or QTc-interval prolongation,59 107 110 112 T-wave inversion or flattening59 113-116 and reduced QRS amplitudes, 59 105 107-109 111-114 which might indicate conducting system or myocardial dysfunction.  Importantly none of the studies identified reported any form of heart block in any of the children studied. All reported PR intervals fall within normal limits, except for one study that reported such abnormally long PR intervals of up to 800ms, suggesting this results 
 47 
 should be treated with extreme caution.107 Although two studies reported a shorter PR interval amongst malnourished children compared to controls, 112 115 it is important to note that in both cases the reported PR intervals fall still within what is now accepted as the normal range.125  There are several theoretical reasons why the QTc interval might be prolonged in severe malnutrition, including direct effects on the myocardium (myocardial changes were seen in some autopsy studies), hypothermia (a common complication of malnutrition even in tropical countries),12 and electrolyte disturbances (hypocalcaemia).123 Of all studies reviewed, only three demonstrated a truly prolonged mean QTc interval in children with malnutrition,107 110 119 and only one showed that the QTc intervals were significantly prolonged compared to controls.107 None of these studies reported the prevalence of hypothermia or electrolyte disturbances nor their association or otherwise with the QTc interval, making interpretation difficult.   Interestingly, Fuenmeyer et al found an increase in arrhythmogenic potential, reflected in an increased QT-interval dispersion, in his cohort of malnourished children. After excluding other causes for increased QT interval dispersions, such as hypocalcaemia or bradycardia, the authors hypothesized that their finding might be due to a relative predominance of m-cells in the deep sub-epicardial layer of the left ventricle.116 These cells have the ability to prolong the action potential duration due to a slower repolarization process, which could contribute to an increased QT-interval dispersion. This in turn could lead to an increased risk of arrhythmias. It is the only study in the literature of paediatric malnutrition so far that examined QT interval dispersion. T-wave morphology seems to vary in children with malnutrition, with flat or inverted T-waves being the most prominent features. However, its significance as a specific feature of malnutrition remains questionable as many T-wave abnormalities can also be attributed to electrolyte perturbations. 123 149As flow of sodium, potassium and calcium into and out of the cells is responsible for the action potential, and therefore the depolarization and repolarization of the myocardium, the length and morphology of the T wave is influenced by the concentration of these electrolytes. It would therefore not be surprising to find prolonged QTc intervals or T-wave changes in children with malnutrition and diarrhoea. Hypokalaemia may also occur as a result of total body potassium depletion in malnutrition in the absence of diarrhoea. 13 65 84 Here again 
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 interpretation of reported ECG changes is made difficult by limited presentation of electrolyte data.  The main reason for studying these ECG changes in this context is as potential signs of either arrhythmogenic properties or myocardial dysfunction. Despite concern that sudden deaths among children with severe malnutrition may be due to arrhythmias,59 it is notable that only one of the studies reported a disturbances of heart rhythm.59  Interestingly, although bradycardia is referred to as a common feature in severe malnutrition in various textbooks,150-152 we identified no studies in our systematic review of cardiac function, that reported absolute bradycardia in severe malnutrition, but two studies demonstrated lower heart rates in children with acute malnutrition compared to controls.59 127 128 Although sinus tachycardia was common it is so non-specific, and limited information on important comorbidities, such as infection and dehydration in these studies makes interpretation impossible.  None of the studies identified for this review attempted to control for the nature of the severe illness that lead to admission of the severely malnourished child, such as diarrhoea, sepsis or pneumonia. It is therefore difficult to conclude that malnutrition per 
se exhibits a higher risk for cardiac arrhythmias and sudden death. The closest observations on whether or not some of the recorded ECG changes are due to malnutrition per se come from Olivares et al. who were able to demonstrate in a stepwise multiple regression model, that BMI alone accounted for 39% of the QTc changes.117 However, this article was excluded from the systematic review as it only examined children with moderate malnutrition.  Only one study provides any evidence of an association between specific ECG findings and risk of death among children with severe malnutrition. Data from the study by Smythe et al, demonstrates an association with increased mortality of both reduced QRS amplitude and prolonged QTc interval.59 Although no associations with cardiac arrhythmias were documented it is plausible that increased QTc intervals might have led to fatal arrhythmias that were not detected. However it is also possible that they may have reflected other common comorbidities such as hypothermia, which were not discussed in the paper. Interpreting the association of low QRS complexes with death is also not straightforward, since it may just be a marker of very severe malnutrition and therefore a higher risk of other comorbidities like infection, which frequently lead to 
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 death.50-52 This reinforces the need to document and adjust for comorbidies as important potential confounders in studies for severe malnutrition.  In summary, looking at the literature so far, there is no good evidence that cardiac arrhythmias are a frequent cause of death in children with severe malnutrition, and insufficient evidence to suggest that malnutrition per se is associated with an increased risk of cardiac arrhythmias. If cardiac arrhythmias are not implicated in the high mortality of children with severe malnutrition, could mechanical cardiac failure still be an important mechanism leading to death in this group? Diastolic function was uniquely reported as normal in all studies. Although a number of studies examining the systolic function of the heart were able to demonstrate that fractional shortening and ejection fraction parameters in children with malnutrition were below those of controls,101 105-107 109 only two studies demonstrated frank systolic impairment with FS below 28%.110 118 One was a very small study of 11 patients with extremely low fractional shortenings (almost universally <20% and <7% in two instances), and it seems almost incredible that cardiac function apparently normalized in all patients by nutritional rehabilitation only.118 Singh et al. only found impaired systolic function in children most severely affected by malnutrition (grade IV malnutrition, IAP classification2) but failed to describe his study patients in terms of other comorbidities such as diarrhoea or sepsis.110 Furthermore, the studies only assessed myocardial contractility by fractional shortening and/or ejection fraction, both of which are highly load dependent parameters that only assess short axis function and display falsely high values when intravascular filling status is reduced. 81 Recently, normal ejection fraction heart failure in adults has attracted the attention of cardiologists which can be associated with abnormal mitral annular plane systolic excursion (MAPSE).129 153 This suggests that non-conventional parameters like the tricuspid annular plane systolic excursion (TAPSE) and MAPSE could add important information on the long axis function of the right and left ventricle. Another advantage of these indices over fractional shortening and ejection fraction is their relative load independence. This is particularly important when assessing the cardiac function of the 
1 Indian Academy of Pediatrics (IAP) classification: Classifies malnutrition according to the degree of 
underweight (Weight-for-Age) based on the IAP reference table for boys and girls which use significantly lower 
reference weights than the WHO reference tables and divides it into four grades, grade IV reflecting the most 
underweight 
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 intravascular depleted malnourished child, whether this is due to its “adaptive hypocirculatory state”, dehydrating diarrhoea or distributive (septic) shock.  A thorough evaluation of cardiac function should include haemodynamic assessment. More than half a century ago, Kerpel-Fronius performed one of the first studies using the dye dilution technique to show that CO decreases with increasing severity of malnutrition.137 Alleyne also found CO to be decreased and demonstrated, that with recovery, CO increases alongside with an increase in both stroke volume (SV) and heart rate (HR).136 In the 1970s Viart et al. used right heart catheterization to shed further light on the cause of death in malnourished children in Zaire. In previous studies he demonstrated a proportional reduction in the circulation of blood volume and the metabolic demands.154 However, he described that “the haemodynamic pattern of the 
most severely malnourished cases – with low cardiac output, low ventricle filling pressures 
and high vascular resistances - were comparable to hypovolaemic shock in which the heart 
did not play a direct role”. He also added that intravenous fluid administration “neither 
improved the peripheral circulatory failure nor induced clinical heart failure.” 127 128  This reduction in cardiac output is generally considered an adaptive mechanism reflecting the reduction in metabolic activity. However, it remains unclear by which mechanism this is regulated and whether stress, in form of infections or intravenous fluids worsen cardiac function. Whatever the mechanism, once the CO is indexed to body weight or body surface area the resulting cardiac index (CI) is usually within the normal range,107 and sometimes even higher than in controls. 105 106 Good haemodynamic evidence of cardiac failure in children with severe malnutrition is therefore also lacking.  What about the heart muscle itself? Do autopsy studies provide any evidence of abnormalities that might indicate myocardial dysfunction? The descriptions of myocardial vacuolation in small numbers of patients need to be interpreted with caution. Vacuolation or cytoplasmic clearing of myocytes are non-specific findings that can also be due to glycogen storage diseases, carnitine deficiency, Fabry disease, mitochondrial and idiopathic cardiomyopathies, and other non-metabolic disorders such as hypoxic cell injuries. Contraction band artefacts can also give artificial clearing of the sarcoplasm. 155 Since special fixation to prevent leaching of water-soluble or water-extractable material such as glycogen was not used by most studies,60 it is difficult to determine that myocyte vacuolation, as the only significant characteristic histopathologic finding in 
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 children with kwashiorkor, 102 is due to hydropic degeneration, and its clinical significance remains uncertain.   Despite several studies over more than half a century, very limited conclusions can be drawn about the role of cardiac dysfunction as a cause of death among children with severe malnutrition. Specifically, there is little evidence that cardiac mass is reduced more than in proportion to body size; no good evidence that arrhythmias play a role; and only limited evidence from a minority of studies of clinically significant cardiac failure. Methodological limitations are common and many of the studies pre-date modern non-invasive imaging techniques such as echocardiography. For all these reasons there is a pressing need for further studies of cardiac structure and function in severe childhood malnutrition, incorporating clear case definitions; clinical, electrocardiographic and echocardiographic assessment; a suitable control group of children without severe malnutrition; and detailed information on comorbidities and other potential confounders. In the next chapter the methods of the present CAPMAL study are presented which was influenced by all these considerations.   
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3 Patients and Methods 
3.1 Study site  The study took place at Kilifi District Hospital in Coast Province, Kenya. The WHO Global Health Observational Data Repository for Kenya reported that in 2009 7% of children under the age of 5 years were wasted nationally, 16.4% underweight, and 35.2% stunted. The estimated national under-five mortality rate was reported as 85/1000 live births (http://apps.who.int/ghodata/). Kilifi District is one of the six Coast Province districts, and covers an area of 4779 km2 that borders Malindi, Tana River and Lamu in the north, Taita Taveta in the west, Mombasa in the south and the Indian Ocean in the east. Kilifi District Hospital is located in Kilifi town along the coast, about 50 miles north of Mombasa. It provides adult and paediatric in-and outpatient services to the district and has strong clinical and research links with the Kenya Medical Research Institutes (KEMRI) Wellcome Trust Research Programme, which is based on the same site.  
Figure 3.1 Map of Kilifi District showing the annual paediatric admission rate per 10,000 total 
population 
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 3.2 Patients   The CAPMAL study was introduced alongside an existing descriptive study of severe protein calorie malnutrition (the ‘PCM descriptive study’), such that children admitted to KDH and recruited to the PCM descriptive study were also invited to participate in the CAPMAL study if they fulfilled the following inclusion criteria based on WHO definitions of severe malnutrition:  
• Age 6 months to 12 years with bipedal oedema plus skin and/or hair changes of malnutrition (kwashiorkor); or 
• Age 6 months to < 5 years with mid upper arm circumference (MUAC) < 11.0 cm; 3 or 
• WHZ <-3 or visible severe wasting   Children with known congenital heart disease at admission, or who were found to have congenital heart disease during their first ECHO assessment, were excluded from the study.   
 A group of 22 patients was chosen to serve as a control group. Recruitment of the control group was initiated after enrolment into the malnourished group had stopped. Patients were frequency matched for age and diagnosis in order to investigate whether electrocardiographic, echocardiographic and laboratory findings in the malnourished group were specific to children with severe malnutrition per se, or more in line with general features of critical illness in this setting.  
3 Although the WHO currently uses a MUAC cut-off <11.5 cm to define severe malnutrition, for this study a cut-off of <11.0 cm (the old WHO cut-off) was chosen for consistency with the PCM descriptive study and to focus on cardiac function in the most severely malnourished children. 
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  Children were eligible for inclusion in the control group if they fulfilled all of the following inclusion criteria: 
• No clinical signs of severe malnutrition; and  
• MUAC ≥ 12.6 cm; and  
• WHZ score of more than -2SD; and  
• Presented to hospital with one of the following clinical syndromes by which they were frequency matched to malnourished cases: diarrhoea, pneumonia, other febrile illness.  Children were excluded as controls if they had known congenital heart disease or if they were found to have congenital heart disease on first ECHO assessment.  
  
3.3 Sampling procedure and sample size  All children presenting to hospital Monday to Friday between 8 am and 8 pm were screened for the study eligibility criteria in two ways. The online database management system was set up to flag eligible children to the admitting clinician, who in turn would inform the study team. Furthermore, during normal working hours between 8 am and 5 pm, the study nurse would also identify eligible children and inform the study team. Those consented were enrolled consecutively until at least 25 children with kwashiorkor and 50 children with marasmus were recruited. All children eligible for this study completed the local standard admission process at the time of admission. This included history, examination and routine clinical blood sampling.  The sample size of 25 kwashiorkor and 50 marasmic children was chosen to give >90% power to detect a 15% relative difference in mean ejection fraction (EF) among children with kwashiorkor compared with those with marasmus, assuming a mean EF of 60% among children with marasmus and a standard deviation of 10.5% in both groups.105 The same sample size gives 83% and 94% power respectively to detect a 15% or 20% relative difference in mean fractional shortening (FS) among children with kwashiorkor compared with those with marasmus, assuming a mean FS of 31% among children with marasmus and a standard deviation of 7% in both groups.109  Controls who fulfilled the inclusion criteria during the hours of recruitment were enrolled consecutively until the desired number in each matching category was achieved.
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3.4 Consent  Prior to the study, fieldworkers were trained in taking consent. At admission the study was then explained to the child’s caretaker in their local language (usually Giriama or Swahili) and written consent was sought by signature or thumbprint. A witness´ signature was necessary if the primary caretaker was unable to sign the consent form. When consent was refused only investigations needed for the clinical management of the child were performed. If consent for the study was refused at a later stage, no study specific follow up investigations were performed but care takers were asked whether information gathered so far was allowed to be included for analysis. Parents were given the option to consent separately for blood samples being stored and taken abroad for analysis. The KEMRI/National Ethical Review Committee approved the study in 2010 (SCC No 1777). 
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3.5 Clinical procedures  
3.5.1 Cardiac Assessment  Children recruited into the study underwent a full cardiac assessment within 4 hours of admission. This included a clinical examination, a comprehensive echocardiogram, and an electrocardiogram. Cardiac assessment was repeated at any point of deterioration, at day 7 of admission and at follow up on day 28.   For children who developed or presented with features of shock, cardiac function was assessed immediately and their response to any bolus of fluid rehydration was monitored using well established echocardiographic measures of fluid responsiveness and ventricular function 156-158 until resolution of features of shock. A full cardiac assessment including ECG was done as soon as possible after initiation of treatment; importantly, this assessment did not delay emergency treatment.   
Clinical examination Clinical assessment included anthropometry, a record of bedside observations (heart rate, blood pressure, capillary refill time, temperature gradient, pulse volume, respiratory rate, transcutaneous oxygen saturation and temperature) as well as auscultation of the heart and lungs, and palpation of the abdomen.  
Electrophysiologic assessment ECG monitoring was done on all children. A 12 lead ECG was performed at admission, at day 7, at any point of deterioration and on day 28 follow up appointment. An unselected subset of patients also received a continuous ECG monitoring (Holter ECG) for up to 7 days.  
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Echocardiographic assessment Echocardiography (Vivid i GE portable echograph) was performed to assess cardiac structure and function. All stable children recruited into the study had a comprehensive echocardiogram at presentation to exclude any congenital heart disease. All children with features of shock only had haemodynamic measures taken initially before and following fluid resuscitation. A comprehensive echocardiogram was then performed within 12 hours of presentation. Follow up echocardiograms for children were performed on day 7 and day 28 (when children routinely returned for their follow up).. For reliable images three readings were taken for each measurement and then averaged. The following parameters (Table 3.1) were measured, images digitally stored and assessed for sufficient quality by the cardiologist, who was blinded for the type of malnutrition and other underlying comorbidities.  
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 Table 3.1 Cardiac measurements used in the CAPMAL study and their abbreviations 
Measures of cardiac dimensions 
IVSd (mm) Interventricular septum thickness in diastole 
IVSs (mm) Interventricular septum thickness in systole 
LVPWd (mm) Left ventricular posterior wall thickness in diastole 
LVPWs (mm) Left ventricular posterior wall thickness in systole 
LVIDs (mm) Left ventricular internal diameter in diastole 
LVIDd (mm) Left ventricular internal diameter in systole 
Measures of cardiac volume and mass 
LV mass (g) Left ventricular mass (in diastole) 
LVEDV (ml) Left ventricular enddiastolic volume 
LVESV (ml) Left ventricular endsystolic volume 
Measures of systolic function 
FS [%] Fractional shortening 
MAPSE [mm] Mitral annular plane systolic excursion 
TAPSE [mm] Tricuspid annular plane systolic excursion 
Sa wave velocity (mm/s) Early systolic mitral annular velocity 
Measures of diastolic function 
E/A ratio Early to late diastolic filling 
E/Ea ratio Early filling (E) to early diastolic mitral annular velocity (Ea) 
Ea wave velocity (mm/s) Early diastolic mitral annular velocity 
Measures of global cardiac function 
Tei Index Left ventricular myocardial performance index 
Measures of cardiac haemodynamics 
SV (ml) Stroke volume 
SVI (ml/min/m2) Stroke volume index 
CO (L/min) Cardiac output 
CI (L/min/m2) Cardiac index 
IVCCI Inferior vena cava collapsibility index 
SVRI (ds/cm5/m2) Systemic vascular resistance index    
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3.6 Laboratory procedures and definitions  The standard investigations performed at admission for all children admitted to KDH include a full blood count (Beckman Coulter, Buckinghamshire, United Kingdom), thick and thin blood films for malaria parasites, electrolytes (U&E; ILyte Na/K Analyzer) and a blood culture (BACTEC PedsPlus, Becton Dickinson, CA, USA). A rapid HIV test is offered to all paediatric admissions on a ´opt-out` basis in keeping with Kenyan national guidelines.159  Malnourished children also had clinical blood samples taken at admission for plasma electrolytes, creatinine, lactate and blood gases. Furthermore this study stored plasma for electrolyte and micronutrient analysis as well as for thyroid function, cytokines and markers for cardiac dysfunction (Table 3.2). Study bloods were repeated on day 7 and day 28 day follow up. Remaining plasma from routine clinical samples taken at admission, follow up or during any deterioration were likewise stored for retrospective analysis.    
Lactate Lactate (mmol/L) testing was done at the bedside using the Lactate Pro portable analyser by KDK Corporation (Kyoto, Japan).  The Lactate Pro is supplied with a check strip to ensure the analyser is operating correctly and a calibration strip for internal quality control. The reaction principle of the chemical strips has been described elsewhere.161 Abnormal lactate defined as lactate above 2mmol/l. 162 Results were found to correlate well with other non-portable lactate analysers in other studies.163 164 
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 Table 3.2 Number and timings of additional laboratory tests done for the CAPMAL study 
 Admission Day 7 Day 28 
Serum biochemistry 
Urea & Creatinine (88/88) (82/85) (57/62) 
Electrolytes* (88/88) (82/85) (57/62) 
Albumin (88/88) (82/85) (57/62) 
Blood Gas (78/88) (81/85) (56/62) 
Serum Lactate (82/88) (77/85) (56/62) 
Haematology 
Full blood count (86/88) (84/85) (59/62) 
MPS (76/88) - - 
Hormone & Vitamins  
Thyroid stimulating Hormone (58/88) - - 
Free thyroxin (58/88)   
Free trijodthyronin (20/88) (4/85) (1/62) 
Vitamin D  (79/88) - - 
Vitamin B12 (79/88) - - 
Cardiac markers 
NT-proBNP (54/88) (49/85) (25/62) 
Cytokine assays 
Interleukin (IL) 6  (53/88) (49/85) (34/62) 
Interleukin (IL) 1b (53/88) (49/85) (35/62) 
TNF-a (53/88) (49/85) (34/62) 
Interferon (IFN) g (53/88) (49/85) (34/62) 
Other assays 
HIV testing (88/88) - - 
  
* including sodium, potassium, calcium, magnesium and phosphate  Calcium and magnesium levels were both corrected for albumin using the following formula:  
Corrected Calcium (mmol/L)= measured Ca+ 0.02*(40-albumin)165 
Corrected Magnesium (mmol/L)= measured Mg+ 0.005*(40-albumin)166  Where not otherwise specified, reference ranges are from Nelson´s Textbook of Pediatrics and are quoted in Table 3.3.  
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 Table 3.3 Normal reference ranges and cut-offs found in the general literature 
Sodium167 Normal range 138-145 (mmol/L)  
Severe hyponatraemia50 <125 (mmol/L)  
Potassium167 Normal range 3.5-6.0 (mmol/L)  
Severe hypokalaemia50 < 2.5 (mmol/L)  
Phosphate168 169 Normal range 0.8 -1.78 (mmol/L)  
Hyperphosphataemia >1.78 (mmol/L)  
Moderate hypophosphataemia 0.32-0.8 (mmol/L)  
Severe hypophosphataemia <0.32 (mmol/L)  
Magnesium170 Normal range 0.75-1.5 (mmol/L)  
Hypermagnesaemia >1.5 (mmol/L)  
Hypomagnesaemia <0.75 (mmol/L)  
Calcium Normal range 2.1-2.6 (mmol/L)  
Hypercalcaemia >2.6 (mmol/L)  
Hypocalcaemia <2.1 (mmol/L)  
Albumin167 Normal range 39-53 (g/L) 
Hypoalbuminaemia171 < 34 (g/L) 
Severe hypoalbuminaemia127 < 15 (g/L) 
Vitamin D172 Normal range 50-150 (nmol/L) 
Insufficient <50 >25 (nmol/L) 
Deficient <25 (nmol/L) 
Vit B12167 Normal range 140-700 (pg/ml) 
NT-proBNP, elevated173 1 – 12 months > 650  (pg/ml) 
12 – <24 months  > 400  (pg/ml) 
2 years - < 6 years > 300  (pg/ml) 
6 years – 18 years > 160  (pg/ml) 
Lactate 162 Normal < 2.0 (mmol/L) 
TSH Normal 0.3-4.2 (mIU/L) 
Free T4 Normal 9-26 (pmol/L) 
Free T3  Normal 2.5-5.7 (pmol/L) 
Haemoglobin174 Severe anaemia Hb < 5 g/dl 
 Moderate anaemia Hb 5 - <9.3 g/dl 
 Mild anaemia Hb 9.3 -<11 g/dl174 
White Cell Count Leukocytosis As per Goldstein definition for 
SIRS175  Leucopenia 
Thrombocytes Thrombocytopenia < 80 x 109/L 
 Thrombocytosis >480 x 109/L 
Severe acidaemia176 pH <7.20  
Low Bicarbonate HCO3- < 18 (mmol/L)  
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NT-proBNP  NT-proBNP was measured in duplicate using the electrochemiluminescence immunoassay by MSD (Meso Scale Discovery; Human NT-proBNP; Multi-Spot Assay System, Gaithersburg, MD, USA) according to the manufacturer’s assay protocol. The average lower limit of detection was 13.3 pg/mL.  
Cytokine assays Serum levels of interferon gamma (IFN-g), tumor necrosis factor alpha (TNF-a), interleukin 1-b (IL-1b) and interleukin-6 (IL-6) were measured in duplicate using the electrochemiluminescence immunoassay by MSD (Meso Scale Discovery; Human ProInflammatory I 4-Plex Assay; Multi-Spot Assay System, Gaithersburg, MD, USA) according to the manufacturer’s assay protocol. The average lower detection limits for the cytokines across 5 plates were 1.4 pg/mL for INF-g, 1.0 pg/mL for TNF-a, 0.4 pg/mL for IL-1b and 0.4 pg/mL for IL-6.   Due to limited financial resources, IL-6, IL-1b, TNF-a, IFN-g and NT-proBNP were only measured on a random subset of malnourished children at admission, day 7 and day 28.  The above assays were run by a laboratory technician whom I assisted in the procedure.    
3.7 Clinical Management and Follow up  Clinical, ECG and ECHO findings from each assessment were communicated to the clinician looking after the patient. The clinician was informed of any pericardial tamponade or structural heart defects that helped guiding the treatment. Children found to have a significant structural heart defect were referred for further cardiac assessment and follow-up by a cardiac specialist. 
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3.8 Data Management and Statistical Methods   
3.8.1 Data Management and Storage  Routine admission clinical data and laboratory data were entered onto computer using Filemaker Pro version 9.0 and stored on the KEMRI data server under each child’s unique inpatient serial number. Additional clinical and laboratory data were entered onto computer using EpiData, and stored under the same unique serial number. CAPMAL specific data was entered on paper CRFs at the time of assessment and entered into the CAPMAL database by data entry clerks after patients had completed their follow up visit. All data was regularly backed up and backup copies were stored both on and off site. Paper records were archived in locked cabinets at KEMRI, Kilifi. Prior to analysis all clinical and laboratory datasets were merged by inpatient serial number.  
 
3.8.2 Data Analysis  General methods of analysis are presented here. Further details of individual analyses are presented in specific chapters. All analyses were performed using Stata version 10 (Stata® corp., USA).  
Descriptive analysis of all children with severe acute malnutrition Descriptive data were presented in terms of the numbers and proportions of categorical variables. We assessed continuous data for normality and presented the means (and standard deviations) of normally distributed variables and the medians (and interquartile ranges) of non-normal data as appropriate. We used box and whisker plots to illustrate these data graphically.  We presented crude odds ratios (OR) and 95% confidence intervals (CI) for associations between putative clinical risk factors and both indices of cardiac function and death. To identify independent associations between these exposures and outcomes we used multivariable logistic regression and presented adjusted ORs and 95% CIs. We included in each model all variables associated with the outcome in the univariable analysis, and/or for which there was a strong a priori hypothesis of an association.177 We 
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 explored relationships between continuous variables using simple and multivariable linear regression.   To further explore the likely clinical significance of our findings in each assessment modality, we summarised the number and proportion of children with clinical, biochemical and echocardiographic evidence of cardiac dysfunction. For the purposes of this analysis we defined clinical evidence of congestive cardiac failure (CCF) as the co-existence of three or more clinical signs of CCF (Tachycardia, gallop rhythm, tender hepatomegaly, tachypnoea or distended neck veins). We generated Venn diagrams to illustrate the overlap between clinical, biochemical and echocardiographic evidence of cardiac dysfunction.  
Comparative analyses  We compared indices of cardiac function between children with kwashiorkor and marasmus, and between children with and without severe malnutrition, to test the null hypotheses that there was no difference between these groups. We presented descriptive data as described above. For each categorical variable we derived crude ORs and 95% CIs for associations between groups. We used the χ2 test of heterogeneity to explore whether the presence or type of malnutrition modified the effect of clinical and biochemical indices on cardiac dysfunction and death. We used the Wilcoxon rank-sum test (for non-parametric data) or Student’s t test (for normally distributed data) to compare continuous variables between the groups.  To identify indices of cardiac function that were independently associated with a particular clinical group (kwashiorkor vs marasmus; malnourished cases vs non-malnourished controls) we created multivariable logistic regression models incorporating all variables associated with the outcome in the univariable analysis, and/or for which there was a strong a priori hypothesis of an association.177  
Multiple testing As a uniquely comprehensive descriptive study incorporating a combination of clinical, biochemical, electrocardiographic and echocardiographic indices, there is a risk that multiple comparisons will lead to apparently ‘significant’ differences between groups due to chance alone (type 1 error). Statistical methods like the Bonferroni correction may be used to correct for multiple testing. However these methods tend to be conservative, so risk limiting power to detect real differences, particularly in a study of this size. 177 Therefore, rather than correcting p values, we chose to present all 
 65 
 comparisons with uncorrected p-values and instead to take account of multiple testing in interpreting our results.178 179 Rather than relying on observed associations with individual indices, we used complementarity to infer significance.180 Thus, when similar differences were observed in several complementary indices (e.g. clinical features of shock; echocardiographic features of cardiac dysfunction; etc), we concluded these were important.  
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4  Clinical description and laboratory investigations  
4.1 Introduction  The limitations of the existing literature on cardiac function in children with severe malnutrition have been presented and discussed in detail in chapters 1 and 2. These include the failure of most publications to describe their study cohorts in detail; hence generalization of their results is questionable.  Over the last 10 years, roughly 600 to 1000 children meeting anthropometric criteria for severe malnutrition are admitted to Kilifi District Hospital each year (12-18% of all admissions), of whom 38% present with nutritional oedema (Kwashiorkor).51 181 Yet despite the fact that children with malnutrition are frequently viewed as a high-risk group for developing cardiac failure, there is little evidence historically that cardiac failure is a problem among severely malnourished children admitted to Kilifi District Hospital.  Data on biochemical measures of cardiac performance in malnourished children are also limited.100 This includes general markers of poor cardiac output such as serum lactate and acidosis; as well more specific markers of cardiac function such as N-terminal pro-brain natriuretic peptide (NT-proBNP). Serum lactate is a marker for tissue hypoperfusion and cellular hypoxia and has recently been shown to be independently associated with in-hospital mortality in critically ill children.182 BNP is released in response to increased filling pressures (myocardial wall stretch) and pressure load on the heart and is known to correlate well with cardiac dysfunction,183 184 but has never been studied in children with severe malnutrition.   Whether or not cardiac failure is a factor, severe malnutrition carries a high attributable mortality in Kilifi as in other settings. 185 186However to understand the determinants of a poor outcome, and the potential role and causes of cardiac dysfunction, we need also to understand common comorbidities among children with severe malnutrition - particularly those conditions like sepsis, anaemia, HIV and dehydration which themselves have cardiovascular effects (section 1.5, page 21).  
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 Diarrhoea, HIV, bacteraemia, anaemia, impaired perfusion and electrolyte perturbations frequently complicate severe malnutrition, and are themselves associated with high mortality rates.50 51 Thus although the overall 48 hour mortality of children admitted with severe malnutrition to Kilifi District Hospital has fallen in the last 10 years from 33% to 11%,50 51 it remains as high as 52% amongst those who present in shock63 and those with proven bacteraemia. The overall prevalence of HIV infection among children admitted to Kilifi District Hospital is about 6%.187 Among children with severe malnutrition it is about 16%. 185 It is also known that malnourished children are at high risk of developing re-feeding syndrome, which has been described in chapter 1 in more detail, which can be fatal. However the impact of re-feeding on host biochemistry, and the possible effects of this on fluid shifts and/or haemodynamic parameters, have not been examined in malnourished children admitted to Kilifi District Hospital. The presence at admission of severe anaemia and electrolyte perturbations such as hyponatraemia and hypokalaemia have been previously reported to help in identifying children at moderate risk of early mortality.50  I aim in this chapter to describe the cohort of children with severe malnutrition admitted to the CAPMAL study, including: 1) clinical presentation; 2) prevalence of comorbidities known to be associated with cardiac dysfunction;  3) detailed clinical cardiovascular profiles; 4) laboratory investigations 5) differences in any of the above between marasmus and kwashiorkor 
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 4.2 Methods 
4.2.1 Patient enrolment, investigation and management  Methods for patient enrolment, investigation and management are set out in chapter 3. Baseline demographic and clinical characteristics of children recruited to the study were summarized and compared to those of children not recruited to the study.   
4.2.2 Clinical Definitions  We used published WHO definitions of clinical syndromes (Table 4.1). We also used WHO definitions of tachycardia and shock (Table 4.2). Because the WHO has not published definitions of all haemodynamic parameters, and published definitions of paediatric shock vary, and we also used European Paediatric Life Support (EPLS) and Paediatric Advanced Life Support (PALS) definitions of shock and other haemodynamic parameters (Table 4.2).  We used the standard internationally recognized definition of Systemic Inflammatory Response Syndrome (SIRS).175 Hypothyroidism was defined by high TSH (mIU/mL) and low free T4 levels (pmol/L). Secondary hypothyroidism was defined by low free thyroxine (fT4) regardless of the thyroid stimulating hormone (TSH) level. Subclinical hypothyroidism was defined by a TSH >10 (mIU/mL) regardless of the free T4 level. 160 Throughout this thesis no distinction will be made between the three forms and they will be summarized by the term ´hypothyroidism´.  
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Table 4.1 WHO Clinical Definitions Pneumonia (p80)* Tachypnoea:  Age <2 months:     >=60/min                            Age 2-11 months: >=50/min                            Age 1-5 years:        >= 40/min plus signs of pneumonia chest auscultation Severe pneumonia (p78)* Chest wall indrawing, grunting, nasal flaring plus signs of pneumonia Very severe pneumonia (p73)* Central cyanosis, severe respiratory distress, inability to drink, lethargy plus signs of pneumonia or severe pneumonia Signs of congestive cardiac failure (p106)* 
Tachycardia, gallop rhythm, tender hepatomegaly, tachypnoea in young children or oedema and distended neck veins as a sign of raised central venous pressure in older children Weight gain   (p195)* Poor:             < 35g/kg/week Moderate:    35-70g/kg/week Good:             >70g/kg/week *Note: pages locating definitions in the WHO Pocket Book of Hospital care for children  We defined a simple clinical cardiac failure score as the number of WHO clinical signs of congestive cardiac failure (CCF) that were present (0-5). Each of these clinical signs of CCF are non-specific on their own in this clinical setting - especially tachycardia and tachypnoea, both of which are occur in common comorbidities like pneumonia or sepsis. We therefore reported the numbers of children with 0, 1, 2, 3, 4 and 5 clinical signs of CCF. To increase specificity we arbitrarily chose a cut-off of 3 signs of CCF to define clinical cardiac failure.     
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Table 4.2 Various haemodynamic definitions according to published guidelines WHO Tachycardia Heart rate:       Age <12 months:               >160/min Age 12 months -5 years: >120/min WHO shock Lethargic or unconscious and cold hands and CRT >3 seconds and weak pulse and tachycardic EPLS shock Lethargic or unconscious and cold hands and CRT >2 seconds and weak pulse and tachycardic EPLS tachycardia Heart rate:      Age <12 months:               >180/min Age 12 months -5 years: >160/min EPLS bradycardia Heart rate:      Age <12 months:               <80/min Age >12 months:              <60/min PALS Hypotension188 Systolic BP     Age 1 – 12 months:            <70mmHg Age >1 year to 10 years :<70mmHg + (2* age in years)  Age >10 years:                    <90mmHg  
WHO: World Health Organisation; EPLS: European Paediatric Life Support; PALS: Pediatric Advanced Life Support      
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4.3 Results 
4.3.1 Description of the cohort  Enrolment to the CAPMAL study took place between March 2011 and February 2012. One hundred and thirty-four patients met the entry criteria (Figure 4.1). Thirty-nine of these children could not be recruited because they presented during a 4-week period while the echo machine was out of service. The parent/guardian refused consent for a further two children, and one was transferred to another hospital before enrolment.  Ninety-two patients were therefore enrolled and consented for the study, of whom four were subsequently found not to meet the inclusion criteria: in two patients anthropometric measurements were just outside the study inclusion criteria when rechecked, and two others met the study exclusion criteria because they had pre-existing heart disease - one with an atrioventricular septum defect and one atrial fibrillation, both causing failure to thrive. The final analysis therefore included 88 children with severe malnutrition. Follow up rates at day seven and day twenty-eight were 100% and 84% respectively. Recruitment of malnourished children preceded those of controls and their follow up period ended in November 2011.   
Figure 4.1 Enrolment and follow up flow chart of CAPMAL patients4 
 
4 During the study period 134 children were found eligible for the CAPMAL study. Thirty-nine children could not 
be recruited due to equipment failure. Ninety-two children were assessed on admission of which 2 were found 
to have underlying heart disease and 2 were actually incorrectly measured and not found to be malnourished. 
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4.3.2 Comparison of CAPMAL children and other children with severe malnutrition admitted to 
KDH  Baseline characteristics and outcome of children enrolled to the study (‘CAPMAL children’) are compared in Table 4.3 with 230 other severely malnourished patients who were not enrolled because they were admitted outside the study recruitment hours of 8am to 8pm Monday to Friday during the same enrolment period. The two groups were similar in demographics, and in the proportions with kwashiorkor, marasmus, and other important comorbidities. However, CAPMAL patients had a lower median weight and MUAC. Although overall mortality was similar among children who were and were not recruited to the study, a greater proportion of those recruited to CAPMAL study died after seven days of admission suggesting participation in the study may have delayed but not prevented some deaths. 
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Table 4.3 Baseline characteristics between recruited and non-recruited severely malnourished 
patients at admission 
     
Category Features at admission 
 
Recruited 
N=88 
Non-recruited 
N=230 
 
p value 
Gender Male (%) 48 (55%) 134 (58%) 0.549 
Age Median age (months) 19 (13, 35) 19 (12, 38) 0.814 
Anthropometry Median weight (kg) 6.79 (5.80, 7.96) 7.26 (6.06, 9.22) 0.007 
Median WH z-scorea -3.2  (-3.8,  -2.5) -3.1 (-3.6, -2.5) 0.176 
Median MUACb (cm) 10.9 (10.0-11.5) 11.5  (11.0-13) <0.001 
Malnutrition type Kwashiorkor 36  (41%) 70 (31%) 0.085 
Temperature Fever (>37.5°C) 25  (28%) 107 (47%) 0.235 
Hypothermia (< 35.0°C) 2 (3%) 1 (0.4%) 0.129 
Respiratory Tachypnoea (>40/min) 25 (23%) 60 (31%) 0.150 
Cardiovascular Tachycardia (>160/min) 22 (25%) 52 (23%) 0.744 
Bradycardia (<80/min) 0 (0.0%) 0 (0.0%) N/A 
Neurological Impaired consciousness * 7 (8%) 27 (12%) 0.329 
History of convulsions 5 (6%) 17 (8%) 0.579 
Clinical diagnosis Diarrhoea * 42 (46.7%) 112 (49%) 0.693 
Pneumonia *  16 (18%) 50 (22%) 0.484 
Outcome Death (any time) 14 (16%) 25 (11%) 0.170 
Death< 48 hrs  1 (1%) 6 (3%) 0.816 
Death ≥2 days  < 7days  2 (2%) 7 (3%) 0.306 
 Late deaths ≥ 7 days 11 (79%) 12 (48%) 0.062  
* as diagnosed by the admitting clinician Data is presented as absolute numbers and proportions (%) and medians and interquartile ranges (IQR). aWHZ= weight-for-height z-score bMUAC= Mid upper arm circumference
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4.3.3 Description of CAPMAL cohort and comorbidities   The median age of children admitted with severe malnutrition (SAM) was 19 months with slightly more males than females (Table 4.3).  Their median weight was 6.8 kg, their median WHZ score was -3.2 and their median MUAC was 10.9 cm.   In addition to severe malnutrition, the main presenting complaints in both study and non-study patients were fever (28%), pneumonia (13%) and diarrhoea (26%) (Table 4.4). Developmental delay, either due to cerebral palsy or for other reasons, was found in 17%. Twenty (23%) of enrolled children were HIV positive. HIV data on severely malnourished patients not recruited to the study was less comprehensive and therefore not reported as selection bias for testing cannot be excluded.  By the 7th day of admission fever had resolved in 20/25 (80%) children who were febrile on admission, but a further 4 children had developed fever.  Similarly, clinical signs of pneumonia resolved within the first week in 7/11 (64%) children with pneumonia at admission, and one child had developed new signs of pneumonia by day 7. Of the 23 children with diarrhoea at admission 7 (30%) were still symptomatic at day 7 and a further 13 had developed diarrhoea. One child who was HIV positive suffered from persistent diarrhoea throughout admission and died shortly after the day 28 review.  Interestingly, the proportion of children meeting the clinical definition of SIRS (presumptive sepsis) remained unchanged in approximately 33% of patients between admission and day 7, and had only reduced slightly to 26% of children by day 28.    
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Table 4.4 Overview of clinical features in severely malnourished children at admission, day 7 and day 
28   
Category Features  
 Admission 
N=88 
Day 7 
N=85 
Day 28 
N=62 
Temperature Fever (>37.5°C) 25  (28%) 9 (11%) 5 (8%) 
Hypothermia (< 35.0°C) 2 (2%) 0 (0%) 0 (0%) 
Respiratory Tachypnoea  (WHO)a 18 (21%) 22 (26%) 12 (19%) 
Indrawing 5 (6%) 2 (2%) 1 (2%) 
Deep breathing 6 (7%) 6 (7%) 0 (0%) 
Hypoxia (O2 saturations<95%) 1 (1 %)  4 (5%) 2 (3%) 
Hydration status Decreased skin turgor 8 (10%)  1 (1 %) 0 (0%) 
Sunken eyes 22 (26%) 3 (4%) 0 (0%) 
Dry mucous membranes 10 (12%) 2 (2%) 0 (0%) 
Neurological Blantyre Coma Score ≤ 4 11 (13%) 8 (9%) 3 (5%) 
Cerebral Palsy 10 (11%) not assessed not assessed 
Developmental delay 15 (17%) not assessed not assessed 
Clinical  
diagnosis 
Pneumonia (WHO)b 11 (13%) 5 (6%) 2 (3%) 
SIRSc 29 (33%) 28 (33%) 16 (26%) 
Diarrhoea (WHO)d 23 (26%) 20 (24%)  1 (2%) 
HIVe 20  (23%) not assessed not assessed Data is presented as absolute numbers and proportions (%) aTachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years bPneumonia encompasses mild, moderate and severe forms as defined by WHO (see Table 4.1) c SIRS denotes systemic inflammatory response syndrome and was defined per Goldstein criteria dDiarrhoea was defined as ≥ 3 watery stools eHIV denotes human immunodeficiency virus 
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4.3.4 Cardiovascular profile of malnourished children  
Cardiovascular profile of children with malnutrition during the course of admission 
 Clinical haemodynamic parameters at admission, day 7 and day 28 are summarized in Table 4.5 and Table 4.6. Features of impaired perfusion (tachycardia, prolonged capillary refill time, weak pulse and temperature gradient) were present in less than 10% of patients at admission, and only 4/88 (5%) of children fulfilled EPLS criteria for shock, all of whom had diarrhoea (Table 4.17), suggesting intravascular depletion as the likely cause. Signs of impaired perfusion reduced in prevalence over the course of hospital admission. A small minority (<10%) of patients were hypotensive at each time point, none of whom had a prolonged CRT or temperature gradient. Only one of the children with hypotension required fluid resuscitation and died the same day (day 28). Clinical signs of heart failure (gallop rhythm, neck vein distension, tachypnoea and hepatomegaly) were rare at all time points (see section 4.3.7).    
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 Table 4.5 Overview of continuous haemodynamic data of malnourished children at each review point 
 Admission 
N=88 
Day 7 
N=85 
Day 28 
N=62 
Heart rate (bmp) 132 (120, 142) 133 (124, 148) 134 (121, 146) 
BP systolic (mmHg) 89 (89, 102) 92 (83, 100) 95 (88, 105) 
BP diastolic (mmHg) 62 (55, 73) 64 (55, 70) 67 (57, 72) 
BP mean (mmHg) 73 (65, 83) 77 (68, 82) 77 (70, 87) 
Pulse pressure (mmHg) 25 (22, 32) 27 (23, 33) 30 (24, 35)  Data is presented as medians and interquartile ranges (IQR)  
Table 4.6 Clinical haemodynamic parameters in all malnourished children at each review point 
 Admission 
N=88 
Day 7 
N=85 
Day 28 
N=62 
Tachycardia  (WHO)a 52 (59%) 52 (61%) 38 (61%) 
Tachycardia (EPLS)b 7 (8%) 5 (6%) 2 (3%) 
Bradycardia (<80/min) 0 (0%) 0 (0%) 0 (0%) 
Weak pulse 5 (6%) 1 (1%) 0 (0%) 
Temperature gradientc 6 (7%) 3 (4%) 0 (0%) 
CRT>3 secd 1 (1%) 0 (0%) 0 (0%) 
CRT>2 sec 5 (6%) 1 (1%) 0 (0%) 
Hypotension (PALS)e 8 (9 %) 6 (7%) 2 (3%) 
Shock (WHO)f       1 (1%) 0 (0%) 0 (0%) 
Shock (EPLS)g 4 (5%) 0 (0%) 0 (0%) 
Gallop rhythm 2 (2%) 2 (2%) 1 (2%) 
Neck vein distension  1 (1%) 2 (2%) 1 (2%) 
Hepatomegalyh 15 (17%) 19 (22%) 13 (21%) 
Tachypnoea (WHO)e 18 (21%) 22 (26%) 12 (19%) Data is presented as absolute numbers and proportions (%). a WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years b EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years c The temperature gradient (TG) was assessed by running the back of the hand from the toe to the knee. A positive gradient was defined as a temperature change from cold to warm. d CRT denotes capillary refill time. The CRT was assessed by applying pressure to whiten the nail of the thumb or big toe for 3 seconds and determining the time form the moment of release until total recovery of the pink colour. e Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  f  WHO shock= Lethargy/unconsciousness plus TG plus CRT>3sec plus weak pulse plus tachycardia g EPLS shock= Lethargy/unconsciousness plus TG plus CRT>2sec plus weak pulse plus tachycardia h Hepatomegaly was defined as a palpable liver edge ≥ 2cm below the costal margin in the mid-clavicular line. e Tachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years  
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4.3.5 Laboratory findings in children with severe malnutrition  
Serum biochemistry  Serum biochemistry at days 0, 7 and 28 is summarized in Table 4.7. Five percent of children were severely hyponatraemic at admission. Consistent with published reports severe hyponatraemia and hypokalaemia were frequent at admission. More than 25% of children had severe hypokalaemia (K<2.5mmol/L). Both median sodium and median potassium concentration  rose across the study period as seen in Figure 4.2. with potassium levels normalising in all children by day 7. These were the two major electrolyte perturbations. Contrary to previous reports (which had some selection bias), other major electrolyte abnormalities were not so prevalent. For example, median serum phosphate concentration was not low at admission but continued to increase over the 28-day study period. In fact, a higher proportion of children displayed concentrations above normal and this proportion increased from one time point to the next. Overall, six patients had low serum phosphate concentrations at day 7 but in only two patients was this de novo. One of these two patients also showed low magnesium levels at day 7 but normal potassium levels. The mean concentration of magnesium fell during the course of realimentation. By day 7, 15/85 (18%) of children had serum magnesium below the normal range. Those were nearly 8 times more likely to die (OR 7.88, 95%CI 1.8 to 34, p=0.006). This did not seem to be mediated by increasing phosphate levels described above, as there was no association between hyperphosphataemia and hypomagnesaemia at any time point. Albumin is known to be low in malnutrition. Median admission albumin concentration was 24 g/L.  Severe hypoalbuminaemia (<15g/L) was present in 14 (16%) children By day 7, 19 (23%) children had severe hypoalbuminaemia. Severe hypoalbuminaemia at admission was not associated any sign of impaired perfusion nor with death, however children with severe hypoalbuminaemia at day 7 were 9 times more likely to die (OR 9, 95% CI 2  to 42, p=0.004). 
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Table 4.7 Biochemical parameters of malnourished children at admission, day 7 and day 28 
 
Admission 
N=88 
Day 7 
N=85 
Day 28 
N=62 
Sodium (mmol/L) 136 (132, 138) 138 (137, 140) 139 (138, 140) 
Hyponatraemia (No, %)<125mmol/L) 4 (5%) 0 - 0 - 
Hypernatraemia (>146mmol/L) 1 (1%) 4 (5%) 0 - 
Potassium (mmol/L) 3.2 (2.5, 3.9) 4.3 (3.9, 4.7) 4.3 (3.8, 4.6) 
Hypokalaemia (<2.5mmol/L) 20 (27%) 0 - 0 - 
Hyperkalaemia (>6.0mmol/L) 0 - 1 (1%) 0 - 
Phosphate (mmol/L) 1.3 (1.1, 1.5) 1.6 (1.2, 1.8) 1.7 (1.4, 1.9) 
Hypophosphataemia (<0.32mmol/L) 9 (10%) 6 (8%) 0  
Hyperphosphataemia (>1.78mmol/L) 13 (15%) 20 (24%) 25 (44%) 
Calcium (mmol/L) 2.3 (2.2, 2.4) 2.4 (2.3, 2.5) 2.5 (2.5, 2.6) 
Hypocalcaemia (<2.1mmol/L) 6 (7%) 2 (2%) 0 - 
Hypercalcaemia (>2.6mmol/L) 2 (2%) 5 (6%) 19 (33%) 
Magnesium (mmol/L) 0.97 (0.86, 1.1) 0.91 (0.80, 0.97) 0.90 (0.86, 0.97) 
Hypomagnesaemia (<0.75mmol/L) 4 (5%) 15 (18%) 2 (4%) 
Hypermagnesaemia(>1.5mmol/L) 1 (1%) 0 - 0 - 
Albumin (g/L) 24 (18, 34) 22 (16, 29) 33 (28, 36) 
Hypoalbuminaemia (<34g/L) 66 (75%) 76 (93%) 37 (65%) 
Severe hypoalbuminaemia (<15g/L) 14 (16%) 19 (23%) 0 - 
Urea (mmol/L) 2.3 (1.5, 3.4) 1.9 (1.1, 2.8) 2.3 (1.8, 3.3) 
Hyperuricaemia (>6.4mmol/L) 8 (9%) 4 (5%) 2 (4%) 
Creatinine (μmol/L) 34 (29, 40) 31 (28, 36) 38 (35, 40) 
Hypercreatinaemia (>74 μmol/L) 5 (6%) 3 (4%) 1 (2%) 
Blood glucose (mmol/L) 4.2 (3.4, 4.4)     
Hypoglycaemia (<3.0mmol/L) 16 (23%) - - - -  Data is presented as medians (IQR), as well as absolute number (%)above and below the normal reference range. Numbers analysed can be found in Table 3.2 
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 Figure 4.2 Box and whisker plots of electrolyte and albumin concentrations in all malnourished 
children at admission, day 7 and day 28 
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Thyroid function Thyroid function tests were done at admission. Eleven malnourished children (19%) had an elevated TSH level and 17 (20%) had a low free T4 concentration (Table 4.8). Children with kwashiorkor tended to have higher TSH levels than children with marasmus (p=0.042). Overall 18 (21%) met the clinical definition of hypothyroidism, a proportion that was similar among children with marasmus and kwashiorkor. None of the children was hyperthyroid.  
Table 4.8 Thyroid function status of malnourished children overall and differences between children 
with marasmus and kwashiorkor at admission  
 All malnourished Marasmus Kwashiorkor p value 
TSH (mIU/mL) 2.4 (1.5, 3.3) 1.6 (0.9, 3.3) 2.5 (1.9, 3.5) 0.042 
Low TSH 2/59 (3%) 2/33 (6%) 0/26 (0%) 0.202 
High TSH 11/59 (19%) 6/33 (18%) 5/26 (19%) 0.918 
Free T4 (pmol/L) 10.6 (9.3, 12.9) 11.2 (9.7 to 13.7) 10.1 (9.1, 11.7) 0.090 
Low free T4 17/84 (20%) 9/50 (18%) 8/35 (23%) 0.614 
High free T4 1/84 (1%) 1/50 (2%) 0/35 (0%) 0.395 
Hypothyroid 18/85 (21%) 10/85  (12%) 8/85 (9%) 0.751   Data is presented as medians(IQR), as well as absolute number (%)above and below the normal reference range. Numbers analysed can be found in Table 3.2 The following definitions were applied: Low TSH (<0.3mIU/mL), high TSH (> 4.2 mIU/mL), low fT4 (<9pmol/L), high fT4(>26pmol/L), Hypothyroidism is used to describe established hypothyroidism, secondary and subclinical hypothyroidism (see definitions used on page 68). 
 
Vitamin levels Median Vitamin D levels at admission were within normal range but 5/83 (6%) of children were Vitamin D deficient. There was no difference in the Vitamin D status of children with marasmus or kwashiorkor.  Vitamin B12 levels were abnormally high in 35/83 (42%) of children and those with kwashiorkor had higher median concentrations than children with marasmus (885 vs. 592 nmol/L, p=0.021). Median Vitamin B12 concentrations were not significantly lower in children with haemoglobin concentrations below 9.3 g/L (735 vs. 607; p=0.420). 
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Table 4.9 Vitamin D and Vitamin B12 levels of malnourished children overall and differences between 
children with marasmus and kwashiorkor at admission  
 
All malnourished 
N=83 
Marasmus 
N=49 
Kwashiorkor 
N=34 
p value 
Vitamin D (nmol/L) 89 (70, 116) 86 (70, 107) 96 (74, 117) 0.442 
Vitamin D deficiency 5 (6%) 3 (6%) 2 (6%) 0.940 
Elevated Vitamin D  3 (4%) 1 (2%) 2 (6%) 0.356 
Vitamin B12  (nmol/L) 701 (407, 1136) 592 (373, 1058) 885 (581, 1249) 0.021 
Vitamin B12 deficiency 3 (4%) 2 (4%) 1 (3%) 0.784 
Elevated Vitamin B12 35 (42%) 17 (35%) 18 (53%) 0.098  Data is presented as medians(IQR), as well as absolute number (%)above and below the normal reference range. Numbers analysed can be found in Table 3.2 The following definitions were applied: Vitamin D deficient (<25nmol/L), elevated Vitamin D (>150nmol/L), Vitamin B12 deficient (<160nmol/L).   
 
Blood gas analysis, NT-proBNP and cytokines A high proportion of children had biochemical features of tissue hypoperfusion at admission with acidosis and hyperlactataemia (Table 4.10). Acidosis improved slightly in the first week, however the proportion of children with elevated lactate levels increased further and remained elevated throughout until day 28. In total, only 5 children had lactate levels above 5mmol/L of which one child died shortly after his day 7 review of fulminant sepsis. The OR for death was 6 (95% CI 1.5 to 26, p=0.013) if lactate was above 5mmol/L at any time during the observation period. 
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Table 4.10 Biochemical markers of tissue hypoperfusion and cardiac dysfunction in malnourished 
children overall at admission, day 7 and day 28  
 
Admission 
N=78 
Day 7 
N=81 
Day 28 
N=57 
pH 7.39 (7.31, 7.45) 7.38 (7.31, 7.42) 7.39 (7.36, 7.41) 
Severe acidaemia (pH<7.2) 10 (13%) 8 (10%) 1 (2%) 
Base excess -8.1 (-12.2, -5.4) -6.7 (-11.7, -2.8) -4.9 (-7.5, -3.5) 
Base deficit >10 mmol/L 27 (38%) 25 (33%) 5 (9%) 
Lactate (mmol/L) 2.1 (1.7, 2.7) 2.4 (2.0, 3.2) 2.2 (1.9, 2.7) 
Hyperlactataemia (>2mmol/L) 50 (61%) 59 (77%) 40 (74%) 
Hyperlactataemia (>3mmol/L) 15 (18%) 26 (34%) 9 (17%) 
Hyperlactataemia (>5mmol/L) 1 (1%) 2 (3%) 3 (6%) 
NT-proBNP (pg/mL) 256 (111, 766) 315 (118, 606) 245 (86, 515) 
Elevated NT-pro BNPa 18 (38%) 17 (40%) 9 (39%)  Data is presented as median (IQR), and absolute number (%)above and below the normal reference range. Numbers analysed can be found in Table 3.2 a Elevated NT-proBNP was defined by Nir 173as >650pg/ml in children up to 12m of age, >400pg/ml in children aged 12m-<24m, >300 in children aged 2y-<6y and >160pg/ml for children >6 y.   Almost 40% of children who had cytokines and NT-proBNP measured retrospectively, had an elevated NT-proBNP at admission (Table 4.10). There was no change in this proportion between admission and day 28. Median levels of IL-6, TNF-a and IFN-g were highest at admission with subsequent fall until day 28. IL-1b appeared to rise again at day 28 (Table 4.11).  Median cytokine concentrations were not different in severely malnourished children with or without SIRS.   
Table 4.11 Median cytokine concentration in severely malnourished children overall at admission, 
day 7 and day 28 
 
Admission 
N= 53 
Day 7 
N= 49 
Day 28 
N=34 
IL-6 (pg/ml) 15 (4,39) 6.0 (3, 12) 3.2 (2, 7) 
TNF-a (pg/ml) 24 (13, 42) 18 (9, 24) 17.6 (12, 25) 
IL-1b (pg/ml) 0.5 (0.2, 2.1) 0.3 (0.03, 0.8) 0.53 (0.14, 2.3) 
IFN-g (pg/ml) 5.3 (2.6, 10.2) 8.6 (3, 23) 4.3 (1.9, 9.1) Data is presented as medians and interquartile ranges (IQR) 
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Full blood count   Haematological parameters of children with malnutrition are summarized in Table 4.12. Most had at least moderate anaemia throughout the observation period. By day 7 the median haemoglobin concentration fell before recovering to just above the admission level by day 28. About one in four children had a raised white cell count at admission; this proportion fell to 7% by day 28. 
 
Table 4.12 Haematological parameters of malnourished children overall at admission, day 7 and day 
28 
 
 
Admission 
N= 86 
Day 7 
N= 84 
Day 28 
N= 59 
Haemoglobin (g/dL) 8.9 (7.7, 9.9) 8.1 (7.0, 9.0) 9.1 (8.5, 10.1) 
Severe anaemia 2 (2%) 1 (1%) 1 (2%) 
Moderate anaemia  47 (55%) 64 (76%) 32 (54%) 
White cell count (103/mm) 13.6 (8.9, 17.3) 11.9 (9.1, 15.5) 10.5 (8.2, 12.3) 
Leucopaenia  5 (6%) 5 (6%) 5 (8%) 
Leucocytosis 21 (24%) 17 (20%) 4 (7%) 
Platelet count (103/mm) 364 (210, 581) 442 (238, 616) 420 (193, 562) 
Thrombocytopaenia 3 (3%) 4 (5%) 1 (2%)  Data is presented as medians and interquartile ranges (IQR) in bold and absolute numbers and proportions (%) The following definitions were applied: Severe anaemia (Hb <5.0 g/dL), moderate anaemia (Hb<9.3 g/dL), leucopaenia and leucocytosis were defined using the cut-offs by Goldstein et al175, thrombocytopaenia was defined as a platelet count of <80.000/mm3. 
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4.3.6 SIRS, sepsis and bacteraemia   Although criteria for systemic inflammatory response syndrome (SIRS) were met by 33% of children at admission (Table 4.4), there was no association between SIRS and culture-proven bacteraemia (p= 0.936). There was also no statistical difference in the prevalence of SIRS in children with marasmus or kwashiorkor. A total of 85/88 (97%) children had a blood cultures taken at admission, of which 6 (7%) grew a definite pathogen (Table 4.13). A further 31 blood cultures were taken for clinical reasons post admission, of which 8 (25%) were positive.   Owing to limited numbers with proven bacteraemia the association between positive blood cultures and mortality (OR 3, 95% CI 0.6 to 12) was not statistically significant (p=0.209). There was a trend towards a higher proportion of bacteraemia in kwashiorkor than marasmus, although this difference was not significant (19% vs. 10%; p=0.167). 
 86 
 Table 4.13 Overview of blood culture isolates associated clinical features at the time and outcome in children with severe malnutrition5   
Day 
culture 
taken 
Isolate Likely clinical significance 
Malnutrition 
type Presenting clinical syndrome SIRS Outcome 
0 Streptococcus pneumoniae  (C28) Pathogen Marasmus Diarrhoea, fever, HIV No Discharged 
0 Escherichia coli (C65) Pathogen Marasmus Diarrhoea, Sepsis Yes Discharged 
0 Staphylococcus epidermidis (C89) Contaminant Marasmus Diarrhoea, HIV Yes Died D19 
0 Streptococcus viridans (C55) Contaminant Kwashiorkor Sepsis, widespread skin desquamation  No Died D7 
0 Bacillus species (C63) Contaminant Kwashiorkor Cerebral palsy, diarrhoea No Died D1 
0 Micrococcus species (C49) Contaminant Kwashiorkor Stable malnutrition No Discharged 
0 Unidentified gram –ve fastidious rod (C20) Uncertain Kwashiorkor Cerebral palsy, diarrhoea Yes Discharged 
0 Streptococcus pneumoniae (C72) Pathogen Kwashiorkor Diarrhoea No Discharged 
4 Enterococci species (C5) Pathogen Marasmus Fever Yes Died D11 
4 Proteus Mirabilis (C55) Pathogen Kwashiorkor Sepsis, widespread skin desquamation  No Died D7 
5 Candida species (C76) Pathogen Kwashiorkor Diarrhoea No Discharged 
7 Staphylococcus epidermidis (C76) Contaminant Kwashiorkor Candida sepsis, HIV negative No Discharged 
7 Staphylococcus epidermidis (C9) Contaminant Marasmus Fever, HIV Yes Discharged 
12 Candida species (C76) Pathogen Kwashiorkor On treatment for candida sepsis Yes Discharged 
13 Staphylococcus epidermidis (C24) Contaminant Marasmus Diarrhoea, HIV No Died D21 
20 Staphylococcus epidermidis (C47) Contaminant Marasmus Diarrhoea, HIV No Died D28 
5 All children had routine blood cultures taken at admission. Subsequent blood cultures were taken if there was a clinical suspicion for sepsis. 
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 4.3.7 Malnutrition and clinical signs of congestive cardiac failure  Table 4.14 summarizes the number of clinical signs of congestive cardiac failure (CCF) in SAM children at each time point, and the proportion of children tested in each group who had a raised serum NT-proBNP. Three quarters of children had only one or no clinical signs of CCF, of whom about a fifth had a raised NT-proBNP at admission.  Most of the remainder (~20%) had only two clinical features of possible CCF. Half of these cases were accounted for by a combination of tachycardia and tachypnoea, for which there was a reasonable alternative explanation including pneumonia, signs of dehydration, fever or anaemia. An equally non-specific combination of tachycardia and hepatomegaly accounted for all but one of the remaining children with two clinical signs of heart failure. One child (C91) was admitted with hepatomegaly and became tachypnoeic with signs of pneumonia around day 7 without any other features of cardiac failure. Only a very small proportion of children had three or more clinical signs of CCF. A triad of tachycardia, tachypnoea and hepatomegaly accounted for 14/16 cases with three signs. One child (C65; Table 4.15) had tachycardia, hepatomegaly and distended neck veins accompanied by a high NT-proBNP level and anaemia (Hb 5.6 g/dL) at day 28 but was making good clinical progress when followed up a month later.  Another child (C87) had 4 clinical signs of cardiac failure (tachycardia, tachypnoea, gallop rhythm and distended neck veins) and a raised NT-proBNP at admission. He was the only patient that was started on anti-failure therapy with furosemide and captopril. This child was HIV positive with close household contact with smear-positive TB and was started on empiric TB treatment. By day 7 the NT-proBNP level had increased five fold accompanied by high serum lactate and IL-6 levels, and he had also developed hepatomegaly (Table 4.15). However he also went on to make a good recovery and was discharged home, though he still had tachycardia, gallop rhythm and hepatomegaly when reviewed at day 28 on a background of culture proven TB and TB pericarditis. Table 4.15 shows associations of clinical and laboratory parameters with the presence of three or more clinical signs of cardiac failure. Interestingly we did not demonstrate an association with high NT-proBNP levels. The only factor for which there was evidence of an association on both univariable and multivariable analysis was HIV (OR 5.7, 1.3 to 23.8, p=0.008; Table 4.16). 
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 Table 4.14 Breakdown of number of children with severe malnutrition meeting any feature of the 5 WHO “cardiac failure” signs and elevated levels of NT-proBNP 
at admission, day 7 and day 28  
 
No. clinical signs 
of heart failure.* 
Admission Day 7 Day 28 
No children 
(% of total) 
(N=86) 
No. (%) with high 
NT-proBNP in 
each group.†1  
No children 
(% of total) 
(N=81) 
No. (%) with high 
NT-proBNP in 
each group. †2   
No children 
(% of total) 
(N=60) 
No. (%) with high 
NT-proBNP in 
each group. †3 
0 27 (31%) 7 (26%) 21 (26%) 5 (24%) 17 (28%) 2 (12%) 
1 38 (44%) 7 (18%) 37 (46%) 6 (16%) 26 (43%) 2 (8%) 
2 15 (17%) 2 (13%) 16 (20%) 5 (31%) 12 (20%) 4 (33%) 
3 5 (6%) 0 (0%) 6 (7%) 0 (0%) 5 (8%) 1 (20%) 
4 1 (1%) 1 (100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
5 0 (0%) 0 (0%) 1 (1%) 1 (100%) 0 (0%) 0 (0%)  * The WHO “WHO Pocket Book of Hospital Care for Children” 12 considers tachycardia, tachypnoea, hepatomegaly, gallop rhythm and distended neck veins as clinical signs of congestive cardiac failure. A total randomly selected for NT-proBNP testing: †1 =47; †2 N=43; †3N=23   
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Table 4.15 Summary table of clinical and laboratory features of children with severe malnutrition at each review point who met at least 3 signs of cardiac failure at 
any of the set time points  
Study 
No 
SAM   CCF score NT-proBNP IL -6 Haemoglobin Lactate 
Type HIV Cx * D 0 D 7 D 28 D 0 D 7 D 28 D 0 D 7 D 28 D 0 D 7 D 28 D 0 D 7 D 28 
3 M +ve P 0 2 3 - - - - - - 8.3 7.4 - 1.0 - 2.1 
6 M +ve F 1 3 2 - - - - - - 9.7 9.7 - 1.8 1.2 1.8 
9 M +ve P 3 3 3 - - - - - - 8.5 8.3 8.5 2.6 4.6 - 
14 M +ve - 2 3 2 200 320 245 6 11 69 9.9 9.3 10.2 2.8 1.6 - 
87 M +ve TB 4 5 3 1250 60620 - 18 840 - 6.3 6.7 8.7 2.4 4.0 2.8 
90 M +ve D+P 0 3 Died 50 71  . - 6 16 12.2 12.2 - 1.9 3.7 - 
7 K +ve P 3 2 3 - - - - - - 7.6 6.3 9.2 2.3 2.1 2.2 
51 M -ve S+D 3 0 1 20170 1020 290 346 16 10 8.4 6.0 8.8 2.4 2.1 1.8 
65 M -ve D 1 1 3 6840 4893 11920 40 8 2 6.6 5.2 8.6 2.3 2.2 6.2 
82 M -ve TB 3 2 2 310 610 1080 5 7 3 8.5 7.9 9.4 3.1 2.3 1.7 
16 K -ve CP 1 3 0 34 45 - 38 69 3 7.8 - 9 1.6 2.1 1.4 
76 K -ve D+B 0 3 2 210 46990 - 65 104 - 8.6 8.1 4.3 1.1 2.3 4.3 
84 K -ve F 3 1 1 - - - - - - 7.6 7.2 7.7 1.3 2.8 1.8  * Co-morbidities at admission: P= pneumonia; TB= confirmed tuberculosis; F= fever; CP= cerebral palsy; S=shock; D= diarrhoea; B=bacteraemia CCF score denotes clinical cardiac failure score
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Table 4.16 Univariate odds ratios (95% confidence intervals) between clinical and laboratory 
parameters and the presence of three or more clinical signs of cardiac failure   
 Overall malnutrition 
OR for CCF 
(95% CI) 
 
 
p value 
EPLS shocka 1.7 (0.2 to 18.6) 0.675 
SIRSb 3.2 (0.8 to 13.2) 0.085 
HIV 5.7 (1.3 to 23.8) 0.008 
Moderate anaemiac 1.0 (0.2 to 4.4) 0.959 
Hypotensiond 0.4 (0.1 to 3.3) 0.390 
High NT-proBNPe 0.7 (0.2 to 2.6) 0.595 
Any IV fluids  0.5 (0.1 to 5.2) 0.593   a EPLS shock = Lethargy/unconsciousness plus TG plus CRT>2sec plus weak pulse plus tachycardia b SIRS denotes systemic inflammatory response syndrome and was defined per Goldstein criteria c Moderate anaemia = Hb<9.3g/dL d Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years e Elevated NT-proBNP was defined by Nir173 as >650pg/ml in children up to 12m of age, >400pg/ml in children aged 12m-<24m, >300 in children aged 2y-<6y and >160pg/ml for children >6 y.   
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4.3.8 Severely malnourished children with diarrhoea  Diarrhoea was common in children with malnutrition with no difference in prevalence in children with marasmus or kwashiorkor (Table 4.17). Malnourished children with diarrhoea had a higher prevalence of abnormal cardiovascular features than children without diarrhoea. All 4 children who met WHO or EPLS criteria for shock were marasmic and had diarrhoea and three of the four had renal impairment. However, there was no difference in the proportion with hypotension; or in the median pulse pressure in those with and without diarrhoea (26 vs. 25 mmHg, p=0.6714). The prevalence of tachypnoea was lower in the diarrhoea group. Diarrhoea was strongly associated with renal impairment, particularly among children with marasmus (no child with kwashiorkor had an elevated creatinine and only one had a raised urea); and with severe metabolic acidosis (Table 4.17).  Diarrhoea was also associated with hyponatraemia and hypoalbuminaemia. There was no overall association with severe hypokalaemia, but among children with marasmus, severe hypokalaemia was more common in those with diarrhoea (33% vs. 9%, p=0.039). There was no association among marasmic or kwashiorkor children, or overall, between diarrhoea and culture-proven bacteraemia.  
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 Table 4.17 Comparison of cardiovascular and biochemical features of severely malnourished children 
with and without diarrhoea at admission     
  
Admission 
No diarrhoea 
N=42 
Diarrhoea 
N=38 
 
p value 
SAM Type Kwashiorkor 20 (46%) 15 (35%) 0.315 
 
 
 
 
 
Cardiovascular 
findings 
Tachypnoea (WHO)a 13 (30%) 5 (12%) 0.039 
Hypoxia (O2 saturations <95%) 1 (2%) 0 (0%) 0.320 
Tachycardia (EPLS)b 6 (14%) 1 (2%) 0.052 
CRT >2 sec 1 (2%) 4 (9%) 0.159 
Weak pulse 0 (0%) 5 (12%) 0.018 
Temperature gradientc 0 (0%) 6 (14%) 0.010 
EPLS Shockd 0 (0%) 4 (9%) 0.038 
WHO Shocke 0 (0%) 1 (2%) 0.309 
Hypotensionf 4 (9%) 4 (9%) 0.973 
Gallop rhythm 1 (2%) 1 (2%) 1.000 
Neck vein distension 1 (2%) 0 (0%) 0.326 
Hepatomegalyg 10 (23%) 5 (12%) 0.171 
 
 
 
 
Clinical 
biochemistry 
Hyponatraemia  (<125mmol/L) 0 (0%) 4 (11%) 0.031 
Hypokalaemia  (<2.5mmol/L) 6 (15%) 12 (32%) 0.064 
Hypocalcaemia (<2.1mmol/L) 2 (5%) 3 (7%) 0.626 
Hypomagnesaemia  (<0.75mmol/L) 3 (7%) 1 (2%) 0.317 
Hypophosphataemia  (<0.32mmol/L) 4 (9%) 5 (12%) 0.698 
Severe Hypoalbuminaemia (<15g/L) 8 (18%) 6 (14%) 0.592 
Hypoalbuminaemia (<34 g/L) 38 (86%) 28 (65%) 0.021 
Hypercreatininaemia (>74μmol/L) 0 (0%) 5 (12%) 0.020 
Hyperuricaemia (6.4 mmol/L) 1 (2%) 7 (16%) 0.024 
 
Tissue perfusion 
 &  
NT-proBNP 
Severe Acidaemia (pH< 7.2) 0 (0%) 10 (26%) 0.001 
Base deficit >10mmol/L*, ** 4 (11%) 23 (64%) <0.001 
Low Bicarbonate * (<18mmol/L) 21 (55%) 38 (97%) <0.001 
Lactate (> 2mmol/L) 26 (65%) 23 (56%) 0.413 
Lactate (>3 mmol/L) 9 (23%) 6 (15%) 0.362 
Elevated NT-proBNPh 7 (30%) 11 (46%) 0.278 
 Data is presented as absolute numbers and proportions (%);* also significant at day 7, ** also significant at day 28 a Tachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years b EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years c The temperature gradient (TG) was assessed by running the back of the hand from the toe to the knee. A positive gradient was defined as a temperature change from cold to warm. d EPLS shock= Lethargy/unconsciousness plus TG plus CRT>2sec plus weak pulse plus tachycardia e WHO shock= Lethargy/unconsciousness plus TG plus CRT>3sec plus weak pulse plus tachycardia f Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  g hepatomegaly was defined as a palpable liver edge of more than 2cm below the costal margin h Elevated NT-proBNP was defined by Nir 173as >650pg/ml in children up to 12m of age, >400pg/ml in children aged 12m-<24m, >300 in children aged 2y-<6y and >160pg/ml for children >6 y.
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4.3.9 Important comparisons of baseline characteristics in children with marasmus and 
kwashiorkor  The prevalence of kwashiorkor amongst malnourished children was 41%.  The median age of children presenting with marasmus and kwashiorkor was 17.5 (IQR 11, 27.5) and 20 (IQR 16, 41.5) months respectively (p=0.034), with a similar gender mix. As expected, anthropometric indices were significantly lower in marasmic children (Table 4.18). However, there were no differences in the proportions with each clinical syndrome at any time point, except for HIV, which was more common in marasmus as expected (33 vs. 8%; p=0.013).  Overall, there were also no significant differences in prevalence of signs of impaired perfusion between marasmus and kwashiorkor at any time point. However, as noted above, all children who met WHO or EPLS criteria for shock were marasmic and had diarrhoea. Apart from a higher prevalence of hypoalbuminaemia in kwashiorkor, we did not demonstrate any consistent differences in serum biochemistry between the two groups (Table 4.18 to Table 4.20). Haematological parameters were also similar in both groups except for median haemoglobin levels at day 28, which were lower in children with kwashiorkor (8.8 g/dL vs. 9.5 g/dL, p=0.0015) see Figure 4.3.  
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Table 4.18 Comparison of clinical and laboratory findings between children with marasmus and 
kwashiorkor at admission  
Category Features at admission 
 
Marasmus 
N=52 
Kwashiorkor 
N=36 
 
p value 
Gender Male 29 (56%) 19 (53%) 0.782 
Age Months 17.5 (11, 27.5) 20 (16, 41.5) 0.034 
Anthropometry 
WHZ -3.3 (-3.9, -3.0) -2.8 (-3.5, -2.1) 0.002 
MUAC 10.5 (9.8, 11.0) 11.3 (10.5, 12.3) <0.001 
Temperature Fever (>37.5°C) 15 (29%) 10 (28%) 0.913 
Hypothermia (< 35.0°C) 2 (6%) 0  0.086 
 
Respiratory 
 Findings 
Tachypnoea (WHO)a 12 (23%) 6 (17%) 0.465 
Indrawing 5 (10%) 0 (0%) 0.076 
Deep breathing 5 (10%) 1 (3%) 0.394 
Hypoxia (O2 saturations <95%) 1 (2%) 0 N/A 0.403 
 
 
 
 
Cardiovascular 
Findings 
Tachycardia (WHO)b 25 (51%) 23 (66%) 0.182 
Tachycardia (EPLS)c 4 (8%) 3 (8%) 0.913 
Bradycardia (<80/min) N/A N/A N/A N/A N/A 
CRT >2 sec 4 (8%) 1 (3%) 0.348 
Weak pulse 5 (10%) 0 N/A 0.074 
Temperature gradient 6 (12%) 0 N/A 0.077 
Hypotensiond 4 (8%) 4 (11%) 0.583 
Gallop rhythm 2 (4%) 0 N/A 0.513 
Hepatomegalye 8 (15%) 7 (20%) 0.635 
Neck vein distension 1 (2%) 0 N/A 1.0 
 
Hydration 
Status 
Decreased skin turgor 6 (13%) 2 (6%) 0.350 
Sunken eyes 16 (32%) 6 (17%) 0.129 
Dry mucous membranes 7 (14%) 3 (9%) 0.430 
Blantyre Coma Score ≤ 4 7 (14%) 4 (11%) 0.743 
 
Clinical 
Syndromes 
Pneumonia (WHO)f 9  (17%) 2 (6%) 0.119 
Diarrhoea (≥ 3 watery stools/24 hours) 13 (25%) 10 (28%) 0.771 
Cerebral Palsy 3 (6%) 7 (20%) 0.060 
SIRSg 19 (37%) 10 (28%) 0.391 
HIV 17 (33%) 3 (8%) 0.013 
 
Haematology 
Severe anaemia (Hb<5g/dL) 1 (2%) 1 (3%) 0.786 
Moderate anaemia (Hb <9.3g/dL) 26 (51%) 21 (60%) 0.409 
Leucocytosish 11 (21%) 10 (28%) 0.474 
 Thrombocytopaenia ( <80.000/mm3) 1 (2%) 2 (6%) 0.356 
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 Table 4.18 continued  
Category Features at admission 
 
Marasmus 
N=52 
Kwashiorkor 
N=36 
 
p value 
 
 
 
Clinical 
biochemistry 
Hyponatraemia (<125mmol/L) 3 (7%) 1 (3%) 0.492 
Hypokalaemia (<2.5mmol/L) 10 (22%) 8 (24%) 0.810 
Hypocalcaemia (<2.1 mmol/L) 3 (6%) 3 (8%) 0.639 
Hypomagnesaemia  (<0.75 mmol/L) 2 (4%) 2 (6%) 0.705 
Hypophosphataemia (<0.32 mmol/L) 4 (8%) 5 (14%) 0.346 
Hyperphosphataemia (>1.78mmol/L) 11 (21%) 2 (6%) 0.043 
Hypoalbuminaemia (<34 g/L) 32 (62%) 34 (94%) <0.0001 
Severe Hypoalbuminaemia (<15g/L) 1 (2%) 13 (36%) <0.0001 
Hypercreatininaemia (>74μmol/L) 5 (10%) 0 (0%) 0.055 
Hyperuricaemia (>6.4mmol/L) 6 (12%) 2 (6%) 0.337 
Tissue 
perfusion & 
NT-proBNP 
Acidaemia (ph<7.2) 6 (13%) 4 (13%) 0.958 
Base deficit > 10mmol/L 19 (42%) 8 (30%) 0.285 
High Lactate (>3mmol/L) 9 (18%) 6 (18%) 0.983 
Elevated NT-proBNPi 4 (31%) 5 (50%) 0.349  Data is presented as absolute numbers and proportions (%)  a Tachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years b WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years c EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years d Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  e Hepatomegaly was defined as a palpable liver edge of more than 2cm below the costal margin f Pneumonia encompasses mild, moderate and severe pneumonia as defined by WHO in Table 4.1 g /hSIRS and leucocytosis were defined using the criteria by Goldstein et al175 i Elevated NT-proBNP was defined by Nir 173as >650pg/ml in children up to 12m of age, >400pg/ml in children aged 12m-<24m, >300 in children aged 2y-<6y and >160pg/ml for children >6 y.  
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 Table 4.19 Comparison of clinical and laboratory findings between children with marasmus and 
kwashiorkor on day 7  
Category Features at day 7 
 
Marasmus 
N=51 
Kwashiorkor 
N=34 
 
p value 
Temperature Fever (>37.5°C) 7 (14%) 2 (6%) 0.250 
Hypothermia (< 35.0°C) 0 (0%) 2 (6%) 0.086 
 
Respiratory 
Findings 
Tachypnoea (WHO)a 17 (33%) 5 (15%) 0.064 
Indrawing 2 (4%) 0 (0%) 0.243 
Deep breathing 6 (12%) 0 (0%) 0.038 
Hypoxia (O2 saturations <95%) 3 (6%) 1 (3%) 0.530 
 
 
 
 
Cardiovascular 
Findings 
Tachycardia (WHO)b 30 (59%) 22 (65%) 0.586 
Tachycardia (EPLS)c 3 (6%) 2 (6%) 1.000 
Bradycardia (<80/min) 0 (0%) 0 (0%) N/A 
CRT >2 sec 1 (2%) 0 (0%) 0.411 
Weak pulse 1 (2%) 0 (0%) 0.418 
Temperature gradient 2 (4%) 1 (3%) 0.810 
Hypotensiond 4 (8%) 2 (6%) 0.730 
Gallop rhythm 1 (3%) 0 (0%) 0.398 
Hepatomegalye 12 (24%) 7 (21%) 0.750 
Neck vein distension 1 (2%) 1 (3%) 0.770 
 
Hydration 
Status 
Decreased skin turgor 1 (2%) 0 (0%) 0.409 
Sunken eyes 3 (6%) 0 (0%) 0.150 
Dry mucous membranes 2 (4%) 0 (0%) 0.243 
Blantyre Coma Score ≤ 4 4 (8%) 4 (12%) 0.544 
Clinical 
Syndromes 
Pneumonia (WHO)f 4 (8%) 1 (3%) 0.347 
Diarrhoea (≥ 3 watery stools/24 hours) 15 (29%) 5 (15%) 0.117 
SIRSg 16 (31%) 12 (35%) 0.706 
 
Haematology 
Severe anaemia (Hb<5g/dL) 0 (0%) 1 (3%) 0.211 
Moderate anaemia (Hb <9.3g/dL) 36 (71%) 28 (85%) 0.134 
Leucocytosish 10 (20%) 7 (21%) 0.912 
 Thrombocytopenia (Plts <80.000/mm3) 2 (4%) 2 (6%) 0.676   
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 Table 4.19 continued  
Category Features at day 7 Marasmus Kwashiorkor p value 
 
 
 
 
Clinical 
biochemistry 
Hyponatraemia (<125mmol/L) 0 (0%) 0 (0%) N/A 
Hypokalaemia (<2.5mmol/L) 0 (0%) 0 (0%) N/A 
Hypocalcaemia (<2.1mmol/L) 2 (4%) 0 (0%) 0.228 
Hypercalcaemia (>2.6mmol/L) 3 (6%) 2 (4%) 0.945 
Hypomagnesaemia  (<0.75mmol/L) 9 (19%) 6 (18%) 0.899 
Hypophosphataemia (<0.32mmol/L) 1 (2%) 5 (16%) 0.024 
Hyperphosphataemia (>1.78mmol/L) 14 (29%) 6 (18%) 0.231 
Hypoalbuminaemia (<34g/L) 43 (90%) 33 (97%) 0.200 
Severe Hypoalbuminaemia (<15g/L) 4 (8%) 15 (44%) <0.0001 
Hypercreatininaemia (>74μmol/L) 1 (4%) 1 (3%) 0.790 
Hyperuricaemia (6.4mmol/L) 4 (8%) 0 (0%) 0.084 
Tissue 
perfusion  
&  
NT-proBNP 
Acidaemia (pH<7.2) 4 (8%) 4 (12%) 0.574 
Base deficit > 10mmol/L 12 (27%) 13 (42%) 0.164 
High Lactate (>3mmol/L) 15 (33%) 9 (28%) 0.627 
Elevated NT-pro-BNPi  8 (33%) 9 (47%) 0.350 
 Data is presented as absolute numbers and proportions (%)  a Tachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years b WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years c EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years d Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  e Hepatomegaly was defined as a palpable liver edge of more than 2cm below the costal margin f Pneumonia encompasses mild, moderate and severe pneumonia as defined by WHO in Table 4.1 g /hSIRS and leucocytosis were defined using the criteria by Goldstein et al175 i Elevated NT-proBNP was defined by Nir 173as >650pg/ml in children up to 12m of age, >400pg/ml in children aged 12m-<24m, >300 in children aged 2y-<6y and >160pg/ml for children >6 y. 
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 Table 4.20 Comparison of clinical and laboratory findings between children with marasmus and 
kwashiorkor on day 28  
Category Features at day 28 
 
Marasmus 
N=37 
Kwashiorkor 
N=25 
 
p value 
Temperature Fever (>37.5°C) 2 (5%) 3 (12%) 0.350 
Hypothermia (< 35.0°C) 0 (0%) 0 (0%) N/A 
 
Respiratory 
Findings 
Tachypnoea (WHO)a 9 (24%) 3 (12%) 0.228 
Indrawing 1 (3%) 0 (0%) 0.407 
Deep breathing 0 (0%) 0 (0%) N/A 
Hypoxia (O2 saturations <95%) 2 (5%) 0 (0%) 0.237 
 
 
 
 
Cardiovascular 
Findings 
Tachycardia (WHO)b 18 (49%) 20 (80%) 0.013 
Tachycardia (EPLS)c 2 (5%) 0 (0%) 0.237 
Bradycardia (<80/min) 0 (0%) 0 (0%) N/A 
CRT >2 sec 0 (0%) 0 (0%) N/A 
Weak pulse 0 (0%) 0 (0%) N/A 
Temperature gradient 0 (0%) 0 (0%) N/A 
Hypotensiond 2 (5%) 0 (0%) 0.237 
Gallop rhythm 1 (3%) 0 (0%) 0.417 
Hepatomegalye 7 (19%) 6 (24%) 0.630 
Neck vein distension 1 (3%) 0 (0%) 0.401 
 
Hydration 
Status 
Decreased skin turgor 0 (0%) 0 (0%) N/A 
Sunken eyes 0 (0%) 0 (0%) N/A 
Dry mucous membranes 0 (0%) 0 (0%) N/A 
Blantyre Coma Score ≤ 4 1 (3%) 2 (8%) 0.340 
Clinical 
Syndromes 
Pneumoniaf 1 (3%) 1 (4%) 0.777 
Diarrhoea (≥ 3 watery stools/24 hours) 1 (3%) 0 (0%) 0.407 
SIRSg 9 (24%) 7 (28%) 0.746 
 
Haematology 
Severe anaemia (Hb<5g/dL) 0 (0%) 1 (4%) 0.223 
Moderate anaemia (Hb <9.3g/dL) 16 (46%) 16 (67%) 0.113 
Leucocytosish 2 (5%) 2 (8%) 0.683 
 Thrombocytopenia (Plts<80.000/mm3) 1 (3%) 0 (0%) 0.407 
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 Table 4.20 continued   
Category Features at Day 28 Marasmus Kwashiorkor p value 
 
 
 
 
Clinical 
biochemistry 
 
Hyponatraemia (<125mmol/L) 2 (6%) 0 (0%) 0.236 
Hypokalaemia (<2.5mmol/L) 0 (0%) 0 (0%) N/A 
Hypocalcaemia (<2.1mmol/L) 14 (41%) 11 (48%) 0.620 
Hypercalcaemia (>2.6mmol/L) 9 (27%) 10 (44%) 0.181 
Hypomagnesaemia  (<0.75mmol/L) 2 (6%) 0 (0%) 0.236 
Hypophosphataemia (<0.32mmol/L) 0 (0%) 0 (0%) N/A 
Hyperphosphataemia (>1.78mmol/L) 14 (41%) 11 (48%) 0.620 
Hypoalbuminaemia (<34g/L) 19 (56%) 18 (78%) <0.0001 
Severe hypoalbuminaemia (<15g/L) 0 (0%) 0 (0%) N/A 
Hypercreatininaemia 1 (3%) 0 (0%) 0.407 
Hyperuricaemia 2 (6%) 0 (0%) 0.236 
Tissue 
perfusion 
&  
NT-proBNP 
Acidaemia (pH<7.2) 0 (0%) 1 (4%) 0.227 
Base deficit >10mmol/L 3 (9%) 2 (9%) 0.959 
High Lactate (>3mmol/L) 4 (12%) 4 (20%) 0.237 
Elevated NTproBNPi 4 (31%) 5 (50%) 0.349  Data is presented as absolute numbers and proportions (%)  a Tachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years b WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years c EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years d Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  e Hepatomegaly was defined as a palpable liver edge of more than 2cm below the costal margin f Pneumonia encompasses mild, moderate and severe pneumonia as defined by WHO in Table 4.1 g /hSIRS and leucocytosis were defined using the criteria by Goldstein et al175 i Elevated NT-proBNP was defined by Nir 173as >650pg/ml in children up to 12m of age, >400pg/ml in children aged 12m-<24m, >300 in children aged 2y-<6y and >160pg/ml for children >6 y.  
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 Figure 4.3 Box and whiskers plots of clinically important biochemical and haematological parameters 
and comparison of their concentrations in children with marasmus and kwashiorkor at admission, 
day 7 and day 28 
  Groups were compared using the Wilcoxon rank-sum test for non-parametric data 
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 4.3.10 Comparison of HIV positive and negative malnourished children  Overall, 20/88 (23%) malnourished patients were HIV positive. HIV positive children tended to be older (median age 23.5 vs. 18.5 months; p=0.258) and more wasted than HIV negative children (median WHZ score -3.7 vs. -3.0; p=0.005) respectively. Clinically, HIV positive children presented more frequently with pneumonia than HIV negative children (Table 4.21), and tended to have a higher prevalence of tachypnoea, hypoxia and hepatomegaly (Table 4.21, and appendix Table 11.14 and Table 11.15).   HIV infected children appeared no more likely to have signs of impaired perfusion than HIV uninfected children, however the prevalence of hypotension was higher among those with HIV (OR 6.5, 95% CI 1.4 to 29.7, p=0.005; Table 4.21). At day 28, the median heart rate of HIV positive children was also significantly higher than in HIV negative children (see appendix Table 11.19 Comparison of). Serum biochemistry and full blood count in HIV positive and negative children with severe malnutrition did not significantly differ (Table 4.22). The prevalence of leucopaenia however was more prevalent in the HIV positive group (15% vs. 3%, p=0.041). HIV infection was weakly associated with an increased risk of dying in this small cohort (OR 3.2, 95% CI 0.96 to 11; p=0.05).  Univariate analysis identified pneumonia, systemic inflammatory response syndrome (SIRS) and hypotension to increase the odds for HIV (Table 4.23) and weight for height z-score, kwashiorkor and hyperphosphataemia decrease the odds for HIV.  In a multivariable logistic regression model, only malnutrition type, pneumonia, SIRS and hyperphosphataemia showed independent associations with HIV status (Table 4.23).   
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Table 4.21 Comparison of baseline characteristics, bedside observations and comorbidities between 
HIV negative and HIV positive malnourished patients at admission 
Category Features at admission 
HIV –ve 
N=68 
HIV +ve 
N=20 
 
p value 
Demographics Gender, male 36 (53%) 12 (60%) 0.577 
 Kwashiorkor 33 (92%) 3 (8%) 0.007 
Temperature 
Fever (>37.5°C) 16 (24%) 9 (45%) 0.066 
Hypothermia (< 35.0°C) 2 (2 %) 0 N/A 0.438 
Tachypnoea  (WHO)a 11 (16%) 7 (35%) 0.073 
Indrawing 3 (4%) 2 (10%) 0.356 
Deep breathing 3 (4%) 3 (15%) 0.119 
Hypoxia (O2 saturations<95%) 1 (2%) 0 N/A 0.585 
 
 
 
Cardiovascular 
Tachycardia (WHO)b 36 (56 %) 12 (60%) 0.767 
Tachycardia (EPLS)c 4 (6%) 3 (15%) 0.201 
CRT > 2 sec 4 (6%) 1 (5%) 0.881 
Weak pulse 2 (5%) 2 (10%) 0.364 
Temperature gradient 4 (6%) 2 (10%) 0.525 
Hypotensiond 5 (7%) 3 (15%) 0.296 
Hepatomegalye 10 (15%) 5 (26%) 0.267 
Hydration status 
Decreased skin turgor      7 (11%) 1 (6%) 0.541 
Sunken eyes 16 (25%) 6 (30%) 0.631 
Dry mucous membranes 5 (8%) 5 (25%) 0.049 
Neurological Blantyre Coma Score ≤ 4 9 (13%) 2 (10%) 0.702 
Clinical 
diagnosis 
Pneumoniaf  5 (7 %) 6 (30%) 0.012 
Diarrhoeag 19 (28%) 8 (40%) 0.744 
SIRSh  19 (28%) 10 (50%) 0.070 Data is presented as absolute numbers and proportions (%)  a Tachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years b WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years c EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years d Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  e Hepatomegaly was defined as a palpable liver edge of more than 2cm below the costal margin f Pneumonia encompasses mild, moderate and severe pneumonia as defined by WHO, see Table 4.1 gDiarrhoea was defined as ≥3 watery stools in 24 hours h Systemic inflammatory response syndrome was defined using the Goldstein criteria 175 
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Table 4.22 Comparison of abnormal laboratory results in HIV negative and positive malnourished 
children at admission 
Admission  
HIV –ve 
(n=68) 
HIV+ve 
(n=20) 
 
p value 
Acidaemia (pH<7.2) 9 (15%) 1 (6%) 0.302 
Base deficit >10 mmol/l 20 (36 %) 7 (41%) 0.720 
Hyperlactataemia (>2mmol/l) 38 (60 %) 12 (63%) 0.824 
Hyperlactataemia (>3mmol/l) 12 (19%) 3 (16%) 0.747 
Hypoglycaemia (<3mmol/l) 14 (25%) 2 (14%) 0.410 
Moderate anaemia (Hb <9.3g/dL) 36 (55%) 11 (55%) 0.971 
Leucopeniaa 2 (3%) 3 (15%) 0.041 
Leucocytosisa 18 (27%) 3 (15%) 0.290 
Thrombocytopenia (<80.000/mm3) 2 (3%) 1 (5%) 0.656 
Bacteriaemia (B/C positive) 6 (9%) 2 (10%) 0.872 
SIRSb 19 (28%) 10 (50%) 0.065 
Hypoalbuminaemia (<34g/dL) 50 (74%) 16 (80%) 0.557 
Severe hypoalbuminaemia (<15g/dL) 12 (18%) 2 (10%) 0.411 
Hyponatraemia (< 125mmol/l) 3 (5%) 1 (7%) 0.732 
Hypernatraemia (>145mmol/L) 1 (2%) 0 (0%) 0.631 
Hypokalaemia (< 2.5mmol/l) 15 (23%) 3 (20%) 0.819 
Hyperkalaemia (>6.0mmol/L) 0 (0%) 0 (0%) N/A 
Hypophosphataemia (<0.32mmol/L) 7 (10 %) 2 (10%) 0.970 
Hyperphosphataemia (>1.78mmol/L) 10 (15%) 3 (15%) 0.974 
Hypocalcaemia (<2.1mmol/L) 6 (9%) 0 (0%) 0.169 
Hypercalcaemia (>2.6mmol/L) 2 (3%) 0 (0%) 0.438 
Hypomagnesaemia (<0.75mmol/L) 3 (4 %) 1 (5%) 0.912 
Hypermagnesaemia (>1.5mmol/L) 1 (2%) 0 (0%) 0.585 
Hyperuricaemia (>6.4mmol/L) 6 (9%) 2 (10%) 0.872 
Hypercreatinaemia (>74μmol/L) 3 (4%) 2 (10%) 0.343  Data is presented as absolute numbers and proportions (%) a+b Leucocytosis, leucopaenia and SIRS were defined as per criteria set out by Goldstein et al175
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 Table 4.23 Univariate and adjusted odds ratios for associations of clinical and laboratory parameters 
with HIV status   
 Univariate OR 
(95% CI) 
 
p value 
Adjusted OR 
(95% CI) 
 
p value 
WHZ 0.5 (0.2 to 0.9) 0.014 0.7 (0.3 to 1.5) 0.329 
Kwashiorkor 0.19 (0.1 to 0.7) 0.013 0.07 (0.01 to 0.4) 0.005 
Pneumonia 5 (1.4 to 16) 0.012 4.9 (1.1 to 22.2) 0.039 
SIRS 3.4 (1.0 to 11.6) 0.038 4.8 (1.0 to 22.7) 0.049 
Hypotension 6.5 (1.4 to 29.7) 0.005 4.3 (0.8 to 23.7) 0.090 
Hyperphosphataemia 0.1 (0.03 to 0.6) 0.002 0.1 (0.02 to 0.5) 0.006     
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 4.3.11 Case fatality 
                   During the 28-day study period 14 (16%) children died 8, of whom had marasmus. Three (21%) of these deaths occurred before day 7.  Admission characteristics of survivors and non-survivors were similar (Table 4.25) but children who died tended to be more severely wasted, (lower WHZ score) and to lose weight in the first week (median weight loss 28 g/kg/week vs. median weight gain 25g/kg/week among survivors). They were also more likely to have a reduced level of consciousness (Blantyre Coma Score <4) and to be hyponatraemic (<125mmol/L) at admission. As previously noted there was weak evidence of an association between HIV infection and death.  There were no systematic differences in cardiovascular features at admission and day 7 between children who died and survived, although non-survivors were more likely to have a weak pulse at day 7 (Table 4.26) accompanied by a lower median diastolic blood pressure and higher median respiratory rate than survivors (see appendix Table 11.20). There was a tendency towards higher levels of TNF-a, IL-6, IFN-g and IL-1b among non-survivors at both time points (Table 4.27) with a 30-fold higher IL-6 in non-survivors on day 7 (p=0.030), which was probably due to sepsis. Table 4.28 shows univariable associations between death and the presence of potential clinical predictors at any time point (i.e. admission, day 7 or day 28). Severe hyponatraemia was associated with the greatest risk of death (OR 20, 95% CI 2 to 209, p=0.013), followed by hypotension and a reduced level of consciousness. The same three variables remained independently associated with death in a multivariable logistic regression model (Table 4.29). There was no statistical evidence that risk factors for 
death differed between marasmus and kwashiorkor (Χ2 test for heterogeneity >0.05 in all cases). Importantly intravenous fluid administration in any form (i.e. for resuscitation, rehydration or maintenance) was not associated with death (Table 4.28).     
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  Table 4.24 Comparison of admission characteristics and comorbidities of malnourished survivors and 
non-survivors 
 Admission Survivors Non-survivors p 
value 
  (n=74) (n=14)  
 Male 41 (55%) 7 (50%) 0.710 
Baseline Age 20 (13, 36) 16 (14, 24) 0.355 
features WHZ -3.1 (-3.7, -2.5) -3.9 (-4.1, -3.0) 0.035 
 MUAC (cm) 10.9 (10.0, 11.6) 10.5 (9.5, 11.0) 0.160 
 Kwashiorkor 30 (83%) 6 (17%) 0.872 
 
Clinical 
syndrome 
Pneumoniaa 10 (14%) 1 (7%) 0.516 
Diarrhoeab 22 (30%) 5 (36%) 0.657 
SIRSc 23 (31 %) 5 (36%) 0.733 
 HIV 14 (19%) 6 (43%) 0.058 
 
 
 
CVS 
Features 
Tachycardia (WHO)d 44 (60%) 8 (73%) 0.405 
Weak pulse 4 (6%) 1 (7%) 0.806 
Temperature gradiente 4 (5%) 2 (14%) 0.245 
CRT> 3 sec 1 (1%) 0 (0%) 0.662 
CRT> 2sec 4 (5%) 1 (7%) 0.797 
Hypotensionf 4 (5%) 2 (18%) 0.147 
Hepatomegalyg 17 (23%) 2 (18%) 0.723 
Neurology BCS <4 7 (10%) 4 (29%) 0.047 
 Hypokalaemia (<2.5mmol/L) 14 (20%) 4 (36%) 0.234 
 Hyponatraemia (<125mmol/L) 1 (1%) 3 (27%) 0.007 
Blood Acidaemia (ph<7.2) 8 (12%) 2 (20%) 0.461 
resultsf Lactate (>2mmol/L) 44 (63%) 6 (50%) 0.402 
 Albumin (<15g/L) 11 (15%) 3 (21%) 0.541 
 Moderate anaemia (Hb <9.3g/dL) 43 (60%) 4 (29%) 0.040 
 Hypothyroidh 13 (18%) 5 (36%) 0.145  Data is presented as absolute numbers and proportions (%)  a The term pneumonia includes mild, moderate and severe forms as defined by WHO, see Table 4.1 b Diarrhoea was defined as ≥3 watery stools/ 24 hours c SIRS was defined using the criteria set out by Goldstein et al. 175 d WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years e The temperature gradient (TG) was assessed by running the back of the hand from the toe to the knee. A positive gradient was defined as a temperature change from cold to warm. f Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  g Hepatomegaly was defined as a palpable liver edge >2cm below the costal margin h The term hypothyroid was used to describe established hypothyroidism, secondary and subclinical hypothyroidism (see definitions used on page 60). 
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 Table 4.25 Comparison of bedside observations assessing the circulation in survivors and non-
survivors at day 7 
Day 7 
Survivors 
N=74 
Non-Survivors 
N=11 
 
p value 
Tachycardia  (WHO)a 44 (60%) 8 (73%) 0.400 
Tachycardia (EPLS)b 5 (7%) 0 (0%) 0.374 
Weak pulse 0 (0%) 1 (9%) 0.010 
Temperature gradientc 2 (3%) 1 (9%) 0.284 
CRT >2 sec 1 (1%) 0 (0%) 0.698 
Hypotensiond 4 (5%) 2 (18%) 0.123 
Shock (WHO)e 0 (0%) 0 (0%) N/A 
Shock (EPLS)f 0 (0%) 0 (0%) N/A 
Gallop rhythm 1 (1%) 1 (10%) 0.098 
Neck vein distension 1 (1%) 1 (10%) 0.114 
Hepatomegaly (WHO)g 17 (23%) 2 (18%) 0.722 
Tachypnoeah 18 (24%) 4 (40%) 0.290  Data is presented as absolute numbers and proportions (%)  a WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years b EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years c The temperature gradient (TG) was assessed by running the back of the hand from the toe to the knee. A positive gradient was defined as a temperature change from cold to warm. f Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  g Hepatomegaly was defined as a palpable liver edge >2cm below the costal margin   
Table 4.26 Comparison of cytokine concentration of survivors and non-survivors of severe 
malnutrition at admission and day 7 
 
Admission Survivors Non-Survivors p value 
Number  tested 50/74 (68%) 7/14 (50%) - 
IL-6 (pg/mL) 13 (4, 30) 36 (7, 71) 0.125 
IL-1b (pg/mL) 0.5 (0.2, 2) 1.2 (0.3, 2.5) 0.282 
TNF-a (pg/mL) 22 (11, 37) 26 (19, 32) 0.676 
INF-g (pg/mL) 5 (2, 10) 5 (2. 7) 0.881 
Day 7      
Number tested 39/74 (53%) 4/11 (36%) - 
IL-6  (pg/mL) 6 (3, 12) 197 (20, 14393) 0.030 
IL-1b (pg/mL) 0.2 (0.01, 0.7) 1 (0.4, 15) 0.102 
TNF-a (pg/mL) 16 (9, 24) 22 (20, 77) 0.112 
INF-g (pg/mL) 8 (3, 16) 27 (12, 78) 0.070 
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 Table 4.27 Univariate analysis of risk factors for death in severely malnourished overall as well as in children with marasmus and kwashiorkor across admission, 
day 7 and day 28 
 
 Overall malnutrition 
OR for death 
(95% CI) 
 
 
p value 
Marasmus 
OR for death 
(95% CI) 
 
 
p value 
Kwashiorkor 
OR for death 
(95% CI) 
 
 
p value 
 
χ2 test of 
heterogeneity 
Diarrhoea 4.3 (0.8 to 21.4) 0.056 3.3 (0.3 to 30.6) 0.272 5.7 (0.5 to 62.2) 0.105 0.737 
HIV 4.0 (0.99 to 16.1) 0.037 4.4 (0.8 to 23.3) 0.053 2.8 (0.2 to 39.4) 0.425 0.769 
BCS <4 5.4 (1.4 to 20.9) 0.006 4.7 (0.8 to 27.9) 0.062 6.5 (0.8 to 51.5) 0.041 0.813 
CRT>2 seconds 1.1 (0.2 to 10.7) 0.941 1.4 (0.1 to 15.1) 0.766 0 - 0.655 0.604 
Weak pulse 3.3 (0.47 to 23.5) 0.200 3.3 (0.47 to 23) 0.200 - - - - 
Hypotension 6.2 (1.6 to 24.3) 0.003 4.7 (0.8 to 27.9) 0.062 9.0 (1.0 to 81.9) 0.018 0.650 
K+ (<2.5mmol/L) 1.7 (0.5 to 6.4) 0.420 1.5 (0.2 to 9.0) 0.656 2.0 (0.3 to 14.2) 0.480 0.832 
Na+ (<125mmol/L) 21.6 (1.6 to 297.1) 0.001 14.3 (0.9 to 223.8) 0.012 - - 0.025 0.573 
Albumin (<15g/L) 4.0 (0.96 to 17) 0.041 7.0 (0.7 to 66.2) 0.048 3.0 (0.4 to 20.3) 0.237 0.566 
Hb  (<9.3g/dL) 0.4 (0.1 to 1.3) 0.103 0.6 (0.1 to 3.1) 0.561 0.06 (0 to 1.3) 0.017 0.154 
Any IV fluids 3.8 (0.7 to 21.5) 0.104 3.8 (0.7 to 21.5) 0.104 - - - -    
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Table 4.28 Adjusted odds ratios and 95% confidence intervals for associations of clinical and 
laboratory parameters with death in severely malnourished children   
 Odds ratio for death 
(95% CI) 
 
p value 
BCS <4 5 (2 to 14) 0.003 
Hypotension 8 (3 to 21) <0.001 
Severe hyponatraemia 6 (1 to 32) 0.039 
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4.4 Discussion  
4.4.1 Clinical description of CAPMAL study patients In order to interpret our study results and to be able to compare them with other studies, we need first to understand the often complex clinical presentations of severely malnourished children admitted to hospital and recruited to the study. This chapter therefore describes in detail their clinical presentation including comorbidities that may be relevant to any cardiac dysfunction or haemodynamic compromise. At the same time we aimed to identify high-risk groups and detect possible signs of cardiac failure. We will build on this in considering any abnormal echocardiographic and electrocardiographic findings in the next two chapters. Common clinical features of children admitted to hospital with SAM in this study were fever, pneumonia and diarrhoea. Their baseline characteristics were comparable with the group of malnourished children who presented outside the study recruitment hours. However, patients in the CAPMAL study were more wasted, had a longer average hospital stay and a higher proportion of late deaths. Although this might slightly limit the generalizability of our findings to all children with severe malnutrition, inclusion of a more severely malnourished group also increases the chance of finding any clinically significant cardiac or haemodynamic compromise if we assume this is related to malnutrition severity. Put another way, it would give additional reassurance to clinicians and guideline makers, if no evidence of clinically important cardiac dysfunction were found in this high-risk group.  The accompanying comorbidities in the CAPMAL group nicely demonstrate the wide range of possible aetiologies of malnutrition, including ‘primary’ malnutrition due to food insecurity alone; and ‘secondary’ malnutrition due to cerebral palsy or developmental delay with subsequent long-term feeding difficulties, gastroenteritis causing acute malabsorption and weight loss, and HIV and other infections which increase the calorie demand on the body. They also reinforce the point that any cardiac dysfunction observed could not be necessarily attributed to malnutrition per se. Overall there was no difference in the presenting clinical syndromes of children with marasmus or kwashiorkor at the time of admission apart from HIV infection, which was commoner in marasmic children.  
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 The overall HIV prevalence of severely malnourished children in the CAPMAL study was 23%, similar to the average prevalence of 29% in a meta-analysis of 17 studies of severe malnutrition undertaken in sub-Saharan Africa.93 This suggests our findings are likely to be generalizable to other settings. As reported in other studies, death was more common in HIV positive children. 51 93 61 189 HIV positive children tended to be older and more wasted. Heart rate and blood pressure were also less likely to improve with nutritional rehabilitation, probably reflecting ongoing high metabolic requirements due to HIV itself and/or opportunistic infections, and possibly also dysregulation of the autonomic nervous system that has been described in HIV positive individuals.190 97  Overall mortality in our cohort was identical to a recent study of severely malnourished children in Kilifi. 51 Clinical predictors of death were in line with previous studies, although small numbers in this focused study of cardiovascular function limited power in our analyses. 50 51 50 51 69 191  
4.4.2 Clinical evidence and risk factors for cardiovascular compromise Heart failure describes a state in which cardiac output cannot meet the metabolic demands of the body, resulting in inadequate oxygen delivery to the tissues, which results in lactic acidosis. In some cases of heart failure, cardiac output can be normal or increased but because of alterations in the oxygen carrying capacity of the blood (e.g. due to anaemia) or increased metabolic demands (e.g. secondary to infection or increased metabolic rate) the amount of oxygen transported to the tissues is still inadequate, resulting in high cardiac output failure. Although the intrinsic function of the heart is initially normal, chronic high cardiac output can eventually reduce the myocardial performance once the heart’s own metabolic requirements are not met.192 Difficulties in diagnosing and staging cardiac failure in children are well recognised.193 194 Existing heart failure classifications such as the New York Heart Association (NYHA) and Ross classifications were originally developed for adults and only subsequently modified for use in children. A further limitation of both systems is that they only apply to patients with established chronic heart failure. Adult guidelines further suggest left ventricular systolic dysfunction precedes clinical signs of heart failure,195 but limited evidence exists for children.193 There therefore remains a lack of evidence based definitions of heart failure in children, and a need for a validated prognostic score for paediatric heart failure. 194 196 
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 Since completion of the CAPMAL study the Canadian Cardiovascular Society has now published guidelines for the diagnosis and management of heart failure in children.197 However, reflecting the very real challenges, even these guidelines stop short of providing an actual clinical definition of heart failure and much of the evidence on which they are based is acknowledged to be poor quality. Furthermore, many of the clinical signs of heart failure listed by the guidelines are so non-specific in the context of African children with severe malnutrition (e.g. feeding difficulties, vomiting, sweating, pallor, oedema, fatigue, etc) that they are unlikely to be applicable in this setting. For all these reasons, and because WHO guidelines are also the basis for the existing management package for severe malnutrition, we used in our analysis the clinical signs of heart failure included in the WHO guidelines.12  Despite careful monitoring for these signs of cardiac failure we only identified one patient with overt clinical heart failure that required treatment among all children recruited to the study. This is consistent with previous clinical experience in our setting, but might we be missing subtle or subclinical cardiac failure? To explore this further we carefully examined the cardiovascular profiles of all children, including clinical features that might reflect undiagnosed cardiac insufficiency.    Most children had very few or no signs of possible heart failure, all of which are rather unspecific, such as tachycardia and tachypnoea or hepatomegaly. The latter is particularly redundant as a sign of clinical heart failure in malnutrition, as children with both forms of malnutrition are known to have fatty liver degeneration.13 65 Less than 10% of children had three or more clinical signs consistent with cardiac failure, but further exploration showed little correlation between these and raised serum NT-proBNP levels. As it is possible that sub-clinical cardiac dysfunction might precede clinical symptoms, we will explore any overlap of clinical, biochemical and echocardiographic signs of cardiac failure in Chapter 5. There was also little overt evidence at admission of the clinical picture so often described as a “hypocirculatory state”. 127 128 136 Although 17% of children had at least one sign of impaired perfusion at admission, only four children met EPLS criteria for shock, one of whom met the WHO criteria. Interestingly all of them were marasmic and had diarrhoea, and 3 out of the 4 children had a raised urea and creatinine. Hypovolaemia therefore seems the most likely cause for shock.  
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 The high prevalence of hypoalbuminaemia at all three time points adds to the high risk of intravascular fluid depletion among malnourished children. Low albumin is associated with death in critically ill children admitted to intensive care unit. 171 198 Viart, whose work greatly emphasizes the hypovolaemic state of the malnourished child,127 128 154 199 also reported transition from an “adaptive hypocirculatory state” to frank circulatory failure when albumin concentration fell below 15g/L. 127 Hypoalbuminaemia lowers the plasma colloid osmotic pressure,199,200 leading to intravascular volume depletion and potentially to peripheral circulatory collapse, which may be accompanied by inadequate blood flow to vital organs including the gut.198 Hypovolaemia could therefore be a reasonable explanation for the high lactate levels we have observed in our population. However the lack of any difference in heart rate, respiratory rate, blood pressure, pulse volume or temperature gradient between children with and without hypoalbuminaemia suggests this may not be the whole story. The possible effect of hypoalbuminaemia on cardiac output will be explored further in chapter 5.   The haematological and biochemical profile of malnourished children at admission were largely consistent with previous descriptions.65 154 84 Importantly, there was very little biochemical evidence of re-feeding syndrome (see Chapter 1) such as hypophosphataemia and hypokalaemia. Hypophosphataemia in severely malnourished children has been described, 200 201 and has been associated with an increased mortality. 201 Therefore the WHO feeding protocol suggests the use of milk formulas and mineral mix that are designed to minimize the risks for re-feeding syndrome. Interestingly, a high proportion of marasmic children had abnormally high phosphate levels at admission and against expectation, phosphate levels rose even further in both groups during the first week of realimentation. The cause of this elevation is poorly understood but has recently also been described by Bartz who studied the metabolic and hormonal status of malnourished children in Uganda during nutritional rehabilitation.189 We did however find low magnesium levels at day 7 that were associated with higher odds of dying. Through various mechanisms, magnesium regulates vascular smooth muscle tone, and plays an important role in the electrical and contractile function of the heart in general.202-204 How low levels might affect cardiac function and the electrophysiological properties of the malnourished heart will be further explored in chapters 5 and 6. 
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 Anaemia was common in both types of malnutrition and the median haemoglobin concentration fell towards day 7 and only reached admission concentrations around day 28. Anaemia is well described in malnutrition154 199 and a drop in haemoglobin concentration during recovery from malnutrition has been attributed to an increase in plasma volume. 154 199 Severe anaemia (Hb < 5.0 g/dL) was not a common feature among SAM children in CAPMAL, probably due to the small number of malaria infection. It is also unlikely that cobalamin deficiency plays a role in the anaemia prevalence, as there was no difference in median Vitamin B12 concentrations between anaemic and non-anaemic children. To the contrary, 42% of SAM children demonstrated abnormally high levels of Vitamin B12. This phenomenon has also been reported by others, 205 206 and was observed to drop to normal levels after nutritional rehabilitation. 206 Our data however does not suggest that it is associated with an adverse outcome. Vitamin D deficiency is common among patients with heart failure, 207-209 has been associated with death among African children, 210 211 and is associated with protein-calorie malnutrition in other settings.212 We therefore measured vitamin D levels of patients in our study. However the prevalence of Vitamin D deficiency was low so is unlikely to have a major role in any cardiac dysfunction. Although the prevalence of WHO clinical features of cardiac failure was very low in our cohort, when looking at cellular level, signs of tissue hypoperfusion were much more evident, particularly at admission and day 7. Diarrhoea and sepsis might explain the high incidence of metabolic acidosis at admission, however the acidosis tended to persist for longer than clinical symptoms. Another explanation might be the high prevalence of anaemia. As previously discussed the already low haemoglobin dropped further between admission and day 7 which was more pronounced but not significantly different in marasmic children. This is thought to be due to a relative increase in plasma volume, due to fluid shifts between the compartments or just due to better hydration of the previously haemoconcentrated and dehydrated group of children with diarrhoea. This further lowering of the oxygen carrying capacity in conjunction with increased metabolic demands during re-feeding could be an explanation why serum lactate rose between admission and day 7. This in combination with an increase in heart rate would be in keeping with high cardiac output failure and will be further explored in Chapter 5 when looking at the echocardiographic assessment of cardiac function.  
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 Not supporting the high cardiac output theory is the fact that NT-proBNP levels did not tend to rise during the observation period. NT-proBNP is known to be elevated in congestive cardiac failure (CCF) and is more accurate in identifying CCF as the cause of dyspnoea than any other marker.213 NT-pro BNP has also been reported to be elevated in adults214 and children with sepsis and in children with impaired left ventricular function.183 215 However, it is recognized that NT-proBNP cannot be used on its own to differentiate between sepsis and LV dysfunction, although a small study has shown that NT-proBNP levels above 11,000 pg/mL probably reflect a cardiac aetiology for acute hemodynamic deterioration. 216  One limitation of our study was that we were only able to analyse NT-proBNP and cytokine levels on a subset of patients due to financial constraints. We might therefore have missed some children with elevated NT-proBNP levels, although the clinical significance of this is uncertain in the absence of clinical or echocardiographic evidence of heart failure as discussed above. For the same reason we were also only able to measure vitamin B12 and D levels on admission samples, hence we cannot comment on whether or not vitamin levels might have improved or deteriorated during realimentation. Some deficiencies only become evident once the basal metabolic rate has increased with nutritional rehabilitation.  
4.5 Conclusion 
 The clinical presentation of Kenyan children admitted to hospital with severe malnutrition is frequently complicated by factors known to affect haemodynamic status including pneumonia, hypoalbuminaemia, anaemia and diarrhoea. Diarrhoea in particular is associated with signs of impaired perfusion and hypovolaemic shock. However the prevalence of clinical cardiac failure is low. Nevertheless, children with malnutrition do show biochemical evidence of tissue hypoperfusion and further evaluation of their myocardial function with echocardiography is needed to understand these findings better.    
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5 Echocardiographic findings in severe malnutrition  
5.1 Introduction In Chapter 4 we have seen that a few severely malnourished children in the CAPMAL study show clinical and laboratory signs that could be in line with high output cardiac failure. Here we present the results of transthoracic echocardiography (TTE) as a further tool in the assessment of cardiac anatomy and function. Echocardiography is an easy, non-invasive tool to assess cardiac anatomy and haemodynamic function. However, it is operator dependent and the Gold Standard to determine cardiac output remains the pulmonary artery catheter thermodilution technique. 217 Although echocardiography has been used since the 1980s to evaluate cardiac function in malnourished children, different definitions of malnutrition and the wide range of aetiology and comorbidities complicate generalization of results. The long-standing debate whether the heart in the severely malnourished child functions normally is mainly based on studies undertaken before the era of echocardiography. Furthermore, the few existing echocardiographic studies of cardiovascular function present conflicting results as outlined in Chapter 2. 100 105 107 111 117 118 127 128 136 137  One reason for this is the variation in inclusion criteria and classifications of severe malnutrition that have been used in previous studies.  Another important reason may be the methods used to index cardiac structure and function parameters. Over the years there has been a wide debate on how to index cardiac variables in the general population in order to allow valid comparison of data independent of body size. 139 140 218-221 However choosing an appropriate anthropometric variable to which to index cardiac data has proven difficult. This has been the topic of a longstanding debate,81 139 140 222 a detailed description of which would exceed the scope of this thesis. However several different methods have been proposed, many of which have been criticized not to meet the necessary underlying statistical assumptions. 81 The most commonly used method is to index cardiac parameters to estimated body surface area. This is problematic for several reasons. Firstly, there are important limitations in the equations used to estimate body surface area. For example, one of the most widely used equations - still routinely used in leading echocardiography software 
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 today - was derived by DuBois in an unrepresentative population of only five subjects, including a 34 year old “cretin dwarf” and no children!223 Although alternative equations have been derived in more representative samples of normal children, extrapolation to children with severe malnutrition is likely to under- or overestimate true body surface area in kwashiorkor and marasmus, respectively, due to their different body habitus.139 224 It has also been postulated that body surface area in malnourished children might not actually reflect active cell mass,127 which is the main driver for cardiac output.  In response to the limitations of indexing methods, and recognizing the complex relationship between growth of various cardiac structures and body size, 139 140 population-specific reference ranges have been advocated. These utilize z-scores based on regression equations to adjust for the effect of age, gender and/or body size on the cardiovascular parameters of interest.81 225 However there are no published normal reference ranges for a population with a high incidence of chronic undernutrition and stunting.  To try to present our data as meaningful and correct as possible, we have used the Haycock formula226 to derive body surface area, which has been proposed formula in paediatrics. Furthermore we have applied published z-score regression equations that were derived using age, gender and body surface area for cardiac dimensions.225 Where this was not possible, we stratified our data according to published normal reference ranges using body surface area rather than age.  
5.1.1 Objectives of this chapter We aim in this chapter to build on the detailed clinical description outlined in chapter 4 by presenting a comprehensive echocardiographic assessment of cardiac status over the course of admission including:  1. Cardiac dimension, mass and function  2. Examining associations with clinical or biochemical features of possible cardiac dysfunction 3. Examining the differences between children with marasmus and children with kwashiorkor in any of the above   
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5.2 Methods Echocardiograms were performed according to American Society of Echocardiography (ASE) guidelines 227 at each of the set time points at admission, day 7 and day 28. We used a GE Vivid I portable echocardiograph with a 6S RS or 10S RS phased array transducer depending on the patient´s size. Images were recorded digitally and either analysed in real time or retrospectively.  Cardiac measurements and their abbreviations are summarized in Table 3.1. For each measurement the mean of three readings was used. All images and measurements were independently reviewed by a cardiologist who was blinded for the malnutrition type and other underlying comorbidities.   
5.2.1 Cardiac structure 
 Cardiac dimensions M-mode data was obtained at the level of the tips of the mitral leaflets in the parasternal long axis view and measurements performed according to the ASE guidelines.  Linear measurements included septal and posterior wall thickness and left ventricular internal dimensions in systole and diastole.  Cardiac Mass Left ventricular muscle mass (LVM) was calculated from M-mode data following the recommendations of the American Society of Echocardiography227 using the following formula developed by Devereux:228 
LV mass (ASE) = 0.8 (1.04 ((LVIDd + LVPWd + IVSd3 –(LVIDd)3)) +0.6 g. Measurements were repeated over three consecutive cardiac cycles and averaged. Left ventricular mass was derived in all children and indexed to (m2.7). In order to compare CAPMAL data with previously published measurements of left ventricular mass index, cardiac mass was also indexed to body surface area (m2). 
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 5.2.2 Cardiac function  
Systolic function 
Circumferential systolic function: M Mode linear measures were used to derive stroke volume as well as left fractional shortening (FS) using the following equation:    FS (%)= (LVIDd-LVIDs)/LVIDD x 100 where LVIDd refers to left ventricular internal dimensions in diastole and LVIDs refers to left ventricular internal dimensions at end-systole. 227 
Longitudinal systolic function: Tricuspid annular plane systolic excursion (TAPSE) and mitral annular plane systolic excursion (MAPSE) were also measured using the standard M-mode technique with the cursor placed on the lateral side of the annulus from the apical 4-chamber view.227 We stratified results for MAPSE and TAPSE using published reference values by body surface area for age81 summarized in Table 5.1.  In the absence of published reference ranges for TAPSE and MAPSE in our population we also calculated left and right ventricular longitudinal shortening using the following formulae, assuming no discrepancy between the LV and RV proportions in the absence of underlying congenital cardiac disease229: 
LV longitudinal shortening= MMode MAPSE/ 2D LVd length (A4CH) 
RV longitudinal shortening= MMode TAPSE/2D LVd length (A4CH) Tissue Doppler imaging (TDI) was used to measure the early systolic (Sa) mitral annular velocities using the standard technique.227 All measures were expressed as medians and interquartile ranges. Systolic dysfunction was defined as a reduction in FS and/or low MAPSE and/or low TAPSE and/or low Sa velocity  
Diastolic Function Pulsed wave mitral inflow Doppler tracings were used to measure the E/A ratio in the standard manner and published reference values were applied to define normality (Table 5.1). Tissue Doppler imaging (TDI) was obtained to measure the early diastolic (Ea) mitral annular velocity using the standard technique.227 Diastolic dysfunction was defined as an abnormal E/A ratio and/or low Ea velocity and/or high E/Ea ratio.  
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 Global Function We calculated the Tei index, or left myocardial performance index (LMPI), as 
LMPI= (IVCT + IVRT) / Ejection time, where the sum of the isovolumic contraction time (IVCT) and isovolumic relaxation time (ISRT) is computed by subtracting ejection time from the interval between cessation and onset of mitral inflow. 230 
5.2.3 Haemodynamic parameters  Cardiac index (CI) was calculated as  
CI= (Stroke volume x heart rate)/Body surface area 
 Systemic vascular resistance (SVR) was calculated as follows using Darcy´s formula (Resistance= Pressure/Flow) which, for practical reasons, we modified to:  
SVR = Mean blood pressure/VelocityTimeIntegralaorta The above formula however does not take central venous pressure into account and therefore assumes a CVP of 0.  Left ventricular stroke work index (LVSWI) was calculated using the following formula231 
LVSWI= Stroke Volume Index x Mean Blood Pressure x 0.0136  A LVSWI of 44-68 cJ was considered normal. 232  
5.2.4 Inferior vena cava  We measured the maximal diameter (ICVDmax) during expiration and minimum diameter during inspiration (IVCDmin) in the sub-xyphoid view below the level of the hepatic veins, 5cm from the IVC-right atrium junction. We calculated the inferior vena cava collapsibility index (IVCCI), an indirect marker of fluid responsiveness,156 using the following formula:233 
IVCCI= ((IVCDmax – IVCDmin)/IVCDmax)) x 100 
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5.2.5 Pericardial Effusion  The presence of pericardial effusions was documented and pericardial effusions were divided into greater or smaller than 0.5cm in diastole. 
  
5.2.6 Indexing and reference values  In order to allow comparisons with data published by other groups, we present the cardiac mass data as raw values, left ventricular mass (LVM (g)), indexed to body surface area (LVM1 (g/m2) and indexed to body surface area to the power of 2.7 (LVM2 (g/m2.7), as this is thought to be most accurate. 222 For cardiac dimensions we presented both raw values and z-scores derived using the age, body-size and gender adjusted z-score regression equation by Pettersen et al, derived in a healthy US population.225 Left ventricular dilatation was defined as a LVIDd z-score of greater than +2.  Reference ranges for systolic and diastolic cardiac function stratified by body surface area were taken from the published literature as summarized in Table 5.1.129 132 We calculated body surface area using the Haycock formula226 below, which is thought to provide the best correlation between BSA and the size of cardiovascular structures: 227   BSA(m2) = 0.024265  x weight (kg)0.5378 x height (cm)0.3964 To calculate the body surface area in kwashiorkor we used the dry (oedema-free) weight, estimated as the lowest recorded weight during admission.  For fractional shortening and the Tei Index we used reference ranges of 28-44% and 0.24-0.45, respectively234 132 as reference ranges do not vary significantly with age or body surface area and therefore no stratification was needed.  Reference ranges for haemodynamic variables stratified by height were adapted from Cattermole et al. (Table 5.2). 235   
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Table 5.1 Derived cut- off points grouped by body surface area (BSA) using published means and 
standard deviation (SD) 
Source Parameter Age 
(yr) 
BSA  
(m2) 
 Mean   (2 SD) Lower 
limit 
Upper 
limit 
Eidem et al 
2004 
Sa (cm/s) 
 
<1 <0.42 5.7 (3.1) 2.6 8.8 
1-5 0.42-<0.76 7.7 (4.1) 3.6 11.8 
5-9 0.76<1.34 9.5 (4.1) 5.4 13.6 
Koestenberger 
et al 2012 
MAPSE <1 N/S 8 (2.1) 5.9 10.1 
1-5 N/S 11.3 (2.3) 9.0 13.6 
6-9 N/S 13.1 (2.6) 10.5 15.7 
Nurez-Gil et al 
2011 
TAPSE <1 <0.41 13.2 (4.4) 8.8 17.6 
1-5 0.41<0.72 18.3 (5.5) 12.7 23.8 
5-9 0.72<0.93 19.3 (5.8) 13.5 25.1 
Eidem et al 
2004 
E/A ratio <1 <0.42 1.24 (0.59) 0.65 1.83 
1-5 0.42-<0.76 1.60 (0.9) 0.7 2.5 
6-9 0.76<1.34 1.99 (1.0) 0.99 2.99 
Eidem et al 
2004 
Ea (cm/s) <1 <0.42 9.7 (6.5) 3.2 16.2 
1-5 0.42-<0.76 15.1 (6.7) 8.4 23.5 
6-9 0.76<1.34 17.2 (7.3 9.9 24.5 
Eidem et al 
2004 
E/Ea ratio <1 <0.42 8.8 (5.3) 3.5 14.1 
1-5 0.42-<0.76 6.5 (3.9) 2.6 10.4 
6-9 0.76<1.34 5.8 (3.7) 2.1 9.5 
Eidem et al 
2004 
LVM (g/m2) <1 <0.42 18.9 (12.7) 6.2 31.6 
1-5 0.42-<0.76 43.6 (32.1) 11.5 75.7 
6-9 0.76<1.34 82.3 (55.5) 26.8 137.8   
Table 5.2 Normal reference ranges for haemodynamic variables using height to define groups6  
 Group I Group II Group III 
Height (cm) <92.8 92.8-111.1 >111.1 
Cardiac Index (L/min/m2) 3.5 -6.5 3.6-7.1 3.3-6.9 
SVRI (ds/cm5/m2) 750-1600 750-1700 910-2000 
SVI (ml/m2) 31-55 37-67 42-76   
6 This data was derived by Cattermole et al (2010) in healthy Chinese children but modified to present 
cut-offs grouped by height rather than age as this appears more appropriate for malnourished 
children. 
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5.3 Results 
5.3.1 Cardiac structure and size  
Cardiac dimensions Cardiac dimensions are summarized overall in Table 5.3, and separately for children with kwashiorkor and marasmus in Table 11.3 (see appendix). Apart from the thickness of the interventricular septum in systole (IVSs) all other measures appear to increase over the 28-day observation period, particularly in marasmus. Most marked among marasmic children was the increase in left ventricular internal dimensions, which were significantly greater than kwashiorkor children at day 7 (Table 11.3 and Figure 5.1), and negatively correlated with both haemoglobin concentration (Coef. -0.32, p<0.001, R2=0.19) and SVRI (Coef -0.001, p=0.002, R2=0.08). The relationships remained independent in a multiple linear regression model.     Consistent with this, the proportion of marasmic children with left ventricular (LV) dilatation was also higher. LV dilatation occurred in nine marasmic and one kwashiorkor child over the course of admission and was associated with systolic dysfunction in four children, diastolic dysfunction in one and combined systolic and diastolic dysfunction in one child. LV dilatation at admission had an OR for systolic dysfunction of 20.7 (95% CI 2.0 to 219, p=0.012) and an OR for diastolic dysfunction of 8.4 (95% CI 0.7 to 107, p=0.100). However NT-proBNP concentrations in children with LV dilatation were not significantly different from children without LV dilatation. Six children with LV dilatation were HIV positive. Death occurred in one child with LV dilatation, but this child tested HIV negative and had preserved cardiac function. 
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 Table 5.3 Cardiac dimensions of all children with severe malnutrition as raw measurements and z-
scores at admission, day 7 and day 28  
  Admission 
N=83 
Day 7 
N=82 
Day 28 
N=59 
Sy
st
ol
ic
 d
im
en
si
on
s 
IVSs (mm) 8 (7, 9) 8 (7, 9) 8 (7, 9) 
z-IVSs 1.67 (0.89, 2.11) 1.75 (0.92, 2.10) 1.59 (1.26, 2.31) 
LVIDs (mm) 15 (14, 17) 16 (14, 19) 16 (15, 19) 
z-LVIDs -0.01 (-0.66, 0.67) 0.09 (-0.74, 1.03) 0.23 (-0.67, 0.96) 
LVPWs (mm) 6 (6, 8) 7 (6, 8) 8  (7, 8) 
z-LVPWs -0.26 (-0.77, 0.68) 0.20 (-0.40, 0.65) 0.50 (-0.36, 1.15) 
Di
as
to
lic
 d
im
en
si
on
s IVSd (mm) 6 (5, 7) 6 (6, 7) 7 (6, 8) 
z-IVSd 1.58 (0.90, 2.18) 1.81 (1.22, 2.38) 2.17 (1.62, 2.49) 
LVIDd (mm) 24 (22, 27) 25 (23, 28) 26 (23, 28) 
z-LVIDd -0.21 (-1.16, 0.72) -0.18 (-0.84, 0.61) 0.10 (-0.62, 0.86) 
LVPWd (mm) 4 (4, 5) 5 (4, 5) 5 (4, 6) 
z-LVPWd 1.01 (0.60, 1.79) 1.15 (0.65, 1.92) 1.57 (0.80, 2.11)  Data is presented as medians (IQR). The folloing abbreviations were used: IVSs=intraventricular septum in systole, IVSd=intraventricular septum in diastole, LVIDs= left ventricular inner diameter in systole, LVIDd= left ventricular inner diameter in diastole, LVPWs=left ventricular posterior wall in systole, LVPWd=left ventricular posterior wall in diastole    
Figure 5.1 Box and whiskers of left ventricular inner diameter in diastole z-scores7 in children with 
marasmus and kwashiorkor at admission, day 7 and day 28 
 
7 The z-scores allow comparison to a population of healthy US children (Pettersen et al. 2008) with most malnourished cases falling within the normal range (+/- 2 z-scores). 
 
 125 
                                                        
  
Left ventricular mass The left ventricular mass (LVM) and left ventricular mass index (LVMI) of marasmic, kwashiorkor and all malnourished children are summarized in Table 5.4. Both LVM and LVMI1 (g/m2) measured in diastole increased over time. Median LVMI2 (g/m2.7) remained below the 95th percentile of published norms by Foster.222 Overall, median cardiac mass increased by 8 gram from admission to day 28: 11gram in marasmic children and 7 gram in children with kwashiorkor. This equates to 48% and 30% increase, respectively. Left ventricular mass normalized for body surface area using two different indexing methods revealed higher left ventricular mass indices for both methods with a steady increase. There was no significant difference in cardiac mass between children with marasmus and kwashiorkor at any time point. However, since their anthropometric indices were significantly different, once indexed for body size, cardiac mass index was significantly lower in children with kwashiorkor on admission and day 7.  
Table 5.4 Median left ventricular mass (LVM), left ventricular mass indices (LVMI) and interquartile 
ranges in malnourished children overall and comparison between those with marasmus and 
kwashiorkor at admission, day 7 and day 28 
 
 
Admission 
All SAM Marasmus Kwashiorkor p value 
N=83 N=48 N=35 
LVM (g) 23 (17, 31) 23 (17, 31) 23 (16, 29) 0.861 
LVMI1 (g/m
2) 63 (51, 77) 65 (53, 78) 56 (46, 72) 0.138 
LVMI2 (g/m
2.7) 50 (42, 62) 53 (45, 66) 45 (38, 57) 0.010 
       
Day 7 N=82 N=48 N=34  
LVM (g) 26 (20, 36) 26 (20, 36) 25 (20, 35) 0.714 
LVMI1 (g/m
2) 68 (58, 80) 74 (63, 86) 65 (54, 75) 0.023 
LVMI2 (g/m
2.7) 58 (47, 70) 65 (55, 75) 52 (46, 62) 0.004 
       
Day 28 N=59 N=35 N=24  
LVM (g) 31 (23, 39) 34 (23, 39) 30 (26, 38) 0.728 
LVMI1 (g/m
2) 77 (65, 92) 80 (64, 92) 75 (65, 91) 0.902 
LVMI2 (g/m
2.7) 67 (58, 81) 73 (59, 85) 61 (56, 74) 0.151 
 Data is presented as medians (IQR)   Left ventricular mass (LVM) is presented as raw data, indexed to height (LVMI1) and indexed to BSA (LVMI2) to allow comparison with previous studies and to acknowledge that the ideal method of indexing is subject of a long standing debate, especially in malnutrition where BSA might be underestimated in marasmic and overestimated in Kwashiorkor children. 
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 Pericardial effusions Pericardial effusions were present in more than one in five children at each time point (Table 5.5). Most of these were small (<0.5 cm) and none was haemodynamically significant enough to require intervention. A higher proportion of children with kwashiorkor had pericardial effusions at admission. There was weak evidence of an association between severe hypoalbuminaemia and pericardial effusion among kwashiorkor children at admission only (OR 4.2, 1.0 to 18.3, p=0.056). Among children with marasmus, pericardial effusion was associated with hypothyroidism (OR 6.0, 1.2 to 30.7, p=0.032).   
Table 5.5 Prevalence of pericardial effusions among malnourished children overall and comparison 
between children with marasmus and kwashiorkor at admission, day 7 and day 28  
 Overall Marasmus Kwashiorkor P value* 
Admission    (N=88)                         (N=52)                        (N=36) 
Small effusion (<0.5 cm) 18 (21%) 7 (14%) 11 (31%) - 
Large effusion (>0.5 cm) 2 (2%) 1 (2%) 1 (3%) - 
Total 20  (23%) 8 (15%) 12 (33%) 0.048 
Day 7                                                    (N=85)                         (N=51)                        (N=35) 
Small effusion (<0.5 cm) 14 (17%) 8 (16%) 6 (18%) - 
Large effusion (>0.5 cm) 6 (7%) 5 (10%) 1 (3%) -- 
Total 20 (24%) 13 (26%) 7 (21%) 0.602 
Day 28                                                  (N=62)                         (N=37)                        (N=25) 
Small effusion (<0.5 cm) 11 (18%) 5 (14%) 6 (24%) - 
Large effusion (>0.5 cm) 2 (3 %) 2 (5%) 0 (0%) - 
Total 13 (21%) 7 (20%) 6 (24%) 0.630 *p value comparing marasmus and kwashiorkor Data is presented as absolute numbers and proportions (%)   
5.3.2 Cardiac function A summary of systolic, diastolic and global indices of cardiac function among all malnourished children is presented in Figure 5.2 and Figure 5.3. Differences between children with marasmus and kwashiorkor over the course of admission are presented in Table 5.6 to Table 5.8. Median values of all variables were within the normal range. The minority of children with indices outside the normal range are considered below.     
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 Systolic function Short axis function At admission 6 (7%) of malnourished children had reduced fractional shortening (FS%) the proportion did not differ significantly between marasmus and kwashiorkor (Table 5.6). However by day 7 this proportion had risen from 8% to 13% among marasmic children but none of the kwashiorkor children had a reduced FS, suggesting there may be important differences in their cardiac physiology during that first week of re-alimentation. Examining serial measurements of FS and LVIDd z-scores for the 6 marasmic children with a low FS at day 7 (Table 11.10) it appears that in all children with admission echocardiographic data (5/6 children), the fractional shortening had dropped to its lowest point at day 7. Two of these children (C47 & C89) increased their stroke volume index in response to an increase in LVIDd but showed concomitant fall in FS, which implies that the degree of contractile impairment was masked by relative hypovolaemia. Both children had HIV and one of them (C47) died shortly after the day 28 review. In another child, the increase in LVIDd and drop in FS was associated with no change in SVI (C19). This child did not have any clinical signs of cardiac failure but serum lactate increased from 1.7mmol/L to 3.4mmol/L in absence of metabolic acidosis, suggesting there might be a degree of cardiac failure overall. The child also failed to put on weight during the first week of admission but made a good recovery overall by day 28. In the remaining two children (C51, C82) the fall in FS was associated with a fall in both LVIDd and SVI, which might be explained by an accompanying fall in systemic vascular resistance.  Both children were HIV negative and made a full recovery by day 28. Comparison between admission and day 7 data was not possible in C87 due to incomplete data. Systolic longitudinal function was reduced in 2/6 (C87, C89) of these children at day 7. Long axis function Overall there was no difference in systolic long axis function between children with marasmus and those with kwashiorkor. Thirteen children had isolated low MAPSEs during admission, 3 had low TAPSEs and 1 had low systolic mitral annular velocity. Another two children had both, low MAPSEs and TAPSEs and one child had low indices for all long axis parameters. Interestingly, at day 28, systolic long axis function (MAPSE) seemed to be more impaired than short axis function (Table 5.8).  
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 Diastolic function Overall, there was very little overlap between the diastolic function indices. Diastolic dysfunction also did not persist in the same way as systolic dysfunction during the course of admission (Figure 5.2 and Figure 5.3) total of seven children, six of which had marasmus, showed a restrictive filling pattern with high E/A ratios. A high E/Ea ratio, suggesting increased left ventricular end-diastolic pressure, was present in seven children, four of which had kwashiorkor. Five children (all kwashiorkor) had low myocardial relaxation velocities. Only one child with kwashiorkor had both, low myocardial relaxation velocity and high E/Ea at day 7. Another child with marasmus was found to have high E/Ea ratio and high E/A ratio at day 28. None of the children with high E/Ea ratios, ie high LV filling pressures, had left ventricular dilatation or increased SVRI whereas high E/A ratios were associated with left ventricular dilatation in two children (C82, C25) and high SVRI in another child (C82, C52). Overall, there is some evidence that children with kwashiorkor have impaired left ventricular relaxation, whereas children with marasmus seemed to show more problems with restrictive filling. Overall the E/Ea ratio slowly increased over time indicating an increase in the LV filling pressures (Figure 5.3). 
 
Global function The median Tei Index was within normal range at each time point, but a large proportion of children had abnormally high Tei indices over the course of admission. The odds ratio for dying in children with a high Tei Index was 7 (95% CI 2 to 28, p=0.005). The association was stronger in children with marasmus with an OR of 11 (95% CI 1 to 98, p=0.030). 
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 Figure 5.2 Box-and-whisker plots of systolic function indices8 in children with severe malnutrition at 
admission, day 7 and day 28 
 
 
 
 
 
 
 
 
8 Fractional shortening (FS) is a measure of circumferential left ventricular shortening, mitral and tricuspid 
annular plane systolic excursions (MAPSE and TAPSE) are measures of the longitudinal shortening of the 
ventricles. All of them are load-dependent parameters. Early systolic mitral annular velocity is derived using 
tissue Dopplers and is known to be a load independent measure of longitudinal left ventricular function. The 
normal reference range for FS is 28-44%, the normal range for the other parameters depend on the patient´s 
body size. 
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 Figure 5.3 Box-and-whisker plots of diastolic function indices9 and Tei Index in children with severe 
malnutrition at admission, day 7 and day 28 
9 The early to late diastolic filling ratios (E/A ratio) deliver information about the relaxation and compliance 
properties of the left ventricle. Reduced relaxation leads to low early diastolic mitral annular velocities (Ea). High 
early filling to early diastolic mitral annular velocities ratios (E/Ea ratio) are a sign of high left ventricular filling 
pressures. Normal reference ranges depend on the child´s BSA. The Tei Index represents global cardiac function 
and has a normal reference range of 0.24 to 0.44. 
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 Table 5.6 Cardiac function indices of severely malnourished children overall, and comparison between those with marasmus and kwashiorkor at admission  
Admission  All SAM 
N=83 
Marasmus 
N=48 
Kwashiorkor  
N=35 
 
p value 
 
 
 
 
 
Systolic 
Function 
FS (%) 36 (34, 39) 36 (34, 39) 36 (33, 40) 0.732 
High FS 5 (6%) 4 (8%) 1 (3%) 0.300 
Low FS 6 (7%) 4 (8%) 2 (6%) 0.649 
MAPSE (mm) 8 (7, 10) 13 (11, 15) 14 (13, 16) 0.123 
High MAPSE 5 (6%) 4 (8%) 1 (3%) 0.357 
Low MAPSE 8 (10%) 5 (10%) 3 (9%) 0.903 
TAPSE(mm) 14 (12, 16) 8 (7, 9) 9 (8, 10) 0.067 
High TAPSE 3 (4%) 3 (6%) 0 (0%) 0.148 
Low TAPSE 3 (4%) 3 (6%) 0 (0%) 0.148 
Sa (cm/s) 5 (5, 7) 5 (5, 6) 5 (5, 7) 0.314 
High Sa 3 (3.9%) 2 (4%) 1 (3%) 0.748 
Low Sa 1 (1%) 1 (2%) 0 (0%) 0.389 
 
 
 
Diastolic 
Function 
E/A ratio 1.17 (1.06, 1.35) 1.15 (1.08, 1.37) 1.18 (1.04, 1.35) 0.966 
High E/A ratio 3 (4%) 2 (4%) 1 (3%) 0.757 
Low E/A ratio 0 (0%) 0 (0%) 0 (0%) N/A 
Ea (cm/s) 11 (9, 12) 10 (8, 12) 11 (10, 13) 0.034 
High Ea 3 (4%) 1 (2%) 2 (6%) 0.384 
Low Ea 1 (1%) 0 (0%) 1 (3%) 0.240 
E/Ea (m/s) 6.78 (5.75, 8.29) 7.28 (6.12, 8.55) 6.08 (5.09, 7.33) 0.020 
High E/Ea 0 (0%) 0 (0%) 0 (0%) N/A 
Low E/Ea 1 (1%) 0 (0%) 1 (3%) 0.240 
Global 
Function 
Tei Index 0.37 (0.26, 0.45) 0.38 0.30, 0.48 0.30 0.24, 0.42 0.118 
High Tei Index 20 (24%) 14 (29%) 6 (18%) 0.231  Data is presented as medians (IQR) and absolute numbers (%) outside the normal range. The cut-offs used can be found in Table 5.2 The following abbreviations were used: FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity, E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea) 
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 Table 5.7 Cardiac function indices of severely malnourished overall and comparison between children with marasmus and kwashiorkor at day 7 
Day 7 All SAM 
N=82 
Marasmus 
N=48 
Kwashiorkor 
N=34 
 
p value 
 
 
 
Systolic 
Function 
FS (%) 37 (34, 41) 36 (34, 40) 38 (35, 42) 0.206 
High FS 5 (6%) 2 (4%) 3 (9%) 0.385 
Low FS 6 (7%) 6 (13%) 0 (0%) 0.032 
MAPSE (mm) 9 (8, 10) 9 (8, 10) 9 (9, 10) 0.546 
High MAPSE 4 (5%) 2 (4%) 2 (6%) 0.756 
Low MAPSE 4 (5%) 3 (7%) 1 (3%) 0.468 
TAPSE (mm) 15 (13, 17) 14 (13, 16) 15 (13, 17) 0.218 
High TAPSE 2 (3%) 2 (5%) 0 (0%) 0.218 
Low TAPSE 3 (3.8%) 2 (5%) 1 (3%) 0.743 
Sa (cm/s) 5 (5, 6) 5 (4, 6) 0.06 (5, 6) 0.261 
High Sa 1 (2%) 0 (0%) 1 (4%) 0.255 
Low Sa 1 (2%) 0 (0%) 1 (4%) 0.255 
 
 
 
 
Diastolic 
Function 
E/A ratio 1.26 (1.1, 1.4) 1.29 (1.1, 1.5) 1.18 (1.09, 1.33) 0.079 
High E/A ratio 2 (3%) 2 (4%) 0 (0%) 0.220 
Low E/A ratio 0 (0%) 0 (0%) 0 (0%) N/A 
Ea (cm/s) 11 (9, 12) 10 (9, 12) 0.11 (9, 12) 0.819 
High Ea 1 (2%) 1 (3%) 0 (0%) 0364 
Low Ea 3 (5%) 0 (0%) 3 (10%) 0.049 
E/Ea (m/s) 7.7 (6.4, 9.3) 8.3 (6.9, 9.6) 6.78 (5.85, 8.29) 0.038 
High E/Ea 2 (3%) 0 (0%) 2 (7%) 0.109 
Low E/Ea 0 (0%) 0 (0%) 0 (0%) N/A 
Global 
Function 
Tei Index 0.31 (0.24, 0.42) 0.33 (0.26, 0.46) 0.28 (0.19, 0.37) 0.039 
High Tei Index 17 (21%) 23 (27%) 4 (13%) 0.118  Data is presented as medians (IQR) and absolute numbers (%) outside the normal range. The cut-offs used can be found in Table 5.2 The following abbreviations were used: FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity, E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea) 
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 Table 5.8 Cardiac function indices of severely malnourished overall and between children with marasmus and kwashiorkor at day 28 
Day 28  All SAM 
N=59 
Marasmus 
N=35 
Kwashiorkor 
N=24 
 
p value 
 
 
 
 
 
Systolic 
Function 
FS (%) 37 (33, 39) 36 (32, 39) 37 (34, 39) 0.551 
High FS 2 (3%) 1 (3%) 1 (4%) 0.785 
Low FS 3 (5%) 2 (6%) 1 (4%) 0.790 
MAPSE (mm) 9 (8, 10) 9 (8, 10) 10 (8, 10) 0.089 
High MAPSE 1 (1.8%) 0 (0%) 1 (4%) 0.237 
Low MAPSE 9 (16%) 5 (15%) 4 (17%) 0.877 
TAPSE (mm) 16 (14, 18) 16 (14, 18) 16 (13, 19) 0.871 
High TAPSE 8 (14%) 4 (12%) 4 (17%) 0.626 
Low TAPSE 0 (0%) 0 (0%) 0 (0%) N/A 
Sa (cm/s) 6 (5, 7) 6 (5, 7) 6 (5, 7) 0.348 
High Sa 1 (2%) 1 (3%) 0 (0%) 0.413 
Low Sa 1 (2%) 0 (0%) 1 (5%) 0.213 
 
 
Diastolic 
Function 
E/A ratio 1.22 (1.11, 1.38) 1.24 (1.07, 1.37) 1.2 (1.15, 1.41) 0.769 
High E/A ratio 2 (3%) 2 (6%) 0 (0%) 0.243 
Low E/A ratio 1 (2%) 0 (0%) 1 (4%) 0.565 
Ea (cm/s) 11 (9, 13) 11 (9, 15) 11 (10, 12) 0.949 
High Ea 0 (0%) 0 (0%) 0 (0%) N/A 
Low Ea 2 (4%) 0 (0%) 2 (10%) 0.075 
E/Ea (m/s) 7.9 (6.7, 10.1) 8.4 (6.6, 10.4) 7.5 (6.8, 9.0) 0.573 
High E/Ea 5 (9%) 3 (9%) 2 (10%) 0.986 
Low E/Ea 0 (0 %) 0 (0%) 0 (0%) N/A 
Global 
Function 
Tei Index 0.29 (0.23, 0.42) 0.3 (0.26, 0.43) 0.28 (0.19, 0.42) 0.192 
High Tei Index 9 (15%) 6 (17%) 3 (13%) 0.626   Data is presented as medians (IQR) and absolute numbers (%) outside the normal range. The cut-offs used can be found in Table 5.2 The following abbreviations were used: FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity, E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea) 
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 Summary of systolic and diastolic dysfunction Overall, 14 children (16%) had systolic dysfunction at admission, 11 (13%) at day 7 and 11 (18%) at day 28, of whom three had systolic dysfunction at all three time points, six had de novo systolic dysfunction at day 7 and five had de novo systolic dysfunction at day 28. Four children (5%) had diastolic dysfunction at admission, six (7%), all de novo at day 7 and seven (11%) – six de novo – at day 28. There were six children who had both systolic and diastolic dysfunction at the same time during the course of admission. Only one of these children died (C31). This child had kwashiorkor, diarrhoea and HIV and the Tei -Index was high at admission.   
Effect of known risk factors for cardiac impairment  Overall, among the potential clinical risk factors for cardiac impairment discussed in Chapter 4, only HIV and SIRS were associated with systolic dysfunction, with no real difference between marasmic and kwashiorkor children (χ2 test for heterogeneity >0.5 in all cases; Table 5.9). The only cytokine that was significantly higher among children with systolic dysfunction was IL-6 at day 7 (12.0 vs. 4.8, p=0.028). Diastolic dysfunction was associated with a high NT-proBNP (OR 3.7, 1.1 to 12.2, p=0.021; Table 5.10). Neither systolic nor diastolic dysfunction, were associated with clinical signs of heart failure (CCF score≥3).  
5.3.3  Echocardiographic evidence for cardiac dysfunction in children with three or more clinical 
signs of cardiac failure  Of the thirteen children identified in Chapter 4 who have three or more clinical signs of cardiac failure, seven children had signs of cardiac dysfunction (systolic, diastolic or global; Table 5.11). In the remaining six children, the clinical signs were probably due to increased cardiac index in four and high systemic vascular resistance index in two, yet their clinical signs were identical.   
 135 
  
Table 5.9 Crude odds ratios (95%CI) for associations of clinical and laboratory parameters with systolic dysfunction at any time during admission, overall and 
by malnutrition type 
 All SAM 
OR for systolic 
dysfunction 
(95% CI) 
 
 
 
p value 
Marasmus 
OR for systolic 
dysfunction 
(95% CI) 
 
 
 
p value 
Kwashiorkor 
OR for systolic 
dysfunction 
(95% CI) 
 
 
 
p value 
 
χ2 test of 
heterogeneity 
HIV 3.6 (1.1 to 11.1) 0.020 3.0 (0.8 to 10.9) 0.080 7.4 (0.5 to 109.8) 0.090 0.544 
Diarrhoeaa 1.3 (0.5 to 3.5) 0.667 2.2 (0.5 to 9.4) 0.289 0.6 (0.1 to 3.0) 0.569 0.254 
CCF score≥3b 2.5 (0.7 to 8.6) 0.142 3.6 (0.8 to 17.0) 0.079 1.0 (0.1 to 11.4) 1.000 0.368 
Hypotensionc 3.0 (0.9 to 9.5) 0.052 1.4 (0.3 to 7.0) 0.657 10.0 (1.1 to 89.4) 0.011 0.140 
Albumin <15g/dL 2.0 (0.6 to 7.4) 0.265 0.7 (0.1 to 7.8) 0.800 3.4 (0.6 to 18.1) 0.127 0.284 
SIRSd 3.6 (1.2 to 10.6) 0.012 2.2 (0.6 to 7.9) 0.213 11.6 (1 to 138.1) 0.014 0.212 
High NT-proBNPe 1.1 (0.4 to 3.2) 0.797 1.0 (0.3 to 4.0) 1.000 1.4 (0.3 to 6.4) 0.697 0.771 
Severe acidosisf 1.1 (0.4 to 2.9) 0.786 1.5 (0.4 to 5.1) 0.519 0.7 (0.2 to 3.5) 0.704 0.485 
Lactate >3mmol/L 1.3 (0.5 to 3.3) 0.597 1.8 (0.5 to 6.0) 0.335 0.7 (0.1 to 3.6) 0.697 0.373  a Diarrhoea was defined as >=3 loose stool /24 hours b CCF score≥3 denotes more 3 or more of the following clinical cardiac failure signs: tachycardia, tachypnoea, hepatomegaly, gallop rhythm, distended neck veins c Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years d SIRS and leucocytosis were defined using the criteria by Goldstein et al175 e Elevated NT-proBNP was defined by Nir 173as >650pg/ml in children up to 12m of age, >400pg/ml in children aged 12m-<24m, >300 in children aged 2y-<6y and >160pg/ml for children >6 y f Severe acidosis was defined as a base deficit of more than 10mmol/L  
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 Table 5.10 Crude odds ratios (95%CI) for associations of clinical and laboratory parameters with diastolic dysfunction at any time during admission, overall 
and by malnutrition type   
 All SAM 
OR for diastolic 
dysfunction 
(95% CI) 
 
 
 
p value 
Marasmus 
OR for diastolic 
dysfunction 
(95% CI) 
 
 
 
p value 
Kwashiorkor 
OR for diastolic 
dysfunction 
(95% CI) 
 
 
 
p value 
 
χ2 test of 
heterogeneity 
HIV 1.4 (0.4 to 4.8) 0.612 0.6 (0.1 to 3.7) 0.618 9.0 (0.6 to 139.5) 0.057 0.075 
Diarrhoeaa 1.0 (0.3 to 3.3) 0.961 1.3 (0.2 to 7.2) 0.796 0.9 (0.2 to 4.3) 0.860 0.757 
CCF score≥3b 2.5 (0.6 to 9.7) 0.175 3.8 (0.7 to 21.5) 0.104 1.2 (0.1 to 13.8) 0.889 0.440 
Hypotensionc 0.7 (0.1 to 3.6) 0.673 0.8 (0.1 to 7.3) 0.808 0.7 (0.1 to 6.9) 0.724 0.934 
Albumin <15g/dL 1.5 (0.3 to 6.8) 0.565 0 (-) 0.379 2.6 (0.5 to 13.8) 0.241 0.212 
SIRSd 1.5 (0.5 to 4.7) 0.469 1.4 (0.3 to 6.7) 0.680 1.7 (0.3 to 8.6) 0.538 0.875 
High NT-proBNPe 3.7 (1.1 to 12.2) 0.021 3.9 (0.8 to 19.9) 0.079 3.5 (0.6 to 19.6) 0.126 0.934 
Severe acidosisf 1.6 (0.5 to 5.0) 0.397 1.4 (0.3 to 6.7) 0.680 1.9 (0.4 to 10.0) 0.429 0.779 
Lactate >3mmol/L 0.6 (0.2 to 1.8) 0.316 0.3 (0.1 to 1.9) 0.196 0.9 (0.2 to 4.8) 0.928 0.398  a Diarrhoea was defined as >=3 loose stool /24 hours b CCF score≥3 denotes more 3 or more of the following clinical cardiac failure signs: tachycardia, tachypnoea, hepatomegaly, gallop rhythm, distended neck veins c Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years d SIRS and leucocytosis were defined using the criteria by Goldstein et al175 e Elevated NT-proBNP was defined by Nir 173as >650pg/ml in children up to 12m of age, >400pg/ml in children aged 12m-<24m, >300 in children aged 2y-<6y and >160pg/ml for children >6 y f Severe acidosis was defined as a base deficit of more than 10mmol/L 
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 Table 5.11 Summary of normal and abnormal echocardiographic indices among 13 children with a clinical CCF score ≥3 including their malnutrition type and 
HIV status  
Study 
No 
SAM  CCF score S/D Function Tei Index CI SVRI 
Type HIV D0 D7 D28 D0 D7 D28 D0 D7 D28 D0 D7 D28 D0 D7 D28 
7 K +ve 3 2 3 N N N N N N H N H H N N 
3 M +ve 0 2 3 N N N N N N N N H N N N 
6 M +ve 1 3 2 N N N N N N H H N H H H 
9 M +ve 3 3 3 N N N N N N N N H N N H 
14 M +ve 2 3 2 D N N N N N N N H H N N 
87 M +ve 4 5 3 - S S - N N - - H - N N 
90 M +ve 0 3 Died S N - N H - N - - H H - 
16 K -ve 1 3 0 N SD N N N N N N L N N N 
76 K -ve 0 3 2 N N N N N N N N N H H H 
84 K -ve 3 1 1 N N N N N N N N N H H N 
51 M -ve 3 0 1 N S D N H N N N N N N N 
65 M -ve 1 1 3 N N S N N N N N H H N N 
82 M -ve 3 2 2 SD S N N H N H N H H H H 
N= normal; L= low; H= high, S=systolic dysfunction; D=diastolic dysfunction; SD= systolic and diastolic dysfunction  The WHO “WHO Pocket Book of Hospital Care for Children”12 considers tachycardia, tachypnoea, hepatomegaly, gallop rhythm and distended neck veins as clinical signs of congestive cardiac failure. CCF denotes clinical cardiac failure signs 
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 5.3.4 Haemodynamic function in severely  malnourished children 
 
Stroke volume index and cardiac index At admission 33% of children had a low stroke volume index with no difference in children with marasmus and kwashiorkor (Table 5.12). Median stroke volume index changed very little over the time period, from 39 ml/m2 at admission to 41 ml/m2 at day 28, so that one in five children still had a low stroke volume at day 28  (Table 5.12, Table 5.13, Table 5.14).  Median cardiac index was within normal range with approximately equal proportions of children presenting with a high and low cardiac index at admission.  Over the course of admission the proportion of children with high cardiac index increased, more prominent in the marasmic group than the kwashiorkor group. By day 28, thirteen children with marasmus (37%) and four (17%) with kwashiorkor had a high cardiac index, and the proportion with a low cardiac index had also halved by day 28, with no difference between cases with marasmus and cases with kwashiorkor (Table 5.14). This increase in cardiac index happened without a corresponding increase in median stroke volume index.  
Systemic vascular resistance index Median systemic vascular resistance index (SVRI) was 1333 ds/cm5/m2 in malnourished children at admission and fell to 1043 ds/cm5/m2 by day 28. Overall 28 (35%) malnourished children had a high SVRI at admission, and this proportion was higher in marasmus than kwashiorkor (47% vs. 18%; p=0.006) reflecting a higher median SVRI (Table 5.12). Five children (6%) had a low SVRI at admission and 6 children had a low SVRI at day 28 (Table 5.14). In four of the six children with low SVRI at day 28, this had persisted since admission. Among possible clinical and laboratory explanatory variables for SVRI, there was a negative correlation with MUAC (Coefficient -191, R2 = 0.19; Figure 5.4) and base excess (Coefficient -22, R2 = 0.05; Figure 5.5), and a positive correlation with haemoglobin (Coefficient 86, R2 = 0.06; Figure 5.6). All three factors remained independently associated with SVRI in a multivariable regression model (Table 5.15).    
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Figure 5.4 Relationship between mid-upper arm circumference (MUAC) and systemic vascular 
resistance index (SVRI) in severely malnourished children across all time points 
  
 
Figure 5.5 Relationship between Base excess and systemic vascular resistance index (SVRI) in severely 
malnourished children across all time points 
. 
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Figure 5.6 Positive relationship between haemoglobin (Hb) and systemic vascular resistance index 
(SVRI) in severely malnourished children across all time points  
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 Figure 5.7 Box-and-whisker plots of haemodynamic function indices and filling status among all 
severely malnourished children at admission, day 7 and day 28  
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 Table 5.12 Haemodynamic parameters of all severely malnourished children and comparison between children with marasmus and kwashiorkor at 
admission  
Admission All malnourished 
N=83 
Marasmus 
N=48 
Kwashiorkor 
N=35 
 
p value 
SV (ml) 14 (10, 17) 14 (10, 18) 14 (11, 18) 0.651 
SVI (ml/m2) 39 (29, 45) 40 (31, 46) 38 (27, 44) 0.444 
High SVI 5 (6%) 4 (8%) 1 (3%) 0.300 
Low SVI 27 (33%) 14 (29%) 13 (37%) 0.444 
CO (l/min) 1.76 (1.44, 2.42) 1.7 (1.5, 2.3) 1.8 (1.4, 2.5) 0.912 
CI (l/min/m2) 4.86 (3.88, 6.13) 5.2 (4.1, 6.3) 4.5 (3.8, 6.1) 0.181 
High CI 15 (18 %) 10 (21%) 5 (14%) 0.444 
Low CI 14 (17%) 7 (15%) 7 (20%) 0.515 
SVR (ds/cm5) 495 (431, 595) 526 (435, 696) 472 (428, 524) 0.079 
SVRI (ds/cm5/m2) 1333 (1133, 1752) 1561 (1274, 1841) 1237 (1040, 1350) 0.002 
High SVRI 28 (35%) 22 (47%) 6 (18%) 0.006 
Low SVRI 5 (6%) 2 (4%) 3 (9%) 0.399 Data is presented as medians (IQR) and absolute numbers (%) outside the normal range. The cut-offs used can be found in Table 5.2 
Raw data and indexed data are presented. The following abbreviations apply: 
SV= stoke volume, SVI= stroke volume index, CO= cardiac output, CI= cardiac index, SVR= systemic vascular resistance, SVRI= systemic vascular resistance index 
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Table 5.13 Haemodynamic parameters in all malnourished children and comparison between children with marasmus and kwashiorkor at day 7 
  
Day 7 All malnourished 
N=82 
Marasmus 
N=48 
Kwashiorkor 
N=34 
 
p value 
SV (ml) 14 (12, 19) 14 (12, 21) 15 (12, 16) 0.854 
SVI (ml/m2) 39 (31, 46) 40 (32, 49) 38 (30, 42) 0.100 
High SVI 9 (11%) 7 (15%) 2 (6%) 0.214 
Low SVI 22 (27%) 11 (23%) 11 (32%) 0.342 
CO (l/min) 1.94 (1.66, 2.62) 2.05 (1.63, 2.65) 1.9 (1.72, 2.39) 0.734 
CI (l/min/m2) 5.22 (4.45, 6.34) 5.27 (4.53, 7.04) 5.02 (4.22, 5.88) 0.075 
High CI 20 (25%) 16 (34%) 4 (12%) 0.022 
Low CI 6 (7%) 2 (4%) 4 (12%) 0.203 
SVR (ds/cm5) 442 (365, 513) 442 (366, 513) 446 (356, 520) 0.974 
SVRI (ds/cm5/m2) 1093 (932, 1471) 1112 (953, 1523) 1033 (881, 1331) 0.131 
High SVRI 11 (15%) 9 (21%) 2 (6%) 0.076 
Low SVRI 6 (8%) 3 (7%) 3 (9%) 0.705  Data is presented as medians (IQR) and absolute numbers (%) outside the normal range. The cut-offs used can be found in Table 5.2 
Raw data and indexed data are presented. The following abbreviations apply: 
SV= stoke volume, SVI= stroke volume index, CO= cardiac output, CI= cardiac index, SVR= systemic vascular resistance, SVRI= systemic vascular resistance index 
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 Table 5.14 Haemodynamic parameters in all malnourished children and comparison between children with marasmus and kwashiorkor at day 28 
Day 28 All malnourished 
N=59 
Marasmus 
N=35 
Kwashiorkor 
N=24 
 
p value 
SV (ml) 16 (13, 21) 16 (12, 21) 16 (13, 21) 0.877 
SVI (ml/m2) 41 (34, 49) 42 (33, 51) 41 (34, 48) 0.622 
High SVI 8 (13%) 6 (17%) 2 (8%) 0.332 
Low SVI 11 (19%) 6 (17%) 5 (21%) 0.721 
CO (l/min) 2.32 (1.69, 2.86) 2.45 (1.68, 3.13) 2.29 (1.81, 2.79) 0.835 
CI (l/min/m2) 5.95 (4.38, 6.75) 6.14 (4.43, 7.13) 5.77 (4.40, 6.41) 0.371 
High CI 17 (29%) 13 (37%) 4 (17%) 0.088 
Low CI 5 (9%) 3 (9%) 2 (8%) 0.974 
SVR (ds/cm5) 425 (370, 540) 442 (384, 563) 414 (369, 472) 0.294 
SVRI (ds/cm5/m2) 1043 (926, 1443) 1137 (993, 1491) 1014 (868, 1211) 0.110 
High SVRI 7 (12%) 5 (15%) 2 (8%) 0.439 
Low SVRI 6 (11%) 3 (9%) 3 (13%) 0.679 Data is presented as medians (IQR) and absolute numbers (%) outside the normal range. The cut-offs used can be found in Table 5.2 
Raw data and indexed data are presented. The following abbreviations apply: 
SV= stoke volume, SVI= stroke volume index, CO= cardiac output, CI= cardiac index, SVR= systemic vascular resistance, SVRI= systemic vascular resistance index  
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 Table 5.15 Regression coefficients and 95% confidence intervals for associations of clinical and 
laboratory parameters with systemic vascular resistance index in a multivariable linear regression 
model  
 Coefficient 95% CI p value 
MUACa -182 (-238 to -127) <0.001 
Base excess  -15 (-28 to -3) 0.016 
Haemoglobin 68 (24 to 112) 0.002   aMUAC denotes mid upper arm circumference 
 
Table 5.16 Inferior vena cava (IVC) diameter and collapsibility index (IVCCI) as surrogate marker for 
intravascular filling10  in severely malnourished children overall at admission, day 7 and day 28  
 Admission Day 7 Day 28 
Total assessed  57 (65%) 58 (68%) 40 (65%) 
IVC max (mm) 4 (4, 6) 5 (4, 5) 5 (4, 6.5) 
IVC max Index (mm/m2) 12 (10, 14) 12 (9, 15) 14 (11, 15) 
IVCCI (%) 31 (24, 40) 31 (26, 40) 28 (21, 35) 
Data is presented as medians (IQR) and absolute number and proportions (%)  
 
Table 5.17 Comparison of inferior cava diameter and collapsibility index as surrogate marker for 
intravascular filling between children with marasmus and kwashiorkor at admission, day 7 and day 28 
 
 Marasmus Kwashiorkor p value 
Admission  N=29 N=28  
IVC max (mm) 4 (4, 6) 4 (4, 6) 0.815 
IVCCI (%) 31 (23, 41) 30 (24, 37) 0.792 
Day 7 N=34 N=24  
IVC max (mm) 5 (4, 5) 5 (3, 6) 0.838 
IVCCI (%) 30 (24, 38) 36 (30, 41) 0.063 
Day 28 N=24 N=16  
IVC max (mm) 5 (5, 7) 6 (4, 7) 0.670 
IVCCI (%) 30 (23, 38) 25 (20, 33) 0.219 Data is presented as medians (IQR) and absolute number and proportions (%) 
10 The IVCCI is higher the more fluid depleted the child is. A falling IVCCI suggests better intravascular filling.  Note: The IVCCI is likely to be underestimated, as the IVC was not visible in a large number of children, probably due to severe intravascular depletion.  
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 Surrogate markers of intravascular filling status Assessment of the inferior vena cava (IVC) diameters was technically very difficult, in particular in children with respiratory distress, i.e. those in shock with acidotic breathing or with severe pneumonia. Most striking was the difficulty in visualizing the IVC.  Hence data is only available in two thirds of the patients and is likely to be biased towards the less sick patients (Table 5.16). In the remainder, inability to visualize the IVC was probably due to profound under-filling. Overall, IVC diameter tended to increase from admission to day 28 (from a median of 4mm to 5mm), with a corresponding fall in IVC collapsibility index from 31% to 28%. However in children with kwashiorkor, the IVCCI increased from 30% to 36% at day 7 and then fell to 25% at day 28  (Table 5.17).  
Effect of diarrhoeal illness on cardiovascular function in children with SAM Children with severe malnutrition and diarrhoea did not show any adverse effects on haemodynamic function. There was no difference in LVIDd z-score at admission ( -0.09 vs. -0.26, p=0.835) or any other time point. Their cardiac index was similar to the non-diarrhoea group (median CI 4.96 vs. 4.82, p=0.944) and there was no difference in the proportion with systolic (21 vs. 11%, p=0.225) or diastolic (2 vs. 7%, p=0.317) dysfunction at admission or any other time point. Systemic vascular resistance index was higher in the diarrhoea group (1511 ds/cm5/m2 (1159, 2026)) compared to the non-diarrhoea group (1323 ds/cm5/m2 (1112, 1587; p=0.046) and the IVCCI tended to be slightly higher in the diarrhoea group with a median of 35 (27, 44) compared to 28 (23, 37) in the non-diarrhoea group (p=0.076). 
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5.3.5 Description of haemodynamic patterns in severely malnourished children 
 
High cardiac output syndrome At admission, two children (C35 & C66) had a high cardiac index (CI) in the presence of a low SVRI (Figure 5.8), suggesting high cardiac output syndrome. Both children had lactate concentrations of less than 3mmol/L and a normal pH. One of them (C35), a child with kwashiorkor, had severe anaemia and diarrhoea with a haemoglobin level of 5.2 g/dL and a base excess of -14.7. Neither child was hypotensive nor showed any other signs of impaired perfusion or evidence of SIRS. Fractional shortenings were 40% (C35) and 55% (C66) respectively with good longitudinal systolic function and normal to increased left ventricular stroke work index with a median of 62 (52-72). Their LVIDd z-scores were both below 0. 
 
Low cardiac output syndrome  Overall, four children (C25, C47, C78, C90) developed the picture of a low cardiac output state (low CI, high SVRI; Figure 5.8) during the course of the study of which two children died (C47, C90). Three children (C25, C78, C90) presented in a low cardiac output state at admission, which persisted to day 7 in two of them (C25, C78), with no evidence of hypothyroidism, severe metabolic acidosis or high lactate concentrations. Two had diarrhoea (C25 & C90) and the only clinical sign of shock, which was present in one of them (C25), was loss of consciousness and relative bradycardia (HR 103 bpm). The child (C78) with the highest SVRI (3890 ds/cm5/m2) had evidence of SIRS and the lowest albumin concentration (17.5g/L) amongst the three. This child made a full recovery. LVIDd z-score was less than -1.8 in all cases. Fractional shortening was within normal range in all of them but LV longitudinal systolic function was reduced in 2 children (C78, C90). Left ventricular stroke work index (LVSWI) was depressed in all cases (median LVSWI 23 cJ, IQR 20-29). One of them (C90) developed shock and died shortly after his day 7 review. The last SVRI recorded was 3918 ds/cm5/m2. Unfortunately further echocardiographic data are not available due to equipment failure.  Another one (C47) died shortly after his day 28 review. His LVSWI was severely depressed (8.5 cJ) and his LVIDd z-score was -3.0.  
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 The LVSWI in children with low, high and ´normal´ cardiac output states is compared graphically in (Figure 5.9). This shows that even children who are in a ‘normal’ cardiac output state have lower medians than the lower limit of normal. There was a positive relationship between LVSWI and MUAC (coeff 2.4, CI 1.1 to 3.8, p=0.001). Overall, median heart rate tended to be lower in those with low cardiac output syndrome (121 vs. 133 bpm, p=0.097). A low cardiac output state at any time point was weakly associated with death in marasmus (OR 4.6, 0.7 to 29, p=0.072) but not kwashiorkor.   
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 Figure 5.8 Relationship between cardiac index and systemic vascular resistance in all severely 
malnourished children at admission, day 7 and day 28 
 
 
Vertical dotted lines indicate normal range for CI, horizontal dashed lines normal range for SVRI    
Figure 5.9 Box-and-whisker plots of left ventricular stroke work index (LVSWI) 11  in severely 
malnourished children in various cardiac output (CO) states at admission  
 
Dotted lines indicate normal upper and lower limits in the reference population.  
Low CO state: N=3/66, normal CO state: N=61/66, high CO state: N=2/66 
11 Stroke work is the work performed by the ventricle to eject the stroke volume. 
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 5.3.6 Comparison of cardiac structure and function in children with and without HIV 
 
Cardiac mass and size Cardiac mass index was similar in HIV negative and HIV positive children and increased over the 28-day observation period (Figure 5.10).  Median LVIDd z-scores were higher in the HIV positive group at day 7 (1.0 vs. -0.26, p= 0.005) and day 28 (0.7 vs. -0.2, p= 0.025), with a higher proportion of left ventricular dilatation in the HIV positive group at day 7 (22% vs. 3%, p=0.006, see appendix Table 11.16). However LV dilatation was only associated with low fractional shortening in one HIV negative case at admission (p=0.002). The odds of LV dilatation was 9 times greater among children infected with HIV (95% CI 1.5 -53.2, p=0.017). There was no difference between HIV infected and uninfected children in the proportion with a pericardial effusion at admission (Table 5.18), day 7 (Table 11.16) or day 28  (Table 11.17).  
Figure 5.10 Box-and-whisker plots of left ventricular cardiac mass index in severely malnourished 
children with and without HIV at admission, day 7 and day 28 
 Groups were compared using the Wilcoxon rank-sum test  
 
Cardiovascular function  HIV positive children were slightly more likely to have reduced systolic (MAPSE) and diastolic (E/Ea) LV long axis function at admission (Table 5.18) and to have a low fractional shortening at day 28 (23% vs. 0%, p=0.001 see Table 11.17). Across the course of the study, the OR for low FS in the presence of HIV was 4.2 (95% CI 1.0 to 18.0; Table 5.22). Cardiovascular profiles were otherwise similar to HIV negative children at admission but interestingly, stroke volume index and cardiac index were higher in HIV positive children at day 28 (see appendix Table 11.17). 
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 Table 5.18 Comparison of echocardiographic parameters between HIV negative and positive severely 
malnourished children at admission  
 Parameters HIV –ve 
N=68 
HIV +ve 
N=20 
p value 
Left ventricular 
mass 
LV mass 23 (17, 29) 23 (17, 34) 0.505 
LVMI1 (g/m
2.7) 50 (42, 61) 53 (43, 62) 0.931 
 LV dilatation 2 (3%) 2 (11%) 0.186 
 FS 36 (34, 40) 35 (31, 38) 0.164 
 High FS 3 (4.7%) 2 (10.5%) 0.348 
 Low FS 3 (4.7%) 3 (15.8%) 0.101 
 MAPSE 8 (7, 10) 8 (7, 9) 0.337 
Systolic High MAPSE 4 (6.4%) 1 (5.6%) 0.902 
Function Low MAPSE 4 (6.4%) 4 (22.2%) 0.047 
 TAPSE 14 (13, 16) 13 (10,14) 0.080 
 High TAPSE 2 (3.1%) 1 (5.6%) 0.627 
 Low TAPSE 1 (1.6%) 2 (11.1%) 0.057 
 Sa 5 (5, 7) 5 (4, 7) 0.298 
 High Sa 3 (4.8%) 0 (0%) 0.370 
 Low Sa 1 (1.6%) 0 (0%) 0.609 
 
 
 
Diastolic 
Function 
E/A ratio 1.16 (1.05, 1.34) 1.24 (1.12, 1.4) 0.330 
Abnormal e/a ratio 2 (3.1%) 1 (5.9%) 0.593 
Ea 11 (9, 13) 9 (7, 12) 0.066 
High Ea 3 (4.8%) 0 (0%) 0.370 
Low Ea 0 (0%) 1 (6.3%) 0.048 
E/Ea ratio 6.78 (5.75, 8.23) 6.85 (5.83, 8.70) 0.544 
 High E/Ea 0 (0%) 1 (6.3%) 0.048 
 Low E/Ea  1 (1.6%) 0 (0%) 0.609 
Global 
Function 
Tei Index 0.36 (0.26, 0.43) 0.38 (0.29, 0.54) 0.280 
High Tei Index 13 (20%) 7 (41.2%) 0.070 
 
 
 
 
 
Haemodynamic 
Function 
 
 
 
 
SV (ml) 14 (10, 17) 15 (10, 23) 0.474 
SVI (ml/m2) 37 (29, 44) 44 (32,48) 0.308 
High SVI 3 (4.7%) 2 (10.5%) 0.348 
Low SVI 22 (34.4%) 5 (26.3%) 0.510 
CO (l/min) 1.76 (1.46, 2.34) 2.06 (1.44, 2.51) 0.645 
CI (l/min/m2) 4.80 (3.90, 6.05) 5.40 (3.89, 6.43) 0.416 
High CI 11 (17.2%) 4 (21.1%) 0.701 
Low CI 11 (17.2%) 3 (15.8%) 0.886 
SVR (ds/cm5) 480 (424, 573) 533 (480, 760) 0.037 
SVRI (ds/cm5/ m2) 1324 (1110, 1684) 1408 (1263, 1969) 0.608 
High SVRI 21 (32.8%) 7 (41.2%) 0.519 
Low SVRI 5 (7.8%) 0 (0%) 0.234 
Other Pericardial effusion 16 (24%) 4 (20%) 0.741 Data is presented as medians (IQR) and absolute number (%) outside the normal range. The cut-offs used can be found in Table 5.2  The following abbreviations were used: LV= left ventricular, FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity, E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea), SV= stroke volume, SVI= stroke volume index, CO= cardiac output, CI= cardiac index, SVR= systemic vascular resistance, SVRI= systolic vascular resistance index 
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5.3.7 Admission cardiac parameters associated with death and survival 
 
Cardiac mass and size Cardiac mass tended to be lower children who died, even when indexed to body surface area (Table 5.19). Median LVIDd z-scores were significantly lower in non-survivors  (-1 vs. -0.2, p= 0.001).  
Cardiovascular function Of the 14 children who died, four had systolic dysfunction at some point (C47, C70, C89, C90), and one child (C31) had both systolic and diastolic dysfunction. Two of these children (C89, C90) had clinical signs consistent with cardiac failure: one had tachycardia, tachypnoea, and hepatomegaly; the other just hepatomegaly. Both were HIV infected and had raised SVRI. Neither child had a gallop rhythm or distended neck veins.  Only one child (C74) presented with tachycardia, gallop rhythm and distended neck veins. This child had kwashiorkor but no hepatomegaly or echocardiographic signs cardiac dysfunction, and SVRI was normal. The child was severely anaemic with an Hb of 5.3 g/dL and had a lactate of 4.4 mmol/L. She died on the way to another hospital for a blood transfusion after a sudden drop in haemoglobin.  Tachycardia and tachypnoea were common but were not associated with cardiac dysfunction. Hypothyroidism was also common among children who died (5/14, 36%). Non-survivors had lower stroke volume and cardiac index indices than survivors and a higher Tei Index (Table 5.19). There was no difference in systemic vascular resistance index at admission between survivors and non-survivors.  Overall, a high Tei Index and low cardiac index were associated with increased odds of dying (Table 5.20) with no real difference between marasmus and kwashiorkor (χ2 test of heterogeneity >0.05). A summary of the the likely cause of death and final observations are given in Table 9.1 and Table 11.24.  
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Table 5.19 Comparison of cardiac function and haemodynamic indices between survivors and non-
survivors of severe acute malnutrition at admission 
 
 Parameter Survivors 
N=74 
Non-Survivors 
N=14 
p value 
Anthropometry WHZ -3.1 (-3.7, -2.5) -3.9 (-4.1, -3.0) 0.035 
 
LV mass 
LV mass 24 (18, 32) 16 (14, 23) 0.019 
LVMI1 (g/m
2.7) 52 (43, 62) 42 (31, 45) 0.014 
LVMI2 (g/m
2) 65 (53, 77) 53 (37, 55) 0.011 
 FS 36 (34, 39) 38 (32, 42) 0.758 
 High FS 4 (5.7%) 1 (7.7%) 0.783 
 Low FS 4 (5.7%) 2 (15.4%) 0.216 
 MAPSE 8 (7, 10) 8 (7, 9) 0.068 
Systolic High MAPSE 5 (7.3%) 0 (0%) 0.336 
Function Low MAPSE 6 (8.7%) 2 (16.7%) 0.393 
 TAPSE 14 (13, 16) 12 (10, 15) 0.120 
 High TAPSE 3 (4.3%) 0 (0%) 0.465 
 Low TAPSE 2 (2.9%) 1 (8.3%) 0.351 
 Sa 5 (5, 7) 5 (4, 6) 0.224 
 High Sa 3 (4.5%) 0 (0%) 0.474 
 Low Sa 1 (1.5%) 0 (0%) 0.683 
 
 
 
Diastolic 
Function 
E/A ratio 1.17 (1.08, 1.37) 1.15 (0.93, 1.28) 0.273 
Abnormal e/a ratio 4 (4.4%) 0 (0%) 0.462 
Ea 11 (9, 13) 9 (7, 10) 0.051 
High Ea 3 (4.5%) 0 (0%) 0.474 
Low Ea 0 (0%) 1 (9.1%) 0.013 
E/Ea ratio 6.7 (5.8, 8.4) 7.1 (5.4, 8.0) 0.473 
 High E/Ea 0 (0%) 0 (0%) N/A 
 Low E/Ea  1 (1.5%) 0 (0%) 0.683 
Global 
Function 
Tei Index 0.33 (0.25, 0.43) 0.46 (0.36, 0.59) 0.026 
High Tei Index 14 (20.0%) 6 (50.0%) 0.025 
 
 
 
 
Haemodynamic 
Function 
 
 
 
 
SV (ml) 15 (12, 18) 9 (8, 12) 0.003 
SVI (ml/m2) 42 (32, 46) 29 (22, 35) 0.001 
High SVI 5 (7.1%) 0 (0%) 0.320 
Low SVI 19 (27.1%) 8 (61.5%) 0.015 
CO (l/min) 1.81 (1.55, 2.46) 1.31 (1.0, 1.5) 0.009 
CI (l/min/m2) 5.15 (4.21, 6.13) 3.75 (3.26, 4.25) 0.009 
High CI 13 (18.6%) 2 (15.4%) 0.784 
Low CI 9 (12.9%) 5 (38.5%) 0.024 
SVR (d.s./cm 5 ) 486 (423, 586) 558 (460, 809) 0.065 
SVRI (ds/cm5/m2) 1325 (1114, 1746) 1565 (1243, 2476) 0.130 
High SVRI 22 (31.9%) 6 (50.0%) 0.223 
Low SVRI 5 (7.3%) 0 (0%) 0.336  Data is presented as medians (IQR) and absolute number (%) outside the normal range. The cut-offs used can be found in Table 5.2 The following abbreviations were used: LV= left ventricular, FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity, E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea), SV= stroke volume, SVI= stroke volume index, CO= cardiac output, CI= cardiac index, SVR= systemic vascular resistance, SVRI= systolic vascular resistance index 
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 Table 5.20 Crude odds ratios and 95% confidence intervals for associations between abnormal cardiovascular indices at admission and death among all children 
with severe acute malnutrition (SAM), and comparison in those with marasmus and kwashiorkor  
. 
 
 All SAM 
N=83 
OR for death 
(95% CI) 
 
 
p value 
Marasmus 
N=48 
OR for death 
(95% CI) 
 
 
p value 
Kwashiorkor 
N=35 
OR for death 
(95% CI) 
 
 
p value 
 
χ2 test of 
heterogeneity 
Systolic dysfunction 2.6 (0.18 to 9.6) 0.168 1.8 (0.3 to 10.8) 0.536 4.5 (0.5 to 39.6) 0.1369 0.5121 
Diastolic dysfunction 1.8 (0.18 to 18.9) 0.616 0 (-) (-) 5.8 (0.3 to 121.7) 0.120 0.2539 
High Tei Index 3.2 (0.96 to 10.8) 0.058 1.8 (0.4 to 9.0) 0.468 9.0 (1.0 to 81.9) 0.018 0.2325 
LV dilatation - (-) (-) (-) (-) (-) (-) (-) (-) (-) 
Low CI 4.0 (1.1 to 14.7) 0.036 2.6 (0.4 to 17.2) 0.303 6.5 (0.8 to 51.5) 0.041 0.518 
High CI 0.8 (0.2 to 3.9) 0.765 0.6 (0.1 to 5.3) 0.603 1.3 (0.1 to 14.7) 0.832 0.610 
High SVRI 1.8 (0.6 to 5.7) 0.338 2.7 (0.5 to 13.0) 0.213 1.0 (0.1 to 10.9) 1.0 0.500 
Low SVRI - (-) (-) (-) (-) (-) (-) (-) (-) (-) 
 The following definitions and abbreviations were applied: Systolic dysfunction= any of the following: low fractional shortening (FS), low MAPSE, low TAPSE, low early systolic mitral annular velocity (Sa) Diastolic dysfuntion= any of the following: abnormal early to late diastolic filling (E/A), low early diastolic mitral annular velocity(Ea), high early filling (E) to early diastolic mitral annular velocity (Ea) LV dilatation= left ventricular inner diameter z-score ≥+2,  CI= cardiac index, SVRI= systemic vascular resistance index 
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 Table 5.21 Crude odds ratios and 95% confidence intervals for associations between abnormal cardiovascular indices and death among all severe acute 
malnutrition (SAM), marasmus and kwashiorkor across all time points 
 
 All SAM 
OR for death 
(95% CI) 
 
 
p value 
Marasmus 
OR for death 
(95% CI) 
 
 
p value 
Kwashiorkor 
OR for death 
(95% CI) 
 
 
p value 
 
χ2 test of 
heterogeneity 
Systolic dysfunction 1.5 (0.4 to 5.2) 0.506 1.4 (0.3 to 7.0) 0.657 1.7 (0.2 to 11.3) 0.611 0.9137 
Diastolic dysfunction 0.3 (0.03 to 2.6) 0.242 0 (-) 0.194 0.7 (0.1 to 6.9) 0.724 0.321 
High Tei Index 7.9 (1.7 to 26.3) 0.002 11.1 (1.1 to117.1) 0.012 5.5 (0.7 to 41.1) 0.061 0.649 
LV dilatation 0.6 (0.1 to 5.2) 0.604 0.6 (0.1 to 6.1) 0.700 0 (-) 0.655 0.722 
Low CI 3.9 (1.1 to 14.3 0.026 4.7 (0.8 to 27.9) 0.062 3.3 (0.5 to 21.6) 0.189 0.789 
High CI 0.6 (0.1 to 2.0) 0.362 0.6 (0.1 to 2.9) 0.519 0.5 (0.1 to 4.8) 0.512 0.861 
High SVRI 2.9 (0.8 to 10.5) 0.099 3.6 (0.6 to 21.0) 0.128 2.0 (0.3 to 14.2) 0.480 0.660 
Low SVRI 0.5 (0.1 to 4.6) 0.585 1.4 (0.1 to 15.1) 0.766 0 (-) 0.2880 0.258  The following definitions and abbreviations were applied: Systolic dysfunction= any of the following: low fractional shortening (FS), low MAPSE, low TAPSE, low early systolic mitral annular velocity (Sa) Diastolic dysfuntion= any of the following: abnormal early to late diastolic filling (E/A), low early diastolic mitral annular velocity(Ea), high early filling (E) to early diastolic mitral annular velocity (Ea) LV dilatation= left ventricular inner diameter z-score ≥+2,  CI= cardiac index, SVRI= systemic vascular resistance index      
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 Exploration of the effect of known risk factors for cardiac dysfunction  Univariable analyses of potential risk factors for impaired fractional shortening and low cardiac index are summarized in Table 5.22 and Table 5.23.  Low fractional shortening was not associated with malnutrition severity (MUAC), severe hypoalbuminaemia, high SVRI or left ventricular dilatation; but was associated with HIV status (OR 4.2, 95% CI1.0 to 18.0, p=0.038).  Univariable analyses did not show any association between low cardiac index and factors known to influence cardiac index (Table 5.23). However, when all variables were used in a multivariable logistic regression model, severe hypoalbuminaemia was found to be independently associated with low cardiac index (OR 3.9, 95% CI 1.2 to 13.5, p=0.029).   
Table 5.22 Crude odds ratios and 95% confidence intervals for associations with low fractional 
shortening at any time point in all malnourished children 
  
Low fractional shortening 
 
OR 
 
95% CI 
 
p value MUAC 1.1 (0.6 to 1.9) 0.857 Albumin (< 15g/dL) 5.5 (0.6 to 55.5) 0.101 HIV 4.2 (1.0 to 18.0) 0.038 High SVRI 1.0 (0.2 to 4.8) 0.968 LV dilatation 3.6 (0.8 to 15.9) 0.073    
Table 5.23  Crude odds ratios and 95% confidence intervals for associations with low cardiac index at 
any time point in all malnourished children  
Low cardiac index OR 95% CI p value MUAC 0.9 (0.6 to 1.4) 0.703 Albumin (< 15g/dL) 2.4 (0.6 to 9.9) 0.200 HIV 1.3 (0.3 to 5.0) 0.703 High SVRI 2.6 (0.8 to 9.0) 0.109 Hypothyroid 1.1 (0.3 to 4.1) 0.876    
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5.4 Discussion This is the largest detailed echocardiographic study of children in severe malnutrition, and the only echocardiographic study to collect multiple serial measurements throughout the period of nutritional rehabilitation when risk of cardiac complications is thought to be highest. To our knowledge it is also the first study to include tissue Doppler modalities and assessment of cardiac long axis function, and to correlate the echocardiographic findings with detailed clinical and laboratory data including biochemical markers of cardiac failure.  The findings suggest that the myocardial thickness and intracardiac dimensions of children with severe malnutrition is comparable with those of healthy US children when z-score regression equations are used to adjust for body size. Cardiac mass unadjusted for body size at admission, was similar to that reported others, 100 105 and changed rapidly during re-feeding. Cardiac mass increased over the study period by about one-third in children with kwashiorkor and by about 50% in children with marasmus. However, the increase in cardiac mass index over time is possibly also the result of the time point analysis being restricted to survivors. Pericardial effusions were common and seemed to be related to hypoalbuminaemia but not to HIV. However the proportion with measurable pericardial effusion at admission was much lower than reported elsewhere. 236 When adjusted for body size using various methods for normalization, our values are higher than indices published by others who looked at cardiac mass in malnutrition.106 107 117 However, the difficulty of valid comparison of our data with others is that different formulas were used to calculate cardiac mass and different modelling indices to adjust for body size. Raw values are likewise difficult to compare as a younger cohort would be expected to have lower absolute cardiac mass than an older cohort.  Also, we do not have any reference ranges for the East African population and reference ranges used here were developed using a predominantly Caucasian population in which proportional body growth is assumed. This assumption may not be valid - it is known, for example, that healthy Afro-American population has a higher LV mass for height than Americans that descend from Europe. 237 As left ventricular mass (LVM) was determined using two-dimensional guided M-mode echocardiography and derived with a formula that uses the third power of the left 
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 ventricular internal diameter (LVID), one needs to be cautious when assuming this increase all reflects cardiac mass. As LVID is dependent on the intravascular volume status, it is possible that an improved ventricular filling or increased afterload, both of which influence the LVID, cause an inaccurate estimation of the LVM as shown by Kilickap et al.238 However systemic vascular resistance decreases in our patients over time, so is unlikely to play a big role in LVID changes observed at day 7.  Interestingly, z-scores of LVID in systole and diastole are greater in marasmic children at day 7 compared to children with kwashiorkor. As we saw in Chapter 4, children with marasmus and diarrhoea were more likely to develop hypovolaemic shock, hence the increase in LVID measures towards day 7 in the marasmic group is possibly due to an improvement in the intravascular filling status. This was not observed for children with kwashiorkor and diarrhoea and might be due to delayed restoration of their intravascular depletion due to their profound hypoalbuminaemia and associated third spacing. Left ventricular dilatation has also been reported among marasmic children and left ventricular atrophy in children with kwashiorkor in the post-mortem studies by Piza in 1971.60  Fractional shortening indices were within normal reference range in the majority of children and similar to values previously published by others.106 107 111 Longitudinal systolic function parameters such as MAPSE, TAPSE and tissue Doppler derived systolic myocardial velocities (Sa) have not been previously published in malnourished children and it seems that left ventricular longitudinal function more than right ventricular longitudinal function might be impaired at least in some children with malnutrition and more so after nutritional rehabilitation at day 28. The only previous echocardiographic study to look at cardiac function in malnutrition pre- and post realimentation did not show significant deterioration in cardiac function.107 However we describe six marasmic children whose fractional shortening fell to below 28% between admission and day 7. Given the overall increase in left ventricular internal dimensions it was important to establish where these children are likely to have been on the Frank Starling curve, and whether there were any clinical signs of cardiac failure.  In a failing heart, increased ventricular filling eventually causes myocardial stretch to such a degree that any further stretch does not result in an increase in stroke volume. This was the case in one of the six children, and taken all the clinical and laboratory 
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 parameters into account, some degree of cardiac failure was evident. In two HIV positive children, whose FS fell in response to an increase in LVIDd and SVI, hypovolaemia might have masked the degree of contractile impairment. Given the fact that they were still able to increase their SVI despite the fall in FS might suggest however that their Frank Starling curve might be shifted to the right and they require a higher degree of preload. In his extensive haemodynamic studies in 1977, Viart127 128 described children with malnutrition who were in what has been described as an “adaptive hypocirculatory state” that turned into frank circulatory failure, rather than cardiac failure, once the albumin concentrations fell below 15g/L. He also reported low cardiac indices and high systemic vascular resistances that normalized during rehabilitation. 128 However those who died were the most severely malnourished who presented with features of peripheral circulatory failure. In our cohort, one third of children with severe malnutrition had a high systemic vascular resistance index at admission, a proportion, which fell over the 28-day observation in line with nutritional rehabilitation and improvement in intravascular filling status. A persistent elevation of the peripheral resistance might have an effect on gut perfusion, which is especially important when trying to understand why so many children fail to establish enteral feeds. Although we did not demonstrate an association between severe hypoalbuminaemia and high SVRI, severe hypoalbuminaemia was independently associated with low cardiac index in a multivariable logistic regression analysis. Low cardiac index and a high Tei Index were both factors with greater odds of dying. However, we were not able to demonstrate a cut-off at which point children developed frank circulatory failure as postulated by Viart.128 Cardiac index tended to increase during nutritional rehabilitation without a concurrent increase in median stroke volume. The increase in median cardiac index over the observation period is to some degree due to increased metabolic demands and oxygen consumption during catch-up growth, 128 239 and also reflects the fall in haemoglobin during the first week of realimentation. However the reduction in the proportion of children with low cardiac index at day 28 is also affected by the death of some of the children with low CI at admission and day 7. Several other authors also report an increase in cardiac index over the course of rehabilitation. 107 118 128 136 Alleyne and Phornphatkul observed a parallel increased in cardiac output and stroke volume,118 136 whereas Viart, like us, report a lack of increase in stroke volume, questioning whether 
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 this might be due to reduced cardiac reserves and a sign of cardiac failure.128 The increase in lactate from admission to day 7 alongside with the increase in cardiac index could be an early sign of high cardiac output failure and the hearts inability to meet the now increased metabolic demands of the body especially on a background of low haemoglobin concentration. However, clinical cardiac failure and cardiac dysfunction did not seem to correlate very well, as only half of the children with three or more clinical signs exhibited echocardiographic signs of cardiac dysfunction and when looking at the proportion of children with cardiac dysfunction, only a minority of them exhibited clinical signs. Yet, it is known from adult studies, that LV dysfunction precedes clinical signs of cardiac failure195 and that NT-proBNP is a good marker for early cardiac dysfunction.184 215 216 240 In our study, we found that NT-proBNP seemed to correlate well with diastolic dysfunction. This is in keeping with other reports. 241 242 HIV positive children with severe malnutrition have previously been reported to exhibit a paradoxical relationship between nutritional status and cardiac mass with preserved cardiac function.96 There are also reports suggesting hyperdynamic left ventricular function and increased sympathetic tone in children with HIV, which stimulates myocardial hypertrophy.97 HIV positive children are at particular risk of left ventricular dysfunction and dilative cardiomyopathy.95 97 98 243 244 We found no obvious association between HIV status and cardiac mass. This is different from what is reported by Miller et 
al, who found that children with malnutrition and HIV had a reduced ventricular mass. 97 In our cohort, we found some evidence for impaired systolic function in HIV positive children and we did find an association between HIV infection and left ventricular dilatation, but this was not associated with an increased mortality or left ventricular dysfunction.  Although similar in other baseline clinical, haematological and biochemical parameters to children who survived, those who died tended to be more severely malnourished and have lower cardiac mass at presentation. This was also found by El-Sayed.107 Death was also associated with a high Tei Index suggesting global myocardial dysfunction and a low cardiac index. Systolic and diastolic function however was preserved despite high IL-6 levels in non-survivors at day 7, and there was no difference in systemic vascular resistance.  
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  Overall we did see evidence of cardiac dysfunction, however this was not associated with clinical signs of cardiac failure or death. It would have been interesting to follow children up for longer to see whether the degree of dysfunction improves with complete resolution of malnutrition and intercurrent infections. In the following chapter we will examine the electrophysiological properties of the heart of malnourished children to investigate the presence of or risk factors for arrhythmias that might be a cause of sudden cardiac death.  
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6 Electrocardiographic findings in severe malnutrition 
6.1 Introduction   Children with malnutrition often die suddenly and unexpectedly. As a result many suspect cardiac arrhythmias as a possible cause. Death predominantly occurs in the first week of realimentation and fluid and electrolyte shifts and their impact on the myocardium have been postulated to play a major role in these deaths.245 Furthermore previous histological studies in children with kwashiorkor have suggested that myocytolysis and atrophic changes in the conducting tissue of the heart may lead to fatal arrhythmias.102 104  After a prolonged period of starvation, the body is prone to develop re-feeding syndrome, discussed in detail in chapter one.246 The associated changes in electrolyte concentrations in different compartments may also alter the electrophysiological properties of the heart and can lead to rhythm disturbances. Furthermore, as outlined in Chapter 4, children with SAM often present with diarrhoea and electrolyte perturbations, which may puts them at particular risk of cardiac dysrhythmias.  Many also have HIV, which in itself has various effects on the cardiovascular function99 190 243 244 247 and has been associated with a variety of cardiac arrhythmias. 248 249 Low calcium and potassium levels are known to lengthen the ST segment and therefore the QTc interval, which can lead to potentially fatal Torsades des Pointes and ventricular tachycardias. Extremely low potassium concentrations can also prolong the PR interval and eventually lead to a sinoatrial block and bradycardia.123 Lengthening of the QTc and PR interval and widening of the QRS complex have also been described in patients with low magnesium levels. 250 In critically ill patients, low magnesium levels have been associated with higher mortality rates in intensive care unit settings.251 252 More recently, hypophosphataemia in sepsis has not only been shown to impair myocardial contractility but has also been associated with atrial and ventricular arrhythmias. 253 254 Reduced oxygen delivery to the coronary arteries due to impaired cardiac function, anaemia or insufficient gas exchange can lead to arrhythmogenic cardiac ischaemia.  
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 Having reviewed the evidence for cardiac dysrhythmias in severe malnutrition in Chapter 2, published studies appear to provide conflicting results, and interpretation is made difficult by a lack of data on important comorbidities which we have shown are so common in malnourished children. Furthermore, none of the published studies in our literature review conducted Holter monitoring to record any untoward events. In this chapter I therefore aim to: 1. Describe the electrocardiographic profiles of children with severe malnutrition at admission and during realimentation, including the incidence of arrhythmias and ECG features with arrhythmogenic potential.  2. Explore possible associations between ECG findings and the electrolyte status of children with severe malnutrition.  3. Explore possible associations between ECG findings and echocardiographic correlates.   4. Highlight any important differences in all of the above between children with marasmus and kwashiorkor.        
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 6.2 Method  
12 lead Electrocardiograms  12 lead ECGs were recorded digitally in all severely malnourished children at set time points as outlined in Chapter 3 using the CardioSoft v6.51 Diagnostic System from GE Healthcare. We followed American Heart Association (AHA) guidelines for the requisition of ECGs were followed.255 
 
Definitions For ECG data interpretation, Semizel et al published cut off ranges for age and gender were applied to our dataset.122 Values between the 98th and the 2nd centile were used to define normal reference ranges. Other formulas and definitions are given in Table 6.1 were used.  
Table 6.1 ECG formulas and definitions applied to the CAPMAL dataset Corrected QT interval124 QTc= QT/√RR Total voltage (mV) 256 Sum of all QRS amplitudes across the 12 leads Total limb voltage (mV) Sum of all QRS amplitudes across the standard and augmented leads Total precordial voltage (mV) Sum of all QRS amplitudes across V1 –V6 Low voltage146 Mean total limb voltage <0.5mV or mean precordial voltage <1mV Abnormal QRS-T angle 123 QRS-T > 90° Abnormal T waves Negative T waves in V4 – V6  
Heart rate variability  Heart rate variability (HRV) was defined as the difference between the maximum and minimum length (ms) of the RR intervals during the first 10 consecutive RR intervals of each 12 lead ECG recording. We generated a receiver operator characteristics (ROC) curve to explore a potential thresholds (cut-off) in the association between HRV and death.   
Holter monitoring Three-lead, seven-day continuous ECG monitoring was done in a subset of severely malnourished children using a Spacelabs Lifecard CF Holter Monitor. Three Lifecard CF Holters monitors were rented for the study duration and children were consecutively 
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 fitted with a Holter for seven days if they met the study entry criteria consented to participation, and a Holter monitor was available at the time of their admission. The decision on the length of the recording was based on the information from previous studies, that most of the deaths occur during the first week of admission. Spacelabs Software “Email for Holter” Version 4.56 was used to send the anonymised raw data to the analysis centre in Germany (Arbeitsgemeinschaft kardiologisch tätiger Internisten, Horstmar, Germany). Analysis of Holter data was then performed using “Pathfinder SL Digital” software (Spacelabs,Version 8.0, 2011) which incorporates the arrhythmia definitions summarized in (Table 6.2). We defined “significant ventricular arrhythmias” as couplets, triplets, salvos, R on T phenomena and ventricular tachycardias (VT). Data is presented in terms of both the total number of each event, and the total number of cases affected.   
 
Presentation of the Holter Data The number of total events is given as well as the total number of cases affected.  The following definitions applied as per Pathfinder report software:  
Table 6.2 Pathfinder report software arrhythmia criteria  Bradycardia HR <=45/min for at least 4 beats Supraventricular Tachycardia (SVT) Minimum of 5 beats at a HR>130/min Triplets 3 premature ventricular contractions (PVCs) Salvos 4 premature ventricular contractions Ventricular Tachycardia (VT) Minimum of 5 PVCs at a HR>100/min  Couplets, triplets, salvos, R on T and ventricular tachycardias (VT) were summarized by the term “significant ventricular arrhythmias”.  
Data Analysis Data analysis methods are described in Chapter 3.  In addition, we used simple linear regression was used to look for associations between ECG variables and variables known to affect electrophysiological properties of the heart such as electrolytes, haemoglobin, left ventricular mass and body fat. For the latter we used MUAC as this 
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 was thought to correlate better with the lean body mass and therefore impedance, than weight for height z-score. Where not otherwise stated, there was no difference in the measurements between children with marasmus and those with kwashiorkor.  
6.3 Results 
6.3.1 12-lead ECG results at admission, day 7 and day 28  
Rate, rhythm and axes  Median heart rate varied changed only slightly between admission and day 28 (Table 6.3). All children were in sinus rhythm at the time of the ECG recordings, with the exception of one child (C22) who was admitted in hypovolaemic shock and had a period of bigeminy at admission. Some patients showed evidence of abnormal QRS and T-wave axes. Ten patients (11%) had left axis deviation and two had right axis deviation (2%). At admission, T-axis was abnormal in a higher proportion of patients with kwashiorkor than with marasmus (35% vs. 15%, p=0.048) and a higher proportion of marasmic children at day 7 (14% vs. 0%, p= 0.021). The QRS-T angle was above 90° (signifying possible myocardial dysfunction or ventricular conduction disturbances) in 16 children (18%) at admission which decreased over time (Table 6.4). Overall there was no evidence of an association between an abnormal QRS-T angle and echocardiographic evidence of systolic, diastolic or global cardiac dysfunction (OR 1.5, 0.5 to 5.5, p=0.466). The proportion of children with abnormal T wave axes and QRS-T angles fell following admission, whereas the proportion with left axis deviation remained unchanged (Table 6.3). 
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 Table 6.3 Electrocardiographic findings in all severely malnourished children at each review point 
 Day 0 
N=88 
Day 7 
N=85 
Day 28 
N=62 
Rate Heart rate (bpm) 132 (120, 142) 133 (124, 148) 134 (121, 146) 
Heart rate variability (ms) 25 (15, 45) 25 (15, 50) 30 (20, 45) 
Rhythm Sinus Rhythm 88 (100%) 85 (100%) 62 (100%) 
 QRS -axis° 66 (35, 86) 55 (28, 78) 59 (40, 80) 
Right axis deviation  2 (2%) 2 (2%) 2 (3%) 
Left axis deviation 10 (11%) 9 (11%) 9 (15%) 
T-axis° 31 (3.5, 54) 36 (17, 51) 34 (20, 47) 
Abnormal T-axis 20 (23%) 7 (8%) 4 (7%) 
QRS-T angle >90° 16 (18%) 5 (6%) 4 (7%) 
 
 
Intervals 
and 
Durations 
PR interval (ms) 115 (106, 131) 109 (102, 125) 112 (103,127) 
Short PR  2 (2%) 2  (2%) 0 (0%) 
Long PR  14 (16 %) 5 (6%) 2 (3%) 
QRS duration (ms) 67 (60, 74) 60 (55, 67) 60 (56, 66) 
Short QRS  6 (7%) 26 (31%) 16 (26%) 
Long QRS  3 (3%) 0 (0%) 0 (0%) 
QTc interval (ms) 413 (381, 431) 401 (383, 417) 417 (403, 430) 
Short QTc  24 (27%) 20 (24%) 7 (11%) 
Long QTc  3 (3%) 0 0 1 (2%) 
ST ST depression 8 (9 %) 2 (2%) 1 (2%) 
segment ST elevation 1 (1%) 3 (4%) 5 (8%) 
 Inverted T V4 20 (23 %) 8 (9%) 10 (16%) 
T- wave Inverted T V5 17 (19 %) 4 (5%) 3 (5%) 
 Inverted T V6 13 (15 %) 3 (4 %) 3 (5%)  
Data is presented as medians (IQR) and the number and proportion (%) with values outside the reference range   
Figure 6.1 Box-and-whisker plots of PR intervals, QRS durations and corrected QT intervals of all 
severely malnourished children at admission, day 7 and day 28 
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Intervals and Durations 
 Long PR intervals were seen in 16% children with severe malnutrition and this was associated with severe hypokalaemia (OR 7.3, 95%CI 1.9 to 28.0, p=0.0007). As potassium levels improved, PR intervals shortened. With each 1mmol/L increase in serum potassium concentration, the PR interval decreased by 9 milliseconds (p<0.001). There was no difference in the median PR interval between children with marasmus or kwashiorkor at admission (Table 6.4).  The proportion of children with short QRS intervals increased from 7 % at admission to 31% at day 7. There was a linear relationship between QRS duration and serum potassium, calcium and magnesium concentrations (Figure 6.2). For every 1mmol/L increase in potassium concentration, the QRS duration decreased by 4 milliseconds (ms) (Spearman´s correlation coefficient, r=-0.40; p<0.0001); for every 1mmol/L increase in serum calcium concentration the QRS duration decreased by 15 ms (r=-0.23; p=0.001); and for every 1mmol/L increase in magnesium level, the QRS duration increased by 17 ms (r=0.21; p=0.001).   Short QTc intervals were common, occurring in 24 (27%) children at admission, 20 (24%) at day 7, and 7 (11%) at day 28. The cause of the short QTc interval was unclear in most cases. However 4 cases (1 at day 7 and 3 at day 28) had a short QTc interval associated with hypercalcaemia. There was a weak inverse correlation between potassium concentration and QTc length (r=-0.13, p=0.045).   
Figure 6.2 Association between potassium, calcium and magnesium concentration and QRS duration 
in children with severe acute malnutrition  
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ST segment and T wave morphology 
 Eight children (9%) had ST segment depression at admission (Table 6.3); this persisted to day 7 in two of children and re-occurred in another child on day 28. Interestingly, only children with marasmus had ST segment depression (15% vs. 0%, p=0.014) and in those, the OR for ST depression in the presence of low phosphate levels was 25.8 (CI 1.6 to 428.3, p<0.001). No other electrolyte nor anaemia had an effect on ST segment depression statistically but 7/8 children had a potassium level of <3mmol/L and 6/8 had tachycardia at the time of ST depression. The number of cases with ST segment elevation increased over the 4 week observation period from 1% at admission to 8% at day 28 (p=0.047; Table 6.3). Four children with kwashiorkor and 1 child with marasmus had ST elevation at day 28 (Table 6.4). ST elevation was not associated with inverted T-waves, nor was there an association with pericardial effusion to suggest pericarditis. Neither ST depression (OR 4.8, 0.5 to 46.1, p=0.129) nor ST elevation (OR 2.3, 0.4 to 12.5, p=0.767) were associated with cardiac dysfunction on echocardiography.  A high proportion of children had inverted T-waves from V4-V6 on admission, which improved markedly by day seven. T wave inversion was strongly associated with severe hypokalaemia at admission (OR 5.5, 1.6 to 19.7 p=0.003), but there was no association with any other electrolytes or anaemia. There was no evidence that inverted T-waves were associated with cardiac dysfunction on echocardiography (OR 1.5, 0.6 to 3.7, p=0.464). Interestingly, T wave inversion tended to be more common in kwashiorkor (Table 6.4).   Representative ECG changes as described above are demonstrated in Figure 6.3. 
 170 
 Figure 6.3 Representative electrocardiographic changes in 12-lead ECGs in severely malnourished children 
Flat T waves and long PR interval (PR 182ms) T wave inversion in leads V4 to V6 
  ST depression in V1-V3 and long PR interval (200ms) ST elevation in V1-V3 and short PR interval (84ms, no pre-excitation)  
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 Table 6.4 Comparison of electrocardiographic findings between children with marasmus and kwashiorkor at admission, day 7 and day 28 
 
 Day 0 Day 7 Day 28 
Marasmus 
N=52 
Kwashiorkor 
N=36 
P 
value 
Marasmus 
N=50 
Kwashiorkor 
N=33 
P  
value 
Marasmus 
N=36 
Kwashiorkor 
N=25 
P 
value 
HRV (ms) 23 (10, 40) 25 (15, 50) 0.328 25 (15, 45) 33 (20, 70) 0.101 30 (15, 40) 35 (25, 50) 0.151 
QRS axis° 66 (32, 89) 67 (40, 82) 0.956 57 (25, 80) 54 (32, 72) 0.812 67 (44, 90) 51 (40, 70) 0.204 
RAD 2 (4%) 0 (0%) 0.234 2 (4%) 0 (0%) 0.250 2 (5%) 0 (0%) 0.237 
LAD 9 (17%) 1 (3%) 0.065 8 (16%) 1 (3%) 0.100 6 (16%) 3 (12%) 0.645 
T axis° 35 (13, 56) 25 (-7, 42) 0.048 36 (15, 51) 36 (20, 47) 0.926 32 (20, 45) 39 (21, 53) 0.285 
Abnormal t axis 8 (15%) 12 (33%) 0.048 7 (14%) 0 (0%) 0.025 3 (8%) 1 (4%) 0.518 
QRS-T >90° 6 (12%) 10 (28%) 0.052 4 (8%) 1 (3%) 0.352 3 (8%) 1 (4%) 0.518 
PR interval (ms) 116 (107, 133) 114 (102, 126) 0.295 109 (104, 128) 109 (102, 122) 0.777 112 (101, 128) 111 (105, 122) 0.791 
Short PR  2 (4%) 0 (0%) 0.234 1 (2%) 1 (3%) 0.755 0 (0%) 0 (0%) N/A 
Long PR  11 (21%) 3 (8%) 0.118 4 (8%) 1 (3%) 0.380 2 (5%) 0 (0%) 0.237 
QRS duration (ms) 68 (61, 77) 64 (60, 72) 0.121 63 (55, 68) 59 (55, 63) 0.103 61 (57, 66) 60 (55, 67) 0.447 
Short QRS  3 (6%) 3 (8%) 0.641 13 (26%) 13 (39%) 0.181 9 24.3 7 (28%) 0.746 
Long QRS  3 (6%) 0 (0%) 0.143 0 (0%) 0 (0%) N/A 0 (0%) 0 (0%) N/A 
QTc interval (ms) 414 (393,431) 407 (374, 433) 0.415 401 (383, 417) 402 (389, 417) 0.993 421 (402, 437) 413 (405, 426) 0.401 
Short QTc  13 (25%) 11 (31%) 0.566 15 (30%) 6 (18%) 0.250 5 (14%) 2 (8%) 0.506 
Long QTc  1 (2%) 2 (6%) 0.377 0 (0%) 0 (0%) N/A 1 (3%) 0 (0%) 0.407 
ST elevation 1 (2%) 0 (0%) 0.403 3 (6%) 0 (0%) 0.150 1 (3%) 4 (16%) 0.059 
ST depression 8 (15%) 0 (0%) 0.014 2 (4%) 0 (0%) 0.243 1 (3%) 0 (0%) 0.407 
Inverted T V4 9 (17%) 11 (31%) 0.145 7 (14%) 1 (3%) 0.129 7 (19%) 3 (12%) 0.471 
Inverted T V5 7 (14%) 10 (28%) 0.100 3 (6%) 1 (3%) 0.538 2 (5%) 1 (4%) 0.801 
Inverted T V6 3 (6%) 10 (28%) 0.009 2 (4%) 1 (3%) 0.811 2 (5%) 1 (4%) 0.801  
Data is presented as medians (IQR) and the number and proportion (%) with values outside the reference range 
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 Voltages  Although mean voltages in all 12 ECG leads were above previously published cut-offs for low voltages (<0.5 mV in limb leads and <1mV in precordial leads), 34/88 (39%), 24/83 (29%) and 11/61(18%) of children with severe malnutrition had low voltages in standard limb leads at admission, day 7 and day 28 respectively (Table 6.5).  Only one child had a low mean precordial voltage of less than 1mV at day 7. This child died. However there was no difference in the mean precordial voltage of survivors or non-survivors at admission (2.2mV vs. 2.3mV, p=0.936) or day 7 (2.2 vs. 1.6, p=0.203). Voltages in most leads were significantly lower in children with kwashiorkor on admission and day 7 (Table 6.6).  Simple linear regression showed there was an association between total voltage and serum albumin with an increase in voltage by 0.2 mV with every 1g/L increase in serum albumin concentration (Spearman´s correlation coefficient 0.37, p<0.001).  Other variables known from the literature to affect voltages did not show any evidence of linear relationship with total voltages in a simple linear regression model (Table 6.7). When all variables known to affect voltages were put into a multiple linear regression model (see Table 6.8), serum albumin, haematocrit and kwashiorkor showed independent relationships with total voltages.  
Table 6.5 Mean R/S voltage (mV) and standard deviations in children with severe malnutrition in all 
12 ECG leads  
Lead  Day 0 
N=88 
Day 7 
N=83 
Day 28 
N=61 
I 0.8 (0.5) 0.9 (0.5) 1.0 (0.4) 
II 1.0 (0.5) 0.9 (0.4) 0.9 (0.4) 
III 0.7 (0.4) 0.6 (0.4) 0.7 (0.5) 
aVR  0.3 (0.3) 0.4 (0.4) 0.4 (0.4) 
aVL 0.6 (0.4) 0.7 (0.4) 0.7 (0.4) 
aVF 0.7 (0.4) 0.6 (0.4) 0.7 (0.4) 
V1 1.5 (0.8) 1.6 (0.8) 1.5 (0.6) 
V2 2.9 (1.0) 3.0 (1.0) 3.1 (0.9) 
V3 3.1 (1.2) 2.8 (1.0) 2.9 (0.9) 
V4 3.1 (1.3) 2.7 (1.0) 2.9 (0.9) 
V5 2.0 (1.0) 1.9 (0.8) 2.1 (0.9) 
V6 1.1 (0.6) 1.1 (0.5) 1.3 (0.6) 
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 Table 6.6 Mean R/S voltages (mV) and SD of all 12 leads in children with marasmus and kwashiorkor at admission, day 7 and day 28 
 
Lead Day 0 Day 7 Day 28 
 Marasmus 
N=52 
Kwashiorkor 
N=36 
 
p value 
Marasmus 
N=50 
Kwashiorkor 
N=33 
 
p value 
Marasmus 
N=36 
Kwashiorkor 
N=25 
p value 
 Mean SD Mean SD  Mean SD Mean SD  Mean SD Mean SD  
I 0.9 (0.5) 0.7 (0.3) 0.018 1.0 (0.5) 0.8 (0.3) 0.065 0.9 (0.4) 1.0 (0.4) 0.489 
II 1.1 (0.5) 0.7 (0.3) <0.001 0.9 (0.4) 0.7 (0.3) 0.007 1.0 (0.4) 0.9 (0.4) 0.664 
III 0.8 (0.4) 0.5 (0.3) 0.003 0.7 (0.4) 0.5 (0.3) 0.003 0.7 (0.4) 0.6 (0.3) 0.188 
aVR  0.4 (0.3) 0.3 (0.3) 0.328 0.4 (0.4) 0.4 (0.4) 0.825 0.4 (0.3) 0.3 (0.4) 0.773 
aVL 0.7 (0.4) 0.5 (0.3) 0.019 0.8 (0.4) 0.6 (0.3) 0.059 0.8 (0.5) 0.8 (0.4) 0.849 
aVF 0.8 (0.5) 0.5 (0.3) 0.001 0.7 (0.4) 0.5 (0.3) 0.009 0.8 (0.4) 0.6 (0.3) 0.159 
V1 1.7 (0.9) 1.3 (0.5) 0.013 1.6 (0.7) 1.5 (0.8) 0.276 1.4 (0.6) 1.6 (0.6) 0.493 
V2 3.1 (1.2) 2.5 (0.7) 0.008 3.2 (1.0) 2.7 (1.0) 0.009 3.1 (1.0) 3.1 (0.7) 0.861 
V3 3.5 (1.3) 2.6 (0.8) <0.001 3.1 (1.0) 2.4 (0.9) 0.004 3.0 (0.9) 2.8 (0.8) 0.332 
V4 3.5 (1.4) 2.6 (0.7) <0.001 3.1 (1.1) 2.3 (0.9) 0.001 3.0 (1.0) 2.8 (0.9) 0.498 
V5 2.3 (1.1) 1.7 (0.6) 0.004 2.0 (0.8) 1.7 (0.8) 0.074 2.0 (0.9) 2.1 (0.8) 0.552 
V6 1.3 (0.6) 0.9 (0.3) <0.001 1.2 (0.5) 0.9 (0.4) 0.020 1.3 (0.6) 1.3 (0.6) 0.764 
Total voltage 20 (6.4) 14.8 (3.5) <0.001 18.6 (4.6) 15.3 (3.6) <0.001 18.2 (4.2) 17.9 (3.6) 0.801   Data is presented as means and standard deviation (SD)
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Table 6.7 Regression coefficients and 95% confidence intervals for clinical, laboratory and 
echocardiographic indices as predictors of total ECG voltages using simple linear regression  
Total Voltage Regression 
coefficient 
95% CI p value 
MUAC -0.2 (-0.7 to  -0.3) 0.419 
Serum albumin 0.2 (0.1 to 0.3) <0.001 
Hct -0.02 (-0.1 to 0.1) 0.760 
LV mass 0.03 (-0.02 to 0.1) 0.160 
EDV 0.1 (-0.01 to 0.1) 0.093 
Pericardial Effusion -1.2 (-2.7 to 0.4) 0.130 
TSH 0.2 (-0.3 to 0.8) 0.595   
Table 6.8 Regression coefficients and 95% confidence intervals for clinical, laboratory and 
echocardiographic indices as predictors of total ECG voltages in multiple linear regression model 
 
Total Voltage Coefficient 95% CI p value 
MUAC -0.5 (1.0 to 0.7) 0.087 
Serum albumin 0.2 (0.1 to 0.3) <0.001 
Hct -0.2 (-0.3 to -0.06) 0.004 
LV mass 0.01 (-0.1 to 0.1) 0.867 
EDV 0.1 (-0.04 to 0.2) 0.229 
Pericardial effusion -1.3 (-2.8 to 0.15) 0.079 
Kwashiorkor -1.9 (-3.4 to -0.4) 0.014 
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6.3.2 Effect of diarrhoea  At admission diarrhoea was associated with longer PR, QRS and QTc intervals, and these differences disappeared by day 7 (Table 6.9 Comparison of). However, in multivariable regression models including electrolyte concentrations, only the QRS interval was independently association with diarrhoea (coef 3.8, 0.6 to 7.0, p=0.019) suggesting the remaining associations with diarrhoea were likely due to electrolyte disturbances.     
Table 6.9 Comparison of ECG intervals and durations between severely malnourished children with 
and without diarrhoea at admission and day 7  
Admission No Diarrhoea 
N=44 
Diarrhoea 
N=43 
p value 
 
 
Intervals 
& 
Durations 
PR interval (ms) 113 (99, 124) 121 (109, 139) 0.038 
Short PR  2 (5%) 0 (0%) 0.157 
Long PR  3 (7%) 11 (26%) 0.017 
 QRS duration (ms) 63 (58, 68) 72 (67, 79) <0.001 
Short QRS  6 (14%) 0 (0%) 0.012 
Long QRS  0 (0%) 3 (7%) 0.075 
QTc interval (ms) 396 (371, 421) 420 (407, 443) 0.002 
Short QTc  17 (39%) 7 (16%) 0.020 
Long QTc  2 (5%) 1 (2%) 0.570 
       
Day 7 N=57 N=26  
 
 
 
Intervals 
& 
Durations 
PR interval (ms) 109 (101, 123) 111 (104, 128) 0.435 
Short PR  1 (2%) 1 (4%) 0.564 
Long PR  3 (5%) 2 (8%) 0.666 
 QRS duration (ms) 60 (55, 67) 62 (56, 67) 0.724 
Short QRS  20 (35%) 6 (23%) 0.274 
Long QRS  0 (0%) 0 (0%) N/A 
QTc interval (ms) 400 (384, 420) 407 (378, 416) 0.860 
Short QTc  12 (21%) 8 (31%) 0.337 
Long QTc  0 (0%) 0 (0%) N/A  
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 6.3.3 Electrocardiographic differences in SAM children with and without HIV infection 
 There were no statistically significant differences in axes, intervals and durations, T wave inversion, or total voltages between HIV negative and HIV positive children at admission (Table 6.10) or at days 7 and 28 (Appendix Table 11.18 and Table 11.19 Comparison of). However HIV positive children had a more persistent tachycardia, with a higher median heart rate at day 28. Their heart rate variability also tended to be lower than HIV negative children, a difference that was also most prominent at day 28 (20 vs. 33 ms, p=0.037). A higher proportion of HIV positive children had abnormal QRS-T angles at all three time points compared to HIV negative children (Table 6.10; Table 11.18; Table 11.19 Comparison of).  However there was no association of abnormal QRS-T angles with cardiac dysfunction in either HIV positive children (32% vs. 25%, p=0.591) or HIV negative children (7% vs. 6%, p=0.820) with severe malnutrition.  
Table 6.10 Comparison of admission ECG measurements in HIV negative and positive malnourished 
children 
 HIV –ve 
(n= 68) 
HIV+ve 
(n=20) 
 
p  value 
Rate Heart rate (bpm) 133 (120, 140) 131 (119, 154) 0.901 
Heart rate variability (ms) 25 (15, 45) 20 (10, 43) 0.528 
 
 
Axes 
 
P-axis° 54 (36, 67) 57 (45, 66) 0.434 
QRS -axis 66 (35, 84) 69 (38, 102) 0.414 
Right axis deviation 1 (2%) 1 (5%) 0.352 
Left axis deviation 8 (12%) 2 (10%) 0.827 
T-axis° 32 (5, 56) 26 (-5, 46) 0.278 
Abnormal T-axis 14 (21%) 6 (30%) 0.377 
QRS-T angle >90 ° 9 (13%) 7 (35%) 0.027 
 
 
Intervals 
& 
Durations 
PR interval (ms) 114 (100, 130) 117 (114, 134) 0.076 
Short PR  1 (2%) 1 (5%) 0.352 
Long PR  10 (15%) 4 (20%) 0.569 
QRS duration (ms) 67 (60, 74) 68 (61, 75) 0.672 
Short QRS  4 (6%) 2 (10%) 0.521 
Long QRS  2 (3%) 1 (5%) 0.656 
 QTc interval (ms) 412 (381, 431) 415 (387, 433) 0.858 
Short QTc  20 (30%) 4 (20%) 0.409 
Long QTc  3 (4.4%) 0 (0%) 0.339 
ST 
segment 
ST elevation 1 (2%) 0 (0%) 0.585 
ST depression 4 (6%) 4 (20%) 0.054 
 
T wave 
Inverted T V4 14 (21%) 6 (30%) 0.377 
Inverted T V5 11 (16%) 6 (30%) 0.169 
Inverted T V6 9 (13%) 4 (20%) 0.454 
Other Total 12 lead voltage 17 (13, 20) 18 (15, 24) 0.225 
Data is presented as medians (IQR) and the number and proportion (%) with values outside the reference range 
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 6.3.4 Associations with death Although we have noted a number of ECG abnormalities in children with SAM, some which correlate with severe electrolyte abnormalities, there were no associations with death of any of the ECG measures at admission (Table 6.11 and Table 6.12). The only association with death of ECG measures at days 7 was lower heart rate variability among children who subsequently died (10 vs. 30ms, p<0.001, Table 11.23). Figure 6.4 shows a receiver operator characteristics (ROC) curve for HRV at day 7 as a predictor of survival. The area under the curve was 0.899 (0.823 to 0.975).  All children who died had a HRV < 25ms. The predictive value for death of HRV <25 was 25% (12% to 42%).    
Table 6.11 Comparison of ECG measurements at admission among children who survived and died 
Parameters at admission Survivors 
(n= 74) 
Non-Survivors 
(n=14) 
 
p value 
Rate Heart rate 132 (120, 141) 134 (108, 147) 0.896 
Heart rate variability 25 (15, 50) 15 (15, 30) 0.332 
 
 
Axes 
 
P-axis 54 (38, 66) 56 (39, 69) 0.437 
QRS –axis 66 (34, 85) 71 (40, 89) 0.326 
Right axis deviation 2 (3%) 0 (0%) 0.534 
Left axis deviation 8 (11%) 2 (14%) 0.707 
T-axis 28 (2, 54) 36  (5, 47) 0.905 
Abnormal T-axis 17 (23%) 3 (21%) 0.899 
QRS-T angle >90 14 (19%) 2 (14%) 0.680 
 
 
Intervals 
& 
Durations 
PR interval 115 (106, 131) 114 (108, 133) 0.909 
Short PR  2 (3%) 0 (0%) 0.534 
Long PR  12 (16%) 2 (14%) 0.856 
 QRS duration 67 (60, 75) 67 (62, 74) 0.707 
Short QRS  5 (7%) 1 (7%) 0.958 
Long QRS  2 (3%) 1 (7%) 0.401 
QTc interval 411 (380, 429) 418 (382, 443) 0.368 
Short QTc  2 (3%) 1 (7%) 0.401 
Long QTc  2 (3%) 1 (7%) 0.401 
ST 
segment 
ST elevation 11 (15%) 2 (14%) 0.955 
ST depression 7 (10%) 2 (14%) 0.585 
 
T wave 
Negative T V4 15 (20%) 5 (36%) 0.206 
Negative T in V5 12 (16%) 5 (36%) 0.090 
Negative T in V6 9 (12%) 4 (29%) 0.113 
Other Total 12 lead voltage 17 (13, 22) 17 (12, 21) 0.793 
Data is presented as medians (IQR) and the number and proportion (%) with values outside the reference range   
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 Table 6.12 Crude odds ratios and 95% confidence intervals for associations of abnormal ECG indices 
and death in all severely malnourished children across all time points 
 All SAM* 
OR for death 
(95% CI) 
 
 
p value 
Abnormal QRS-T angle 1.1 ( 0.3 to 4.5) 0.941 
Short PR interval 0 N/A N/A 
Long PR interval 0.7 (0.13 to 3.9) 0.700 
Short QRS duration 1.1 (0.1 to 10.1) 0.960 
Long QRS duration 3.0 (0.2 to 39.4) 0.379 
Short QTc interval 0.4 (0.1 to 1.2) 0.235 
Long QTc interval 2.8 (0.2 to 35.3) 0.417 
ST depression 2.1 (0.3 to 13.4) 0.417 
T wave inversion V4-6 1.2 (0.4 to 9.0) 0.655   
*As there was no difference between marasmus and kwashiorkor, the above represents the combined OR    
Figure 6.4 Receiver operator characteristics curve of heart rate variability (HRV) at day 7 as a 
predictor of survival amongst SAM children  
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6.3.5 Holter results in children with severe malnutrition  Holter monitoring was performed on 55/88 (63%) severely malnourished patients. Table 6.13 compares baseline characteristics of children who were and were not fitted with a Holter monitor. Those fitted with a monitor tended to be less severely malnourished, had a lower prevalence of HIV infection, and were less likely to die. However the proportions with other clinical syndromes and electrolyte disturbances were similar between the two groups.     
Table 6.13 Comparison of important baseline characteristics of severely malnourished children with 
and without continuous ECG recording over 7 days (Holter)  
 Parameters Holter 
N=55 
No Holter 
N=33 
 
p value 
 
Demographics 
Male 31 (56%) 17 (52%) 0.658 
Age (months) 19 (14, 35) 20 (12, 41) 0.942 
WHZ -3.05 (-3.7, -2.3) -3.3 (-3.9, -3.0) 0.040 
 
Clinical 
Syndrome 
Diarrhoea 15 (27%) 5 (18%) 0.492 
Pneumonia 4 (7%) 7 (21%) 0.056 
SIRS 9 (50%) 2 (50%) 1.000 
HIV +ve 8 (15%) 12 (36%) 0.018 
Anaemia (Hb <9.3 g/dL) 8 (15%) 1 (3%) 0.084 
Electrolyte 
Perturbations 
Severe hypokalaemia1 13 (25%) 5 (18%) 0.492 
Severe hyponatraemia2 3 (6%) 1 (4%) 0.680 
Hypomagnesaemia3 2 (4%) 2 (6%) 0.597 
Outcome Died 5 (9%) 9 (27%) 0.024  Data is presented as absolute numbers (%) The following definitions were applied: severe hypokalaemia= K<2.5mmol/L, severe hyponatraemia= Na<125mmol/L, hypomagnesaemia= Mg<0.75mmol/L          
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Baseline information  A total of 6831 hours of continuous ECG monitoring were analysed. The median number of hours recorded was 65 hours (IQR 33 to 103) in the marasmic group and 61 hours (IQR 31 to 94) in the kwashiorkor group. Early deaths, refusal to continue to be attached to the monitor, and loose fittings of ECG electrodes during out of hours accounted for the lost hours among those children who were recorded for less than the planned 7 days.  
6.3.6 Evidence of arrhythmias in severely malnourished children  Three patients had a total of 13 bradycardic episodes. Episodes of supraventricular tachycardia (SVT) were more common, with 392 episodes recorded in 22 patients (Table 6.14). Ventricular arrhythmias, especially premature ventricular contractions (PVCs) and “R on T” PVCs were present in 60% and 55% of severely malnourished children respectively. Significant ventricular arrhythmias (couplets, triplets, salvos, established ventricular tachycardia, and “R on T” PVCs) were present in 33 (60%) of malnourished children. All were self-limiting and none had a clear clinical correlate. Five of these 33 children (15%) died during the course of admission. There was no statistical evidence of an association between documented significant ventricular arrhythmias and death (odds ratio for dying 2.9, 95% CI 0.3-28, p=0.357).  One of the five children with documented ventricular arrhythmias who died (C1) did so during the period of Holter recording.  
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Case description C1: This child was 16 months old severely wasted boy who was admitted with history of recurrent illnesses, fever, poor feeding and an episode of bloody stool. The patient was dehydrated and lethargic but did not have any respiratory distress. His respiratory and cardiovascular system examination were normal. Laboratory tests showed severe hypokalaemia of 1 mmol/L and severe hyponatraemia of 119mmol/L at admission. Blood gas analysis showed compensated metabolic acidosis. His 12 lead ECG at admission showed first degree heart block with left axis deviation and a widened QRS interval. His echocardiogram showed good ventricular function with a FS of 37% but a low cardiac index. He was started on intravenous rehydration with extra potassium. The patient developed scleral jaundice on the second day, which progressively worsened and progressed to the extremities. On day 3 of admission the patient had a respiratory arrest, likely precipitated by a hypoglycaemic episode and shock probably secondary to acute liver failure. In his last 12 lead ECG prior arrest his intervals had normalized. Peri-arrest the child showed a pattern of re-entry tachycardia and during resuscitation had episodes of VT, which did not seem to be the primary cause of the arrest.   Overall we observed no difference between marasmus and kwashiorkor in the in the incidence of arrhythmias. There was no association of significant ventricular arrhythmias with HIV status, (63% vs. 60% among HIV positive and negative children respectively, p=0.876), nor with documented ST elevation on the 12 lead ECG (57% vs. 60% among those with and without ST elevation, p=0.869). None of the children with significant ventricular arrhythmias had low voltages in their 12 lead ECGs.  There was no statistical evidence of an association between the presence of significant ventricular arrhythmias and systolic or diastolic dysfunction.  No linear relationship was demonstrated between the occurrence of significant ventricular arrhythmias and either electrolyte concentrations or malnutrition severity (weight for height z-score).     
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Table 6.14 Total episodes of arrhythmias and number of SAM children affected 
 All SAM 
N=55 
Marasmus 
N=31 
Kwashiorkor 
N=24 
p value 
Bradycardia 3 (6%) 1 (3%) 2 (8%) 0.408 
 Total bradycardias 13  1  12   
SVT 22 (40%) 13 (58%) 9 (38%) 0.739 
Total SVT 392  230  162   
Bigemini 13 (24%) 10 (32%) 3 (13%) 0.085 
Total Bigemini 254  185  69   
Trigemini 13 (24%) 10 (32%) 3 (13%) 0.087 
Total Trigemini 5  4  1   
PVC 33 (60%) 23 (74%) 10 (42%) 0.015 
Total PVCs 1353  752  601   
Couplet 23 (42%) 15 (48%) 8 (33%) 0.262 
Total Couplet 2133  1330  803   
Triplet 10 (18%) 7 (23%) 3 (13%) 0.336 
Total Triplet 387  209  178   
Salvos 10 (18%) 8 (26%) 2 (8%) 0.096 
Total Salvos 385  160  225   
R on T  30 (55%) 19 (61%) 11 (46%) 0.254 
Total R on T 3086  1744  1342   
VT 7 (13%) 4 (13%) 3 (13%) 0.965 
Total VT 50  48  8    
Data is presented as number and proportion (%) of those affected as well as total episodes (cursative) The following abbreviations were used: SVT= supraventricular tachycardia, PVC= premature ventricular contraction, VT= ventricular tachycardia  
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6.4 Discussion  This chapter describes the findings of 12 lead electrocardiograms and 7 day continuous Holter monitoring in children with severe malnutrition and possible associations of ECG features with abnormal clinical and echocardiographical indices. It further explores the role of cardiac arrhythmias as potential cause of cardiac dysfunction and/or sudden cardiac death. 
6.4.1  12- lead ECG In line with what has been previously reported (see Chapter 2), we observed some alterations in the main ECG axes, durations, intervals and waveforms.  Stephens et al have proposed that the ECG axis might be a useful clinical prognosticator in children with severe malnutrition.257 They described an association with death of a QRS axis between +60° and +120°, and progressive leftward movement of the axis among children who survived. This is the first attempt to validate these observations on an independent cohort and we were not able to replicate the findings. Although one in ten children had left axis deviation, only two children had right axis deviation, neither of whom died. It may be that the axis changes noted by Stephens reflected subtle changes in cardiac orientation due to wasting, and that the association with death was confounded by malnutrition severity.   A previous study by El-Sayed also found long PR intervals in malnourished children107  and other studies report on long QTc intervals.59 112 We also found a high proportion of malnourished children with prolonged PR interval at admission, QRS durations and QTc intervals were short. These ECG changes appeared to correlate, as expected, with electrolyte concentrations. Thus severe hypokalaemia was associated with PR prolongation, and the QRS duration was correlated with serum magnesium and negatively correlated with serum potassium and calcium. About a quarter of severely malnourished children in our study had a short QTc interval. Although an association between hypokalaemia and QTc prolongation has previously been reported in malnutrition,59 we found no evidence for this, nor is hypokalaemia a commonly recognized cause of QTc prolongation. Confusion may however occur due to lengthening 
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 of the Q-U interval in hypokalaemia.123 It is possible that QTc interval changes may be mediated by effects on the autonomic nervous system. Bedi et al demonstrated a decrease in parasympathetic tone in malnourished children.258 Although their study population was by no means as malnourished (median WHZ -1.6) as our CAPMAL patients, and not critically ill, it is possible that relatively increased sympathetic tone, driven by severe malnutrition and critical illness, might cause a short QTc.259 260  It is also interesting that the heart rate variability remains static between admission and day 7, which is likewise regulated by the autonomic nervous system,261 and could indicate a preponderance of the sympathetic innervation of the heart. This was already described in Leon-Quinto et al 262 and recently confirmed by Martins et al who looked at the autonomic balance of the heart in undernourished rats.263 He demonstrated by selective blockade of specific receptors, that the sympathetic tone was augmented and the parasympathetic (vagal) tone was reduced in malnourished rats compared to control rats. Both vagal withdrawal and activation of the sympathetic activation have been shown to affect the QT interval independently from heart rate.260 In line with previously published descriptions of ECGs in severely malnourished children59 113 115, we also found a high prevalence of ST depression and T-wave inversion. The latter improved over time in parallel with normalization of the serum potassium level. ST depression was associated with low phosphate levels in marasmic children. This has not been described in malnourished children before but is can usually occur with hypokalaemia and tachycardia.123 ST depression is a marker of myocardial ischaemia, and was associated with severe anaemia in a previous study of severe childhood malnutrition.264 However we did not find a similar association in our study. ST elevation at day 28 could not be explained with our data. However the absence of cardiac dysfunction, pericardial effusions or low voltages in those children with ST elevation make it unlikely to be due to myocarditis. ST and T-wave changes that remained in the absence of electrolyte perturbations can also be due to physiologic variants previously described in African populations.265 266 QRS voltages have been reported to be low in malnourished children.114 We also found that a high proportion of CAPMAL children had low limb lead QRS voltages and voltages in children with kwashiorkor were generally lower at admission and day 7 compared to marasmus. Our data suggests that the attenuation of QRS amplitudes might be due to increased extracellular fluid, apparent as tissue oedema, which decreases the electrical 
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 resistance of the extracellular space. As there is very little tissue between the chest wall and the electrodes in general, and in severely malnourished children in particular, it is not surprising, that voltages are normal across the chest leads. The hypoalbuminaemia driven low colloid oncotic pressure in severely malnourished children is known to cause oedema, which modifies electrical resistance, but albumin also seems to be independently associated with ECG voltages in our study. Heaf et al. reported an increase in QRS amplitudes following albumin infusion and suggests that the increase in blood protein concentration leads to an increased blood conductivity.267 Low voltages have also been described in hypothyroidism and the presence of pericardial effusions. 144 145 However hypothyroidism and pericardial effusions were not associated with low voltages in our cohort, neither was left ventricular mass, which is commonly estimated by voltage criteria in clinical practice.123  HIV positive and negative children did not differ in any of their ECG measures apart from a wide QRS-T angle in HIV infected children, which was of no apparent clinical significance. This was not associated with any clinical or echocardiographic evidence of cardiac dysfunction, nor did it increase the odds of dying.  Failure to increase beat-to-beat variation of the heart rate during recovery was the only ECG sign in non-survivors that was different from survivors. A decrease in heart rate variability usually reflects a degree of autonomic nervous system dysfunction and has been shown to be a predictor of poor outcome in various scenarios including sepsis, trauma and heart failure. 268-270   
6.4.2 Holter monitoring  There are no published Holter data from children with severe malnutrition. More than half the severely malnourished children in our study for whom Holter data were available had an arrhythmia at some point during their Holter recording. However few of these were serious and all were clinically silent. There was no association between documented arrhythmias and subsequent death.  Similarly we were unable to demonstrate an association between arrhythmias and any electrolyte perturbations. As the proportion of children with electrolyte perturbations were the same in the Holter and non-Holter group, and in the absence of good evidence for re-feeding syndrome overall, it seems unlikely that low serum electrolyte levels play 
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 an important role in the occurrence of those arrhythmias detected. Likewise the degree of malnutrition measured by the weight for height z-score did not correlate with the incidence of arrhythmias.  Data on arrhythmias in critically ill children is limited to case reports 271 or studies in children on cardiac intensive care units. 272 Although arrhythmias have been well described in children with myocarditis273-275 and HIV infection, 243 244 248 we found no evidence of the former and no association with HIV. Schwartz et. al also reports cardiac arrhythmias in early sepsis and SIRS that were associated with hypophosphataemia in adult ICU patients. 253 254  We found no statistically significant association between documented ventricular arrhythmias and death. Yet only one child died during the Holter monitoring and death was not unexpected as this child who was admitted with severe electrolyte perturbations, severe jaundice and ongoing diarrhea.  
6.4.3 Limitations  The main limitation of the electrocardiographic component of our study was that, due to financial restrains, we were not able to fit every child with a Holter monitor, nor to continue monitoring for the full 4 week observation period. Nevertheless the addition of continuous ECG monitoring still represents an important advance on previous electrocardiographic studies of children with malnutrition, all of which have been limited to 12 lead ECG data.   Although Holter monitors were assigned consecutively to new admissions as the devices became available, by chance it appears that the children who were not fitted with a Holter monitor tended to be slightly sicker, with a lower median WHZ score, a higher prevalence of HIV infection, and a higher proportion of non-survivors. A degree of caution is therefore required before extrapolating our findings to all malnourished children. However, it is important to note that the median WHZ score (-3.1) and case fatality rate (9%) of children who were fitted with a Holter monitor are actually very similar to the total population of severely malnourished children admitted to Kilifi District Hospital during the study period (-3.1 and 11%, respectively;Table 4.3). It is therefore reasonable to assume that this group is representative of severely 
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 malnourished children admitted to Kilifi District Hospital, and that the findings should therefore be generalizable to this group as a whole.  
6.4.4 Conclusions  Severe hypokalaemia was accountable for 12-lead ECG changes observed such as PR prolongation, QRS shortening and T-wave inversions, which improved in line with normalization in serum potassium level. In general, we detected a number of abnormal ECG patterns and electrolyte perturbations, however these were not associated with the occurrence of clinically significant ventricular arrhythmias. However, only one of 14 children who died was monitored at the time of death so we cannot exclude arrhythmias as a cause of sudden death in general. From our data however it appears, that re-feeding syndrome does not play a role in the deaths of these children but that low heart rate variability was associated with a poor outcome.  
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 7  How does cardiac function in severe malnutrition differ from 
controls?   
7.1 Background   In chapters 4 to 6 we have described in detail the cardiovascular physiology of children with SAM, based on a comprehensive clinical, biochemical, echocardiographic and electrocardiographic assessment. In doing this we have a built up a picture of their cardiac function.  We have shown that, for example, children with SAM showed signs of tissue hypoperfusion which worsened in the first seven days but which did not seem to be due to an overtly hypocirculatory state. In fact, over the course of nutritional rehabilitation, some children with SAM had echocardiographic features of high cardiac output, albeit with few clinical signs of cardiac failure. There was also evidence of cardiac dysfunction, systolic more than diastolic; and signs of altered peripheral vascular tone, with high systemic vascular resistance that correlated with MUAC and fell during nutritional rehabilitation. Electrocardiographic changes included altered conduction, depolarization and repolarization intervals which was associated with electrolyte perturbations, and self-limiting ventricular arrhythmias in some children.  The question remains, however, whether any of these observed abnormalities can be attributed to malnutrition per se, or are due to the accompanying comorbidities, which can be serious. We have established that children with SAM are admitted to hospital with comorbidities such as sepsis, anaemia, dehydrating diarrhoea and HIV that can all affect cardiovascular function and are known to carry a high risk of mortality in themselves, independent of their nutritional status.   In this chapter I aim to compare the clinical, biochemical, echocardiographic and electrocardiographic features of SAM children with a group of matched controls who are not severely malnourished, in order to explore how much malnutrition per se accounts for cardiovascular abnormalities seen in SAM. 
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7.2 Methods  Clinical methods including enrolment of the control group are described in Chapter 3. Briefly, we recruited a control group of children with no clinical or anthropometric signs of severe malnutrition, frequency matched to SAM cases by age and clinical syndrome (diarrhoea, pneumonia, and other febrile illness).  Identical methods of assessment, data presentation and indexing were used for cases and controls. Because control children tended to have shorter periods of Holter monitoring due to shorter inpatient stays, we used for comparison between cases and controls the number of Holter events per day.   
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 7.3 Results 
7.3.1 Baseline clinical characteristics of cases and controls We recruited 22 controls successfully frequency matched by age and clinical syndrome to the 88 severely malnourished cases (Table 7.1). Overall, system specific clinical signs or syndromes were similar in the two groups, except that tachypnoea and very severe pneumonia were more common among controls, and none of the controls was HIV positive. Although signs of impaired perfusion and hypotension were slightly more common among cases, this was not statistically significant. Systolic and diastolic blood pressure were similar in cases and controls, although pulse pressure was narrower in the SAM group at admission. The median heart rate and respiratory rate were also lower in cases than in controls at admission but this difference disappeared by day 7 (Figure 7.1). None of the controls had hepatomegaly, gallop rhythm or neck vein distension at any review time. Although these signs were present in a small number of children with SAM, there was no statistical evidence that either these signs or a raised NT-proBNP were more common in malnutrition (and Table 7.5)  Controls had a higher prevalence of tachypnoea at admission, which probably reflects the higher proportion of pneumonia cases that had severe or very severe pneumonia. This difference did not persist following admission and there was no difference in oxygen saturation at any time (Figure 7.1). By day 7, the proportion of those with hepatomegaly increased modestly in the SAM group from 17% (15/88) to 22% (19/85) compared with no case of hepatomegaly in the control group (p=0.026, see Table 11.1). There was no difference in any of the clinical parameters at day 28 (see appendix Table 11.2).  
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Table 7.1 Comparison of baseline clinical characteristics of severely malnourished children and 
controls at admission  
Category Feature at admission 
SAM Cases 
N=88 
Controls 
N=22 
P value 
Matching 
criteria12 
Male (%) 48 (55%) 15 (68 %) 0.247 
Median age (months) 19  (13, 35) 19 (12, 39) 0.681 
Diarrhoea  23 (26%) 6 (27%) 0.914 
Pneumonia 16 (18%) 6 (27%) 0.340 
Other febrile illness 36  (40%) 8 (45.5%) 0.641 
Anthropometry 
Median weight (kg) 7.9 (6.3, 8.7) 11.0 (8.6, 14.4) 0.005 
Median MUAC (cm) 10.8 (10.0, 11.5) 14.9 (13.5, 16.0) <0.001 
Median WHZ -3.2 (-3.8, -2.5) -1.1 (-1.6,  -0.5) <0.001 
Temperature 
Fever (>37.5°C) 25  (28 %) 7 (32%) 0.753 
Hypothermia (< 35.0°C) 2 (2%) 0 (0%) 0.475 
Hydration 
status 
Decreased skin turgor 8 (10%) 0 (0%) 0.134 
Sunken eyes 22 (26%) 2 (9%) 0.110 
Dry mucous membranes 10 (12%) 1 (5%) 0.333 
Cardiovascular 
system 
Tachycardia  (WHO)a 52 (59%) 15 (68%) 0.436 
Tachycardia (EPLS)b 7 (8%) 2 (9%) 0.862 
Bradycardia (<80/min)  0 (0%) 0 (0%) N/A 
Weak pulse 5 (6%) 0 (0%) 0.250 
Temperature gradientc 6 (7%) 0 (0%) 0.208 
CRT >2 sec 5 (6%) 0 (0%) 0.252 
Hypotensiond 8 (9 %) 0 (0%) 0.142 
Shock (WHO)e 1 (1%) 0 (0%) 0.615 
Shock (EPLS)f 4 (5%) 0 (0%) 0.308 
Impaired perfusiong 15 (17%) 2 (9%) 0.364 
Gallop rhythm 2 (2 %) 0 (0%) 0.483 
Neck vein distension 1 (1%) 0 (0%) 0.613 
Hepatomegalyh 15 (17%) 2 (9%) 0.364  
12 Matching was based on clinical diagnosis made by admitting clinician 
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 Table 7.1  – continued  
Respiratory 
system 
Feature at admission SAM Cases Controls p value 
Respiratory rate>40/min 23 (26%) 10 (46%) 0.082 
Tachypnoea  (WHO)i 18 (21%) 10 (46%) 0.019 
Indrawing 5 (6%) 3 (14%) 0.213 
Deep breathing 6 (7%) 3 (14%) 0.306 
Hypoxia (<95%) 1 (1%) 1 (5%) 0.322 
Neurological 
system 
Blantyre Coma Score ≤ 4 11 (13%) 4 (18%) 0.490 
Cerebral Palsy 5 (6%) 0 (0%) 0.252 
Major clinical 
syndromes 
Severe LRTI (WHO) 8 (9%) 3 (14%) 0.525 
Very severe LRTI (WHO) 0 (0%) 2 (9%) 0.004 
SIRSj 29 (33%) 11 (50%) 0.141 
HIV  20  (23%) 0 (0%) 0.013 Data is presented as medians (IQR) and absolute numbers (%) a WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years b EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years c The temperature gradient (TG) was assessed by running the back of the hand from the toe to the knee. A positive gradient was defined as a temperature change from cold to warm. d Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  e  WHO shock= Lethargy/unconsciousness plus TG plus CRT>3sec plus weak pulse plus tachycardia f EPLS shock= Lethargy/unconsciousness plus TG plus CRT>2sec plus weak pulse plus tachycardia h Hepatomegaly was defined as a palpable liver edge of more than 2cm below the costal margin g Impaired perfusion was defined as any one of the following: tachycardia or TG or weak pulse or CRT>2sec i Tachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years j SIRS was defined using the criteria by Goldstein et al175 
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Figure 7.1 Box-and-whisker plots of bedside observations between severely malnourished cases and 
controls at admission, day 7 and day 28 
 Groups were compared using the Wilcoxon rank-sum test for non-parametric data *  indicates a significance level of p<0.05           ** indicates a significance level of p<0.01  
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 7.3.2 Biochemical and haematological profiles of SAM cases and controls  Table 7.2 summarizes the biochemical profiles of cases and controls at admission. Children with severe malnutrition had lower median concentrations of sodium, potassium and phosphate at admission, and a higher proportion had severe hypokalaemia (Figure 7.2), but these differences disappeared by day 7 (see Appendix Table 11.1, Table 11.2). Serum magnesium concentrations were lower in malnourished cases at day 7 (Figure 7.2). At all three time points, children with malnutrition had significantly lower albumin concentrations (Figure 7.2), with a higher prevalence of hypoalbuminaemia (Figure 7.2). Severe hypoalbuminaemia only occurred in severely malnourished children.  Median TSH concentration was higher and free thyroxine (FT4) concentration lower in malnourished children. 18 cases and 1 control were hypothyroid at admission (p=0.079).  Six (32%) in the control group had a low TSH with normal FT4 levels whereas one out of the two children with malnutrition and low TSH levels also had high FT4.  Median Vitamin D levels were higher in malnourished children, although there were also six cases with Vitamin D deficiency compared with none among controls. High Vitamin B12 levels were also more common among malnourished cases. Cases and controls did not differ significantly in their admission haematological profiles (Table 7.3), although as expected a higher proportion of controls had malaria parasitaemia – the likely cause of admission in many cases.  Both groups had higher proportions of children with moderate anaemia at day 7 which had improved by day 28 (see appendix Table 11.1, Table 11.2). Importantly there was no difference in medial white cell counts nor in the proportion with a leucocytosis, suggesting similar inflammatory response profiles in the two groups. The only difference in their admission cytokine profile was a higher IL-1b level in controls.   
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 Table 7.2 Comparison of admission biochemical profiles of severely malnourished cases (SAM) and 
controls 
 Laboratory parameter SAM cases 
N=88 
Controls 
N=22 
p value 
 
 
 
 
 
 
 
Electrolytes 
Sodium (mmol/L) 136 (132, 138) 138 (137, 140) 0.0047 
Hyponatraemia (<125mmol/L) 4 (5%) 0 (0%) 0.336 
Hypernatraemia (>145mmol/L) 1 (1%) 0 (0%) 0.636 
Potassium (mmol/L) 3.2 (2.5, 3.9) 3.9 (3.5, 4.5) 0.0018 
Hypokalaemia (<2.5mmol/L) 18 (22%) 0 (0%) 0.027 
Hyperkalaemia (>6.0mmol/L) 0 (0%) 0 (0%) N/A 
Phosphate (mmol/L) 1.3 (1.1, 1.5) 1.6 (1.4, 1.9) <0.0001 
Hypophosphataemia (<0.32mmol/L) 9 (10%) 6 (8%) 0.117 
Hyperphosphataemia (>1.78mmol/L) 13 (15%) 7 (32%) 0.070 
Calcium (mmol/L) 2.3 (2.2, 2.4) 2.3 (2.2, 2.3) 0.485 
Hypocalcaemia (<2.1mmol/L) 6 (7%) 1 (5%) 0.698 
Hypercalcaemia (>2.6mmol/L) 2 (2%) 0 (0%) 0.475 
Magnesium (mmol/L) 0.97 (0.86, 1.1) 1.0 (0.9, 1.1) 0.698 
Hypomagnesaemia (<0.75mmol/L) 4 (5%) 1 (5%) 1.0 
Hypermagnesaemia (>1.5mmol/L) 1 (1%) 0 (0%) 0.615 
 
Protein 
Albumin (g/dL) 24 (18, 34) 39 (36, 42) <0.0001 
Hypoalbuminaemia (<34g/L) 66 (75%) 4 (18%) <0.0001 
Severe hypoalbuminaemia (<15g/L) 14 (16%) 0 (0%) 0.045 
 
Renal 
function 
Urea 2.3 (1.5, 3.4) 3.3 (2.0, 4.8) 0.013 
Hyperuricaemia (<6.4mmol/L) 8 (9%) 3 (14%) 0.528 
Creatinine 34 (29, 40) 36 (32, 43) 0.275 
Hypercreatinaemia (<74μmol/L) 5 (6%) 0 (0%) 0.252 
 
Other 
Blood glucose 3.8 (3.1, 4.9) 3.5 (2.6, 4.4) 0.408 
Hypoglycaemia (<3mmol/L) 16 (23%) 3 (27%) 0.729 
 
 
Thyroid 
function 
TSH 2.4 (1.5, 3.3) 0.9 (0.3, 1.9) 0.002 
Low TSH (<0.3 mIU/L) 2 (3%) 6 (32%) <0.001 
High TSH (<4.2 mIU/L) 11 (19%) 0 (0%) 0.070 
Free T4 10.6 (9.3, 12.9) 15.1 (13.4, 16.4) <0.001 
Low fT4 (<9pmol/L) 17 (20%) 1 (5%) 0.08 
High fT4 (>26pmol/L) 1 (1%) 0 (0%) 0.607 
Hypothyroida 18 (24%) 1 (5%) 0.079 
 
 
Vitamins 
Vitamin D 89 (70, 116) 75 (68, 87) 0.019 
Vitamin D deficiency (<25nmol/L) 5 (6%) 0 (0%) 0.238 
Vitamin B12 701 (407, 1136) 423 (278, 630) <0.001 
Low Vitamin B12 (<140nmol/L) 3 (4%) 0 (0%) 0.366 
High Vitamin B12 (>700nmol/L) 35 (42%) 3 (14%) 0.013 Data is presented as medians (IQR) and absolute numbers (%) a Hypothyroidism is used to describe established hypothyroidism, secondary and subclinical hypothyroidism (see definitions used on page 68).   
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Figure 7.2 Box-and-whisker plots of electrolytes and albumin concentrations in severely 
malnourished cases and controls at admission, day 7 and day 28 
 Comparisons were made using the Wilcoxon rank-sum test for nonparametric data *  indicates a significance level of p<0.05           ** indicates a significance level of p<0.01 
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 Table 7.3 Comparison of haematological profile in severely malnourished cases (SAM)and controls at 
admission 
 SAM cases  Controls p value 
Haemoglobin (g/dL) 8.9 (7.7, 9.9) 8.5 (7.4, 10.1) 0.651 
Severe anaemia (<5g/L) 2/86 (2%) 1/20 (5%) 0.516 
Moderate anaemia (<9.3g/L) 47/86 (55%) 10/20 (50%) 0.707 
White cell count (103/mm) 13.6 (8.9, 17.3) 12.6 (7.2, 20.2) 0.787 
Leucopeniaa  5/88 (6%) 2/22 (9%) 0.558 
Leucocytosisa 21/88 (24%) 7/22 (32%) 0.444 
Platelet count (103/mm) 364 (210, 581) 306 (191, 485) 0.237 
Thrombocytopaenia (<80.000/mm3) 3/88 (3%) 1/22 (5%) 0.799 
Malaria parasites seen 3/76 (4%) 3/10 (30%) 0.030 Data is presented as medians (IQR) and absolute numbers (%) outside the normal range 
a Leucocytosis and leucopenia were defined using the criteria by Goldstein et al.175    
Table 7.4 Comparison of cytokine concentrations in severely malnourished cases (SAM) and controls 
at admission  
Cytokines SAM cases 
N=44 
Controls 
N=10 
p value 
IL-6 (pg/ml) 15 (4, 39) 30   (10, 207) 0.130 
TNF-a (pg/ml) 24 (13, 42) 19 (11, 79) 0.894 
IL-1b (pg/ml) 0.5 (0.2, 2.1) 2.7 (0.8, 5.5) 0.008 
IFN-g (pg/ml) 5.3 (2.6, 10.2) 25.8 (4.1, 88.7) 0.086 Data is presented as medians (IQR)  
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 7.3.3 Biochemical markers of tissue perfusion and cardiac dysfunction  Table 7.5 presents the number and proportion of children with abnormal markers of tissue perfusion and cardiac function across the three time points (Table 7.5). There were no significant differences in laboratory markers of tissue hypoperfusion between the groups.  Metabolic acidosis was common at admission in both cases and controls, with a median base deficit of -8.1 (-12.2, -5.4) in SAM and -7.2 (-12, -2.5) in controls (p=0.300). Median lactate concentrations were 2.1mmol/L (1.7, 2.7) and 2.3 mmol/L (1.7, 2.7) in cases and controls (p=0.653). However metabolic acidosis tended to be more persistent in SAM children, being present in 33% at day 7 compared to only 6% of controls (see Appendix Table 11.1, p=0.031).  Median NT-pro BNP was similar in both groups with a concentration of 251pg/mL (100, 740) in cases and 368 pg/mL (86, 781) in controls (p=0.850) at admission. NT-proBNP remained elevated in about 40% of both cases and controls throughout the 28-day study period without any association with pneumonia, SIRS or severe anaemia at any time point.   
Table 7.5 Comparisons of markers of tissue hypoperfusion and cardiac dysfunction between cases 
with severe malnutrition (SAM) and controls at admission, day 7 and day 28  
Admission SAM cases Controls p value 
Acidaemia (pH<7.2) 10/79 (13%) 2/19 (11%) 0.857 
Base deficit (>10 mmol/L) 27/72 (38%) 5/19 (28%) 0.443 
Hyperlactataemia (>2mmol/l) 50/82 (61%) 12/22 (55%) 0.586 
Hyperlactataemia (>3mmol/l) 15/22 (18%) 4/22 (18%) 0.990 
Elevated NT-pro BNPa 18/47 (38%) 4/10 (40%) 0.920 
Day 7      
Acidaemia (ph<7.2) 8/81 (10%) 0/17 (0%) 0.176 
Base deficit (>10 mmol/L) 25/76 (33%) 1/16 (6%) 0.031 
High Lactate (>3mmol/L) 24/77 (31%) 5/18 (28%) 0.779 
Elevated NT-pro BNPa 17/43 (40%) 2/10 (20%) 0.246 
Day 28      
Acidaemia (ph<7.2) 1/56 (2%) 1/15 (7%) 0.310 
Base deficit (>10 mmol/L) 5/56 (9%) 1/13 (8%) 0.887 
High Lactate (>3mmol/L) 8/54 (15%) 6/17 (35%) 0.064 
Elevated NT-pro BNPa 9/23 (39%) 4/9 (44%) 0.783  Data is presented as absolute numbers (%) a Elevated NT-proBNP was defined by Nir 173as >650pg/ml in children up to 12m of age, >400pg/ml in children aged 12m-<24m, >300 in children aged 2y-<6y and >160pg/ml for children >6 y 
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 7.3.4  Comparison of cardiac mass and function in serverly malnourished cases and controls Severely malnourished children had a lower cardiac mass than controls at admission (Table 7.6). However this difference disappeared as cardiac mass increased in SAM cases during nutritional rehabilitation (Figure 7.3).   
Table 7.6 Comparison of cardiac mass and cardiac mass indices between severely malnourished 
children (SAM) and controls at admission  
Admission SAM cases 
N=88 
Controls 
N=22 
p value 
LVM (g) 23 (17, 31) 33 (26, 47) <0.001 
LVMI1 (g/m2.7) 50 (42, 62) 60 (51, 71) 0.009 
LVMI2 (g/m2) 63 (52, 77) 71 (57, 93) 0.030 Left ventricular mass (LVM) is presented as raw data, indexed to height (LVMI1) and indexed to BSA (LVMI2). Data is presented as medians (IQR)  
  
Figure 7.3 Box-and-whisker plots of cardiac mass index in severely malnourished children and 
controls at admission, day 7 and day 28 
  Groups were compared using the Wilcoxon rank-sum test for non-parametric data *  indicates a significance level of p<0.05             As expected, median values of most non-indexed echocardiographic parameters were lower in cases than controls due to their smaller overall body size, which in turn is correlated with cardiac structure and function (Figure 7.4 and Figure 7.6; also see Appendix Table 11.4, Table 11.6 and Table 11.8).  
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 However, after controlling for this confounding by applying published reference ranges stratified by body surface area, few of these differences remained (Appendix Table 11.5, Table 11.7 and Table 11.9). Although the proportion with high LV filling pressures (E/Ea ratio) at admission and day 7 was higher among controls (Appendix Table 11.5, Table 11.7), as was the proportion with a high MAPSE at day 28 (Appendix Table 11.9), no clear pattern emerges and the significance of these differences is unclear. Importantly there was no evidence that SAM cases were more likely to have overall systolic, diastolic or global dysfunction (Table 7.7). Indeed the only differences observed were a higher prevalence among controls of diastolic dysfunction at day 7 and lower right ventricular shortening fraction at day 28 (Figure 7.5).  
Table 7.7 Comparison of cardiac function in severely malnourished children (SAM) and controls at 
admission, day 7 and day 28 
 SAM cases 
N=88 
Controls 
N=22 
p value 
Admission      
Systolic dysfunction1 14 (16%) 2 (10%) 0.417 
Diastolic dysfunction2  4 (5%) 1 (5%) 1.000 
Global dysfunction3 20 (24%) 3 (14%) 0.281 
Day 7  N=85  N=18  
Systolic dysfunction1 11 (13%) 2 (11%) 0.832 
Diastolic dysfunction2 6 (7%) 4 (22%) 0.048 
Global dysfunction3 20 (24%) 3 (14%) 0.281 
Day 28  N=62  N=19  
Systolic dysfunction1 11 (18%) 2 (11%) 0.453 
Diastolic dysfunction2 7 (11%) 2 (11%) 0.926 
Global dysfunction3 17 (21%) 3 (17%) 0.663 
 Data is presented as absolute numbers (%)  
1  any of the following: low FS, low MAPSE, low TAPSE, low Sa velocity (for cut-offs see Table 5.1) 
2  any of the following: abnormal E/A ratio, low Ea velocity, high E/Ea ratio (for cut-offs see Table 5.1) 
3  High Tei Index (for cut-offs see Table 5.1) 
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 Figure 7.4 Box-and-whisker plots of systolic function parameters (non-indexed) in cases  with severe 
malnutrition and controls at admission, day 7 and day 28  
 FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity   
Figure 7.5 Box-and-whisker plots  of left and right ventricular longitudinal shortening in severely 
malnourished cases and controls  
 Comparisons between groups were made using the Wilcoxon rank-sum test for nonparametric data *  indicates a significance level of p<0.05           ** indicates a significance level of p<0.01 
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 Figure 7.6 Box-and-whisker plots of diastolic function indices (non-indexed) in severely malnourished 
cases and controls at admission, day 7 and day 28 
 Comparisons between groups were  made using the Wilcoxon rank-sum test for nonparametric data *  indicates a significance level of p<0.05           ** indicates a significance level of p<0.01 E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea) 
 Figure 7.7 and Table 7.7 compare cardiac index (CI), stroke volume index (SVRI) and systemic vascular resistance index (SVRI) among cases and controls. Median CI was lower in malnourished cases than controls at admission, but increased during nutritional rehabilitation to exceed that of controls by day 28. The prevalence of low CI did not differ between cases and controls, but a greater proportion of SAM cases had a high CI at day 28. Consistent with a decrease in heart rate (Figure 7.1), the median stroke volume index was higher in controls on day 7. Median systemic vascular resistance index was significantly higher in SAM cases than in controls at all time points. Interestingly, while the proportion of SAM cases with high SVRI following admission decreased, the proportion of controls with low SVRI remained constant.  
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 Figure 7.7 Box-and-whisker plots of cardiac index, stroke volume index and systemic vascular 
resistance index of severely malnourished cases and controls at admission, day 7 and day 28 
 Comparisons between groups were made using the Wilcoxon rank-sum test for nonparametric data *  indicates a significance level of p<0.05           ** indicates a significance level of p<0.01  CI= cardiac index, SVI= stroke volume index, SVRI= systolic vascular resistance index 
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  Table 7.8 Comparison of total number and proportion with abnormal cardiac index and systemic 
vascular resistance in all severely malnourished cases (SAM) and controls at admission, day 7 and day 
28  
Admission SAM cases 
N=83 
Controls 
N=22 
p value 
High CI (L/min/m2) 15 (18%) 7 (32%) 0.159 
Low CI  (L/min/m2) 14 (17%) 1 (5%) 0.142 
High SVRI (ds/cm5/m2) 28 (35%) 0 (0%) 0.002 
Low SVRI (ds/cm5/m2) 5 (6%) 13 (62%) <0.001 
Day 7  N=81  N=18  
High CI (L/min/m2) 20 (25%) 5 (28%) 0.785 
Low CI  (L/min/m2) 6 (7%) 0 (0%) 0.234 
High SVRI (ds/cm5/m2) 11 (15%) 0 (0%) 0.084 
Low SVRI (ds/cm5/m2) 6 (8%) 10 (56%) <0.001 
Day 28  N=59  N=19  
High CI (L/min/m2) 17 (29%) 1 (5%) 0.034 
Low CI  (L/min/m2) 5 (9%) 2 (11%) 0.786 
High SVRI (ds/cm5/m2) 7 (12%) 1 (6%) 0.495 
Low SVRI (ds/cm5/m2) 6 (11%) 9 (56%) <0.001  Data is presented as absolute numbers (%). For cut-offs see Table 5.2 The following abbreviations were applied: CI= cardiac index; SVRI= systemic vascular resistance index 
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 7.3.5 Comparison of electrocardiographic findings in SAM cases and controls  Table 7.9 compares 12-lead ECG features of cases and controls at days 0, 7 and 28. Children with severe malnutrition had a lower heart rate and higher heart rate variability than controls at admission. These differences disappeared over time as heart rate reduced and heart rate variability increased in controls. With the exception of one SAM case that presented in bigeminy, all children were in sinus rhythm. There was no difference in QRS axis at any time point but QRS-T angle was abnormal in a higher proportion of malnourished children. Although there was no difference in the median PR interval at admission, SAM cases tended to have shorter PR intervals at days 7 and 28, although the proportion with an abnormal PR interval was not significantly different. Differences were also observed in the QRS duration and the QTc interval at days 7 and 28.  There was no difference in ST segment changes between malnourished and controls and the differences in repolarization properties, evident in negative T waves in the left precordial leads (V4-V6) was only evident at admission (Table 7.9). Although the number of malnourished children with negative T waves reduced over time, it is of note, that none of the controls had negative T waves in leads V4 to V6 at any time point. Children with malnutrition had significantly lower R/S voltages at admission in all leads (Table 7.10). Differences were more prominent in precordial leads than in limb leads. Although voltages increased over the 28-day observation period, total voltages remained lower in malnourished children as shown in Figure 7.8 (see also Appendix Table 11.11). 
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 Table 7.9 Comparison of 12-lead ECG findings in severely malnourished children (SAM) and controls at admission, day 7 and day 28 
 Admission Day 7 Day 28 
 SAM cases Controls p value SAM cases Controls p value SAM cases Controls p value 
 N=88 N=22  N=83 N=18  N=62 N=19  
Heart rate 132 (120, 142) 141 (127, 156) 0.044 133 (124, 148) 128 (110, 140) 0.059 134 (121, 146) 126 (114,139) 0.074 
HRV 25 (15, 45) 15 (10, 25) 0.048 25 (15, 50) 28 (15, 45) 0.925 30 (20, 45) 40 (20, 60) 0.275 
P-axis 53 (40, 62) 53 (40, 62) 0.544 45 (36, 56) 44 (34, 53) 0.887 45 (36, 56) 49 (37, 53) 0.117 
QRS -axis 66 (35, 86) 57 (37, 77) 0.401 55 (28, 78) 50 (28, 72) 0.804 59 (40, 80) 60 (34, 75) 0.894 
RAD 2 (2%) 0 (0%) 0.475 2 (2%) 0 (0%) 0.509 2 (3%) 0 (0%) 0.428 
LAD 10 (11%) 2 (9%) 0.760 9 (15%) 2 (11%) 0.512 9 (15%) 2 (11%) 0.658 
T-axis 31 (3.5, 54) 40 (25, 51) 0.211 36 (17, 51) 42 (30, 51) 0.281 34 (20, 47) 35 (31, 54) 0.358 
Abn T-axis 20 (23%) 2 (9%) 0.153 7 (8 %) 0 (0%) 0.202 4 (7%) 0 (0%) 0.256 
QRS-T >90° 16 (18%) 0 (0%) 0.031 5 (6%) 0 (0%) 0.285 4 (7%) 0 (0%) 0.256 
PR interval 115 (106, 131) 112 (107, 127) 0.791 109 (102, 125) 132 (121, 134) 0.002 112 (103,127) 125 (117, 131) 0.006 
Short PR 2 (2%) 0 (0%) 0.475 2 (2%) 0 (0%) 0.509 0 (0%) 0 (0%) N/A 
Long PR 14 (16%) 1 (5%) 0.195 5 (6%) 2 (11%) 0.441 2 (3%) 1 (5%) 0.684 
QRS duration 67 (60, 74) 66 (62, 72) 0.958 60 (55, 67) 66 (62, 73) 0.002 60 (56, 66) 64 (61, 73) 0.007 
Short QRS 6 (7%) 1 (5%) 0.698 26 (31%) 0 (0%) 0.006 16 (26%) 1 (5%) 0.086 
Long QRS 3 (3%) 0 (0%) 0.380 0 (0%) 0 (0%) N/A 0 (0%) 0 (0%) N/A 
QTc interval 413 (381, 431) 424 (409,437) 0.051 401 (383, 417) 434 (421, 445) <0.001 417 (403, 430) 430 (417, 444) 0.016 
Short QTc 24 (27%) 1 (5%) 0.023  20 (24%) 0 (0%) 0.020 7 (11%) 1 (5%) 0.441 
Long QTc 3 (3%) 0 (0%) 0.380 0 (0%) 1 (6%) 0.030 1 (2%) 0 (0%) 0.578 
Inverted T V4 20 (23%) 0 (0%) 0.013 8 (9%) 0 (0%) 0.175 10 (16%) 0 (0%) 0.062 
Inverted T V5 17 (19%) 0 (0%) 0.025 4 (5%) 0 (0%) 0.348 3 (5%) 0 (0%) 0.329 
Inverted T V6 13 (15%) 0 (0%) 0.055 3 (4%) 0 (0%) 0.419 3 (5%) 0 (0%) 0.290 
ST depression 8 (9%) 1 (5%) 0.459 2 (2%) 0 (0%) 0.511 1 (2%) 0 (0%) 0.578 
ST elevation 1 (1%) 0 (0%) 0.615 0 (0%) 0 (0%) N/A 5 (8%) 0 (0%) 0.201  Data is presented as medians (IQR) and absolute numbers (%). Cut-offs were derived using definitions by Semizel et al.122 The following abbreviations were used HRV= heart rate variability; RAD= right axis deviation; LAD= left axis deviation
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 Table 7.10 Comparison of mean R/S voltage (mV) and standard deviation in severely malnourished 
children (SAM) controls in all 12 ECG leads at admission 
 
Lead  SAM cases N=88 Controls 
N=22 
p value 
I 0.8 (0.5)  1.0 (0.4) 0.021 
II 1.0 (0.5) 1.1 (0.3) 0.085 
III 0.7 (0.4) 0.8 (0.5) 0.269 
aVR  0.3 (0.3) 0.5 (0.4) 0.085 
aVL 0.6 (0.4) 0.9 (0.4) 0.010 
aVF 0.7 (0.4) 0.8 (0.4) 0.345 
V1 1.5 (0.8) 1.8 (0.6) 0.112 
V2 2.9 (1.0) 3.5 (0.8) 0.018 
V3 3.1 (1.2) 3.7 (0.9) 0.032 
V4 3.1 (1.3) 4.2 (1.1) <0.001 
V5 2.0 (1.0) 3.1 (1.5) <0.001 
V6 1.1 (0.6) 2.1 (1.1) <0.001 
Total Limb 4.0 (1.8) 5.1 (1.2) 0.003 
Total precordial 13.8 (4.7) 18.4 (4.7) <0.001  Data is presented as means and (SD)   
Figure 7.8  Box-and-whisker plots of total voltages in children with severe malnutrition and controls 
at admission, day 7 and day 28 
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7.3.6 Holter findings in malnourished children and controls A total of 55 SAM cases and 18 controls were equipped with a Holter monitor. The median duration of continuous ECG monitoring was lower for controls due to their shorter hospital stays (38 vs. 64 hours, p<0.001). Median hourly minimum and maximum heart rates are summarized in Table 7.11, which shows that malnourished children tended to have higher heart rates than controls.   
Table 7.11  Comparison of median hourly minimum and maximum heart rate (HR) in SAM cases and 
controls 
 SAM cases  
N=55 
Controls 
N=18 
P value 
Median hourly minimum HR 117 (104, 128) 111 (98, 124) < 0.001 
Median hourly maximum HR 145 (133, 159) 137 (124, 151) < 0.001   Table 7.12 compares the frequency of arrhythmias among cases and controls. Commonly found arrhythmias were premature ventricular contractions (PVCs), premature ventricular contractions with an R on T pattern, and self-resolving runs of supraventricular tachycardias. There was no statistical difference for any events in the proportion of children affected or the number of episodes per Holter monitoring day between the groups.  
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 Table 7.12 Comparison of total number of arrhythmias and number of affected malnourished cases 
and controls 
  SAM cases  
N=55 
Controls 
N=18 
p value 
 No. patients 3 (6%) 0 (0%) 0.312 
Bradycardia Total no. episodes 13  0  - 
 No. episodes/day* 0.06  0  0.409 
 No. patients 22 (40%) 4 (22%) 0.172 
SVT Total no. episodes 392  19  - 
 No. episodes/day* 1.4  0.3  0.366 
 No. patients 13 (24%) 3 (17%) 0.535 
Bigemini Total no. episodes 254  7  - 
 No. episodes/day* 0.8  0.1  0.278 
 No. patients 13 (24%) 3 (17%) 0.535 
Trigemini Total no. episodes 5  6  - 
 No. episodes/day* 0.02  0.1  0.071 
 No. patients 33 (60%) 8 (44%) 0.248 
PVC Total no. episodes 1353  746  - 
 No. episodes/day* 5  12  0.133 
 No. patients 23 (42%) 4 (22%) 0.135 
Couplet Total no. episodes 2133  413  - 
 No. episodes/day* 9  7  0.722 
 No. patients 10 (18%) 2 (11%) 0.482 
Triplet Total no. episodes 387  44  - 
 No. episodes/day* 2  1  0.506 
 No. patients 10 (18%) 3 (17%) 0.884 
Salvos Total no. episodes 385  10  - 
 No. episodes/day* 2  0.2  0.333 
 No. patients  30 (55%) 6 (33%) 0.118 
R on T Total no. episodes 3086  943  - 
 No. episodes/day* 14  15  0.920 
 No. patients 7 (13%) 1 (6%) 0.398 
VT Total no. episodes 50  1  - 
 No. episodes/day* 0.2  0.02  0.447 
Significant 
ventricular 
arrhythmias 
 
No. patients 33 (60%) 6 (33%) 0.049 
Total no. episodes 6041  1411   
Mean no. episodes/day* 26  22  0.788 
 * Mean number of episodes per 24 hour period of Holter monitoring  The following abbreviation were used: SVT= supraventricular tachycardia; PVC= premature ventricular contraction; VT= ventricular tachycardia   
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 7.4 Discussion  Although abnormal cardiovascular features have frequently been documented in severe malnutrition 106 63 136 109 110 137, the cardiovascular effects of many of the common comorbidities in these children means it is difficult to know to what extent these are due to malnutrition per se or secondary to other causes of critical illness. Although some previous studies have compared findings in malnourished children with a control group105 107, to our knowledge this is the first study to match controls for comorbidities to control for confounding due to co-existent critical illness, and to study malnourished children over the course of their nutritional rehabilitation and recovery. Therefore while the relatively small number of controls limits the power of some analyses, our results nevertheless represent a significant advance on previous studies. 
7.4.1 Clinical and biochemical profiles  In line with other reports117 110, bedside assessment of vital signs revealed no clinically significant difference in the haemodynamic status of children with malnutrition and controls at any time point. In particular, there was no difference in the proportion of malnourished children presenting with signs of impaired perfusion when compared to equally sick controls.  Whilst a greater proportion of non-malnourished controls had tachypnoea it is unlikely that this is due to congestive cardiac failure in the absence of any other signs such as hepatomegaly or gallop rhythm in the controls. It is more likely that it is due to the more severe spectrum of pneumonia among controls. This difference in severity is probably due to a reduced threshold for hospital admission among severely malnourished cases with pneumonia due to their higher vulnerability compared with non-malnourished children.  We did not demonstrate any statistically significant differences in clinical cardiovascular parameters between malnourished children and controls. In particular we did not find evidence of an association between malnutrition and clinical heart failure, which is in keeping with local clinical experience. While this argues against a major effect of malnutrition as a cause of clinical heart failure we cannot rule out more subtle effects in a study of this size. A small number of SAM cases but no controls did have clinical signs of possible heart failure but this difference was not statistically significant and the clinical significance remains unclear.   
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  Interestingly heart rate in malnourished children remained almost constant throughout the observation period with very little change in the heart rate variability. Loss of heart rate variability, as a measure of autonomic vascular control, has been described in critical illness. Although we were only able to assess heart rate variability across a very short time period, (RR min – RR max over 10 beats) we found that controls appeared to have lost heart rate variability to a greater extend than malnourished children at admission but showed evidence of recovery, whereas the heart rate variability in malnourished children remained relatively static. This was mainly evident in HIV positive malnourished children and in those who died and may be due to an increased sympathetic tone 276 and their degree of failure to recover from acute severe illness. Changes in thyroid function parameters have also been described in critical illness and associated starvation, and it remains unclear whether these might represent adaptive changes of the body to preserve energy by reducing the metabolic activity or malfunction. 277 278 Studies in paediatric intensive care unit settings have demonstrated that low levels of T4 and T3 were a strong predictor of fatal outcome.279 The changes in free thyroxin levels observed in malnourished children in the CAPMAL study could be due to prolonged starvation or critical illness. Reverse T3 levels might have helped to distinguish between secondary hypothyroidism and non-thyroidal illness but were not measured in this study due to limited resources and plasma volume. However, since TSH levels did not tend to be low in malnourished children, it is more likely the alterations in thyroid hormones in malnourished children reflect starvation-induced hypothyroidism. In contrast, TSH levels were significantly lower in controls than in malnourished patients. This could be due to high levels of circulating glucocorticoids during critical illness, which are thought to reduce TSH secretion.280 Although free T4 levels are often low in non-thyroidal illness, 278 low TSH levels have been reported in critically ill children after surgery in the absence of low T3 and T4 levels.281  Reflecting a similar spectrum of critical illness, we observed no difference between cases and controls in markers of tissue hypoperfusion at admission. The higher proportion of malnourished children with acidosis at day 7 was is probably driven by ongoing diarrhoea.  
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 To our knowledge, NT-proBNP has never been measured in malnourished children before, and although raised throughout admission to Day 28, we found that this was also the case in significant numbers of controls. It is well known that NT-proBNP is a good marker of ventricular dysfunction 131 213 but it can also be raised in sepsis and respiratory illnesses.183 216 High levels of brain natriuretic peptide have also been associated with a higher risk of mortality in adults.282 283 In the absence of supporting evidence of significant cardiac failure it therefore seems likely that the high levels observed were due to co-existent infections. However, it remains unclear why NT-proBNP remained raised in both groups despite apparent clinical recovery and normalised renal function.  
7.4.2 Cardiac structure and function  In line with results of most other studies, we found SAM cases had a lower cardiac mass compared to controls, even when adjusted for body size.101 105 107 117 Interestingly a recent study in Egypt and a study in Turkey reported cardiac mass reduction in proportion to the reduced body surface area.100 106 However neither study reported detailed anthropometry on their patient cohort, which makes it difficult to judge how malnourished these children were. In keeping with previous reports,105 107 systolic, diastolic and global parameters of cardiac function, such as fractional shortening, E/A ratio and the Tei Index, showed no difference between malnourished cases and controls. Each of these parameters is defined as a ratio of one cardiac measure to another and does not change with body surface area. Most other measures usually require indexing to allow comparison between individuals of different body size, however, so it is not surprising that significant differences between SAM cases and controls were observed when non-indexed values were used.  Dichotomising our data using normal ranges published for body surface area rather than age, we found no significant differences in the prevalence of abnormal cardiac function indices. Although statistical power is lost by dichotomizing data, it is of much more clinical significance to know how many of the children developed abnormal indices. So far, studies published seemed to report on medians only and failed to emphasize that those were mostly still within the normal range, hence of dubious clinical significance.100 105-107 109 117 Nevertheless, one still needs interpret our results with caution as the 
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 normal ranges used were derived from a healthy population in the developed world, 234 and several reports have shown that chronic malnutrition, evident as stunted growth in childhood can have various effects on the cardiovascular system.284 285 286 Currently there are no reference ranges for echocardiographic or electrocardiographic measurements available for East African children, however, so we believe our analysis represents the best available method to control for confounding due to body size.  To compare measures of long axis function we used a novel approach, expressing the mitral and tricuspid annular plane systolic excursions as proportions of the left ventricular length. This is exactly analogous to the way fractional shortening is used as a measure of short axis function, and might be viewed as ‘longitudinal fractional shortening’.  Using these measures we observed no differences in long axis function between cases and controls. Although there are no reference values for this parameter we believe it is a better index than body surface area in the context of malnutrition for the reasons already discussed.  
7.4.3 Haemodynamic profiles  Median cardiac index, although lower in malnourished children at admission compared to controls, was still within the normal range. Over time we observed an increase in cardiac index among SAM cases during nutritional rehabilitation, which was also reported by El-Sayed, Kothari and others105 107 128, and probably reflects increased metabolic demands during catch up growth. It has been reported, that the metabolic rate remains elevated up to one year after rehabilitation from severe malnutrition. 239  Systemic vascular resistance was higher in malnourished children at all time points. These findings are similar to a 1978 study of severe childhood malnutrition by Viart et al, who examined severely malnourished children and controls over a 60-day period. Others have described increased systemic vascular resistance in adult survivors of childhood malnutrition and suggested this may cause systemic hypertension in later life.284 285 
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 7.4.4 Electrocardiographic findings  Contrary to other reports, we found that malnourished children tended to have shorter PR, QRS and QTc intervals than controls. This only became apparent at day 7, and it is possible that abnormal serum electrolyte concentrations might have masked prior differences.  It is thought that the conduction time relates to muscle mass287 and it therefore seems plausible that intervals are shorter in malnourished children as their cardiac mass is reduced compared to controls.  We did not find any evidence that malnourished children were at higher risk of significant ventricular arrhythmias. However as discussed in chapter 6, despite random assignment to Holter monitoring, the malnourished children that were equipped with Holter monitors were less sick looking at baseline, than those without Holter monitoring. Therefore we cannot exclude the possibility of selection bias having masked an association. However, it seems reassuring that all arrhythmias detected were asymptomatic and self-limiting. 
7.4.5 Conclusions  In summary, while clinical, echocardiographic and electrocardiographic features of cardiac dysfunction were present in some cases of severe malnutrition, we did not find strong evidence in this study that these were more common than in non-malnourished controls matched by presenting clinical syndrome. Although cardiac mass is reduced in malnourished children compared to controls (even when controlling for body size), and some 12 lead ECG changes were more common in SAM (possibly related to electrolyte perturbations, protein status and decreased muscle mass) there was no evidence that these differences were clinically significant in our cohort.  To our knowledge this is the first study that attempts to distinguish the effects on cardiovascular physiology of malnutrition per se from the effects of common comorbidities that cause critical illness in these children. Small numbers of controls limit the power of some analyses and larger studies would no doubt be helpful in the future. However the most important question for many clinicians on the ground is not the exact mechanism but the clinical implications of any cardiovascular dysfunction in severe malnutrition. This is particularly relevant to questions about the effect of intravenous fluids in this group, which we will explore in the next chapter.  
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8 Intravenous fluids in children with severe malnutrition  
8.1 Introduction  The widely held belief that children with severe malnutrition suffer from imminent cardiac failure has influenced WHO guidelines, which strongly discourage the use of intravenous fluids in this group of patients unless they present with all of the following clinical features: weak, fast pulse, cold peripheries and capillary refill time of >3 seconds plus signs of impaired consciousness. The presence of all of these signs would usually constitute a very advanced state of shock, which, in the developed world, would be aggressively fluid resuscitated. Haemodynamic studies in malnutrition are limited, and mostly from the pre-echocardiography era when dye dilution techniques were used to estimate cardiac output but myocardial contractility could not be assessed. However the results of even these studies suggest peripheral vascular collapse rather than cardiac failure.127 128   More recently a study in Bangladesh examined the safety of up to 100ml/kg isotonic intravenous fluids over 6 hours in children with severe malnutrition. This study did not demonstrate any adverse effects of rapid intravenous rehydration among Bangladeshi children with severe malnutrition complicated by cholera, which typically presents with secretory diarrhoea and copious electrolyte and water losses.288   These findings are further supported by a study (Fluids in Malnutrition, FIM trial) from Kenya by Akech et al, in which there were no instances of either pulmonary oedema or heart failure among severely malnourished children in shock who received more rapid volume expansion with isotonic fluid compared to those who received half strength solution (5% dextrose-saline) recommended by WHO.12 63 In this study even a modestly increased volume of isotonic fluid was associated with improvements in physiological parameters including persistent shock, tachycardia, oliguria, severe tachypnoea, and base deficit. Nevertheless the volumes used were still not sufficient to reverse shock in 78% of those children who survived the first 24 hours, suggesting higher volumes may be required. The universal fatal outcome of children who met WHO criteria for shock suggests the WHO guidelines for fluid resuscitation may delay intervention until it is too 
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 late, when shock is already irreversible. Interestingly, in children with kwashiorkor, there were no worse outcomes in those receiving isotonic fluids, including in the sub-group with dehydrating diarrhoea. These findings, coupled with the high overall mortality of 51% across all arms of this study, led to the trial being stopped prematurely due to concerns of withholding internationally accepted treatment recommendations.63 Indeed, prior to the publication of the only controlled trial of fluid resuscitation (FEAST), which was conducted after the FIM trial, it used to be well established that, at least among well nourished children, early aggressive intravenous fluid resuscitation, is associated with better outcomes in both sepsis and severe hypovolaemia. 289 290  However, this notion has recently been thrown into question following the results of the FEAST study. This very large multi-centre, randomised controlled trial examined the effectiveness of fluid resuscitation in African children with severe infection and impaired perfusion.291 Rather surprisingly, FEAST demonstrated that early rapid fluid resuscitation, using protocols similar to those used industrialized nations, was associated with a >40% increase in both early and late mortality.291 Importantly, for generalization, harm was shown across every subgroup, all ages and all severities of shock regardless of aetiology (sepsis, malaria, pneumonia or anaemia). There was no subgroup in whom fluid boluses were shown to be beneficial. As children with severe malnutrition and diarrhoeal illnesses were excluded from FEAST, it remains unclear how generalizable these results might be for these groups. Diarrhoea is common in malnourished children and associated with a high mortality.50-52 Management of severe dehydration and/ or shock in the malnourished child remains a frequent clinical challenge in many settings.  
Chapter aims  In this chapter I aim to explore 1) the effect of fluid resuscitation on cardiovascular physiology among children with severe malnutrition, and  2) whether intravenous fluid therapy is associated with worsening cardiac function, especially when fluid boluses are administered for shock.  To do this I examine the cardiovascular profiles of children who receive intravenous fluid therapy and describe their changes following fluid resuscitation.   
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8.2 Methods  
8.2.1 Clinical definitions and management Clinical definitions are presented in detail in chapter 3, and clinical management followed local protocols based on WHO guidelines, which recommend bolus intravenous fluids for children meeting the WHO definition of shock. Children were assessed and managed by the attending clinician, with whom the final decision to prescribe intravenous fluids rested in each case.  Children requiring intravenous fluid resuscitation were closely monitored on the high dependency unit. A fluid bolus (20ml/kg Ringers Lactate) was given over one hour, and repeated a maximum of two times if the patient still had 2 or more signs of shock and no signs of pulmonary oedema. Vital signs were recorded by nursing staff in half hourly intervals during the first 2 hours, then hourly for the next 6 hours and then 4 hourly until 24 hours post fluid bolus.   The study team also assessed each child before and after every unit of intravenous fluid. Echocardiographic assessment was done pre-fluid bolus, post fluid bolus and 24 hours after the first fluid bolus. Furthermore, available blood samples were analysed for full blood count, electrolytes, blood gas, cytokines and NT-proBNP at the time of shock, as well as 8 and 24 hours post shock.    
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8.3 Results 
8.3.1 Intravenous fluid therapy in children with severe malnutrition  A total of 26 (30%) malnourished patients received intravenous fluids of some point during their admission. Weight for height z-scores were not significantly different in children who received and those who did not receive intravenous fluids at some point   (-3.4 vs. -3.0; p=0.087). However not surprisingly recipients of intravenous fluids were more likely to have signs of impaired perfusion and diarrhoea at admission, and mortality was higher in this group (Table 8.1).  
Table 8.1 Admission characteristics of IV fluid recipients at any point during the course of admission 
versus non-IV fluid recipients   
Category Features at admission 
IV fluids 
N=26 
No IV fluids 
N=62 
 p 
value 
Gender Male 14 (53.9%) 34 (54.8%) 0.932 
SAM Type Kwashiorkor 8 (30.8%) 28 (45.2%) 0.210 
 Tachypnoea  (WHO)a  4 (15.4%) 14 (22.6%) 0.445 
Respiratory Indrawing 1 (3.9%) 4 (6.5%) 0.630 
 Deep breathing  5 (19.2%) 1 (1.6%) 0.003 
 Hypoxia (<95%) 0 (0.0%) 1 (1.6%) 0.515 
 Tachycardia (WHO)b 10 (38.5%) 42 (67.7%) 0.011 
Cardio- Tachycardia (EPLS)c 1 (3.9%) 6 (9.7%) 0.356 
vascular CRT > 2 sec  4 (15.4%) 1 (1.6%) 0.011 
 Weak pulse  5 (19.2%) 0 (0.0%) <0.001 
 Temperature gradientd 5 (19.2%) 1 (1.6%) 0.003 
 Hepatomegalye 4 (15.4%) 11 (17.7%) 0.788 
Neurological Blantyre Coma Score ≤ 4 7 (26.9%) 4 (6.5%) 0.008 
 
Clinical 
diagnosis 
Pneumoniaf 3 (11.5%) 8 (12.9%) 0.860 
Diarrhoea (≥3 stools/24hr) 10 (38.5%) 13 (21.0%) 0.088 
SIRSg 10 (38.5%) 19 (30.7%) 0.477 
HIV 9 (34.6%) 11 (17.7%) 0.085 
Outcome Died 11 (42.3%) 3 (4.8%) <0.001  Data is presented as total number (%) aTachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years b WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years c EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years d Temperature gradient (TG) was assessed by running the back of the hand from the toe to the knee. A positive gradient was defined as a temperature change from cold to warm  h Hepatomegaly was defined as a palpable liver edge ≥ 2cm below the costal margin in the mid-clavicular line. f Pneumonia encompasses mild, moderate and severe pneumonia as defined by WHO  g SIRS and leucocytosis were defined using the criteria by Goldstein et al175 
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 Overall, 26 malnourished patients received intravenous fluid therapy during the 28-day period, some of which had more than one episode of fluid therapy. In total, 45 episodes of intravenous fluid therapy were recorded: 15 episodes of fluid resuscitation for shock, 11 episodes of intravenous rehydration and 19 episodes of maintenance fluids. The proportion of those receiving any kind of intravenous fluid was higher in the marasmic group (Figure 8.1).  
Figure 8.1 Number of episodes and reason of intravenous fluid administration in children with 
marasmus and kwashiorkor 
  There was no clinical or echocardiographic evidence that normal maintenance or rehydration fluids were associated with volume overload and cardiac failure. Physiological responses to bolus IV fluid therapy for shock are considered below.  
Table 8.2 Admission characteristics of severely malnourished children who developed shock at some 
point during admission 
Category Baseline 
characteristics 
No. (%)  
N=12 
Gender Male 6/12 (50%) 
Malnutrition Type Marasmus 9/12 (75%) 
 
Clinical 
diagnosis 
Pneumonia 1/11 (9%) 
Diarrhoea 10/11 (91%) 
SIRS 7/12 (58%) 
HIV positive 5/12 (42%) 
Outcome Overall mortality 7/12 (58%) 
 24 hour mortality* 3/7 (43%) 
* death occurred within 24 hours of bolus fluid resuscitation in 3 of the 7 children who died 
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 Table 8.3 summarizes the clinical and laboratory parameters at the onset of shock. Five (33%) and 8 (53%) fulfilled WHO and EPLS shock criteria, respectively. The aetiology of shock was mixed, however the majority (10, 91%) had diarrhoea. Only 3 children had hypotension suggesting compensated shock in most cases. Most children had deep breathing consistent with underlying metabolic acidosis (see below).   There was no obvious overall trend towards improvement in most bedside physiological parameters following fluid resuscitation (Figure 8.2), but nor is there any obvious evidence of deterioration to suggest a harmful effect of fluids. Most notable is the overall fall in respiratory rate reflecting an improvement in metabolic acidosis (Figure 8.4). However even at 24 hours post fluids 5 (45%) children had persistent tachypnoea and 5 (71%) had a persistent severe acidosis. The fall in serum potassium observed is most likely to be due to partial correction of the metabolic acidosis unmasking pre-existing low body potassium.  None of the children who received IV fluid resuscitation developed clinical signs of pulmonary oedema, nor is there any suggestion of a subtle worsening in hypoxia that might hint at subclinical pulmonary oedema.   Although only a minority of patients had plasma available to retrospectively measure NT-proBNP at the onset of shock, most of those with data (4/5) had raised baseline NT-proBNP levels. Two of these children (C8 and C51) had tachycardia, tachypnoea and hepatomegaly consistent with possible cardiac failure. C8 had a normal IL-6 (6.4 pg/mL) but a marked neutrophil leucocytosis and a low fractional shortening. C51 did not have any echocardiographic features of myocardial dysfunction, but did have a high IL-6 (346 pg/mL) leucocytosis (WBC 34.4) consistent with sepsis. Both the remaining children (C89 and C22) were clinically dehydrated and hypovolaemic due to severe diarrhoea.  The observed increase NT-proBNP levels post fluid resuscitation (Figure 8.3) is consistent with an increase in myocardial stretch due to improved ventricular filling and does not itself imply worsening cardiac failure.  
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 Table 8.3 Bedside observations and laboratory findings in severely malnourished patients with shock 
at onset of fluid resuscitation  
Category Features at time of shock Episodes of shock  =15 
Temperature Fever (>37.5°C) 3/12 (25%) 
Hypothermia (< 35.0°C) 1/13 (8%) 
Tachypnoea  (WHO)a 10/14 (71%) 
Indrawing 0/13 (0%) 
Deep breathing 13/13 (100%) 
Hypoxia (<95%) 1/14 (7%) 
Tachycardia (WHO)b 10/14 (71%) 
Tachycardia (EPLS)c 3/14 (21%) 
CRT > 2 sec 10/14 (71%) 
CRT >3 sec 3/14 (21%) 
Weak pulse  6/13 (46%) 
Bounding pulse 0/13 (0%) 
Temperature gradientd 12/15 (80%) 
Gallop rhythm 0/12 (0%) 
Hepatomegalye 3/15 (20%) 
Neurological Blantyre Coma Score ≤ 4 10/14 (71%) 
 
 
 
 
Laboratory 
Severe hypoalbuminaemia (<15g/L) 2/15 (13%) 
Severe hyponatraemia (<125mmol/L) 3/10 (30%) 
Severe hypokalaemia (<2.5mmol/L) 2/10 (20%) 
Lactate>2 (mmol/L) 5/7 (71%) 
Lactate>3 (mmol/L) 3/7 (43%) 
Severe acidaemia (pH<7.20) 6/13 (46%) 
Base deficit >10mmol/L  11/13 (85%) 
Elevated NT proBNPf 4/5 (80%)   Data is presented as total numbers (%)  a Tachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years b WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years c EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years d was assessed by running the back of the hand from the toe to the knee. A positive gradient was defined as a  temperature change from cold to warm. e was defined as a palpable liver edge >2cm below the costal margin in the mid-clavicular line. fElevated NT-proBNP was defined by Nir 173as >650pg/ml in children up to 12m of age, >400pg/ml in children aged 12m-<24m, >300 in children aged 2y-<6y and >160pg/ml for children >6 y.      
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 Figure 8.2 Box-and-whisker plots of bedside observations in severely malnourished children before 
fluid resuscitation, at one hour and 24 hours after fluid resuscitation 
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 Figure 8.3 Box-and-whisker plots of serial laboratory indices in severely malnourished children before 
fluid resuscitation, at one hour and 24 hours after fluid resuscitation 
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8.3.2 Echocardiographic and haemodynamic profiles of children who received IV fluids for shock Figure 8.4, Figure 8.5 and Figure 8.6 show the overall distributions of systolic and diastolic function and haemodynamic indices before and following IV fluid bolus therapy for shock. The prevalence of abnormal cardiovascular indices at each time point post fluids is summarized in Table 8.4. These overall trends suggest the physiological response to fluids is generally appropriate. Thus, on average, fractional shortening and systolic myocardial velocity appear to increase slightly; and TAPSE reduces consistent with better right ventricular filling, although the number with an abnormally low TAPSE actually reduces Table 8.4. The trend is also towards improved diastolic function, with normalization of the early myocardial relaxation velocity but no abnormal rise in the E/lateral Ea ratio to suggest over filling. Consistent with this, trends in haemodynamic indices post fluids also appear appropriate, with a slight fall in heart rate accompanied by increased stroke volume index and cardiac index, and a fall in systemic vascular resistance index.  
Figure 8.4  Box-and-whisker plots of systolic function indices in severely malnourished children 
before fluid resuscitation, at one hour and 24 hours after fluid resuscitation 
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Figure 8.5 Box-and-whisker plots of different diastolic function indices in severely malnourished 
children before fluid resuscitation, at one hour and 24 hours after fluid resuscitation  
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Figure 8.6 Box-and-whisker plots of haemodynamic indices in severely malnourished children before 
fluid resuscitation, at one hour and 24 hours after fluid resuscitation 
 
 
Table 8.4 Trend of serial abnormal cardiac indices in severely malnourished children following shock 
and subsequent fluid resuscitation over 24 hours 
 Shock 0 Shock 1 Shock 8 Shock 24 Chi2 trend 
Low FS 3/13  (23%) 2/12 (17%) 0/6 (0%) 1/11 (9%) 0.601 
Low MAPSE 1/10 (10%) 0/8 (0%) 1/5 (17%) 2/10 (20%) 0.413 
Low TAPSE 3/10 (30%) 2/8 (25%) 2/7 (29%) 2/11 (18%) 0.890 
Low Sa 1/9 (11%) 0/8 (0%) 0/4 (0%) 0/10 (0%) 0.471 
Low Ea N/A - N/A - N/A - N/A - N/A 
High E/Ea ratio 1/8 (13%) 1/8 (13%) 1/3 (25%) 0/9 (0%) 0.563 
Low CI 4/13 (31%) 3/12 (25%) 2/6 (33%) 0/11 (0%) 0.356 
High SVRI 9/11 (82%) 7/12 (58%) 4/7 (57%) 5/9 (56%) 0.689  Data is presented as total number (%). Cut-offs used can be found in Table 5.1 and Table 5.2. The following abbreviations were applied:  FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic myocardial velocity, E/A= early to late diastolic filling, Ea= early diastolic myocardial velocity, E/Ea= early filling (E) to early diastolic myocardial velocity (Ea) 
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Figure 8.7 Frank Starling diagram of malnourished children pre and post fluid resuscitation 
  Dashed lines indicate patients with decreasing stroke volume index post fluid resuscitation Solid lines indicate patients with improving stroke volume index Triangles indicate patients who died within 24 hours post fluid resuscitation   
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 Examination of the individual cases provides further evidence that the haemodynamic responses to fluids are generally appropriate (Table 8.5 and Figure 8.7). In most cases fluid resuscitation led to a fall in heart rate (HR) accompanied by an increase in left ventricular internal dimensions in diastole (LVIDd) and stroke volume index (SVI), driving an increase in cardiac index (CI; see Table 8.5). Fractional shortening (FS) also increases in most cases. None of the children developed left ventricular dilatation and there were no cases in which increasing LVIDD caused the SVI to fall, suggesting that in all cases fluid volume expansion occurred within the normal physiological range of the Frank Starling curve. In particular fluid response of those who died within the first 24hours of fluid resuscitation appeared appropriate and their SVI and EDV index suggested that they are still on the upward slope of the Frank starling curve (Figure 8.7, triangles).  Even in children with three or more signs of congestive cardiac failure, fractional shortening increased with fluid resuscitation. In those who demonstrated a fall in fractional shortening following a fluid bolus, sepsis may have modified the response to fluids. The concurrent fall in LVIDD however argues against volume induced cardiac failure and supports the view that the initial poor response might have been driven by sepsis. Sepsis probably also modified the response to fluids in C22, C47 and C89. All of these children had some degree of myocardial dysfunction on echocardiography, which may have been explained by the high levels of sepsis related myocardial depressant factors and severe metabolic acidosis observed in each case. C47 also had a very low free T3 that may have further impaired myocardial contractility. This was a 16 month old HIV positive child with diarrhoea, who never properly established feeding and eventually developed shock on day 28. Although the clinical and haemodynamic response to fluid resuscitation was appropriate, with no evidence of fluid overload or pulmonary oedema, the heart eventually failed. In another setting he may have benefitted from inotropic support.   One child required fluid resuscitation for shock on 3 separate occasions. This 6 month old girl had been diagnosed with HIV 2 months previously and started on antiretroviral medication (ARVs). She presented with marasmus, diarrhoea and severe hypovolaemia, hypoglycaemia and severe metabolic acidosis. However she responded well to a combination of IV fluids, glucose and antibiotics. Five days later she deteriorated again, however, this time with neutropaenic sepsis. The effect of IV fluids was unclear at this stage (Table 8.5). The heart rate fell appropriately, but there was a reduction in FS, SV 
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 and CI. A concomitant fall in LVIDd suggested that volume-induced cardiac failure was unlikely but there was global and systolic myocardial dysfunction, presumably caused by sepsis but perhaps also related to HIV. Although she survived this acute episode she failed to respond to nutritional rehabilitation with signs of persisting sepsis despite empiric broad-spectrum antibiotics and antituberculous therapy. She responded appropriately to fluid resuscitation for a third episode of shock on day 17, again accompanied by clinical and biochemical evidence of sepsis, but eventually died 2 days later of overwhelming sepsis.  
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 Table 8.5 Summary of changes in cardiovascular parameters in response to fluid resuscitation for shock  
Patient HR SVI CI FS LVIDD SVR Comments 
C5 ⬇ ⬆ ⬌ ⬌ ⬆ ⬇ Appropriate response to fluids.  
C8 ⬇ ⬆ (⬇) ⬆ (⬇) ⬇ Clinically septic with clinical signs of CCF. Appropriate response to fluids.  
C22 ⬇ ⬇ (⬇) (⬇) ⬇ ⬇ Initially hyperdynamic circulation with abnormally high FS and CI. Appropriate response to fluids.  
C24 ⬇ ⬆ ⬆ ⬆ ⬆ ⬇ Appropriate response to fluids.  
C36 ⬇ ⬆ ⬆ ⬆ ⬌ ⬇ Appropriate response to fluids.  
C37 ⬌ ⬆⬆ ⬆ ⬆ ⬆ ⬇ Severe hypovolaemia and very low LVIDD initially. Appropriate physiological response to fluids, although child died within 24 hours of fluid resuscitation.  
C40 ⬌ ⬆ ⬆ ⬌ ⬆ ⬇ Overall appropriate response to fluids.  
C47 ⬇ ⬆ ⬆ ⬇ ⬆ ⬇ HIV infected child with sepsis and severe hypovolaemia. Appropriate physiologic response to fluids but myocardial contractility impaired and child died within 24 hours despite fluid resuscitation.  
C51 
⬆   
then   
⬇ 
⬇ ⬇ 
⬇    
then    
⬆ 
⬇    
then    
⬆ 
⬇ 
Presented in warm septic shock with myocardial dysfunction. Initial worsening of physiological 
parameters despite fluids but LVIDD not increased and FS recovered with further fluids so initial 
deterioration probably due to sepsis (see main text).  
C70 (⬇) ⬆ ⬆ ⬆ ⬆ - Appropriate physiological response to fluids, although child died within 24 hours of fluid resuscitation.  
C89 (a) ⬆ ⬆ ⬆ ⬌ ⬆⬆⬆ - HIV infected, recently started ARVs. Presented severely hypovolaemic with a hypercontractile cardiac state. Appropriate cardiovascular physiological response to IV fluid resuscitation and rehydration.  
C89 (b) ⬇ ⬇ ⬇ ⬇ ⬇ ⬆ Second episode of shock on day 5 of admission. Better intravascular filling than at admission, but has not responded to nutritional rehabilitation and now has neutropenic sepsis.   
C89 (c) ⬌ ⬆ ⬆ ⬆ ⬆ ⬇ Ongoing diarrhoea and suspected sepsis with high IL-6 (2978 pg/mL). Clinically hypovolaemic. Appropriate physiological response to fluids.  
C90 ⬇ ⬆ ⬆ ⬆ ⬆ ⬆ Overall appropriate response to fluids. Reason for increase in SVRI unclear.  
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 8.3.3 Deaths following intravenous fluid therapy for shock The timing, frequency and type of fluid therapy in relation to time of death is shown in Figure 8.8. Intravenous fluid therapy occurred most commonly in the first 7 days (31/45, 69%), including most IV fluid boluses for shock, yet the majority of deaths occurred after day 7. The relationship of fluid boluses therapy to the eventual cause of death is therefore unlikely. Of the 12 children who received bolus IV fluids for shock, a total of 8 (67%) died, but death only followed within 24 hours of fluid therapy in 3 cases (C37, C47 and C70). All three were severely wasted, two were HIV positive (C37, C47), and the third had kwashiorkor (C70). All responded poorly to standard medical and nutritional management and were investigated for tuberculosis; two of the three were started on empiric antituberculous therapy. None of them showed evidence of cardiac failure clinically, and although it is likely that myocardial failure contributed to the death of C47 as discussed above, fluid overload did not appear to have a role in this. Death in the other two children was most likely a combination of ongoing diarrhoea and sepsis. 
Figure 8.8 Type, timing and frequency of IV fluids and timing of deaths during the 28-day 
observation period 
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8.4 Discussion  Our study is one of very few published studies to describe physiological responses to fluids in children with severe malnutrition. We did not observe any evidence of fluid overload and cardiac failure associated with lower volumes of rehydration and maintenance IV fluids. While clinical outcomes were often poor in the higher risk group receiving bolus IV fluids for shock, with a high mortality, we found only limited evidence that myocardial dysfunction played a role in these deaths, probably driven by sepsis and/or HIV. One child who died of shock might have benefitted from inotropic support, but inotrope therapy cannot safely or reliably be delivered in this and similar low resource settings.  Importantly, we found no evidence that IV fluid bolus therapy caused cardiac failure due to volume overload.  These findings appear to be in contrast with a prospective observational study of severely malnourished children in Uganda, in which both IV fluid therapy and blood transfusions were associated with an increased risk of death even after adjusting for markers of illness severity. 53 However it is unclear in that study how many of the children who died following fluid therapy had signs of fluid overload or cardiac failure. Furthermore, malnutrition severity is not presented, and the effect appears to have been confined to children who did not have either severe anaemia or severe dehydration / hypovolaemia. It is therefore unclear how generalizable these findings would be to our population of severely malnourished children among whom severe hypovolaemia was frequent.  Other studies have concluded that irreversible peripheral rather than cardiogenic circulatory failure associated with severe hypoalbuminaemia appears to be a more common mode of death,137 which occurs despite intravenous fluid therapy, although impaired myocardial contractility could not be excluded during realimentation.127 128 Our results support the findings of Akech’s study in the same hospital, in which there was no evidence that IV fluids caused volume overload or clinical heart failure in severely malnourished children.63 The inclusion of echocardiography 
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 as part of a more detailed assessment of cardiovascular function in the CAPMAL study builds on these results. Both studies concluded that those in shock, who are managed with isotonic fluid boluses have a very high mortality (~60%). In both studies the response to fluid bolus therapy appeared appropriated (with lower numbers in the FIM trial showing shock reversal), and boluses did not appear to cause excess fluid overload events. From the detailed follow up of our children, fatal events occurred many days or hours following fluid boluses, which is different to the FEAST trial, in which peak mortality occurred 6-12 hours post bolus, largely due to cardiovascular collapse.291 292  These findings support further intervention studies combined with detailed physiological assessment to define optimum fluid therapy regimens in severe malnutrition. While the physiological responses to fluid resuscitation do not suggest they are harmful, ultimately this can only be assessed in properly  
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9 Conclusion of the CAPMAL study  
9.1 Introduction  The strengths of the CAPMAL study derive from its detailed prospective assessment of severely malnourished children using a range of complementary assessment tools. Not only is it one of the largest studies of cardiovascular physiology in children with severe malnutrition, it is also the largest to use echocardiography to assess cardiac size and function; the only one to incorporate ambulatory ECG monitoring, serum NT-proBNP measurements and a detailed assessment of response to fluids; and one of very few to systematically study cardiac physiology through nutritional rehabilitation and recovery. Inclusion of an equally sick group of non-malnourished children to control for confounding effects of comorbidities also enabled us to assess the effect of malnutrition per se on cardiovascular function for the first time.   In this final chapter I summarize the results from each of these components of the study, and attempt to synthesize them into a coherent understanding of the cardiovascular physiology in severely malnourished Kenyan children. 
9.2 Physiological adaptations to starvation Some studies have described a “hypocirculatory state” in children with malnutrition with features of low cardiac output which is linearly related with the degree of malnutrition and which they hypothesise, is a physiological response (adaptation) to starvation in order to preserve energy.127 137 Starvation induces a cascade of hormonal alterations, which eventually lead to a reduction in metabolic rate, controlled by the hypothalamic-pituitary-thyroid axis. Consistent with this, we found low free thyroxin levels in many children with severe malnutrition in our study. In the adaptive model, reduced metabolic rate, decreased external work (malnourished children are apathetic and lethargic) and decreased thermogenesis (hypothermia probably occurs secondary to both this and reduced subcutaneous fat) all lead to a reduction in 
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 the oxygen demand of the tissues. Auto-regulation then leads to a reduction in cardiac output, which in turn further preserves energy through minimizing cardiac work. This observation was made in some of our severely malnourished children and is supported by a median cardiac index that tended to be lowest at admission.  The inferior vena cava diameter was narrow and frequently difficult to visualize in SAM children, and median left ventricular internal diameter z-scores were low at admission, suggesting an overall reduction in preload. This may be mediated by the low albumin state in which these children present, which affects plasma oncotic pressure and leads to intravascular fluid depletion, similar to the physiology found in nephrotic syndrome. The reduced preload affects contractility due to suboptimal fibre stretch which results in lower stroke volume and again contributes to low cardiac index.  It has been suggested that marasmus represents the extreme result of adjusting to low calorie intake, whilst features of kwashiorkor such as oedema and fatty liver may represent a failure in some aspects of this adaptation.85  
9.3 Severe acute malnutrition: the effect of comorbidities  The above model is that of stable severe malnutrition.  However, in keeping with reports from many other settings 24 40 69-71, children presenting to Kilifi Hospital with severe acute malnutrition often have an intercurrent illness, and these comorbidities may have direct effects on cardiovascular physiology and carry a high mortality in themselves. In this scenario, the hypothesis of the adaptive model is disturbed. The “adaptation” (minimizing energy expense) fails when metabolic demands are not met due to increased requirements in response to infections (such as pneumonia, sepsis or HIV) or the inability to meet basic calorie needs (ongoing diarrhoea leading to continued electrolyte, nutrient and water loss). Both were common complications in children admitted with SAM in the CAPMAL study (see Chapter 4) Tissue oxygen demand in these critically ill children is increased, yet the oxygen carrying capacity is frequently reduced due to anaemia. The pre-existing 
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 insufficient preload described in the adaptive model, which may be further aggravated by diarrhoea, leads to failure to increase stroke volume and therefore cardiac output is mainly regulated by heart rate. This is consistent with the persistently high heart rate observed among SAM children in our study. Insufficient preload is also suggested by the abnormally low inferior cava (IVC) diameter observed in most children in whom we were able to visualize the IVC; even in the remainder in whom the IVC was not visible this was probably due to profound under filling. Importantly, there was very little change in the IVC diameter over time, and although left ventricular dimensions increased, this was not associated with an overall increase in median stroke volume, probably because a high proportion of malnourished children had not completely recovered from malnutrition by day 28 and their albumin status was still low. In response to the overall picture of reduced intravascular filling, we found that the SVRI is elevated in a high proportion of malnourished children at admission and falls over the course of the study. However, median SVRI remains significantly higher than in non-malnourished controls, which may reflect a compensatory mechanism in the face of incomplete intravascular repletion, or possibly autonomic dysfunction affecting vascular tone. A high SVRI may also have an effect on intestinal perfusion but this was not assessed in our study. Other people have found that SVRI remains elevated in adult survivors of childhood malnutrition and hypothesize that this may contribute to the high prevalence of systemic hypertension in some settings.284 However, low preload was not the only explanation for impaired myocardial contractility in SAM children in our study. Sepsis was almost certainly a major cause in many children, and both IL-6 (a marker of sepsis and a myocardial depressant factor) and HIV demonstrated associations with systolic dysfunction.  Against a background of ‘subclinical’ myocardial impairment, whatever the aetiology, markers of tissue hypoperfusion such as elevated lactate concentrations might indicate that the heart is not entirely able to meet the oxygen demands of the tissue. This suggests the observed myocardial dysfunction may be clinically important even in the absence of obvious clinical signs of cardiac failure.   
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9.4 Synthesizing the evidence for heart failure from each assessment 
modality Overall, although a high number of children demonstrated echocardiographic evidence of cardiac dysfunction, a constellation of clinical features suggestive of cardiac failure was uncommon, rarely associated with elevated NT-proBNP, and not associated with death.  Figure 9.1 shows schematically for each study time point the overlap of clinical features of congestive cardiac failure (CCF) with echocardiographic evidence of cardiac dysfunction and raised NT-proBNP.  There was generally very little 
overlap between the presence of ≥3 clinical features of CCF and increased levels of NT-proBNP. This probably reflects the poor specificity of both clinical signs and serum NT-proBNP levels for cardiac failure. Sepsis is a well-documented cause of elevated NT-proBNP levels,184 216 283 which were commonly raised among children with pneumonia and sepsis in our study in the absence of other features of cardiac failure.  Echocardiographic features of cardiac dysfunction were common, but again rarely associated with clinical features of CCF. There seemed to be more overlap between echocardiographic evidence of dysfunction and NT-proBNP levels, perhaps in keeping with a degree of subclinical cardiac dysfunction. In many cases this improved between day 7 and day 28. Only two children had co-existing clinical, biochemical and echocardiographic evidence of cardiac failure at any of the three set time points (Figure 9.1). One was C87, a 3 year 10 month old boy with culture positive pulmonary TB and pericardial TB who required diuretics and captopril to control his cardiac failure symptoms but went on to make a good recovery on antituberculous therapy.  The second was C65, a 3 year old HIV negative girl admitted with E.coli sepsis, diarrhoea and renal impairment who also made a good nutritional recovery but still had evidence of cardiac failure at day 28.   
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Figure 9.1 Venn diagrams showing the overlap between clinical, biochemical (NT-proBNP) 
and echocardiographic evidence of cardiac failure at admission, Day 7 and Day 28.  
 
1  Clinical signs of CCF defined as a CCF score ≥3 2 Cardiac dysfunction defined as systolic or diastolic or global myocardial dysfunction on echocardiography.   3 Elevated BNP defined according to Nir et al173 
* C87 had culture proven pulmonary TB and pericardial TB.  
 Although there was very little evidence in our study of overt cardiac failure in the 4 weeks following admission, could hypovolaemia have masked underlying ventricular failure?  Hypovolaemia was common, with echocardiographic signs of under-filling (poorly visualized IVC and/or LVIDd z-score < -2) in 45% children at admission, falling to 25% at day 28. This possibility therefore seems plausible, and might have implications for the safety of IV fluid administration in this group.   
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 Reassuringly, despite careful clinical and echocardiographic monitoring, we did not observe any evidence in this study of fluid overload causing cardiac failure or pulmonary oedema in the children who received IV fluid therapy, including bolus IV fluids. Nevertheless the overall outcome of those requiring fluid resuscitation at some point during their admission was poor but seemed to be unrelated to the intervention. 
9.5 Malnutrition, arrhythmias and death Classic heart failure is not the only mechanism by which cardiac dysfunction might affect children with severe malnutrition. Arrhythmias have long been thought to play a role in sudden deaths in malnourished children and major electrolyte shifts during the first week of re-feeding have been postulated as a cause.59 246 However we found only very limited evidence for re-feeding syndrome in our cohort, and Holter recordings did not show that malnourished children were more prone to arrhythmias during the first 7 days of realimentation than matched controls. All observed arrhythmias were self-limiting clinically silent and only identified retrospectively when Holter data was analysed.  Most deaths were anticipated. Only 5/14 (36%) deaths were unexpected (see Table 9.1), all of which appeared to have a non-cardiac cause. Thus, although a high Tei index (a marker of global cardiac dysfunction) was associated with death, its clinical significance is unclear, and the association is likely to be due to the confounding effect of comorbidities such as sepsis. Interestingly, we found an association between reduced heart rate variability and subsequent death, which has not previously been described in children with severe malnutrition. This most likely reflects autonomic dysregulation, and is a marker of poor prognosis in other settings including sepsis, trauma and heart failure.268-270 The inability of severely malnourished children to modify stroke volume due to intravascular depletion was previously discussed and combined with little variation in heart rate this state that has previously been described as “fixed” cardiac adaptation by Apfelbaum et al which was associated with a poor prognosis among malnourished adults.293  
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 Table 9.1 Summary of the causes of death and relationship to IV fluid bolus therapy for the 14 severely malnourished children who died in the CAPMAL 
study 
Study 
No. 
Malnutrition 
syndrome 
Received IV 
fluids for shock 
Died within 24 h  
of IV fluids  
Death expected 
or unexpected Cause of death 
C1 Marasmus No N/A Unexpected Liver failure, diarrhoea, metabolic derangement 
C21 Marasmus No N/A Expected  Respiratory deterioration – confirmed TB 
C31 Kwashiorkor No N/A Unexpected Hypovolaemic shock secondary to diarrhoea 
C63 Kwashiorkor No N/A Unexpected Overwhelming sepsis, underlying cerebral palsy 
C74 Kwashiorkor No N/A Unexpected Presumed sepsis, worsening abdominal distension with sudden drop in Hb 
C75 Kwashiorkor No N/A Unexpected Sudden respiratory deterioration – spontaneous pneumothorax 
C5 Marasmus Yes No Expected Intra-abdominal pathology with worsening abdominal distension 
C24 Marasmus Yes No Expected  Unable to establish enteral feeds Hypovolaemic shock, HIV  
C37 Marasmus Yes Yes Expected Unable to establish enteral feeds, hypovolaemia, HIV  
C47 Marasmus Yes Yes Expected Hypovolaemic shock, HIV, myocardial depression 
C89 Marasmus Yes No Expected Hypovolaemic shock secondary to diarrhoea, underlying HIV, presumed TB 
C90 Marasmus Yes No Expected Hypovolaemic shock secondary to diarrhoea, underlying HIV 
C55 Kwashiorkor Yes No Expected Overwhelming sepsis, hypovolaemic shock 
C70 Kwashiorkor Yes No Expected Hypovolaemic shock secondary to diarrhoea, underlying cerebral palsy 
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 9.6 Comparing cardiovascular function in SAM with non-malnourished controls The above evidence from children with severe acute malnutrition in this study neither suggests that cardiac failure is a major cause of morbidity nor that arrhythmias are a common cause of death. We also compared findings among malnourished children with a control group of non-malnourished children. In matching these controls by clinical syndrome, we aimed to control for the confounding effect of critical illness in order to explore potential associations between cardiovascular parameters and malnutrition per 
se.  Children with malnutrition did have a lower cardiac mass, even when adjusted for body size. They also had a lower cardiac index at admission, and a higher systemic vascular resistance than matched controls. However the clinical significance of these findings is unclear, and both cardiac mass and cardiac index appeared to increase appropriately with nutritional rehabilitation, correction of volume deficits and treatment of the underlying comorbidity. Although Systemic vascular resistance fell, it remained higher than in non-malnourished controls and it would have been interesting to follow these children up for longer. Our study did not provide clear evidence of any other associations between malnutrition and cardiac dysfunction.   
9.7 Study limitations  One of the limitations of the study is the relatively small number of controls enrolled, and the resulting lack of any controls with HIV infection. Nevertheless our study is the first to attempt to match controls by clinical syndrome, and our control group is similar in size to the largest previous studies of cardiovascular physiology with the exception of one echocardiography study from Nigeria that had half the number of malnourished cases.109 Although there are some larger studies, these have not included either invasive or echocardiographic assessment of cardiac function (Table 2.1).      Inclusion of echocardiography presents some challenges, especially as none of the parameters have published reference ranges for this population. This is particularly important in our analyses since body size is so affected by malnutrition. Where possible we used parameters that do not rely on adjusting for body size, such as fractional shortening for short axis function and novel but equivalent measures of longitudinal fractional shortening. For other parameters we stratified the data by body size using the 
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 best available published reference ranges. While not perfect, we believe this represents the best strategy given the available data, and is an advance on previous studies. Importantly, unlike many previous studies, we do not simply report associations of these continuous variables with malnutrition, but rather the proportion of children in or out of the normal range. This allows us to assess the clinical relevance of any differences observed between SAM cases and controls.   In addition to matching our controls by clinical syndrome to explore the effect of malnutrition per se, we also measured serum hormones, cytokines and vitamins to explore potential mechanisms for cardiac dysfunction. Unfortunately we were not able to assay for vitamin B1 (thiamine) deficiency, which is a known cause cardiac failure (‘wet beri beri’)294 295 but has not been studied as a cause for CCF amongst East African children. However all children admitted with SAM receive multivitamins including thiamine.  Another limitation was the need to do NT-proBNP levels on a subset of children rather than all children in the study. However, since our results suggest an elevated NT-proBNP was a very non-specific finding, this may not be a major limitation. In any case this is the first study of children with severe malnutrition to measure NT-proBNP levels.  There are other ways in which our study might have been further strengthened. Although it is the first study of its kind to include Holter data, for logistical reasons we were only able to do continuous ECG monitoring on a subset of patients, and only for the first week of admission. As a result we were only able to capture one of the deaths. With more resources we would ideally have monitored all children throughout their follow up period.  We also limited the period of observation to 28 days for practical reasons. As some children still had a high NT-proBNP and/or echocardiographic evidence of cardiac dysfunction at day 28, and as other data have shown a high post discharge mortality, 296 it would have been interesting and potentially important to follow children up for longer. Post mortem examinations would also have strengthened the study, particularly as this would have allowed correlation with the detailed in vivo data on cardiac structure and function that we collected. However both cultural and logistical barriers prevented their inclusion in this study.  
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 9.8 Conclusions: Implications for clinical practice and future research We have not found evidence that clinical cardiac failure or unexpected deaths are common among Kenyan children admitted to hospital with severe malnutrition. However, there is evidence that some children with SAM have cardiac dysfunction, without any difference in prevalence between children with marasmus and kwashiorkor. In most cases this cardiac dysfunction was associated with comorbidities such as sepsis, diarrhoea, HIV and TB. Furthermore we found no clear evidence in our study that the degree and type of dysfunction was more frequent than in non-malnourished controls.  Importantly, IV fluid resuscitation in children with hypovolaemic shock generally resulted in an expected physiological response and did not precipitate cardiac failure. The number of children receiving IV fluids for shock was relatively small, so the results must therefore be treated with caution. Nevertheless they have important potential implications for clinical practice, suggesting IV fluids may be tolerated better than current guidelines suggest.  Clear descriptions of our cohort and their comorbidities allow a careful assessment of the generalizability of our findings to other contexts. Since the presenting clinical syndromes, HIV prevalence (23%) and case fatality rate (16%) of malnourished children in Kilifi are similar to many other settings in Africa,40 93 we believe the results of the CAPMAL Study are likely to be widely generalizable.  Similar studies in the future might aim to include larger numbers of controls matched for clinical syndrome and illness severity; continuous Holter monitoring of throughout nutritional rehabilitation, recovery and potentially also post-discharge; serial NT-proBNP levels on all patients; and post mortem studies. Perhaps the highest priority should be further observational studies of IV fluid therapy in severe malnutrition, ideally combined with cautious dose-finding studies to define optimum fluid resuscitation regimens in this group and a matched control group. Furthermore it would be interesting to examine the effect of increased SVRI on intestinal perfusion and myocardial wall stress. These studies are urgently needed given the continued unacceptably high mortality of severe malnutrition in Africa.  
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 11 Appendices  
11.1 Supplementary Tables Clinical information and bedside observation  
Table 11.1 Comparison of clinical and laboratory findings between severely malnourished children 
(SAM) and controls on day 7 
Category Feature present at Day 7 SAM cases Controls p value 
 Total number  85  17 N/A 
Temperature Fever (>37.5°C) 9  (11%) 3 (17%) 0.469 
Hypothermia (< 35.0°C) 0 (0.0%) 0 (0%) N/A 
 
Respiratory Findings 
Tachypnoeaa 24 (28%) 7 (39%) 0.373 
Indrawing 1 (1%) 0 (0%) 0.644 
Deep breathing 7 (8%) 0 (0%) 0.207 
Hypoxia (<95%) 4 (5%) 0 (0%) 0.348 
 
 
Cardiovascular 
Findings 
Tachycardia (WHO)b 48 (59%) 6 (38%) 0.116 
Tachycardia (EPLS)c 5 (6%) 0 (0%) 0.291 
Bradycardia (<80/min) 0 (0%) 0 (0%) N/A 
CRT >2 sec 1 (1%) 0 (0%) 0.644 
Weak pulse 1 (1%) 0 (0%) 0.642 
Temperature gradientd 3 (4%) 0 (0%) 0.419 
Hypotensione 6 (7%) 0 (0%) 0.245 
Gallop rhythm 2 (2%) 0 (0%) 0.541 
Hepatomegalyf 19 (22%) 0 (0%) 0.026 
Neck vein distension 2 (2%) 0 (0%) 0.523 
Hydration 
Status 
Decreased skin turgor 0 (0 %) 0 (0%) N/A 
Sunken eyes 4 (5%) 1 (6%) 0.879 
Dry mucous membranes 2 (2%) 0 (0%) 0.511 
Blantyre Coma Score ≤ 4 8 (9%) 0 (0%) 0.175 
Clinical 
Syndromes 
LRTI (WHO)g 6 (7%) 0 (0%) 0.245 
Diarrhoea (>3stools/24hrs) 17 (20%) 1 (6%) 0.143 
SIRSh 27 (32%) 6 (33 %) 0.897 
 
Haematology 
Severe anaemia (<5g/L) 1 (1%) 0 (0%) 0.651 
Moderate anaemia (<9.3g/L) 64 (76%) 11 (65%) 0.323 
Leucocytosish 17 (20%) 3 (17%) 0.745 
Thrombocytopenia (<80.000/mm3) 4 (5%) 1 (6%) 0.879 
Malaria Parasites seen 0 (0.0%) 0 (0%) N/A 
 
 
 
Clinical 
biochemistry 
Hyponatraemia (<125mmol/L) 0 (0%) 0 (0%) N/A 
Hypokalaemia (<2.5mmol/L) 0 (0%) 0 (0%) N/A 
Hypocalcaemia (<2.1mmol/L) 2 (2%) 0 (0%) 0.515 
Hypercalcaemia (>2.6mmol/L) 5 (6%) 1 (6%) 0.973 
Hypomagnesiaemia (<0.75mmol/L)  15 (18%) 0 (0%) 0.056 
Hypophosphataemia (<0.32mmol/L) 6 (8%) 0 (0%) 0.244 
Hyperphosphataemia (>1.78mmol/L) 20 (24%) 4 (24%) 0.940 
Hypoalbuminaemia (<15g/dL) 19 (22%) 0 (0%) 0.026 
Hypercreatininaemia (>74μmol/L) 3 (4%) 0 (0%) 0.420 
Hyperuricaemia (>6.4mmol/L) 4 (5%) 0 (0%) 0.353      
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 Table 11.1 - continued  
Category Feature present at Day 7 SAM cases Controls p value 
Tissue 
hypoperfusion 
markers 
Acidaemia (pH<7.2) 8 (10%) 0 (0%) 0.176 
Base deficit >10mmol/L 25 (33%) 1 (6%) 0.031 
High Lactate (>3mmol/L) 24 (31%) 5 (28%) 0.779 
NT-pro-BNP elevationi 17 (40%) 2 (20%) 0.246 
Data is presented as absolute numbers and proportions (%)  a Tachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years b WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years c EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years d The temperature gradient (TG) was assessed by running the back of the hand from the toe to the knee. A positive gradient was defined as a temperature change from cold to warm. e Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  f Hepatomegaly was defined as a palpable liver edge ≥ 2cm below the costal margin in the mid-clavicular line. g The term pneumonia includes mild, moderate and severe forms as defined by WHO, see Table 4.1 h SIRS and leucocytosis were defined using the criteria by Goldstein et al175 i Elevated NT-proBNP was defined by Nir 173as >650pg/ml in children up to 12m of age, >400pg/ml in children aged 12m-<24m, >300 in children aged 2y-<6y and >160pg/ml for children >6 y.  
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Table 11.2 Comparison of clinical and laboratory findings between severely malnourished children 
(SAM) and controls on day 28  
Category Feature present at Day 28 SAM cases Controls p value 
 Total number 62 17  
Temperature Fever (>37.5°C) 5  (8 %) 1 (5%) 0.686 
Hypothermia (< 35.0°C) 0 (0%) 0 (0%) N/A 
 
Respiratory Findings 
Tachypnoeaa 12 (19%) 5 (30%) 0.371 
Indrawing 1 (2%) 0 (0%) 0.621 
Deep breathing 0 (0%) 0 (0%) 0.122 
Hypoxia (<95%) 2 (4%) 0 (0%) 0.578 
 
 
Cardiovascular 
Findings 
Tachycardia (WHO)b 37 (62%) 8 (47%) 0.284 
Tachycardia (EPLS)c 2 (4%) 0 (0%) 0.428 
Bradycardia (<80/min) 0 (0%) 0 (0%) N/A 
CRT >2 sec 1 (1%) 0 (0%) 0.644 
Weak pulse 0 (0%) 0 (0%) N/A 
Temperature gradientd 0 (0%) 0 (0%) N/A 
Hypotensione 2 (3%) 0 (0%) 0.428 
Gallop rhythm 1 (2%) 0 (0%) 0.585 
Hepatomegalyf 13 (21%) 1 (5%) 0.113 
Neck vein distension 1 (2%) 0 (0%) 0.574 
 
Hydration 
Status 
Decreased skin turgor 0 (0%) 0 (0%) N/A 
Sunken eyes 0 (0%) 0 (0%) N/A 
Dry mucous membranes 0 (0%) 0 (0%) N/A 
Blantyre Coma Score ≤ 4 3 (5%) 0 (0%) 0.329 
Clinical 
Syndromes 
LRTI (WHO)g 2 (3%) 2 (11%) 0.224 
Diarrhoea (>3stools/24hrs) 1 (2%) 0 (0%) 0.578 
SIRSh 16 (26%) 7 (36%) 0.353 
 
Haematology 
Severe anaemia (<5g/L) 1 (1%) 0 (0%) 0.578 
Moderate anaemia (<9.3g/L) 32 (54%) 7 (39%) 0.254 
Leucocytosish 4 (7%) 4 (21%) 0.062 
Thrombocytopenia (<80.000/mm3) 1 (2%) 2 (11%) 0.072 
Malaria Parasites seen 1 (2%) 0 (0%) 0.880 
 
 
 
Clinical  biochemistry 
Hyponatraemia (<125mmol/L) 0 (0%) 0 (0%) N/A 
Hypokalaemia (<2.5mmol/L) 0 (0%) 0 (0%) N/A 
Hypocalcaemia (<2.1mmol/L) 0 (0%) 0 (0%) N/A 
Hypercalcaemia (>2.6mmol/L) 19 (33%) 5 (29%) 0.762 
Hypomagnesiaemia (<0.75mmol/L)  2 (4%) 0 (0%) 0.447 
Hypophosphataemia (<0.32mmol/L) 0 (0%) 0 (0%) N/A 
Hyperphosphataemia (>1.78mmol/L) 25 (44%) 7 (41%) 0.845 
Hypoalbuminaemia (<15g/dL) 0 (0%) 0 (0%) N/A 
Hypercreatininaemia (>74μmol/L) 1 (2%) 0 (0%) 0.582 
Hyperuricaemia (>6.4mmol/L) 2 (4%) 0 (0%) 0.434           
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  Table 11.2  - continued  
Category Feature present at Day 28 SAM cases Controls p value  
Tissue hypoperfusion 
markers 
Acidaemia (pH<7.2) 1 (2%) 1 (7%) 0.310 
Base deficit >10mmol/L 5 (9%) 1 (8%) 0.887 
High Lactate (>3mmol/L) 8 (15%) 6 (35%) 0.064 
NT-pro-BNP elevationi 9 (39%) 4 (44%) 0.783 
Data is presented as absolute numbers and proportions (%)  a Tachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years b WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years c EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years d The temperature gradient (TG) was assessed by running the back of the hand from the toe to the knee. A positive gradient was defined as a temperature change from cold to warm. e Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  f Hepatomegaly was defined as a palpable liver edge ≥ 2cm below the costal margin in the mid-clavicular line. g The term pneumonia includes mild, moderate and severe forms as defined by WHO, see Table 4.1 h SIRS and leucocytosis were defined using the criteria by Goldstein et al175 i Elevated NT-proBNP was defined by Nir 173as >650pg/ml in children up to 12m of age, >400pg/ml in children aged 12m-<24m, >300 in children aged 2y-<6y and >160pg/ml for children >6 y.     
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11.2 Supplementary Tables: Echocardiography   
Table 11.3 Comparison of cardiac dimensions represented as raw values and z-scores between 
children with marasmus and kwashiorkor at admission, day 7 and day 28  
Admission  Marasmus 
N=48 
Kwashiorkor 
N=35 
p value 
 
Systolic 
dimensions 
IVSs (mm) 8 (7, 9) 8 (7, 9) 0.928 
z-IVSs +1.8 (1.0, 2.1) +1.4 (0.9, 2.0) 0.197 
LVIDs (mm) 15 (13, 17) 15 (14, 17) 0.687 
z-LVIDs -0.02 (-0.6, 1.0) -0.02 (-0.8, 0.6) 0.333 
LVPWs (mm) 7 (6, 8) 7 (6, 7) 0.400 
z-LVPWs +0.1 (-0.7, 0.9) -0.6 (-0.9, 0.2) 0.023 
 
Diastolic 
dimensions 
IVSd (mm) 6 (5, 7) 6 (5, 7) 0.7681 
z-IVSd +1.6 (1.0, 2.3) 1.6 (0.8, 1.9) 0.269 
LVIDd (mm) 24 (22, 27) 25 (22, 27) 0.620 
z-LVIDd -0.1 (-1.0, 0.8) -0.3 (-1.3, 0.4) 0.220 
LVPWd (mm) 4 (4, 5) 4 (4, 5) 0.921 
z-LVPWd +1.1 (0.7,1.8) +0.9 (0.5, 1.7) 0.261 
 LV dilatation 3 (6%) 1 (3%) 0.476 
Day 7  N=48 N=34  
 
 
Systolic 
dimensions 
IVSs (mm) 8 (7, 9) 8 (7, 9) 0.854 
z-IVSs +1.8 (1.0, 2.1) +1.7 (0.9, 2.0) 0.376 
LVIDs (mm) 16 (14, 19) 15 (14, 17) 0.213 
z-LVIDs +0.5 (-0.5, 1.5) -0.5 (-1.1, 0.2) 0.003 
LVPWs (mm) 7 (6, 8) 7 (6, 8) 0.700 
z-LVPWs +0.3 (-0.3, 0.8) +0.2 (-0.7, 0.3) 0.194 
 
 
Diastolic 
dimensions 
IVSd (mm) 6 (6, 7) 6 (6, 7) 0.617 
z-IVSd +1.9 (1.1, 2.4) +1.7 (1.3, 2.4) 0.778 
LVIDd (mm) 25 (23, 29) 24 (23, 26) 0.520 
z-LVIDd +0.08 (-0.5, 1.0) -0.5 (-1.3, 0.2) 0.002 
LVPWd (mm) 5 (4, 5) 5 (4, 5) 0.925 
z-LVPWd +1.2 (0.8, 2.0) +1.0 (0.6,1.9) 0.267 
 LV dilatation 6 (13%) 0 (0%) 0.032 
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 Table 11.3 – continued  
  Marasmus Kwashiorkor p value 
Day 28  N=38 N=24  
 
Systolic 
dimensions 
IVSs (mm) 8 (7, 9) 8 (8, 9) 0.457 
z-IVSs +1.6 (1.2, 2.5) +1.6 (1.5, 2.1) 0.963 
LVIDs (mm) 16 (15, 19) 16 (15, 18) 0.895 
z-LVIDs +0.3 (-0.6, 1.0) +0.1 (-0.7, 0.8) 0.422 
LVPWs (mm) 8 (6, 9) 7 (7, 8) 0. 862 
z-LVPWs 0.7 (-0.5, 1.3) +0.3 (-0.2, 0.8) 0.440 
 
 
Diastolic 
dimensions 
IVSd (mm) 7 (6, 8) 7 (7, 7) 0.343 
z-IVSd +1.9 (1.5, 2.5) +2.2 (1.7, 2.4) 0.527 
LVIDd (mm) 26 (23, 29) 26 (24, 28) 0.963 
z-LVIDd 0 (-0.5, 1.0) +0.2 (-0.8, 0.7) 0.547 
LVPWd (mm) 5 (4, 5) 5 (4, 6) 0.527 
z-LVPWd +1.5 (0.9, 2.0) +1.6 (0.7, 2.5) 0.817 
 LV dilatation 4 (11%) 0 (0%) 0.086  Data is presented as medians (IQR), z-scores are presented in italic font.  The folloing abbreviations were used: IVSs=intraventricular septum in systole, IVSd=intraventricular septum in diastole, LVIDs= left ventricular inner diameter in systole, LVIDd= left ventricular inner diameter in diastole, LVPWs=left ventricular posterior wall in systole, LVPWd=left ventricular posterior wall in diastole   
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Figure 11.1 Box-and-whisker plots of z-scores in severely malnourished children and controls of 
cardiac dimensions at admission, day 7 and day 28 
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Table 11.4 Comparison of cardiac function indices between severely malnourished children (SAM) overall and controls and  between children with 
marasmus and kwashiorkor at admission 
Admission SAM cases  
N=83 
Controls 
N=22 
p value Marasmus 
N=48 
Kwashiorkor  
N=35 
p value 
Systolic FS (%) 36 (34,39) 38.5 (31,43) 0.278 36 (34,39) 36 (33,40) 0.732 
EF (%) 68 (65,73) 71 (61,75) 0.495 68.5 (65,73) 68 (64,72) 0.722 
MAPSE 8 (7,10) 10  (9,12) <0.001 13 (11,15) 14 (13,16) 0.123 
TAPSE 14 (12,16) 16 (14,20) <0.001 8 (7,9) 9 (8,10) 0.067 
Sa (cm/s) 5 (5,7) 7 (7,9) <0.001 5 (5,6) 5 (5,7) 0.314 
Diastolic E/A ratio 1.17 (1.06,1.35) 1.18 (1.06,1.27) 0.4738 1.15 (1.08,1.37) 1.18 (1.04,1.35) 0.966 
Ea (cm/s) 11 (9,12) 13 (12,16) <0.001 10 (8,12) 11 (10,13) 0.034 
E/Ea (m/s) 6.78 (5.75,8.29) 7.24 (6.32,8.29) 0.352 7.28 (6.12,8.55) 6.08 (5.09,7.33) 0.020 
Global Tei Index 0.37 (0.26,0.45) 0.36 (0.28,0.42) 0.588 0.38 0.30,0.48 0.30 0.24,0.42 0.118 
 
 
 
Haemodynamics 
SV (ml) 14 (10, 18) 21 (17, 25) <0.001 14 (10, 18) 14 (11, 18) 0.651 
SVI (ml/m2) 39 (29, 45) 37 (32, 48) 0.345 40 (31, 46) 38 (27, 44) 0.444 
CO (l/min) 1.8 (1.5, 2.4) 2.7 (2.2, 3.9) <0.001 1.7 (1.5, 2.3) 1.8 (1.4, 2.5) 0.912 
CI (l/min/m2) 4.9 (3.9, 6.1) 5.5 (4.8, 7.2) 0.047 5.2 (4.1, 6.3) 4.5 (3.8, 6.1) 0.181 
SVR (dyn·s/cm5) 495 (431, 594) 363 (309, 402) <0.001 526 (435, 696) 472 (428, 524) 0.079 
SVRI dyn s/cm 5/m2 1333 (1133, 1752) 676 (622, 911) <0.001 1561 (1274, 1841) 1237 (1040, 1350) 0.002  
Data is presented as medians (IQR) The following abbreviations were used: LV= left ventricular, FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity, E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea), SV= stroke volume, SVI= stroke volume index, CO= cardiac output, CI= cardiac index, SVR= systemic vascular resistance, SVRI= systolic vascular resistance index 
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Table 11.5 Comparison of abnormal cardiac function indices between severely malnourished children (SAM) and controls overall and between children with 
marasmus and kwashiorkor at admission  
Admission 
SAM cases  
N=83 
Controls 
N=22 
p value Marasmus 
N=48 
Kwashiorkor 
N=35 
p value 
High FS 5 (6.0%) 4 (18%) 0.070 4 (8%) 1 (3%) 0.300 
Low FS 6 (7%) 0 (0%) 0.194 4 (8%) 2 (6%) 0649 
High MAPSE 5 (6.2%) 3 (13.6%) 0.246 4 (8%) 1 (3%) 0.357 
Low MAPSE 8 (9.9%) 2 (9.1%) 0.912 5 (10%) 3 (9%) 0.903 
High TAPSE 3 (3.7%) 0 (0.0%) 0.363 3 (6%) 0 (0%) 0.148 
Low TAPSE 3 (3.7%) 0 (0.0%) 0.363 3 (6%) 0 (0%) 0.148 
High Sa 3 (3.9%) 3 (15.8%) 0.053 2 (4%) 1 (3%) 0.748 
Low Sa 1 (1.3%) 0 (0.0%) 0.620 1 (2%) 0 (0%) 0.389 
High E/A ratio 4 (4.9%) 0 (0.0%) 0.288 0 (0%) 0 (0%) N/A 
Low E/A ratio 0 (0.0%) 0 (0.0%) N/A 1 (2%) 2 (66%) 0.384 
High Ea 3 (3.9%) 1 (5.3%) 0.781 2 (4%) 2 (6%) 0.739 
Low Ea 1 (1.3%) 1 (5.3%) 0.273 0 (0%) 1 (3%) 0.240 
High E/Ea 0 (0.0%) 1 (5.3%) 0.042 0 (0%) 0 (0%) N/A 
Low E/Ea 1 (1.3%) 0 (0.0%) 0.620 0 (0%) 1 (3%) 0.240 
High Tei Index 20 (24.4%) 3 (13.6%) 0.281 14 (29%) 6 (18%) 0.231  Data is presented absolute number (%) outside the normal range. The cut-offs used can be found in Table 5.2  The following abbreviations were used: LV= left ventricular, FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity, E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea), SV= stroke volume, SVI= stroke volume index, CO= cardiac output, CI= cardiac index, SVR= systemic vascular resistance, SVRI= systolic vascular resistance index 
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Table 11.6 Comparison of cardiac function indices between severely malnourished children (SAM) and controls and between children with marasmus and 
kwashiorkor at day 7 
Day 7 SAM cases  
N=82 
Controls 
N=18 
p value Marasmus 
N=48 
Kwashiorkor 
N=34 
p value 
Systolic FS (%) 37 (34,41) 36.5 (34,43) 0.532 36 (34,40) 38 (35,42) 0.206 
EF (%) 69 (64,74) 69 (65,75) 0.719 68.5 (64,73) 70.5 (66,74) 0.193 
MAPSE 9 (8,10) 10 (9,11) 0.115 9 (8,10) 9 (9,10) 0.546 
TAPSE 14.5 (13,17) 18.5 (15,21) 0.001 14 (13,16) 15 (13,17) 0.218 
Sa (cm/s) 5 (5,6) 7 (6,8) 0.002 5 (4,6) 0.06 (5,6) 0.261 
Diastolic E/A ratio 1.26 (1.1,1.4) 1.31 (1.2,1.4) 0.151 1.29 (1.1,1.5) 1.18 (1.09,1.33) 0.079 
Ea (cm/s) 11 (9,12) 12 (10,15) 0.031 10 (9,12) 0.11 (9,12) 0.819 
E/Ea (m/s) 7.7 (6.4,9.3) 7.9 (6.2,8.49) 0.724 8.3 (6.9,9.6) 6.78 (5.85,8.29) 0.038 
Global Tei Index 0.31 (0.24,0.42) 0.33 (0.25,0.44) 0.494 0.33 (0.26,0.46) 0.28 (0.19,0.37) 0.039 
Haemodynamic 
 
SV (ml) 15 (12, 19) 25 (21, 30) <0.001 14 (12, 21) 15 (12, 16) 0.854 
SVI (ml/m2) 39 (31, 46) 49 (41, 54) 0.007 40 (32, 49) 38 (30, 42) 0.100 
CO (l/min) 1.97 (1.67, 2.63) 2.82 (2.38, 3.65) 0.001 2.05 (1.63, 2.65) 1.9 (1.72, 2.39) 0.734 
CI (l/min/m2) 5.21 (4.46, 6.32) 5.50 (4.69, 6.83) 0.462 5.27 (4.53, 7.04) 5.02 (4.22, 5.88) 0.075 
SVR (dyn·s/cm5) 442 (365, 513) 355 (299, 451) 0.004 442 (366, 513) 446 (356, 520) 0.974 
SVRI dyn s/cm 5/m2 1093 (932, 1472) 703 (510, 836) <0.001 1112 (953, 1523) 1033 (881, 1331) 0.131 
 Data is presented as medians (IQR) The following abbreviations were used: LV= left ventricular, FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity, E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea), SV= stroke volume, SVI= stroke volume index, CO= cardiac output, CI= cardiac index, SVR= systemic vascular resistance, SVRI= systolic vascular resistance index 
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 Table 11.7 Comparison of abnormal cardiac function indices between severely malnourished children (SAM) and controls and children with marasmus and 
kwashiorkor at day 7  
Day 7 
SAM cases  
N=82 
Controls 
N=21 
p value Marasmus 
N=48 
 Kwashiorkor  
N=34 
p value 
High FS 5 (6%) 2 (11%) 0.450 2 (4%) 3 (9%) 0.385 
Low FS 6 (7%) 0 (0%) 0.100 6 (13%) 0 (0%) 0.032 
High MAPSE 4 (5%) 1 (6%) 0.913 2 (4%) 2 (6%) 0.756 
Low MAPSE 4 (5%) 3 (4%) 0.329 3 (7%) 1 (3%) 0.468 
High TAPSE 2 (3%) 1 (6%) 0.497 2 (5%) 0 (0%) 0.218 
Low TAPSE 3 (3.8%) 1 (6%) 0.726 2 (5%) 1 (3%) 0.743 
High Sa 1 (2%) 0 (0%) 0.599 0 (0%) 1 (4%) 0.255 
Low Sa 1 (2%) 0 (0%) 0.599 0 (0%) 1 (4%) 0.255 
High E/A ratio 0 (0%) 0 (0%) N/A 0 (0%) 0 (0%) N/A 
Low E/A ratio 2 (3%) 1 (6%) 0.511 2 (4%) 0 (0%) 0.364 
High Ea 1 (2%) 0 (0 %) 0.602 1 (3%) 0 (0%) 0.220 
Low Ea 3 (5%) 1 (6%) 0.848 0 (0%) 3 (10%) 0.049 
High E/Ea 2 (3%) 3 (17%) 0.032 0 (0%) 2 (7%) 0.109 
Low E/Ea 0 (0%) 0 (0%) N/A 0 (0%) 0 (0%) N/A 
High Tei Index 17 (21%) 3 (17%) 0.663 23 (27%) 4 (13%) 0.118  Data is presented absolute number (%) outside the normal range. The cut-offs used can be found in Table 5.2  The following abbreviations were used: LV= left ventricular, FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity, E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea), SV= stroke volume, SVI= stroke volume index, CO= cardiac output, CI= cardiac index, SVR= systemic vascular resistance, SVRI= systolic vascular resistance index 
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Table 11.8 Comparison of cardiac function indices between severely malnourished children (SAM) and controls and between children with marasmus and 
kwashiorkor at day 28 
Day 28  SAM cases  
N=59 
Controls 
N=19 
p value Marasmus 
N=35 
Kwashiorkor 
N=24 
p value 
Systolic FS (%) 37 (33, 39) 35 (33, 39) 0.893 36 (32, 39) 37 (34, 39) 0.551 
MAPSE 9 (8, 10) 10 (8, 12) 0.079 9 (8, 10) 10 (8, 10) 0.089 
TAPSE 16 (14, 18) 17 (14, 20) 0.264 16 (14, 18) 16 (13, 19) 0.871 
Sa (cm/s) 6 (5, 7) 7 (5, 9) 0.015 6 (5, 7) 6 (5, 7) 0.348 
Diastolic E/A ratio 1.22 (1.11, 1.38) 1.37 (1.31, 1.55) 0.002 1.24 (1.07, 1.37) 1.2 (1.15, 1.41) 0.769 
Ea (cm/s) 11 (9, 13) 13 (10, 15) 0.057 11 (9, 15) 11 (10, 12) 0.949 
E/Ea (m/s) 7.9 (6.7, 10.1) 7.5 (6.1, 8.2) 0.371 8.4 (6.6, 10.4) 7.5 (6.8, 9.0) 0.573 
Global Tei Index 0.29 (0.23, 0.42) 0.35 (0.31, 0.43) 0.208 0.3 (0.26, 0.43) 0.28 (0.19, 0.42) 0.192 
Haemodynamic 
 
SV (ml) 16 (13, 21) 22 (17, 25) 0.011 16 (12, 21) 16 (13, 21) 0.877 
SVI (ml/m2) 41 (34, 50) 42 (35, 48) 0.811 42 (33, 51) 41 (34, 48) 0.622 
CO (l/min) 2.55 (1.7, 2.87) 2.55 (1.93, 3.05) 0.474 2.45 (1.68, 3.13) 2.29 (1.81, 2.79) 0.835 
CI (l/min/m2) 5.96 (4.43, 6.84) 5.07 (3.86, 5.71) 0.013 6.14 (4.43, 7.13) 5.77 (4.40, 6.41) 0.371 
SVR (dyn·s/cm5) 425 (370, 540) 334 (275, 442) 0.003 442 (384, 563) 414 (369, 472) 0.294 
SVRI dyn s/cm 5/m2 1044 (926, 1443) 674 (495, 944) <0.001 1137 (993, 1491) 1014 (868, 1211) 0.110  Data is presented as medians (IQR)  The following abbreviations were used: LV= left ventricular, FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity, E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea), SV= stroke volume, SVI= stroke volume index, CO= cardiac output, CI= cardiac index, SVR= systemic vascular resistance, SVRI= systolic vascular resistance index 
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Table 11.9 Comparison of abnormal cardiac function indices in severely malnourished children (SAM)and controls and between children with marasmus and 
kwashiorkor at day 28 
Day 28 
SAM cases  
N=59 
Controls 
N=19 
p value Marasmus 
N=35 
 Kwashiorkor  
N=24 
p value 
High FS 2 (3%) 0 (0 %) 0.712 1 (3%) 1 (4%) 0.785 
Low FS 3 (5%) 0 (0 %) 0.316 2 (6%) 1 (4%) 0.790 
High MAPSE 1 (1.8%) 3 (16%) 0.018 0 (0.0%) 1 (4.2%) 0.237 
Low MAPSE 9 (16%) 2 (11%) 0.572 5 (15.2%) 4 (16.7%) 0.877 
High TAPSE 8 (14%) 0 (0 %) 0.084 4 (12.1%) 4 (16.7%) 0.626 
Low TAPSE 0 (0 %) 0 (0 %) N/A 0 (0.0%) 0 (0.0%) N/A 
High Sa 1 (2%) 1 (5%) 0.442 1 (3.1%) 0 (0.0%) 0.413 
Low Sa 1 (2%) 0 (0 %) 0.547 0 (0.0%) 1 (4.8%) 0.213 
High E/A ratio 1 (2%) 0 (0 %) 0.565 0 (0.0%) 1 (4.8%) 0.213 
Low E/A ratio 2 (4%) 0 (0 %) 0.412 2 (5.7%) 0 (0.0%) N/A 
High Ea 0 (0 %) 0 (0 %) N/A 0 (0.0%) 0 (0.0%) 0.243 
Low Ea 2 (4%) 2 (11%) 0.270 0 (0.0%) 2 (9.5%) 0.075 
High E/Ea 5 (9%) 2 (11%) 0.890 3 (9.4%) 2 (9.5%) 0.986 
Low E/Ea 0 (0 %) 0 (0 %) N/A 0 (0.0%) 0 (0.0%) N/A 
High Tei Index 9 (15%) 3 (16%) 0.955 6 (17.1%) 3 (12.5%) 0.626  Data is presented absolute number (%) outside the normal range. The cut-offs used can be found in Table 5.2  The following abbreviations were used: LV= left ventricular, FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity, E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea), SV= stroke volume, SVI= stroke volume index, CO= cardiac output, CI= cardiac index, SVR= systemic vascular resistance, SVRI= systolic vascular resistance index 
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 Table 11.10 Cardiovascular and laboratory parameters of severely malnourished children with low FS at day 7  
 
 274 
 11.3 Supplementary Tables: Electrocardiography    
Table 11.11 Comparison of mean R/S Voltage (microvolt) and standard deviations between children with severe malnutrition (SAM) and controls at 
admission, day 7 and day 28 
Lead Day 0 Day 7 Day 28 
 SAM cases 
N=88 
Controls 
N=22 
p value SAM cases 
N=83 
Controls 
N=18 
p value SAM cases 
N=61 
Controls 
N=19 
p value 
 Mean SD Mean SD  Mean SD Mean SD  Mean SD Mean SD  
I 792 452 1035 351 0.021 886 427 1056 393 0.123 964 381 972 393 0.938 
II 947 493 1138 283 0.085 855 363 1067 234 0.020 929 369 1062 239 0.143 
III 645 402 756 480 0.269 588 347 657 424 0.464 676 583 670 410 0.957 
aVR  322 318 459 377 0.085 374 410 564 430 0.079 349 367 524 446 0.089 
aVL 606 391 853 400 0.01 684 402 833 425 0.160 765 430 758 380 0.951 
aVF 714 444 814 430 0.345 580 352 738 389 0.092 692 359 736 338 0.632 
V1 1491 757 1771 623 0.112 1565 761 1984 842 0.040 1484 577 1869 570 0.013 
V2 2886 1039 3453 749 0.018 2999 1052 3670 870 0.013 3066 911 3813 1010 0.003 
V3 3141 1186 3733 932 0.032 2827 1027 3651 1054 0.003 2881 848 3695 1055 <0.001 
V4 3133 1275 4207 1080 <0.001 2744 1078 3783 1198 <0.001 2933 927 4030 1110 <0.001 
V5 2010 959 3129 1482 <0.001 1869 780 2772 1092 <0.001 2070 822 3019 961 <0.001 
V6 1109 559 2102 1112 <0.001 1063 453 1712 770 <0.001 1293 549 1812 494 <0.001 
Total 1483 496 1954 418 <0.001 1419 400 1874 415 <0.001 1508 323 1913 351 <0.001 
Total limb 671 299 842 197 0.012 661 258 819 202 0.016 729 257 787 184 0.364  Data is presented as means and SD 
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 Table 11.12 Comparison of mean R/S Voltage (microvolt) between children with marasmus and kwashiorkor at day 7 and day 28 follow up 
Lead Day 0 Day 7 Day 28 
 Marasmus 
N=52 
Kwashiorkor 
N=36 
p value Marasmus 
N=50 
Kwashiorkor 
N=33 
p value Marasmus 
N=36 
Kwashiorkor 
N=25 
p value 
 Mean SD Mean SD  Mean SD Mean SD  Mean SD Mean SD  
I 886 (505) 657 (322) 0.018 956 (485) 782 (296) 0.065 936 (354) 1005 (421) 0.489 
II 1091 (530) 739 (345) <0.001 941 (366) 726 (323) 0.007 946 (386) 904 (348) 0.664 
III 751 (434) 494 (293) 0.003 676 (371) 455 (259) 0.003 726 (408) 601 (284) 0.188 
aVR  350 (301) 282 (342) 0.328 365 (405) 386 (425) 0.825 361 (311) 333 (444) 0.773 
aVL 687 (429) 489 (295) 0.019 751 (467) 584 (252) 0.059 757 (455) 778 (397) 0.849 
aVF 837 (473) 536 (329) 0.001 670 (367) 459 (294) 0.009 745 (373) 613 (328) 0.159 
V1 1657 (847) 1252 (528) 0.013 1639 (744) 1454 (784) 0.276 1442 (584) 1546 (574) 0.493 
V2 3126 (1150) 2538 (741) 0.008 3239 (1020) 2739 (1008) 0.009 3049 (1049) 3091 (676) 0.861 
V3 3503 (1289) 2618 (774) <0.001 3087 (1008) 2436 (938) 0.004 2967 (866) 2753 (822) 0.332 
V4 3488 (1380) 2619 (739) <0.001 3046 (1093) 2290 (892) 0.001 3000 (968) 2835 (874) 0.498 
V5 2255 (1097) 1658 (560) 0.004 1993 (778) 1684 (756) 0.074 2018 (872) 2146 (753) 0.552 
V6 1275 (636) 870 (296) <0.001 1155 (466) 924 (402) 0.020 1275 (554) 1319 (552) 0.764 
Total 1659 (533) 1229 (294) <0.001 1542 (377) 1235 (365) <0.001 1519 (344) 1494 (296) 0.790 
Total limb 767 (310) 533 (299) <0.001 725 (264) 565 (219) 0.005 745 (270) 706 (238) 0.558   Data is presented as means and SD 
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 Table 11.13 Comparison of Holter findings between children with marasmus and kwashiorkor 
 
 Marasmus 
N=31 
Kwashiorkor 
N=24 
p value 
Bradycardia 1 (3%) 2 (8%) 0.408 
 Total bradycardias 1  12   
SVT 13 (58%) 9 (38%) 0.739 
Total SVT 230  162   
Bigemini 10 (32%) 3 (13%) 0.085 
Total Bigemini 185  69   
Trigemini 10 (32%) 3 (13%) 0.087 
Total Trigemini 4  1   
PVC 23 (74%) 10 (42%) 0.015 
Total PVCs 752  601   
Couplet 15 (48%) 8 (33%) 0.262 
Total Couplet 1330  803   
Triplet 7 (23%) 3 (13%) 0.336 
Total Triplet 209  178   
Salvos 8 (26%) 2 (8%) 0.096 
Total Salvos 160  225   
R on T 19 (61%) 11 (46%) 0.254 
Total R on T 1744  1342   
VT 4 (13%) 3 (13%) 0.965 
Total VT 48  8   
 
Data is presented as absolute numbers of patients affected (%) and total episodes 
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 11.4 Subgroup Analysis – HIV 
11.4.1 Supplementary tables  
Table 11.14 Comparison of clinical parameter between HIV negative and HIV positive severely 
malnourished children at day 7 
Day 7 HIV negative HIV positive p value 
Tachycardia  (WHO)a 38 (58%) 14 (74%) 0.204 
Tachycardia (EPLS)b 3 (4%) 2 (11%) 0.329 
Bradycardia  0 (0%) 0 (0%) N/A 
Weak pulse 0 (0%) 1 (5%) 0.063 
Temperature gradientc 2 (3%) 1 (5%) 0.642 
CRT >2 sec 1 (2%) 0 (0%) 0.589 
Hypotensiond 2 (3%) 4 (21%) 0.007 
Shock (WHO)e 0 (0%) 0 (0%) N/A 
Shock (EPLS)f 0 (0%) 0 (0%) N/A 
Gallop rhythm 1 (2%) 1 (5%) 0.363 
Neck vein distension 1 (2%) 1 (5%) 0.342 
Hepatomegaly (WHO)g 9 (14%) 10 (53%) <0.001 
Tachypnoeah 13 (20%) 9 (47%) 0.017 
Hypoxia (SpO2<95%) 1 (2%) 3 (16%) 0.010 
 
a WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years b EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years c The temperature gradient (TG) was assessed by running the back of the hand from the toe to the knee. A positive gradient was defined as a temperature change from cold to warm. d Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  e  WHO shock= Lethargy/unconsciousness plus TG plus CRT>3sec plus weak pulse plus tachycardia f EPLS shock= Lethargy/unconsciousness plus TG plus CRT>2sec plus weak pulse plus tachycardia g Hepatomegaly was defined as a palpable liver edge ≥ 2cm below the costal margin in the mid-clavicular line. h Tachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years  
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Table 11.15 Comparison of clinical parameter between HIV negative and HIV positive severely 
malnourished children at day 28 
Day 28 HIV negative HIV positive p value 
Tachycardia  (WHO)a 27 (56%) 11 (79%) 0.131 
Tachycardia (EPLS)b 1 (2%) 1 (7%) 0.346 
Bradycardia  0 (0%) 0 (0%) N/A 
Weak pulse 0 (0%) 0 (0%) N/A 
Temperature gradientc 0 (0%) 0 (0%) N/A 
CRT >2 sec 0 (0%) 0 (0%) N/A 
Hypotensiond 0 (0%) 2 (14%) 0.008 
Shock (WHO)e 0 (0%) 0 (0%) N/A 
Shock (EPLS)f 0 (0%) 0 (0%) N/A 
Gallop rhythm 0 (0%) 1 (7%) 0.065 
Neck vein distension 1 (2%) 0 (0%) 0.582 
Hepatomegaly (WHO)g 7 (15%) 6 (43%) 0.022 
Tachypnoeah 6 (13%) 6 (43%) 0.011 
Hypoxia (SpO2<95%) 1 (2%) 1 (7%) 0.346 
 
a WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years b EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years c The temperature gradient (TG) was assessed by running the back of the hand from the toe to the knee. A positive gradient was defined as a temperature change from cold to warm. d Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  e  WHO shock= Lethargy/unconsciousness plus TG plus CRT>3sec plus weak pulse plus tachycardia f EPLS shock= Lethargy/unconsciousness plus TG plus CRT>2sec plus weak pulse plus tachycardia g Hepatomegaly was defined as a palpable liver edge ≥ 2cm below the costal margin in the mid-clavicular line. h Tachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years 
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 Table 11.16 Comparison of echocardiographic indices between HIV negative and HIV positive 
severely malnourished children at day 7  
Day 7 Parameters HIV –ve HIV +ve p value 
Left ventricular 
mass 
LV mass (g) 26 (20, 34) 33 (23, 43) 0.002 
LVMI1 (g/m
2.7) 57 (46, 69) 64 (55, 78) 0.172 
 LV dilatation 2 (3%) 4 (22%) 0.006 
 
 
Systolic 
Function 
High FS 4 (6%) 1 (6%) 0.913 
Low FS 3 (5%) 3 (17%) 0.085 
High MAPSE 3 (5%) 1 (6%) 0.851 
Low MAPSE 2 (3%) 2 (12%) 0.149 
High TAPSE 2 (3%) 0 (0%) 0.457 
Low TAPSE 1 (2%) 2 (12%) 0.050 
High S prime 1 (2%) 0 (0%) 0.635 
Low S prime 0 (0%) 1 (8%) 0.033 
 
Diastolic 
Function 
Abnormal E/A ratio 1 (2%) 1 (6%) 0.295 
High Ea 1 (2%) 0 (0%) 0.621 
Low Ea 2 (4%) 1 (8%) 0.532 
High E/Ea 2 (4%) 0 (0%) 0.473 
Low E/Ea  0 (0%) 0 (0%) N/A 
Global Function High Tei Index 10 (16%) 7 (37%) 0.057 
 
 
 
Haemodynamic 
Function 
SVI (ml/m2) 37 (30, 44) 45 (39, 53) 0.015 
High SVI 5 (8%) 4 (22%) 0.084 
Low SVI 18 (28%) 4 (22%) 0.618 
CI (l/min/m2) 5.1 (4.3, 6.2) 6.1 (4.9, 7.7) 0.112 
High CI 14 (22%) 6 (32%) 0.254 
Low CI 6 (9%) 0 (0%) 0.190 
SVRI (ds/cm5/ m2) 1112 (932, 1450) 1041 (925, 1548) 0.867 
High SVRI 8 (14%) 3 (19%) 0.603 
Low SVRI 4 (7%) 2 (13%) 0.454 
Other Pericardial effusion 13 (20%) 7 (37%) 0.121  Data is presented as medians (IQR) and absolute number (%) outside the normal range. The cut-offs used can be found in Table 5.2 The following abbreviations were used: LV= left ventricular, FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity, E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea), SV= stroke volume, SVI= stroke volume index, CO= cardiac output, CI= cardiac index, SVR= systemic vascular resistance, SVRI= systolic vascular resistance index 
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Table 11.17 Comparison of echocardiographic indices between HIV negative and HIV positive 
severely malnourished children at day 28  
Day 28 Parameters HIV –ve HIV +ve p value 
Left ventricular 
mass 
LV mass (g) 30 (24, 38) 36 (23, 42) 0.012 
LVMI1 (g/m
2.7) 66 (58, 80) 71 (61, 81) 0.499 
 LV dilatation 2 (4%) 2 (15%) 0.162 
 
 
Systolic 
Function 
High FS 2 (4%) 0 (0%) 0.444 
Low FS 0 (0%) 3 (23%) 0.001 
High MAPSE 1 82%) 0 (0%) 0.602 
Low MAPSE 7 (16%) 2 (17%) 0.925 
High TAPSE 7 (16%) 1 (8%) 0.522 
Low TAPSE 0 (0%) 0 (0%) N/A 
High S prime 1 (3%) 0 (0%) 0.565 
Low S prime 0 (0%) 1 (8%) 0.077 
 
Diastolic 
Function 
Abnormal E/A ratio 2 (4%) 1 (8%) 0.641 
High Ea 0 (0%) 0 (0%) N/A 
Low Ea 1 (3%) 1 (8%) 0.393 
High E/Ea 5 (13%) 0 (0%) 0.180 
Low E/Ea  0 (0%) 0 (0%) N/A 
Global Function High Tei Index 6 (13%) 3 (23%) 0.374 
 
 
 
Haemodynamic 
Function 
SVI (ml/m2) 39 (33, 46) 48 (44, 51) 0.018 
High SVI 6 (13%) 2 (15%) 0.828 
Low SVI 10 (22%) 1 (8%) 0.251 
CI (l/min/m2) 5.5 (4.2, 6.4) 6.6 (6.3, 7.8) 0.007 
High CI 10 (22%) 7 (54%) 0.024 
Low CI 4 (9%) 1 (8%) 0.909 
SVRI (ds/cm5/ m2) 1042 (907, 1410) 1150 (1010, 1443) 0.608 
High SVRI 6 (14%) 1 (8%) 0.566 
Low SVRI 4 (9%) 2 (15%) 0.516 
Other Pericardial effusion 11 (23%) 2 (14%) 0.485 
 Data is presented as medians (IQR) and absolute number (%) outside the normal range. The cut-offs used can be found in Table 5.2 The following abbreviations were used: LV= left ventricular, FS= fractional shortening, MAPSE= mitral annular plane systolic excursion, TAPSE= tricuspid annular plane systolic excursion, Sa= early systolic mitral annular velocity, E/A= early to late diastolic filling, Ea= early diastolic mitral annular velocity, E/Ea= early filling (E) to early diastolic mitral annular velocity (Ea), SV= stroke volume, SVI= stroke volume index, CO= cardiac output, CI= cardiac index, SVR= systemic vascular resistance, SVRI= systolic vascular resistance index 
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 Table 11.18 Comparison of ECG findings between HIV negative and  HIV positive severely 
malnourished children at day 7  
 HIV –ve HIV+ve p value 
Rate Heart Rate 135 (120, 148) 130 (126, 160) 0.752 
Heart rate variability 28 (15, 50) 20 (10, 35) 0.108 
 
 
Axes 
 
P-axis 42 (32, 53) 48 (45, 59) 0.017 
QRS –axis 53 (28, 76) 70 (43, 89) 0.065 
Right axis deviation 1 (2%) 1 (6%) 0.325 
Left axis deviation 9 (14%) 0  0.095 
T-axis 34 (17, 50) 38 (18, 51) 0.703 
Abnormal T-axis 5 (8%) 2 (11%) 0.644 
QRS-T angle >90 1 (2%) 4 (22%) 0.001 
 
 
Intervals 
& 
Durations 
PR interval 109 (102, 123) 118 (106, 134) 0.255 
Short PR  1 (2%) 1 (6%) 0.325 
Long PR  3 (5%) 2 (11%) 0.305 
Mean QRS duration 60 (55, 66) 62 (55, 68) 0.761 
Short QRS  20 (31%) 6 (33%) 0.836 
Long QRS  N/A - N/A - N/A 
Mean QTc interval 401 (387, 417) 395 (369, 429) 0.667 
Short QTc  13 (20%) 7 (39%) 0.104 
Long QTc  0 (0%) 0 (0%) N/A 
ST 
segment 
ST elevation 15 (23%) 4 (21%) 0.877 
ST depression 1 (2%) 1 (5%) 0.342 
 
T waves 
Inverted T V4 5 (8%) 3 (16%) 0.280 
Inverted T V5 2 (3%) 2 (7%) 0.648 
Inverted T V6 1 (2%) 2 (11%) 0.061 
Other Total 12-lead voltages 17 (14, 20) 17 (14, 18) 0.573  
Data is presented as medians (IQR) and absolute numbers (%)              
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Table 11.19 Comparison of ECG findings between HIV negative and HIV positive severely 
malnourished children at day 28 
 
Day 28 HIV –ve HIV+ve p value 
Rate Heart rate 132 (120, 140) 142 (132, 156) 0.020 
Heart rate variability 33 (25, 50) 20 (15, 30) 0.037 
 
 
Axes 
 
P-axis 42 (32, 48) 46 (42, 50) 0.061 
QRS –axis 57 (37, 73) 78 (44, 108) 0.072 
Right axis deviation 1 (2%) 1 (7%) 0.346 
Left axis deviation 9 (18%) 0 (0%) 0.080 
T-axis 34 (20, 46) 32 (22, 51) 0.866 
Abnormal T-axis 2 (4%) 2 (14%) 0.175 
QRS-T angle >90 1 (2%) 3 (21%) 0.010 
 
 
Intervals 
& 
Durations 
PR interval 111 (103, 124) 123 (105, 131) 0.346 
Short PR  N/A - N/A - N/A 
Long PR  1 (2%) 1 (7%) 0.346 
Mean QRS duration 61 (56, 66) 58 (57, 66) 0.573 
Short QRS  11 (23%) 5 (36%) 0.336 
Long QRS  N/A - N/A - N/A 
Mean QTc interval 429 (405, 433) 415 (387, 429) 0.363 
Short QTc  4 (8.3%) 3 (21.4%) 0.188 
Long QTc  1 (2.1%) 0 (0%) 0.586 
ST 
segment 
ST elevation 12 (25%) 3 (21%) 0.784 
ST depression 0 (0%) 1 (7%) 0.062 
 
T waves 
Inverted T V4 7 (15%) 3 (21%) 0.540 
Inverted T V5 2 (4%) 1 (7%) 0.648 
Inverted T V6 2 (4%) 1 (7%) 0.648 
Other Total 12-lead voltages 18 (16, 21) 16 (13, 20) 0.165  
Data is presented as medians (IQR) and absolute numbers (%) 
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11.5 Subgroup Analysis – Survivors vs. Non-survivors  
11.5.1 Supplementary tables  
Table 11.20 Comparison of clinical features of cardiovascular function in survivors and non-survivors 
of severe acute malnutrition 
 
Admission 
Survivors 
(n=74) 
Non-survivors 
(n=14) 
p value 
Heart rate (bpm) 132  (18) 133 (25) 0.858 
BP systolic (mmHg) 91  (13) 85 (15) 0.117 
BP diastolic (mmHg) 64 (13) 59 (14) 0.243 
Pulse pressure (mmHg) 27 (8) 26 (7) 0.441 
Respiratory rate  38 (12) 36 (9) 0.410 
Saturation (%) 99 (1.4) 99 (1.1) 0.236 
Liver (cm) 0.9 (1.5) 0.5 (0.8) 0.340 
      
Day 7 (n=74) (n=11) 
Heart rate (bpm) 134 (19) 139 (20) 0.372 
BP systolic (mmHg) 92 (11) 87 (10) 0.118 
BP diastolic (mmHg) 64 (11) 55 (10) 0.023 
Pulse pressure (mmHg) 29 (8) 31 (12) 0.342 
Respiratory rate  38 (8) 44 (16) 0.035 
Saturation (%) 98 (2.1) 99 (1.1) 0.877 
Liver (cm) 1.3 (1.9) 1.3 (1.6) 0.950  
Data is presented as means (SD) 
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Table 11.21 Comparison of cardiovascular features in survivors and non-survivors of severe acute 
malnutrition at day 7 
Day 7 
Survivors 
(n=74) 
Non-Survivors 
(n=14) 
p value 
Tachycardia  (WHO)a 44 (60%) 8 (73%) 0.400 
Tachycardia (EPLS)s 5 (7%) 0 (0%) 0.374 
Bradycardia  0 (0%) 0 (0%) N/A 
Weak pulse 0 (0%) 1 (9%) 0.010 
Temperature gradientc 2 (3%) 1 (9%) 0.284 
CRT >2 sec 1 (1%) 0 (0%) 0.698 
Hypotensiond 4 (5%) 2 (18%) 0.123 
Shock (WHO)e 0 (0%) 0 (0%) N/A 
Shock (EPLS)f 0 (0%) 0 (0%) N/A 
Gallop rhythm 1 (1%) 1 (10%) 0.098 
Neck vein distension 1 (1%) 1 (10%) 0.114 
Hepatomegaly (WHO)g 17 (23%) 2 (18%) 0.722 
Tachypnoeah 18 (24%) 4 (40%) 0.290 
Hypoxia (SpO2<95%) 4 (5%) 0 (0%) 0.430  Data is presented as absolute numbers (%)  a WHO tachycardia was defined as a HR>160/min in a child <12months and a HR>120/min in children aged 1-5 years b EPLS tachycardia was defined as a HR>180/min in a child <12months and a HR>160/min in children aged 1-5 years c The temperature gradient (TG) was assessed by running the back of the hand from the toe to the knee. A positive gradient was defined as a temperature change from cold to warm. d Paediatric Advanced Life Support (PALS) hypotension was defined as a systolic BP <70mmHg in children <12months, <70mmHg+(2*age in years) in those aged 1-10 years and <90mmHg in children >10years  e  WHO shock= Lethargy/unconsciousness plus TG plus CRT>3sec plus weak pulse plus tachycardia f EPLS shock= Lethargy/unconsciousness plus TG plus CRT>2sec plus weak pulse plus tachycardia g Hepatomegaly was defined as a palpable liver edge ≥ 2cm below the costal margin in the mid-clavicular line. h Tachypnoea was defined as respiratory rate (RR)>= 50/min in children aged 2-11months, RR>=40/min in those aged 1-5 years and RR >=30 in children >5 years 
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 Table 11.22 Comparison of biochemical and haematological indices between survivors and non-
survivors of severe malnutrition at admission and day 7 
 
 Survivors (n=74) Non-survivors (n=14) p value 
Admission Median  (IQR) Median (IQR)  
Hb 8.8 (7.9, 9.9) 9.5 (7.9, 10.0) 0.421 
WBC 13.4 9.5, 16.9) 14.2 (6.9, 15.6) 0.653 
Platelets 374 (235, 590) 318 (139, 433) 0.074 
pH 7.39 (7.32, 7.46) 7.34 (7.30, 7.44) 0.285 
Base deficit -8.1 (-12.1, -5.4) -9.6 (-12.7, -7) 0.370 
K 3.0 (2.4, 3.9) 2.9 (2.1, 3.4) 0.475 
Na 136 (133, 138) 131 (119, 134) 0.004 
IL-6 14 (4, 34) 43 (6, 71) 0.141 
TNF-a 24 (12, 38) 26 (19, 54) 0.632 
IFN-g 5.4 (3, 12) 4 (3, 6) 0.413 
IL-1b 0.47 (0.17, 1.93) 2.21 (1.23, 2.75) 0.055 
NT-proBNP 224 (111, 714) 359 (88, 683) 0.766 
Lactate 2.1 (1.7, 2.6) 2.1 (1.8, 2.9) 0.738 
 
Day 7    
Hb  8.1 (7.0, 9.1) 8.8 (8.1, 9.4) 0.307 
WBC  12.2 (9.7, 15.8) 8.6 (6.4, 11.1) 0.013 
Platelets  460 (276, 641) 249 (110, 298) 0.004 
pH  7.38 (7.33, 7.42) 7.30 (7.27, 7.429 0.420 
Base deficit -6.6 (-10.5,  0.9) -10.7 (-17.4, -4.8) 0.151 
K  4.3 (3.9, 4.8) 3.9 (2.9, 4.4) 0.014 
Na  138 (137, 139) 137 (135, 139) 0.408 
IL-6  5 (3, 12) 33 (16, 362) 0.013 
TNF-a 16 (9, 24) 24 (20, 44) 0.047 
IFN-g 7 (3, 20) 14 (9, 40) 0.097 
IL-1b 0.27 (0.03, 0.81) 1.34 (0.75, 9.0) 0.047 
NT-proBNP 319 (148, 641) 325 (162, 2493) 0.663 
Lactate 2.4 (2.1, 3.1) 3.1 (2.0, 4.3) 0.366  Data is presented as medians (IQR) 
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Table 11.23 Comparison of ECG findings between survivors and non-survivors of severe malnutrition 
at day 7 
Day 7 Survivors 
(n= 74) 
Non-Survivors 
(n=9) 
 
p value 
Rate Heart Rate variability 30 (20, 50) 10 (10, 15) <0.001 
 
 
 
Axis 
P-axis 45 (32, 53) 55 (42, 58) 0.115 
QRS –axis 53 (26, 78) 66 (60, 77) 0.326 
RAD 2 (3%) 0 (0%) 0.618 
LAD 9 (12%) 0 (0%) 0.268 
T-axis 35 (15, 49) 37 (21, 51) 0.408 
Abnormal T-axis 7 (10%) 0 (0%) 0.335 
QRS-T angle >90 5 (7%) 0 (0%) 0.421 
 
 
Intervals 
& 
Durations 
PR interval 110 (102, 127) 109 (105, 115) 0.412 
Short PR  1 (1%) 1 (11%) 0.071 
Long PR  5 (7%) 0 (0%) 0.421 
Mean QRS duration 61 (55, 67) 56 (56, 71) 0.666 
Short QRS  22 (30%) 4 (44%) 0.369 
Long QRS  0 (0%) 0  N/A 
Mean QTc interval 400 (383, 417) 409 (387, 421) 0.500 
Short QTc  0 (0%) 0 (0%) N/A 
Long QTc  0 (0%) 0 (0%) N/A 
ST 
segment 
ST elevation 18 (24%) 1 (9%) 0.258 
ST depression 1 (1%) 1 (9%) 0.114 
 
T wave  
Negative T V4 7 (10%) 1 (10%) 0.969 
Negative T in V5 3 (4%) 1 (9%) 0.462 
Negative T in V6 3 (4%) 0  0.497 
Other Total 12-lead voltages 17 (15, 20) 13 (11, 18) 0.124  Data is presented as absolute numbers (%) 
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 Table 11.24 Final bedside observations, cardiac function measures and electrocardiographic findings in severely malnourished children who died 
 
Study 
No 
HR 
(bpm) 
No CCF 
features 
HIV 
status 
FS 
(%) 
Systolic 
Dysfunction 
Diastolic 
Dysfunction 
High  
Tei Index 
SVI  
(ml/m2/min) 
CI 
(L/m2/min) 
SVRI 
(ds/cm5/m2) 
PR 
(ms) 
QRS 
(ms) 
QTc 
(ms) 
C1 159 2 Negative 33 No No No 15 2.9 1552 121 58 399 
C5 141 2 Negative 39 No No Yes 42 5.8 1136 134 61 386 
C21 141 2 Negative 42 No No No 74 9.6 1450 109 84 387 
C55 124 0 Negative 39 No No Yes 37 4.6 3183 100 66 373 
C63 108 0 Negative - - - - - - - 99 74 424 
C70 140 0 Negative 40 Yes No No 38 4.5 1977 109 72 380 
C74 164 2 Negative 36 No No No 40 5.2 781 105 55 407 
C75 176 3 Negative 45 No No No 37 6.4 2022 114 51 403 
C24 134 1 Positive 34 No Yes Yes 39 4.8 3245 114 70 314 
C31 98 0 Positive 30 No Yes Yes  3.3 1021 133 65 379 
C37 133 1 Positive 45 No No No 63 7.1 913 116 94 240 
C47 154 1 Positive 22 Yes No Yes 21 2.6 3022 88 50 340 
C89 103 0 Positive 40 Yes Yes No 24 2.1 2120 118 64 443 
C90 179 1 Positive 39 No No Yes 32 4.8 3918 74 50 339 
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 11.6 Protocol for systematic literature review  
 
Objective: The objective of this review is to summarize and update the knowledge on the effect of malnutrition on the heart and its function.   
Methods: Ovid Sp will be used to search the following databases: Embase Classic + Embase: 1947 – to date Ovid Medline® 1946 – to date  
Other 
Bibliographies of all relevant articles will be checked for further studies  
Study types 
• Prospective studies, clinical trials, retrospective autopsy studies (all other studies will be excluded)  
Inclusion criteria 
• Children aged 4m -12 years 
• Malnutrition defined as “severe” according to study criteria, including children with marasmus, kwashiorkor and marasmic kwashiorkor   
Exclusion criteria 
• Non-human studies 
• Malnutrition due to a specific micronutrient, trace element or vitamin deficiency 
• Malnutrition secondary to congenital or acquired cardiac disease 
• Malnutrition secondary to specific organ failure such as renal or liver disease  
Assessment tools 
• Non-invasive: Echocardiography, electrocardiography, ultrasonic cardiac output monitor (USCOM), cardio-thoracic ratios,  
• Invasive: Dye dilution technique, 
• Autopsy studies  
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